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Abstract 
Abstract 
Existing estimates of the incidence of infectious intestinal disease (IID) caused by 
norovirus in the community are based on electron microscopy or reverse transcription- 
polymerase chain reaction (RT-PCR). Neither method accurately represents norovirus 
disease burden: electron microscopy has poor diagnostic sensitivity, RT-PCR has poor 
diagnostic specificity. 
In this thesis, for the first time, viral load measurements were used to identify cases of 
norovirus-associated IID, to update the existing, electron microscopy-based estimates 
of norovirus disease burden in the community in England and to conduct a 
comprehensive analysis of risk factors for sporadic norovirus-associated IID. The 
prevalence and characteristics of asymptomatic norovirus infection in England were 
also described. Data for this work were taken from the Study of Infectious Intestinal 
Disease faecal specimen archive, which had been subject to semi-quantitative real- 
time RT-PCR norovirus testing. Finally, routine surveillance data and time-series 
regression modelling were used to produce an additional and independent estimate of 
the incidence of general practice consultations for norovirus-associated IID in England 
and Wales. 
Using viral load for norovirus diagnosis, the age-adjusted community incidence of 
norovirus-associated IID in England was 4.5 per 100 person-years (95% credibility 
interval: 3.8,5.2), equating to 2 million episodes per year between 1993 and 1996. 
Amongst children aged less than five years, the community incidence was 21.4 per 100 
person-years (95% credibility interval: 15.9,27.7) and the incidence of consultations to 
general practitioners for norovirus-associated IID was 3.2 per 100 person-years (95% 
credibility interval: 2.6,3.8), with 100 000 children visiting their GP for norovirus- 
associated IID each year. 
The main risk factor for sporadic, community-acquired norovirus-associated IID was 
contact with a person with IID symptoms. This result indicates that reduction of person- 
to-person transmission would substantially decrease the burden of norovirus- 
associated IID in the community in England, e. g. through good hand hygiene and 
appropriate cleaning of environmental surfaces. 
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Chapter 1 
Chapter 1: Introduction 
Norovirus is the most common cause of both sporadic cases and outbreaks of 
infectious intestinal disease (IID) in high income countries''9. In the past decade, 
electron microscopy, which was used to first identify norovirus as a pathogen in the 
1970s7°, has been replaced by reverse transcription-polymerase chain reaction (RT- 
PCR) as the method of choice for routine diagnosis of norovirus-associated IID'113. 
However, the only existing estimates of the incidence of sporadic norovirus-associated 
IID in the community in England are based on electron microscopy diagnosis8. These 
estimates therefore need to be updated, to reflect the burden of norovirus disease 
identified by the more sensitive RT-PCR diagnostic methods. 
Accurate estimates of norovirus-associated IID incidence in the community are 
essential for understanding the epidemiology and transmission of norovirus, especially 
in relation to the introduction of norovirus into hospitals and other healthcare 
environments, where norovirus outbreaks cause substantial disruption to service 
provision and can worsen patient prognosis7419. If norovirus vaccines are further 
developed, beyond the phase I trials already completed20, estimates of norovirus- 
associated IID incidence in the community will also be essential for planning and 
assessing the effects of vaccination, and indeed of any other public health interventions 
designed to reduce the burden of norovirus infection and disease. 
RT-PCR methods have much higher diagnostic sensitivity than electron microscopy: 
RT-PCR detects many more norovirus infections amongst exposed individuals than 
electron microscopy' -13. However RT-PCR has much poorer diagnostic specificity for 
norovirus-associated IID than electron microscopy: a substantial proportion of healthy 
individuals without IID symptoms, who therefore do not have norovirus-associated IID, 
are positive for norovirus by RT-PCR in population-based surveys5.21-24. If healthy 
individuals are frequently infected with norovirus and positive by RT-PCR, it is possible 
that some individuals with IID, who are norovirus RT-PCR positive at the time of their 
illness, do not actually have disease caused by norovirus; another pathogen, detected 
or undetected, may be the true underlying cause of their illness. Estimates of norovirus 
disease burden should only include individuals with disease caused by norovirus. 
This thesis therefore focuses on the appropriate interpretation of the diagnostic 
methods available for norovirus, to facilitate the production of updated, accurate 
13 
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estimates of norovirus disease burden in England. Specifically, a quantitative approach 
to diagnosing norovirus-associated IID is developed, to replace the current qualitative 
classification of norovirus aetiology using RT-PCR. In this new method, norovirus 
diagnosis will involve consideration of the amount of norovirus being shed by 
individuals with IID, rather than assigning norovirus aetiology based only on detection 
of norovirus in clinical specimens. The new estimates of norovirus-associated IID 
incidence will have important uses in public health action against norovirus infection in 
England, as described above, but the quantitative methods developed for diagnosing 
norovirus-associated IID will have wider relevance to the diagnosis of sporadic disease 
caused by other enteric viruses, respiratory viruses and any other pathogens that are 
found at notable prevalence in healthy individuals in the general population. 
1.1. Aims and objectives 
The aims of the research presented in this thesis were to obtain new estimates of the 
incidence of IID caused by norovirus in England, based on current RT-PCR diagnostic 
methods, and to examine the transmission of norovirus in the community setting. 
Specific objectives of the work were to: 
i. Develop a method for interpreting the results of a semi-quantitative RT-PCR 
assay to diagnose norovirus aetiology in episodes of IID; 
ii. Estimate the incidence of norovirus-associated IID in the community and of 
consultations to general practitioners, through application of this new method 
for interpreting semi-quantitative RT-PCR diagnostic results; 
iii. Estimate the incidence of general practice consultations for norovirus- 
associated IID in England and Wales, using routine surveillance data on 
laboratory diagnoses of gastrointestinal pathogens and general practice 
consultations for IID; 
iv. Investigate risk factors for norovirus-associated IID and asymptomatic norovirus 
infection occurring in the community. 
1.2. Thesis outline 
This thesis contains eight further chapters in which the background to the work is 
described, each of the research objectives is addressed and the results and outputs 
from the work are discussed. 
14 
Chapter 1 
Chapter 2 provides a review of diagnostic methods used for norovirus, current 
estimates of the incidence of disease caused by norovirus globally and in high income 
countries, and the current evidence on routes of norovirus transmission. In addition, an 
overview of other important information about norovirus is presented, including the 
pathogenesis, symptoms, viral shedding and immune response during human 
norovirus infection and a description of norovirus virology, genetic diversity and 
molecular evolution. 
Chapter 3 provides a description of the datasets used for the analyses presented in 
subsequent chapters. The majority of the work is based on the Study of Infectious 
Intestinal Disease in England. Additional datasets from routine surveillance of 
gastrointestinal pathogen laboratory diagnoses and of general practice consultations 
for IID in England and Wales are also described, which are Used in Chapter 7. 
In Chapter 4, norovirus faecal viral load measurements from individuals with IID and 
healthy individuals are compared, to develop a quantitative method for accurately 
diagnosing norovirus-associated IID. 
In Chapter 5, cases of norovirus-associated IID are identified using the new 
quantitative diagnostic method developed in Chapter 4. The characteristics of 
norovirus-associated IID cases and healthy individuals with norovirus infection are 
described, the prevalence of mixed pathogen infections in these two groups is 
presented and the significance of these mixed infections is investigated. 
In Chapter 6, risk factors for norovirus-associated IID (defined using the quantitative 
diagnostic method developed in Chapter 4) and for asymptomatic norovirus infection 
are investigated, using multivariable logistic regression. 
In Chapter 7, time-series adapted Poisson regression is used to estimate the incidence 
of general practice consultations for norovirus-associated IID in England and Wales, 
based on routine surveillance data on gastrointestinal pathogen laboratory diagnoses 
and general practice consultations for IID. This statistical modelling provides a 
completely independent estimate of general practice consultations caused by 
norovirus, for comparison to the direct estimate provided in Chapter 8. 
In Chapter 8, the quantitative approach to norovirus-associated IID diagnosis is used to 
generate updated and accurate estimates of the incidence of IID caused by norovirus 
in the community and leading to general practice consultations in England, based on 
data from the Study of Infectious Intestinal Disease. 
15 
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In the final chapter, the results from all of the presented analyses are summarised and 
discussed, with consideration of the limitations of the work and recommendations for 
future research and practice in the diagnosis of norovirus-associated IID and estimation 
of norovirus disease burden. 
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Chapter 2: Review of methods for norovirus diagnosis, 
estimates of norovirus disease burden and current 
evidence on norovirus transmission routes 
2.1. The global burden of infectious intestinal disease 
Infectious intestinal disease (IID) is a major cause of morbidity and mortality 
worldwide25. In low and middle income countries III) is among the ten most important 
causes of mortality and disability adjusted life years (DALYs)25. The great majority of 
IID deaths in these countries occur in children aged less than five years, with current 
estimates of between 1.87 and 2.5 million deaths per year globally in this age group26' 
Z'. Whilst the large loss of DALYs is mostly due to the high infant and child mortality 
attributable to IID28, there is also evidence that frequent IID episodes in early life can 
lead to impaired growth and development27. 
In high income countries, IID is not a major cause of mortality or DALYs29, but still 
represents a significant disease burden, with incidence estimates ranging from 194 to 
800 episodes per 1000 person years in prospective cohort studies5- 6,8 , and up to 
1400 
episodes per 1000 person years in retrospective surveys30_33 This disease burden is 
associated with substantial economic costs from healthcare service utilisation and loss 
of economic prod uctivity30.34-36 In addition to the burden of illness in the general 
population, particular gastrointestinal pathogens, such as Listeria spp., Clostridium 
difcile and norovirus, also have a substantial impact on populations in health and long- 
term care facilitieS14" 16,37-42 
Population-based studies show that enteric viruses are amongst the most common 
causes of sporadic IID across all ages in the community in high income countries5"8 16, 
and they are also associated with a significant proportion of more severe IID cases 
presenting to primary care services8'22,43 and hospital emergency services 44-46 
Rotavirus in particular is associated with severe childhood gastroenteritis and is the 
leading cause of general practice and hospital visits for IID amongst children aged less 
than five years in high income countries43'47-52 Astrovirus, Sapovirus and Adenovirus 
types 40 and 41 cause milder, predominantly paediatric IID53. In contrast to these other 
viruses, humans do not develop long-lasting protective immunity after norovirus 
infection 53-57 , meaning that older children and adults experience repeated symptomatic 
infections throughout life. Norovirus is therefore the most common viral cause of 
sporadic community-acquired 1113 in high income countries, in addition to being the 
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most frequently reported causative pathogen in IID outbreaks in a range of settings2,14, 
38,40 
2.2. Norovirus-associated III) characteristics and immunity 
2.2.1. Pathogenesis 
Knowledge of the pathogenesis of norovirus infection comes mainly from adult 
volunteer studies58"81. These volunteer studies demonstrated cellular and structural 
abnormalities in the proximal small intestine (the jejunum) during symptomatic 
norovirus infection58-6'. These histological changes were predominantly present in 
symptomatic volunteers, although a small number of volunteers who remained 
asymptomatic after inoculation developed similar jejunal lesions5s, 60 The lesions were 
present during incubation, acute illness and for a limited number of days after symptom 
resolution59,60, but convalescent biopsies taken at two weeks post-inoculation showed 
normal histology58,61,62 Studies of experimentally inoculated gnotobiotic calves and 
pigs found similar histopathological changes and, importantly, demonstrated 
localisation of norovirus antigen to the affected areas of the jejunum and duodenum, 
but with very little norovirus detected in more distal parts of the intestine (ileum and 
colon)63' 64. A more recent study of individuals presenting to hospital with IID, and 
diagnosed with norovirus infection, indicated that similar damage occurs in the 
epithelium of the duodenum (which joins the stomach and jejunum), with increased cell 
apoptosis in the areas of the epithelium covered by these lesions65. However, a major 
disadvantage of studying natural norovirus infection is the lack of documentation of pre- 
infection intestinal physiology in participants and uncertainty over the microbiological 
aetiology of the IID. 
Whilst delayed gastric emptying, which has been documented in norovirus-inoculated 
volunteers who develop symptomatic infection, may contribute to the vomiting 
mechanism in norovirus-associated IID66, the biochemical pathways leading to 
diarrhoea and vomiting have not been identified67. However, the existing 
histopathological evidence from the volunteer and animal studies, and the lack of any 
readily identifiable secretory toxin genes in the norovirus genome6e, indicate that viral 
replication probably plays a significant role in the pathogenesis of norovirus disease. 
2.2.2. Symptom profile 
Norovirus-associated IID was first described as'winter vomiting disease' by Zahorsky, 
in 192969. When outbreaks of norovirus-associated IID were first investigated in the late 
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1960s and 1970s70, the high prevalence of vomiting amongst cases was a key 
epidemiological characteristic used to attribute outbreaks to norovirus, in the absence 
of any routinely available microbiological diagnostic tests (the Kaplan criteria)62. 
Subsequently, identification and isolation of norovirus from stool specimens collected 
during outbreaks facilitated a number of volunteer inoculation studies, which examined 
the infectiousness, pathogenesis and disease syndrome of norovirus infection 58-60,71 , 
in 
addition to many more volunteer studies investigating the immune response to 
norovirus and the degree of immunological cross-protection between norovirus isolates 
56,72-79 
The volunteer studies, during which otherwise healthy adults were experimentally 
inoculated with norovirus isolated from outbreak stool specimens, confirmed the 
symptom profile reported in the early outbreak investigations. Volunteers who became 
infected and symptomatic after inoculation developed a range of symptoms, 
predominantly diarrhoea and vomiting, or vomiting without diarrhoea, and, in addition, 
headache, nausea, muscle ache, fever and chills, abdominal pain, and loss of 
appetite 58-60.75.80 81. The incubation period of experimental norovirus infection ranged 
from 10 to 48 hours and symptoms lasted between 16 and 48 hours 58-6D. 75.79 A number 
of the volunteers did not develop diarrhoea or vomiting after inoculation, although some 
were shown to be infected by the detection of norovirus in their stools and of a 
norovirus-specific serum antibody response 56,75.77$0.82 These norovirus-infected 
volunteers with no diarrhoea or vomiting did report other symptoms, including 
abdominal pain, nausea and some non-gastrointestinal symptoms such as headache, 
fever and muscle ache. 
The characteristics of natural norovirus infection have been studied in both sporadic 
community cases, ascertained during prospective research studies, and also in cases 
identified during norovirus outbreak investigations. The reported prevalence of 
diarrhoea amongst sporadic community cases is high, at 70% or more, with some 
indication that diarrhoea might be slightly more common in adult cases compared to 
child cases? 83,84. The converse pattern has been reported for vomiting during 
norovirus-associated IID; whilst the prevalence is high, at 60% or more7,83.84 , vomiting 
is more frequently reported in child cases compared to adult cases 133,84 . The average 
symptom duration in adult community cases matches that observed in the volunteer 
studies (two days) but longer symptom duration has been reported in child community 
cases (median up to six days) 83,84 The prevalence of fever in community cases 
ranges from 30 to 70%, although differences in the definition of fever and the way in 
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which information about this symptom is captured in epidemiological questionnaires 
may account for some of the variability between studies? 83"85. Muscle ache, headache, 
abdominal pain and nausea have also been reported by community cases. A number 
of studies have reported disease severity comparable to rotavirus-associated IID 
amongst children presenting to hospital emergency services with norovirus-associated 
IID8 8, with a few reports of more severe manifestations of infection such as 
encephalopathy, seizures and viraemia89-91. Descriptions of symptoms in the elderly 
come mainly from norovirus outbreaks in hospitals and nursing homes. In the elderly, 
symptoms tend to last longer than amongst younger adults, with the median duration at 
3 days92,93, and the prevalence of vomiting is lower. Hospitalisations (amongst nursing 
home residents) and deaths are occasionally reported from norovirus outbreaks in 
15 elderly populations19. 
The incubation period of norovirus after natural infection has been estimated in a small 
number of point-source foodborne outbreaks, with estimates mostly towards the upper 
range of that reported in the volunteer studies (median incubation approximately 36 
hours, ranging from 2 to 61 hours)85' 94-98 However, it is possible that the biology of 
experimental inoculation and foodborne outbreaks may differ from sporadic infection 
acquired by direct person-to-person transmission, if the size of the inoculum is 
significantly different97; a recent volunteer study has demonstrated that the probability 
of developing illness after norovirus infection may increase with the size of the infecting 
dose98. 
Current evidence indicates that norovirus-associated IID is a largely mild and self- 
limiting illness in otherwise healthy adults in the community, with some slight 
differences in clinical manifestation in children and the elderly. However, amongst 
children and the elderly, the duration of symptoms is longer and disease may be more 
severe, with some serious clinical outcomes reported. 
2.2.3. Viral shedding 
Faecal norovirus shedding peaks at or just prior to the onset of symptoms in 
experimentally inoculated volunteers75,80,99. Peak viral loads of between 1010 and 10" 
viral genomes per gram of stool, measured by quantitative real-time RT-PCR, have 
been reported in both experimentally inoculated and naturally infected individualsBO. 100* 
102. Faecal norovirus load remains at this high level throughout the duration of 
symptomatic illness and then begins to decrease at, or just after, resolution of 
1os symptoms8o, 99, , returning to levels seen in asymptomatically infected individuals 
by 
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five to 12 days after symptom onset80 (Figure 2.1). In the one volunteer study that has 
systematically measured the duration of norovirus shedding detectable by RT-PCR, 
volunteers shed norovirus for between 7 and 54 days after symptom resolution. 
Although this volunteer study was not specifically designed to examine the relationship 
between the inoculum dose and the duration of viral shedding, there was no apparent 
correlation between them8o 
In studies of norovirus shedding during and after naturally acquired norovirus- 
associated IID, specimen collection is not as regular or comprehensive as in volunteer 
studies, with study participants dropping out or sampling finishing before norovirus 
shedding has stopped. Despite these limitations, the studies of natural norovirus 
infections indicate that shedding frequently lasts for at least one or two weeks after 
symptom resolution, in norovirus cases of all agesea, toe-ßo7, with a tendency for longer 
shedding in young children (both in the community and those presenting to hospital 
emergency services) and the elderly 84,104.106-108 One study has provided limited 
evidence that symptoms may last longer in individuals who have higher viral loads 
during acute illness102. A single study has reported differences in viral load between 
natural infections with norovirus genogroup I and genogroup II10°, but this is not 
consistent with other published comparisons of viral load between the genogroups'09, 
110, and may be due to differences between the genogroups in the efficiency of 
amplification in the real-time reverse transcription-polymerase chain reaction assay, 
rather than a difference in actual underlying faecal norovirus load (Gray, J. personal 
communication, 2009). 
A substantial prevalence of asymptomatic norovirus shedding has been reported 
amongst otherwise healthy individuals in a number of population-based studies, 
ranging from 5% to 16%5,21.24. Although one study, conducted in Australia, failed to 
identify any asymptomatic norovirus infections in a sample of healthy controls, the 
number of samples tested was substantially smaller than in the other population-based 
studies that reported asymptomatic norovirus infection prevalence and samples were 
only tested during two months that are known to be a time of low norovirus activity in 
Australia"1'113. 
Only a few studies have systematically compared viral load in asymptomatic norovirus 
infections and cases of norovirus-associated IID: one volunteer study and one study of 
paediatric IID cases with a healthy control groupu, 80 Whilst the case definition for 
norovirus-associated IID in the volunteer study was particularly strict and the doses of 
norovirus ingested by some of the volunteers much higher than might normally be 
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expected to be encountered during natural transmission, the study did demonstrate 
that volunteers who did not meet the case definition generally shed norovirus at lower 
concentrations than those with clinical gastroenteritis and for slightly shorter duration 
(Figure 2.1), although shedding lasted up to four weeks80. The study of norovirus 
infection in paediatric IID cases and healthy age-matched controls also showed that the 
viral load was significantly higher in children with IID symptoms and norovirus infection; 
compared to the healthy controls with norovirus infection. Interestingly, the norovirus 
viral load was much lower in IID cases with a concurrent rotavirus infection compared 
to those with only norovirus infection24. A recent analysis of viral loads detected. in food 
handlers who provided stool specimens during investigations of foodborne norovirus 
outbreaks, indicated that viral loads may be similar in symptomatic and asymptomatic 
food handlers' 4, although the study compared mean viral loads rather than median 
viral loads and it did not take account of delays in specimen collection from 
symptomatic food handlers. 
Current evidence indicates that asymptomatic norovirus infection is relatively common 
in the general population in high income countries and that higher concentrations of 
norovirus are shed during symptomatic norovirus infection. However, viral shedding in 
symptomatically infected individuals decreases after symptom resolution and returns to 
levels found in asymptomatic individuals within a week of symptom onset in most 
cases. 
2.2.4. Immunity and resistance to norovirus infection and disease 
Early studies of norovirus outbreaks and volunteer inoculation experiments 
demonstrated a lack of correlation between the occurrence of clinical symptoms after 
exposure to norovirus and pre-existing total serum and IgG anti-norovirus antibody 
levels54"72.15. The volunteer studies showed that short-term immunity to the same 
norovirus strain was generated after initial infection and protected against clinical 
illness. However, volunteers became ill again when re-challenged with the same 
inoculum two or more years after their initial infection 54,56 . Subsequent volunteer 
studies showed that short-term, strain-specific, protective immunity against 
symptomatic norovirus infection probably only lasts up to six months77. Although 
repeated experimental challenge and infection with the same strain led to longer-lasting 
protective immunity in inoculated volunteers77, it is unknown whether the required 
frequency of homotypic re-exposure occurs naturally in the general population. 
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A potential mechanism for the homotypic sterilising immunity observed in the volunteer 
studies comes from the demonstration that strain-specific antibodies block genetically 
homologous norovirus virus-like particles (VLPs) from binding to the human cell 
receptors involved in norovirus host cell entry 116.117 . Whilst 
immunologic cross- 
reactivity between norovirus strains has also been reported 82,118-122 , only the 
IgG 
antibody subclass are strongly cross-reactive and do not bind to the receptor binding 
domain in the norovirus surface protein 120. These cross-reactive IgG antibodies are 
therefore unlikely to provide sterilising immunity, which explains the lack of correlation 
between existing serum anti-norovirus IgG titres and subsequent protection against 
symptomatic infection also observed in the volunteer studies54' 72. »5 Secretory IgA, 
which is directly involved in mucosal immunity, and IgM show significantly less cross- 
reactivity between norovirus strainse2.120' 
123' 124 
In vitro studies of receptor binding by norovirus VLPs and anti-norovirus antibodies 
indicate that cross-protective immunity only exists between very closely related strains 
in genogroup I, with no neutralising cross-reactivity observed between strains in 
genogroup 11125-127. The protective components of acquired-immunity after norovirus 
infection therefore appear to be mostly strain specific, indicating that norovirus strains 
represent a large population of immunologically distinct viruses. Infection with one of 
the many other co-circulating norovirus strains can still occur after development of an 
immune response during a current infection. This is in contrast to the other enteric 
viruses, which induce long-lasting, cross-protective, sterilising immunity after one or 
rs two initial infections in early life, ss,, ze 
Characterisation of immune responses in experimentally inoculated volunteers has 
shown that an antibody response develops at five days after infection, with the IgA and 
1gM antibody subcomponents peaking at approximately 14 days54.73,74'76 8z There is 
some evidence that memory IgA may play a role in protective immunity, or be a good 
correlate of protection82, as has been shown for rotavirus A129. However, clinical 
symptoms resolve in the majority of otherwise healthy adults after two days58-60 . 80.83-85, 
before the adaptive immune response has developed, indicating that the innate 
immune response may play a role in terminating illness. Innate immune system 
components have been shown to be essential for resolution of illness in genetically 
engineered laboratory animals130 
In addition to documenting asymptomatic norovirus infection, the volunteer studies also 
identified a further group of individuals who were completely resistant to norovirus 
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infection, remaining free of clinical symptoms after repeated inoculation over the course 
of several years; these resistant individuals did not mount any immune response 
against the inoculated norovirus strain, indicating a complete lack of infection54,56,72,73, 
75.77. The investigation of innate resistance to norovirus infection has focused on the 
receptors used by norovirus to enter host cells. Initial studies showed that norovirus 
binds to ligands that are ubiquitous on human cells and subsequent work on the 
haemagglutination of red blood cells by norovirus VLPs indicated that the ligands may 
be from the human blood group antigen (HBGA) complex131' 132. X-ray crystallography 
of norovirus VLPs has been used to show that the distal, surface-exposed P2 domain 
of the norovirus capsid protein binds to synthetic HBGA peptides, providing evidence 
that these ligands act directly as receptors for norovirus binding and cell entryt33. The 
HBGAs are highly polymorphic carbohydrate ligands, expressed on the surface of all 
human cells, including those in the mucosal lining of the gut, and binding experiments 
using human tissue biopsies from the intestine have shown that norovirus binds to 
antigens present at the gut mucosal surface134 
The combination of HBGA ligands and the variants of each that are expressed by an 
individual are genetically determined by multiple gene loci. Three groups of HBGAs 
appear to be important for norovirus binding: the H type antigens, the Lewis antigens 
and the A and B antigens135. The specificity of different norovirus strains for particular 
combinations of ligands has been extensively investigated using volunteer studies736' 
138, outbreak and other epidemiological investigations' 39""', seroepidemiological 
studiest48, in vitro VLP-binding studies' 17,149-153 and animal studies 154. Each norovirus 
strain appears to have a unique HBGA binding specificity150 Asa. Ise, meaning that the 
risk of a particular individual becoming ill after exposure to norovirus is dependent on 
the match between the norovirus strain ligand specificity and the host HBGA 
phenotype. 
Norovirus vaccines, based on nasal or oral administration of VLPs have been shown to 
be immunogenic and safe in human and animal studies20 Iss-oez, but currently there has 
been no further development of the vaccines for commercial use. 
Current evidence indicates that the innate immune system probably plays a major role 
in the clearance of norovirus infection, but that secretory IgA formed during the 
adaptive immune response provides protection against the infecting norovirus strain for 
a limited time after infection (approximately six months). The rapid waning of this strain- 
specific immunity and the absence of cross-protective immune responses between the 
large number of norovirus strains are mechanisms by which repeated symptomatic 
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norovirus infections occur throughout life. There also appears to be a genetic 
mechanism that determines the occurrence of infection in an individual after exposure 
to norovirus, based on the match of the norovirus strain receptor specificity and the 
HBGA phenotype of the exposed individual. 
2.3. Norovirus virology 
2.3.1. Virus structure and molecular biology 
Norovirus is part of the family Caliciviridae in which there are four virus genera: 
norovirus and sapovirus, which infect humans and a few other mammals163' 164; 
lagovirus, which infects rabbits and hares; and vesivirus, which infects a range of 
marine and terrestrial mammals68. The norovirus genome is a positive sense single 
stranded RNA molecule with three open reading frames (approximately 7.7kb) (Figure 
2.2)68.163-167 The first open reading frame (ORF) of the norovirus genome codes for 
several non-structural proteins, including the RNA-dependent RNA polymerase (RdRp) 
involved in genome replication; the second ORF codes the single capsid protein; and 
the third ORF codes for a minor additional structural protein of unknown function, which 
has been shown to interact with the capsid protein in vitrosa. Asa. Ise Different levels of 
genetic variability can be functionally tolerated across the norovirus genome and the 
relative genetic conservation or variation in different genome regions has been 
exploited in molecular diagnosis and molecular epidemiological studies. For example, 
the junction region between ORF1 and ORF2 is highly conserved and the most widely 
used primers for polymerase chain reaction diagnostic assays target this region 10. 
Norovirus virions are comprised of a single capsid protein with two principle domains: a 
shell domain (S domain), which forms the main virion capsid and is highly conserved 
across genera, and a protrusion domain (P domain) involved in binding to host cell 
receptors for initiation of cell entry "''176. The highly variable P2 sub-domain, which is 
the most exposed part of the capsid protein, is the site of both the key receptor binding 
sites and the major immunodominant epitopes733, "3,171.180 and shows both sequence 
and structural diversity between norovirus strains 12. 
2.3.2. Genetic diversity and molecular typing schemes 
The degree of genetic diversity between human norovirus strains is much higher than 
for other positive sense single stranded RNA viruses that infect humans18" 182. The 
genetic variability is concentrated in the P domain, probably facilitated by structural 
flexibility between the S domain and P1 and P2 sub-domains, which allows amino acid 
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sequence diversity without compromising the functional properties of the capsid 
protein "Z. However, genetic variation has been detected in other parts of the norovirus 
genome; early genetic typing was based on the relatively conserved RdRp gene in 
ORFI and nucleotide sequence diversity in this region was shown to correlate with 
putative serotypes defined by solid phase immune electron microscopy183. Two 
genetically distinct groups were identified within the human noroviruses based on 
RdRp gene diversity, subsequently designated genogroup I and genogroup I1183_186 
Three further genogroups are now recognised: genogroup III contains bovine 
noroviruses; genogroup IV contains strains that also infect humans; and genogroup V 
which contains murine noroviruses18'. 
A number of distinct genetic clusters, or genotypes, exist within each of the 
genogroups, and are most extensively characterised for the human genogroups I and 
11181.187. There have been difficulties in developing a comprehensive typing scheme, 
because of the high degree of genetic diversity amongst these putative norovirus 
strains and differences in this variability across the norovirus genome: different genome 
regions produce different phylogenetic classifications188-190. Regions of the RdRp gene 
or the capsid gene are typically used for phylogenetic analysis, although it is unclear 
what degree of genetic difference in either region represents an antigenically or 
serotypically distinct strain82,118,121,185,191-195 Currently there are up to nine genotypes 
recognised in genogroup I and 17 in genogroup II, based on capsid sequences 181,185, 
187,188,190.196 
Figure 2.2 Organisation of the norovirus genome. 
Norovirus genome organisation based on Southampton virus from genogroup 168 
Genes p48, p22 and ORF 3 have unknown function; Helicase is a 2C-like helicase, 
VPg is the viral genome linked protein; Pro is a 3C-like protease; RdRp is the RNA 
dependent RNA polymerase; capsid is the capsid protein. 
5' 
ORF 1 ORF ORF 3 
--------------------------------------------------------------------- ,., 
ý 3' 
p48 Helicase p22 VPg Pro RdR Capsid 
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The majority of molecular epidemiological studies have described the distribution of 
genotypes detected in norovirus outbreaks or in paediatric cases presenting to health 
care services. The global predominance of genogroup II genotype 4 (GII. 4) noroviruses 
in outbreaks in healthcare and other institutional settings is widely recognised, but 
poorly understood, with some researchers suggesting that it may have higher 
transmissibility in such semi-closed setting s97,197"204. In other settings, especially those 
linked to food and catering, a broader range of genotypes is detected in norovirus 
outbreaks205"207. In Japan, where a large proportion of norovirus outbreaks are linked to 
consumption of oysters contaminated with human sewage, the strain diversity is 
» particularly high101 4,208 
Strain diversity in sporadic norovirus infections in the community is poorly 
characterised, because these cases are rarely seen by health care services83, so 
specimens are not routinely available for typing. Studies of norovirus infection amongst 
paediatric general practice patients with norovirus-associated IID in the UK and 
Canada indicate that the spectrum of strains is very different to that in the outbreaks 
captured by national surveillance systems in these countries, with a much broader 
diversity, although genogroup II noroviruses were still at high prevalence2OS, 210 
However, the majority of outbreaks reported in the literature involved adults, so it is 
difficult to determine whether the difference in strain diversity between sporadic 
infections and outbreaks is due to the infection setting (sporadic versus outbreak) or 
age-related differences in norovirus strain circulation or levels of strain-specific 
immunity. 
Currently a large number of genetically distinct norovirus genotypes have been 
detected in humans, with the majority of the genetic diversity between these strains 
concentrated in the P domain of the capsid protein, which is involved in receptor 
binding and is the site of the immunodominant epitopes. In spite of this broad range of 
circulating norovirus genotypes, viruses in the GII. 4 genetic cluster predominate in 
causing norovirus outbreaks, although other genotypes are often reported in foodborne 
outbreaks. A greater diversity of genotypes is detected in sporadic paediatric cases of 
norovirus-associated IID, although further detailed characterisation of norovirus 
molecular epidemiology is required at the community level. 
2.3.3. Norovirus evolution and emergence of novel variants 
There is now widespread evidence that both genetic recombination and antigenic drift 
generate genetic diversity in the norovirus genus"'" 179,211-21 6. The highly conserved 
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sequence at the ORF1-ORF2 junction promotes genetic recombination between 
different norovirus strains through homologous RNA interaction2», 214 and recombinant 
norovirus strains have been widely reported, although no recombinants of genogroup I 
and genogroup II strains have been detected, probably because of insufficient 
sequence homology between the genogroups215. The recombinant strains commonly 
possess the RdRp gene (and therefore probably the entire ORF1) of one established 
genotype and the capsid gene (and therefore probably ORF2 and ORF3) of another 
genotype 188.211-2'3, although recombination within the capsid gene has also been 
reported, with breakpoints at the junctions between the capsid domains and sub- 
domains215. Whilst the majority of recombinant strains have been detected during 
retrospective analysis of archived strains, some have spread to sufficient prevalence to 
be detected in routine molecular epidemiological surveillance 217-220. However, it is 
unclear what evolutionary advantage, if any, these recombinant viruses may have, 
especially because the immunodominant epitopes lie within the P2 subdomain of the 
capsid, which is transferred completely intact from the parent strain. 
In contrast to the characterisation of genetic recombination, which has examined 
norovirus genotypes in both genogroups, the study of antigenic drift has focused on the 
most common genotype, GII. 4. During the last 15 years there have been periodic 
global epidemics of norovirus-associated IID, identified by marked increases in the 
incidence of outbreak and/or sporadic cases above the endemic seasonal incidence 221- 
223 
. Molecular epidemiological studies revealed that the majority of the infections during 
'these epidemics were caused by GIIA noroviruses and that each of the recent 
epidemics in 1995,2002,2004 and 2006 coincided with the emergence of a genetically 
novel GIIA variant that replaced the previously circulating GIIA viruses200 201,221,222,224- 
234. Subsequent genetic characterisation of the capsid gene in these sequential GIIA 
variants has revealed amino acid substitutions at sites in the S-domain and P1 and P2 
sub-domains"'' 179,216,235,23s The major structural changes are concentrated in the P2 
sub-domain, with computer modelling suggesting the occurrence of substantial 
alterations in tertiary protein structure and electrostatic surface charge, which would 
affect binding to host antibodies "', 235,236, although there is evidence of negative 
selection acting to preserve specific amino acid residues within the HBGA binding 
site' 80,236-238 Retrospective serological studies using paired sera from historical 
norovirus outbreaks have confirmed the occurrence of the immune-driven selection 
suggested by these virological studies, demonstrating that these novel GIIA variants 
are antibody escape mutants 19.223. With G11.4 being the predominant strain detected in 
cases of norovirus-associated IID, this immune-driven virus evolution, with periodic 
29 
Chapter 2 
emergence of antibody escape mutants, provides a third mechanism by which 
repeated norovirus infections occur throughout life, in addition to waning immunity and 
the existence of multiple other immunologically distinct genotypes. 
2.4. Diagnostic methods 
2.4.1. Electron microscopy 
Immune electron microscopy was first used to identify norovirus as a cause of III) in the 
1970s10; norovirus particles in a stool specimen were allowed to react with antibody in 
convalescent phase sera from the infected individual, prior to microscopic examination, 
to enhance the visibility of the virus and to demonstrate that the observed particles 
were immunogenic and therefore likely to be a pathogen. Direct electron microscopy, 
using only a staining technique, without coating the virus particles in antibody, was 
used for routine norovirus diagnosis in the UK until the end of the 1990s12,239, because 
it was the only method that could detect a broad range of norovirus genotypes until 
reverse transcription-polymerase chain reaction assays became more widely available. 
The detection limit of electron microscopy is approximately 106 virus particles per gram 
of stool, viral loads which are only present during the acute symptomatic phase of 
norovirus infection 240 243 Norovirus is no longer detectable by electron microscopy after 
symptom resolution, when viral loads decrease substantially99,, o3 
The high detection limit of electron microscopy translates into a high diagnostic 
specificity244 for norovirus-associated IID, i. e. the ability to correctly exclude norovirus 
as a cause of illness in individuals with IID caused by another pathogen. Individuals will 
only be positive by electron microscopy if they have high viral loads present during 
norovirus disease; individuals with low viral loads, present in asymptomatic norovirus 
infection, will be negative by electron microscopy80. However, the analytical specificity 
of electron microscopy (the ability to produce a negative test result for specimens with 
other pathogens present in the absence of norovirusz44) may be suboptimal if false 
positive results are produced because other gastroenteritis viruses are wrongly 
identified as norovirus during inspection of the specimen240. Other practical difficulties 
in the use of electron microscopy for norovirus diagnosis are the dependence on 
specimen quality and preparation, which gives low diagnostic sensitivity13'244-246, the 
single specimen throughput and the requirement for highly specialised and 
experienced technicians 11 'z, zao, zag, 243 
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2.4.2. Norovirus detection by nucleic acid amplification 
After the full genome sequences of two prototype norovirus strains were determined in 
the mid 1990s165, Iss, 247, the design of primers for a range of nucleic acid amplification 
diagnostic tests became possible. Conserved regions of the RNA polymerase gene 
were targeted in diagnostic assays 170,186,248-255 , 
for broad detection of all norovirus 
genotypes, whereas more variable regions of the capsid gene were used to 
characterise genetic diversity190' 198,201 . 
All nucleic acid amplification assays require 
extraction of norovirus RNA from the faecal specimen, to free the RNA from the 
norovirus virions and to exclude substances that inhibit the nucleic acid amplification 
reaction 256,257 A variety of techniques have been developed, although the 
commercialised method most commonly used for norovirus RNA extraction employs 
guanidinium thiocyanate to lyse the norovirus virions and silica particles to bind the 
viral RNA for separation from the faecal suspension25s-25s Whilst this has been shown 
to be the optimal method for extraction of norovirus RNA, the exact efficiency of the 
extraction step is unknown 260,261 
2.4.2.1. Reverse transcription-polymerase chain reaction 
Reverse transcription-polymerase chain reaction (RT-PCR) 262,263 is the most widely 
used nucleic acid amplification method for norovirus detection in stool specimens ........ 
250.264-267 In the reverse transcription step, extracted norovirus RNA is converted into a 
DNA copy (cDNA), which is then subject to multiple rounds of DNA amplification in the 
PCR step, with cyclic changes in the temperature of the reaction mixture used to 
initiate the different stages of the DNA replication process. Random primer sequences 
are commonly used for the reverse transcription step, to ensure that all RNA is 
converted to DNA268, but the primers for the PCR are matched to a unique norovirus 
genomic sequence, to provide specific amplification10' 248'249. Originally, the RT-PCR 
assays were developed with a separate amplicon identification step, where the DNA 
products of the PCR were separated on agarose gel, by electrophoresis, and stained to 
demonstrate the presence of a DNA amplicon of the size expected after amplification of 
the target sequence in the norovirus genome. The faecal specimen would be classified 
positive or negative for the presence of norovirus based on the DNA bands identified in 
the gel. The gel-based RT-PCR assay therefore provides a qualitative (binary) 
norovirus diagnosis. 
More recently, real-time RT-PCR assays have been developed, which closely monitor 
the kinetics in the early stages of the PCR and provide a method of quantification, 
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based on the number of PCR cycles required to raise the target sequence copy 
number above a pre-set threshold' 10.261 269-277 The number of PCR cycles completed 
before crossing the threshold is referred to as the cycle threshold (Ct) value (further 
explanation of real-time RT-PCR is provided in Appendix 1.1). The Ct value provides a 
relative indication of the amount of norovirus in different stool specimens tested with 
the same real-time RT-PCR protocol and is inversely related to the faecal viral load: a 
low Ct value indicates a high viral load. Full quantification of the actual faecal viral load 
requires the generation of standard curves, from known dilutions of the target 
sequence, to translate the Ct value into a number of norovirus genomic copies per 
gram of stool278. The major advantages of real-time RT-PCR over gel-based RT-PCR 
are the possibility of quantification and the shorter assay time; the test result is 
produced directly from the PCR without the need for a separate identification step273. 
The real-time RT-PCR assays for norovirus may also have slightly higher analytical 
sensitivity than the gel-based assays, although inclusion of a second set of nested 
primers can increase the sensitivity of gel-based RT-PCR"o, 279,280 Current practice in 
most diagnostic laboratories is to treat any Ct value from the real-time RT-PCR as a 
positive result, effectively making this quantitative assay qualitative, like the gel-based 
RT-PCR. 
Gel-based and real-time RT-PCR both have much lower detection limits than electron 
microscopy; approximately 10° genome copies per gram of stool are required for 
detection by the PCR methods, compared to 106 genome copies for electron 
microscopy8o, 99,110,280. PCR-based methods will therefore detect norovirus in 
individuals with norovirus-associated IID for many more days after symptom resolution, 
when viral loads have decreased below the detection limit of electron microscopy. This 
is generally viewed as a major advantage of PCR over electron microscopy'z, "o, z'9,281, 
However, this high diagnostic sensitivity compromises the diagnostic specificity for 
norovirus-associated IID: individuals who remain asymptomatic after norovirus 
infection, and therefore by definition do not have disease caused by norovirus, are 
frequently positive by RT-PCR5 21-23, eo, es, 114 
The poor diagnostic specificity of RT-PCR has greater significance when diagnosing 
norovirus as the cause of sporadic IID compared to identifying norovirus outbreaks. 
During microbiological investigation of an IID outbreak, specimens are collected from 
multiple cases and if two or more are positive for norovirus after testing, this is taken as 
an indication that norovirus is the likely cause of the outbreak. Even if some cases are 
shedding norovirus at low viral loads at the time of testing, the detection of norovirus in 
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multiple individuals involved in the outbreak provides strong evidence that norovirus 
caused the outbreak. However, when diagnosing norovirus in individual sporadic IID 
cases, this reasoning cannot be used and the low diagnostic specificity of the RT-PCR 
produces uncertainty as to whether a positive result really indicates that norovirus is 
the cause of illness, especially when concurrent infection with other pathogens is 
detected simultaneously. 
2.4.2.2. Nucleic acid sequence-based amplification and loop-mediated isothermal 
amplification 
Nucleic acid sequence based amplification (NASBA) and loop-mediated isothermal 
amplification (LAMP) assays have recently been developed for norovirus, to provide an 
alternative to RT-PCR diagnosis251-255,282,283 NASBA, which requires reverse 
transcription of the norovirus RNA genome into cDNA, and LAMP, which amplifies RNA 
directly, are carried out at a constant reaction temperature, removing the need for the 
thermal cycling machines that are used for PCR252,253,255,282 The sensitivity and 
specificity of NASBA and LAMP are comparable to RT-PCR, although the lower 
amplification temperature used for NASBA (40°C) means that it may have slightly 
poorer analytical specificity than LAMP (carried out at 60°C) and RT-PCR, with some 
studies reporting poor reproducibility of results from NASBA assays25,, 279,282. The use 
of simpler laboratory equipment and the quicker turnaround time are major advantages 
of NASBA and LAMP over RT-PCR, especially for investigation of norovirus outbreaks, 
although the lack of automation, quantitation or production of nucleic acid sequences 
for genotyping, mean that these methods are unlikely to replace RT-PCR diagnosis for 
norovirUS252,253'255' 282. 
2.4.3. Enzyme-linked immunosorbent assays 
Antigen and antibody detection enzyme-linked immunosorbent assays (ELISA) for 
norovirus were initially developed using stool and serum reagents from volunteer 
studies and outbreaks2e4_289 However the limited reagent supplies meant that the first 
generation antigen ELISAs were not suitable for general diagnostic purposes. After 
sequencing of the norovirus genome165,166,165,166,247 and subsequently the capsid gene of 
many different norovirus genotypes 164,182.290,291 the capsid protein was expressed in 
vitro using baculoviruses19' 192.247.291294; the capsid protein monomers self-assembled 
into virus-like particles (VLPs), with similar morphology and immunogenicity to 
norovirus virions 15,295 The baculovirus expression system can produce large 
quantities of norovirus VLPs, which are used to inoculate laboratory animals to 
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generate antibodies against the norovirus capsid protein296. The hyperimmune animal 
sera are then used as reagents in the diagnostic antigen detection ELISAs2as, 297-301 
The VLPs are also used directly in antibody ELISAs for seroepidemiological studies of 
3oz norovirus antibody prevalence-31a 
Whilst the diagnostic antigen ELISAs are cheaper and use simpler technology than RT- 
PCR 245,315,316 , they have very narrow reactivity, only detecting the norovirus genotype 
against which the hyperimmune sera were raised and sometimes a few closely related 
genotypes296. The commercially available antigen ELISAs are targeted against several 
common genotypes, but still cannot provide the broad and reliable detection 
demonstrated by RT-PCR and they are therefore only recommended for screening 
large numbers of specimens for common genotypes before the application of RT-PCR 
11,315.318 
Immunochromatography assays have recently been developed for norovirus, with the 
same advantages, limitations and recommended applications as the existing antigen 
9 ELI SAs31-323 
2.4.4. Cell culture 
Whilst other enteric viruses such as rotavirus and adenovirus (types 40 and 41) can be 
propagated in monolayer cell cultures324,325, the only successful in vitro propagation of 
norovirus has been in a highly differentiated three-dimensional cell culture, which 
reproduces the structure and function of the human small intestine epithelium326.327. 
However, feline calicivirus, a vesivirus, grows readily in monolayer cell culture and has 
been used for studies of receptor binding and cell entry "' and calicivirus survival and 
328-332 inactivation 
2.5. Incidence of norovirus-associated III) 
It is widely recognised that norovirus is the most common cause of sporadic, 
community-acquired IID and of IID outbreaks in high-income countries. A number of 
studies have also shown a notable prevalence of norovirus infection amongst 
paediatric IID cases in low and middle income countries"- 67.333 A range of study 
designs have been used to evaluate the burden of disease caused by norovirus: a 
small number of prospective community-based studies have directly estimated the 
incidence of norovirus-associated IID in high-income countries5"8'22'43'334, but the 
majority of studies consider IID cases presenting to healthcare services and seek to 
determine the prevalence of norovirus infection amongst these individuals49. A number 
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of seroepidemiological studies have examined the general population prevalence of 
antibodies to norovirus, as a proxy for the incidence of infection in childhood 302,304,306, 
307,309-314,335337_ Finally, a few studies have used statistical modelling to examine 
correlations between syndromic disease data and unlinked laboratory diagnoses e. g. 
correlating hospitalisations for IID in England with nationally collated reports of 
norovirus laboratory diagnoses338.339. 
2.5.1. Global estimates of norovirus disease burden 
A recent systematic review and meta-analysis of studies reporting the prevalence of 
norovirus infection amongst cases of IID in high, middle and low income countries 
estimated that 12% of IID cases ascertained in the community or after presentation to 
primary care or outpatient clinics were caused by norovirus, based on RT-PCR 
diagnosis; 12% of hospitalisations for IID amongst children aged less than five years 
were also attributed to norovirus in both high income and in low and middle income 
country settings49. From these prevalences it was estimated that norovirus may cause 
up to 900 000 primary care or outpatient clinic visits and 64 000 hospitalisations 
annually amongst children aged less than five years in high income countries, and 1.1 
million hospitalisations and 218 000 deaths amongst children aged less than five years 
in low and middle income countries. However there are a number of significant 
limitations to this review: (1) norovirus is likely to be at higher relative prevalence in the 
community than amongst IID cases presenting to primary care services because it 
generally causes mild self-limiting disease, but these two groups were combined in the 
review; (2) most studies included in the review recruited only young children, meaning 
that the community/primary care prevalence of 12% is unlikely to be representative of 
the prevalence of norovirus in older children and adults; (3) high, middle and low 
income countries were considered together in the pooled prevalence in the community, 
but are likely to have significantly different prevalences of norovirus, although there 
were only two studies from low or middle income countries that considered community 
or primary care cases; (4) the estimated number of deaths requires the significant 
assumption that the distribution of pathogens amongst IID-related fatalities is the same 
as amongst hospitalised IID cases; (5) all RT-PCR positive cases have been treated as 
cases of norovirus-associated IID, which is unlikely to give an accurate estimate of 
norovirus disease burden because of the poor diagnostic specificity of RT-PCR, as 
discussed above in section 2.4.2; and (6) the prevalence of norovirus amongst IID 
cases will be influenced by the incidence of other pathogens in a population, which is 
likely to vary substantially between high, middle and low income country settings, 
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between different age groups and over time. However, the review does demonstrate 
that norovirus infection is highly prevalent amongst IID cases around the world, and 
that it therefore must be a cause of IID in all countries, although its relative importance 
compared to other pathogens is likely to vary between high income and low and middle 
income settings. 
2.5.2. Norovirus-associated IID incidence in high income countries 
Whilst the review by Patel et al. 49 highlighted the large number of studies that have 
been conducted in high income countries to determine the prevalence of norovirus 
infection amongst paediatric patients presenting to healthcare services 44.49,109,203.340- 
342 
, only a small number of prospective research studies 
have estimated the incidence 
of norovirus-associated IID in the community and amongst patients presenting to 
general practitioners or equivalent primary health care services (Table 2.1)5-8,22,43,334, 
343. These studies have all shown that norovirus is the most common cause of IID at 
the community level, with incidence estimates ranging from 12 to 100 episodes of 
norovirus-associated IID per 1000 person years in the different studies (Table 2.1)5"8. 
334 The Study of Infectious Intestinal Disease in England, which reported the lowest 
norovirus incidence, used electron microscopy for norovirus diagnosis81, so is likely to 
have substantially underestimated the burden of disease caused by norovirus, because 
of the low diagnostic sensitivity of electron microscopy. The other community-based 
studies in the Netherlands, Australia and the United States used RT-PCR diagnosis, so 
it is possible that they may overestimate the burden of norovirus disease to some 
extent, because of the sub-optimal diagnostic specificity of RT-PCR. 
The prevalence of norovirus was higher in the study in the Netherlands compared to 
the Study of Infectious Intestinal Disease in England, but the difference may be less 
than might be expected given the difference in the sensitivity of electron microscopy 
and RT-PCR. A new variant of norovirus GII. 4 emerged in 1995201,222,223.233 , which 
may have caused a periodic increase in norovirus incidence during the study in 
England, whereas the study in the Netherlands was conducted during a time when no 
new GI1.4 variants emerged and would therefore have recorded normal levels of 
norovirus transmission19- 223. In addition, the case definition for IID was less inclusive in 
the study in the Netherlands (at least three diarrhoea and/or vomiting episodes in 24 
hours or two diarrhoea episodes with additional IID symptoms) than in the Study of 
Infectious Intestinal Disease in England, which included anyone who had a diarrhoea 
episode or two or more vomiting episodes in 24 hours; given the milder manifestation 
of norovirus disease in the community, the case definition in the study in the 
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Netherlands may have failed to identify all cases of norovirus-associated IID. In 
contrast, the incidence of norovirus-associated IID was much higher in the Australian 
study compared to both the Study of Infectious Intestinal Disease in England and the 
study in the Netherlands. However, this is because of the comparative over- 
representation of young children in the Australian cohort, which led to a substantially 
higher incidence of all-cause IID than in the other studies. 
Norovirus was also identified as a significant cause of general practice consultations for 
IID, with incidence varying from 0.3 to 6.3 consultations per 1000 person years, 
although the majority of consultations were from young children (Table 2.1)8.22.43 , 343 
The low incidence of consultations in the study in the Netherlands probably reflects the 
much lower incidence of consultations for all-cause IID; in the Netherlands, general 
practice guidelines recommend that mild or uncomplicated cases of IID are given self- 
care advice via the telephone, substantially reducing the number of clinic visits22. 
Seroepidemiological studies have demonstrated a high prevalence of specific IgG 
antibody against a number of genogroup I and genogroup II noroviruses in the general 
population of high income countries", 304309,311.312,335,337,344 A high prevalence of 
maternal antibody was identified in infants aged up to six months304,309,3», 312,337 , 
but 
after this age the prevalence of antibody dropped and gradually increased with age up 
to a seroprevalence of 90% or more in adults302,304,309,311,312,335,337 Seroprevalence 
increases more rapidly with age for genogroup II norovirus genotypes compared to 
those in genogroup I, reflecting the higher incidence of genogroup II infections reported 
in studies of norovirus-associated IID. 
A study of seroconversion to GI. 1 norovirus amongst Finnish infants and children, aged 
up to four years at recruitment, showed that half of the children experienced infection 
during the two year follow-up period307. A similar study in the general population in 
Canada showed that, across all ages, one third of individuals experienced infection 
with G1.1 norovirus during the 18 month follow-up period. These studies demonstrate 
the high incidence of infection, even with this single genogroup I norovirus strain that is 
recognised to be at much lower prevalence than other strains in genogroup II. 
2.5.3. Norovirus incidence in the United Kingdom 
The only estimates of the community incidence of norovirus-associated IID and of 
general practice consultations for norovirus in the United Kingdom (UK) are those from 
the Study of Infectious Intestinal Disease in England, described above8 83 Three recent 
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studies have examined the prevalence of norovirus amongst young children presenting 
to general practitioners or hospital emergency services13, zog, 345 In studies conducted 
between 1999 and 2003, norovirus was identified in approximately 14% of children 
presenting to general practitioners and in 9% to 14% of children presenting to hospital 
emergency services' 3.345, both substantially lower than the prevalence of rotavirus in 
these study populations. The highest prevalence of norovirus infection was amongst 
patients aged less than three years. In the study conducted during 2006 and 2007, 
norovirus infection was identified in 25% of children presenting to general practitioners 
with IID, which was slightly higher than the prevalence of rotavirus in this study209; as 
discussed above, the unusually high prevalence of norovirus in this study could be due 
to the emergence of another novel GI I. 4 variant during 2006 als, zz3, zza 177 
Norovirus is also a major cause of IID outbreaks in the UK, with routine public health 
surveillance systems capturing information on outbreaks in a range of settings1-3,38,40. 
346,347 Outbreaks of norovirus occurring in hospitals in England and Wales are now 
voluntarily reported, in real-time, to the Health Protection Agency by infection control 
teams, using a web-based surveillance system dedicated specifically to norovirus 
hospital outbreaks348. This new surveillance system has confirmed the large burden of 
norovirus outbreaks, and related service disruption from ward closures, which was 
demonstrated in a recent prospective research study in the UK and other previous 
sources of surveillance data t4.40. There is a substantial incidence of norovirus 
outbreaks in other semi-closed settings such as nursing homes, schools, prisons and 
cruise ships1-3.38,346,347, as well as foodborne outbreaks in public food outlets and at 
catered events, which are predominantly due to food contamination by food 
handlers346. 
Laboratory diagnoses of norovirus are also reported to the Health Protection Agency by 
public health microbiology laboratories in England and Wales, providing further 
information about trends in norovirus incidence. However, the majority of these 
diagnoses are likely to come from norovirus outbreaks, rather than sporadic cases in 
the community, and changes in the sensitivity of diagnostic methods (moving from 
electron microscopy to RT-PCR) and a lack of denominator data (number of tests 
carried out) make it difficult to interpret trends in the number of norovirus reports over 
time, or to extrapolate these trends to the incidence of disease in the community. 
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Chapter 2 
Further information about national surveillance of norovirus laboratory reports in 
England and Wales is provided in Chapter 3. 
Whilst there have been no studies directly enumerating hospitalisations and deaths due 
to norovirus-associated IID in the UK, two studies have used statistical modelling 
techniques to estimate the frequency of these events338,339 Data on all-cause 
outcomes, i. e. hospitalisations or deaths. due to IID, are modelled using unlinked data 
on norovirus infections (the norovirus laboratory diagnoses from the Health Protection 
Agency) and a proportion of the all-cause outcomes attributable to norovirus is 
extracted from the model. These studies estimated that there may be more than 3000 
hospital admissions for norovirus-associated IID amongst individuals aged 65 years 
and older each year in England and Wales339, and that there are at least 200 deaths 
from norovirus-associated 1113 in this age group annually 338 
Data on outbreaks of norovirus have been collected in the UK since the mid 1990s and 
the large burden of outbreaks in hospitals and care homes is well documented, 
although there is less knowledge about the frequency of outbreaks in other community 
settings. A new surveillance system has now been set up to routinely capture 
information on the occurrence of norovirus outbreaks in hospitals in England and 
Wales. Whilst a limited number of studies have examined the importance of norovirus 
as a cause of healthcare consultations for paediatric IID, the only existing estimates of 
the amount of sporadic disease caused by norovirus at the community level comes 
from the Study of Infectious Intestinal Disease in England, which used electron 
microscopy for norovirus diagnosis and is therefore likely to have underestimated 
norovirus-associated IID incidence in the community. 
2.6. Norovirus transmission 
2.6.1. Infectious dose and attack rates 
The predominant route of norovirus transmission is faeco-oral, which has been 
demonstrated in a large number of volunteer studies where individuals were inoculated 
with suspensions of stool filtrates from cases of norovirus-associated IID and 
subsequently became ill56,58-61.72-8o Whilst putative vomitus-oral transmission of 
norovirus has been reported from outbreak investigations349.351, the infectiousness of 
vomit from cases of norovirus-associated IID has never been examined in a volunteer 
study. 
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Recently, a comprehensive dose-response volunteer study has confirmed previous 
assumptions about the extremely low infectious dose of norovirus9B. This study showed 
that norovirus infection may occur after ingestion of as few as 100 norovirus virions in 
individuals who are genetically susceptible to the infecting strain. However, even when 
very large infecting doses were given to genetically susceptible individuals the infection 
rate was not 100%, indicating that pre-existing immunity may be preventing infection in 
some individuals, or that further uncharacterised mechanisms of genetic resistance 
exist. Whilst the probability of infection increased only very little with inoculating doses 
greater than 1000 virus particles, the probability of developing disease after infection 
increased almost linearly with the infecting dose, even up to very high inocula of 1010 
particles. However, the precision of the infectious dose measured is limited by the use 
of real-time RT-PCR to quantify norovirus virions in the inocula; it is highly likely that 
not all genome copies detected by real-time RT-PCR were from viable, infectious 
virions, meaning that the number of infectious particles in the inocula may be different 
to the number of genome copies reported as the inocula concentrations in the study. In 
spite of this limitation, the study provides the first direct evidence of the high 
infectiousness of norovirus and provides a useful estimate of the infectious dose for 
risk analyses of environmental and food contamination. 
The infectiousness of norovirus is reflected in the high attack rates reported from both 
food- and water-borne outbreaks and those caused by direct person-to-person 
transmission. The attack rate reported in published investigations of foodborne 
outbreaks is typically close to 60%, ranging from 33% to 67%94,352-365. In person-to- 
person transmitted outbreaks, the attack rates reported are more variable, ranging from 
13% to 62% in hospital settings14,366-369, from 10% to 74% in residential care home 
settings19 370-376, and from 23% to 85% in other community settings such as day care 
centres and hotels377-379 
2.6.2. Risk factors for sporadic flora virus infection and disease 
A small number of case-control studies have examined risk factors for sporadic, 
community-acquired norovirus-associated IIDZZ, 83,140,380 Contact with individuals with 
IID symptoms, either within or outside the household, was identified as a major risk 
factor for norovirus-associated IID in these stud ies2Z, 83" "0,380 and the risk increased as 
the number of household infectious contacts increased 38o Two studies of household 
norovirus transmission have shown that there is a greater risk of norovirus infection in 
household members from child index cases, compared to adult index cases85, and that 
children are at higher risk of becoming infected by a household contact365 
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Recent foreign travel was strongly associated with norovirus-associated IID in one 
case-control study83, possibly reflecting exposure to a broader or different range of 
norovirus strains, or transient behavioural changes that may increase the risk of 
norovirus infection. However, the majority of cases in the study were recruited after 
presentation to a general practitioner with norovirus-associated IID and were compared 
to population-based control subjects; recent foreign travel strongly increases the 
probability of consulting a general practitioner after the development of IID, regardless 
of the causative pathogen38', meaning that the association between norovirus- 
associated IID and foreign travel may be due to non-comparability of the case and 
control groups for this exposure. Individuals in lower social classes (based on 
occupation) were also shown to be at a three-fold higher risk of norovirus-associated 
IID in the same study83. 
The norovirus strains circulating in animal populations are genetically distinct from 
those causing illness in humans and there is no evidence that zoonotic transmission 
contributes to the burden of norovirus-associated IID in humans 163.164,181,382-384 In fact 
two studies have shown that pet-ownership and recent contact with animals is 
associated with a decreased risk of norovirus-associated (ID22,380. Whilst it is possible 
that frequent exposure to norovirus, through contact with infected animals, could boost 
immunity to the virus and therefore decrease the risk of norovirus-associated IID, 
strains that commonly infect animals are genetically distinct from those causing 
disease in humanS163,164.181.382.384, and are therefore unlikely to stimulate cross- 
protective immunity125,126. It is likely that these animal exposures are correlated with 
other life style factors that are protective against norovirus-associated IID. 
Two seroepidemiological studies have investigated risk factors for norovirus infection. 
One study in rural Mexico examined seroconversion during a one year period, across 
all ages, and showed that poor hand hygiene practices amongst household members 
was strongly associated with an increased risk of norovirus seroconversion in young 
children 336 In older children and adults, variables that correlate with low socioeconomic 
status (infrequent meat consumption, agricultural work, dogs near the house) were 
associated with an increased risk of seroresponse in the Mexican study. In a cross- 
sectional seroprevalence study in Chile, individuals in lower social classes (based on 
occupation, education and housing conditions) were more likely to be norovirus 
antibody positive310. Factors such as child care attendance and seafood consumption 
were also associated with norovirus seropositivity, but only in subsets of the study 
population, and it is difficult to assess their potential correlations with social class. 
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Whilst these seroepidemiological studies did not distinguish between norovirus 
infection and disease, there are currently no published studies that specifically 
examined risk factors for asymptomatic norovirus infection. 
A cohort study of infants and young children attending day care centres in the United 
States demonstrated a high incidence of IID amongst cohort participants, with more 
than two episodes per child each yeaell. 386 A case-control study conducted amongst 
children who attended paediatric healthcare clinics with IID, showed that attendance at 
day care centres increased the risk of presenting with IID367. These two studies focused 
on the role of rotavirus in causing IID, but more than half of the cases remained 
undiagnosed after testing for rotavirus and other common bacterial and protozoan 
gastrointestinal pathogens; it is therefore very probable that other enteric viruses, 
including norovirus, were important aetiological agents of IID in these day care settings. 
Environmental testing has also revealed widespread rotavirus contamination on fomites 
and surfaces in day care centres388, and again it is likely that there will be concomitant 
norovirus contamination, because of the high norovirus infection prevalence amongst 
young children and the common faeco-oral transmission route of norovirus and 
rotavirus38s 
2.6.3. Norovirus outbreak investigations 
Norovirus transmission has been most extensively studied in the context of outbreaks 
investigated by public or environmental health authorities. A number of high income 
countries conduct national surveillance of IID outbreaks, including those caused by 
norovirus'"2.4,346,390,391 Direct person-to-person transmission is the most commonly 
reported route of norovirus infection in the outbreaks captured in these national 
surveillance systems. However, all of the surveillance systems rely on passive 
reporting, with some focusing on foodborne outbreaks, whilst others may be more 
biased towards norovirus outbreaks occurring in healthcare settings, and cannot 
therefore be used to conclusively demonstrate the relative importance of person-to- 
person and foodborne transmission 38,392 However, outbreak investigations do provide 
the most direct evidence of the transmission routes of norovirus infection. The spatio- 
temporal spread of infection can be recorded in detail during outbreaks involving 
person-to-person transmission", 350,352,393-395 and modern molecular epidemiological 
methods can be used to link IID cases and particular food items, or water sources, in 
food- and waterborne outbreaks396,3sß This detailed investigation is not possible in 
studies of community-acquired sporadic norovirus-associated IID, where inference of 
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the route of transmission relies on cases retrospectively reporting exposures in 
standard epidemiological questionnaires 22 83.140,380 
In addition to direct faeco-oral transmission, a number of outbreaks have reported 
airborne transmission, following a vomiting episode, with infection occurring after 
inhalation of aerosolised virus particles350,393-395 However, faeco-oral and vomitus-oral 
transmission may also occur through contamination of environmental surfaces and 
objects, rather than through direct transfer between infected and susceptible 
individuals. Environmental norovirus contamination has been demonstrated using 
sensitive RT-PCR testing during outbreak investigations18.398-401, and a number of 
investigations have implemented environmental contamination, with norovirus being 
transferred to the hands of individuals and subsequently ingested, as the most likely 
route of norovirus infection402,403,403-408 A small number of outbreak investigations have 
examined hand hygiene practices amongst exposed individuals; those who practiced 
effective hand-washing were at a lower risk of norovirus-associated IID during a cruise 
ship outbreak where person-to-person transmission was predominant406 and a 
mathematical modelling study showed that implementation of hygiene measures in a 
large and prolonged person-to-person outbreak at a campsite reduced the transmission 
of norovirus, although not sufficiently to completely stop the outbreak409 
The majority of foodborne norovirus outbreaks that occur in commercial catering 
settings are attributed to contamination of food (or drink) during preparation by an 
infected food handler, using either epidemiological information and/or molecular 
testing38.349,351,360,397.400,410-418 Norovirus is the most common cause of foodborne 
outbreaks where food handlers, rather than foodstuffs, are implicated as the source of 
contamination419, highlighting their greater direct transmissibility compared to other 
gastrointestinal pathogens98,420 
Contamination of food at the source, and during industrial processing, has also lead to 
norovirus outbreaks; this is especially a problem for products such as oysters and other 
molluscan shellfish that are consumed raw or after minimal cooking95,354,364,421-430 
Marine mollusc beds are frequently contaminated with human sewage and norovirus 
becomes concentrated on the animals during filter feeding, meaning that large doses 
are ingested when they are eaten 362,431-440 There is also some evidence that the 
internal temperatures reached during steam-cooking of molluscs may not high enough 
to inactivate norovirus9s, 441-443 Outbreaks have also been linked to contamination of 
raw fruit and vegetables, contaminated during production, with inadequate heat- 
44a processing prior to consumption, aas 
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A number of norovirus outbreak investigations have implicated private446-450 and 
public/municipal451 57 drinking water supplies after specific, documented contamination 
events. Norovirus outbreaks have also been reported after contact with sewage 
contaminated recreational water96' 458462 
2.6.4. Experimental virus transfer and survival studies 
Experimental studies of norovirus and other related caliciviruses that are used as 
surrogates for norovirus (murine norovirus and feline calicivirus)468-465, have shown that 
they are readily transferable between human hands and environmental surfaces and 
foods329 466 The viruses can survive for many hours or days on surfaces such as 
computer keyboards and kitchen utensils326' 329 and on refrigerated pre-prepared 
foods331' 332, supporting the epidemiological evidence of these transmission routes from 
outbreak investigations. Survival studies also indicate that some industrial food 
processes designed to decontaminate pre-prepared foods may not be effective against 
norovirus467-470 
Whilst a number of studies have shown that alcohol-based hand sanitizers reduce the 
concentration of infectious feline calicivirus and murine norovirus, using cell culture and 
in vivo pathology assays471- 76, a study of human norovirus inactivation, using real-time 
RT-PCR quantitation of norovirus RNA, has shown that mechanical removal with water 
rinsing and antibacterial soap is more effective at reducing the norovirus RNA load than 
alcohol4". Whilst feline calicivirus and murine norovirus may be poor surrogates for 
noroVirus in inactivation studies, evidenced by differing resistance to heat and pH 
changes"-463465.478 ,a major limitation of using RNA quantitation of human norovirus 
is 
that studies comparing RNA load and the presence of infectious feline calicivirus have 
shown very poor correlation between the two"', 478. Therefore, the efficacy of 
commonly used hand sanitizers against norovirus remains unknown, but mechanical 
330 removal of virus using prolonged washing with soap and water may be effective 
2.7. Summary 
Norovirus is recognised as the most common cause of both sporadic cases and 
outbreaks of IID, across all age groups, in high income countries. Norovirus is highly 
infectious and is predominantly transmitted directly through contact between infected 
and susceptible individuals, or through the contamination of food, drink or 
environmental surfaces by infected individuals. Disease caused by norovirus has rapid 
onset, characterised by vomiting and/or diarrhoea, but is generally self-limiting and of 
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short duration, except in young children and the elderly, who may experience longer- 
lasting and more severe symptoms. Immunity to norovirus is short-lived and strain- 
specific, with a large number of antigenically distinct circulating norovirus strains and 
antigenic drift documented in the predominant genotype, meaning that individuals 
remain susceptible to both infection and disease throughout life. Symptoms are 
probably attributable to norovirus replication in the proximal small intestine and a 
correlation between viral load and the occurrence of disease has been documented. 
However, RT-PCR, which is now the main method of norovirus diagnosis, readily 
detects norovirus in asymptomatic individuals. RT-PCR therefore provides poor 
predictive value for diagnosing sporadic norovirus-associated IID, because of the high 
prevalence of asymptomatic infection in the general population in high income 
countries and the poor diagnostic specificity of the assay. A new method for diagnosing 
norovirus-associated IID in sporadic community cases is therefore required, to produce 
accurate estimates of the incidence of norovirus-associated IID. Current estimates of 
norovirus disease burden in high income countries are based on either electron 
microscopy (in England) or RT-PCR (in the Netherlands, Germany, Australia and the 
United States) and neither method can be considered satisfactory for accurately 
enumerating cases of norovirus-associated IID in the community. 
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Chapter 3: Description of datasets 
The majority of the work presented in this thesis was based on analysis of data from 
the Study of Infectious Intestinal Disease in England. The study methods and the data 
collected are described in detail in this chapter, to aid understanding and interpretation 
of analyses presented in subsequent chapters. In addition, two sources of routinely- 
collected surveillance data are described, which provide information on general 
practice consultations for III) and norovirus laboratory diagnoses in England and 
Wales. These surveillance datasets were used to estimate the incidence of general 
practice consultations for norovirus-associated IID, presented in Chapter 7. 
3.1. The Study of Infectious Intestinal Disease In England 
3.1.1. Aims and objectives 
The Study of Infectious Intestinal Disease was conducted in England between 1993 
and 1996, to address the recommendations of the Richmond Report on the 
microbiological safety of food479. The main aim of this multi-component study was to: 
"estimate the incidence and aetiology of infectious intestinal diseases occurring 
in the population and presenting to [general practitioners] in England. *83 
In the original study, the data used in this thesis were collected to address the following 
research objectives: 
Estimate the number and aetiology of cases of IID in the population, presenting 
to general practitioners and having stool specimens routinely sent for laboratory 
examination; 
ii. Estimate the prevalence of asymptomatic infection with agents associated with 
ID; 
iii. Document differences between cases of IID (in the population and presenting to 
general practitioners) and similar but well people (controls)B3. 
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Figure 3.1 Structure of the community and general practice study components in the 
Study of Infectious Intestinal Disease. 
Community cohort 
70 practices 
General practice Under-ascertainment 
General practice 
enumeration study component case-control 
study 
36 practices 26 GP practices 
34 practices 
The data used in this thesis are taken from the study components based in the 
community and in general practices, shown in Figure 3.1. There were 70 general 
practices included in the study, all of which recruited participants for the community- 
based cohort. Thirty-four general practices were then randomly allocated to the general 
practice case-control study component and 36 to the general practice enumeration 
study. Twenty-six practices also provided data for the under-ascertainment study, 13 
each in the enumeration study and the general practice case-control study83,480 
3.1.2. Case and control definitions 
Cases of IID were defined as: individuals with diarrhoea (any loose stools) or significant 
vomiting (2 or more vomiting episodes per 24 hours), lasting less than two weeks, 
without an identified non-infectious cause, preceded by a symptom-free period of at 
least three weeks83,480 
Controls were defined as: individuals with no recent history of diarrhoea (any loose 
stools) or vomiting prior to the onset of illness in the matched case. 
The exclusion question in the control questionnaire asked: "In the last 10 days did you 
have any diarrhoea or vomiting? "83 If controls had experienced these symptoms in the 
previous 10 days before completing the questionnaire, they were asked to return the 
questionnaire to the study team, without completing any further questions. However, in 
the report and related peer-reviewed papers from the Study of Infectious Intestinal 
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Disease the control definition states that controls had to have been free of diarrhoea 
and vomiting for at least three weeks prior to recruitment83, aal, 482 The analyses 
presented in this thesis include all controls who were free of diarrhoea and vomiting for 
10 days prior to questionnaire completion and/or stool submission. 
3.1.3. Community cohort and nested case-control study 
Each general practice recruited two successive cohorts, which were followed-up for six 
months each. A total of 4026 person-years of follow-up were completed8' 83. At 
recruitment, all cohort members were asked to complete a baseline questionnaire, 
providing basic demographic details and information on employment, accommodation 
and food storage and preparation practices (Table 3.1) 83. The cohort was broadly 
representative of the population of England in terms of age, gender and ethnicity, 
although the following groups were slightly under-represented: adults aged between 15 
and 24 years; individuals in manual occupational social classes. Married individuals 
and property-owners were slightly over-represented in the cohort83. Individuals living in 
institutions, such as care homes or prisons, were not eligible for inclusion in the cohort. 
Active case ascertainment was used to ensure that all cohort members experiencing 
IID symptoms were identified; cohort members returned diary cards to the practice 
nurses in each week of the study to confirm whether they had experienced any IID 
symptoms83"480 Cohort members who were ascertained as IID cases were ineligible to 
be a case again for four weeks after the date of symptom onset in their first episode. 
Those cohort members matching the case definition were asked to join the nested 
case-control study. An age- and sex- matched control was recruited concurrently for 
each case, from within the same general practice. The matching criteria are 
summarised in Appendix A1.2. 
All IID cases and controls were asked to provide a stool specimen for diagnostic testing 
and to complete a risk factor questionnaire, in which they provided information on 
symptoms, illness in other household members and specific exposures related to IID 
(Table 3.1) 83.480 III) cases were also asked to complete an additional questionnaire 
three months after their IID episode, examining the socio-economic costs of their 
illness. Information on long-term symptoms and hospital visits from the socio-economic 
cost questionnaire were used in this thesis (Table 3.1). 
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Adults completed the questionnaires themselves; a parent or guardian completed the 
questionnaires on behalf of children aged less than 16 years. 
3.1.4. General practice case-control study 
Patients presenting to one of the 34 participating general practices, with IID symptoms 
matching the case definition, were invited to participate in the general practice case-control 
studyas, aso Age- and sex- matched controls were recruited concurrently to each case from 
within the same general practice. IID cases and controls were asked to provide a stool 
specimen for diagnostic testing and to complete a single questionnaire, comprised of the 
baseline and risk factor questionnaires used in the community cohort (Table 3.1). IID 
cases were asked to complete the socio-economic cost questionnaire at three months 
after their illness. 
3.1.5. General practice enumeration study 
General practices in the enumeration study were asked to complete a single case-report 
480 form for each patient presenting with IID symptoms matching the case definition83. 
Diagnostic testing was carried out as per routine practice. 
3.1.6. General practice under-ascertainment study 
General practices with electronic patient records were included in the under-ascertainment 
study. Patient records were searched, using Read codes related to IID, to identify all 
patients who presented to the general practices during the study and met the case 
definition 83,410. Under-ascertainment was calculated as the percent of eligible IID cases not 
recruited into the study. Percent under-ascertainment was translated into a practice-level 
adjustment factor, applied to the numerator in the incidence of general practice 
consultations for IID, to improve the accuracy of the incidence estimate. Separate under- 
ascertainment adjustment factors were calculated for practices in the case-control study 
and the enumeration study, and for those in urban and rural locations. 
3.1.7. General practice list inflation 
The patient registers from the general practices were used to generate denominators for 
the incidence of general practice consultations for IID. The number of registered patients in 
each practice who were no longer actively using the practice, because they had died or 
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moved away, was estimated from the proportion of patients who could not be contacted 
during recruitment of the community cohort83'480 The estimated proportion of patients no 
longer actively using each practice was used to adjust the number of registered patients 
used in the denominator for the calculation of IID consultation incidence. 
3.1.8. Diagnostic testing 
Stool specimens from IID cases and controls were tested for the presence of 19 bacterial, 
viral and protozoal gastrointestinal pathogens, shown in Table 3.251. In the original study, 
no polymerase chain reaction (PCR) methods were used; pathogens were detected using 
bacterial culture, light microscopy, electron microscopy and enzyme-linked immunosorbent 
assay (ELISA). All specimens with sufficient volume remaining after testing were archived 
in frozen storages'; 2819 controls provided stool specimens in the original study, with 78% 
being archived, and 3654 IID cases provided specimens, with 66% archived (Table 3.3). 
All archived specimens from IID cases and controls, including those previously positive for 
one or more pathogens in the original testing, were subsequently retested for eight of the 
most common pathogens, using PCR methods (Table 3.2)21. 
Two RT-PCR assays were used to diagnose norovirus, a separate assay for genogroup I 
noroviruses and genogroup II noroviruses. The RT-PCR testing therefore allowed 
identification of the genogroup of norovirus detected, but no further genotyping was carried 
out. The prevalence of norovirus greatly increased in both IID cases and controls with the 
application of RT-PCR testing: in IID cases, the prevalence of norovirus diagnosed by 
electron microscopy was 6%, which increased to 34% by RT-PCR, and amongst controls 
the prevalence increased from 0.2% by electron microscopy to 16% by RT-PCR. 
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Table 3.2 Pathogens targeted in diagnostic testing, diagnostic methods and prevalence in 
IID cases and controls from the Study of Infectious Intestinal Disease specimen archive. 
Pathogen Diagnostic method 
Percentage prevalence 
IID cases Controls 
(n=2422) (n=2205) 
Norovirus EM & RT-PCR 34.4 16.4 
Rotavirus A EM/ELISA & RT-PCR 31.1 14.1 
Campylobacter spp. Bacterial culture & PCR 22.6 5.0 
Diarrhoeagenic Escherichia coli Bacterial culture & PCR 15.4 9.1 
Salmonella spp. Bacterial culture & PCR 5.8 0.7 
Aeromonas Bacterial culture 5.1 4.5 
Clostridium perfringens Bacterial culture & toxin test 4.1 0.8 
Sapovirus EM & RT-PCR 3.9 2.0 
Adenovirus EM & ELISA 2.9 0.2 
Cryptosporidium spp. Light microscopy & PCR 2.5 0.5 
Astrovirus EM & ELISA 2.6 0.2 
Yersinia spp. Bacterial culture 2.2 2.6 
Giardia spp. Light microscopy & PCR 2.1 1.5 
Clostridium difficile Bacterial culture & toxin test 1.5 1.8 
Shigella spp. Bacterial culture 0.8 - 
Rotavirus C EM 0.3 - 
Staphylococcus aureus Bacterial culture & toxin test 0.3 0.2 
Bacillus spp. Bacterial culture & toxin test 0.2 0.5 
Vibrio spp. Bacterial culture 0.04 - 
Abbreviations: EM, electron microscopy; ELISA, enzyme-linked immunosorbent assay; IID, infectious 
intestinal disease; PCR, polymerase chain reaction; RT-PCR, reverse transcription-polymerase chain reaction. 
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3.1.9. Quantitative real-time RT-PCR testing for enteric viruses 
All the norovirus positive specimens were retested using quantitative real-time RT-PCR1° 
to determine the viral load. The viral load was determined for the majority of norovirus 
positive specimens (86% of norovirus positive IID cases and 55% of norovirus positive 
controls). The ascertainment of IID cases into the study, archiving and norovirus testing 
are summarised in Figure 3.2; the numbers of IID cases and controls recruited, archived 
and positive for norovirus are provided in Table 3.3. 
The cycle threshold (Ct) value from the real time RT-PCR assay was used as a proxy 
measure of faecal viral load; it is inversely proportional to the amount of virus present in 
the specimen, so the lower the Ct value the higher the faecal viral load. The Ct value 
represents the number of rounds of PCR replication required to raise the number of copies 
of the target DNA sequence in the reaction mixture above a pre-determined threshold. The 
real time RT-PCR assay was run for 40 cycles, so the maximum possible Ct value for 
positive specimens was 39. Appendix 1.1 provides further explanation of the real-time RT- 
PCR reaction and interpretation of the Ct value. 
Characterisation of the norovirus real-time RT-PCR assay indicates that there is variability 
in the efficiency of the PCR reaction between norovirus genotypes (J. Gray, personal 
communication). This is indicated by the detection limit of the assays, which is determined 
by serial dilution of standard solutions of DNA plasmids containing the norovirus genetic 
sequence targeted in the assay. The majority of the genotypes in genogroup II show the 
same assay efficiency, except two less common genotypes (Appendix Al. 3). The assay 
efficiency is generally lower in genogroup I, with more variation between the genotypes 
(Appendix A1.3). Differences in assay efficiency between norovirus genotypes means that 
the same Ct value is likely to represent a different viral load in the original stool specimens; 
it is therefore not necessarily valid to analyse the Ct value data from different genotypes 
together. The problems with the norovirus real-time RT-PCR assays are discussed further 
in Chapter 4. 
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Figure 3.2 Summary of case recruitment and stool specimen testing for norovirus in the 
Study of Infectious Intestinal Disease. Applicable to both the community cohort and the 
general practice case-control study. 
Base population 
Ascertained cases 
Stool specimen 
Stool Archive 
RT-PCR positive 
Real-time 
RT-PCR 
Ct value 
Abbreviations: Ct, cycle threshold; EM, electron microscopy; RT-PCR, reverse transcription-polymerase chain 
reaction. 
3.1.10. Representativeness of the lID cases and controls in the specimen 
archive 
The analyses presented in this thesis used diagnostic and epidemiological data only from 
the IID cases and controls who provided a stool specimen for diagnostic testing that was 
included in the specimen archive. The IID cases and controls in the specimen archive 
were very similar, in terms of age (Appendix A1.4) and sex (Appendix Al . 5), to all 
the IID 
cases and controls originally recruited in the Study of Infectious Intestinal Disease. 
The proportion of archived IID cases remaining undiagnosed (with no pathogen identified) 
after the original testing, but before application of the PCR retesting, was similar to the 
proportion of all recruited IID cases remaining undiagnosed: 45% of IID cases recruited in 
the general practice case-control study were undiagnosed compared to 42% in the 
archive; and 63% of IID cases recruited in the community cohort were undiagnosed 
compared to 62% in the archive. Amongst both the recruited and archived controls 80% 
had no pathogens detected after the original testing. 
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3.1.11. Ethical approval 
Ethical approval for the Study of Infectious Intestinal Disease, including creation of the 
stool specimen archive, was granted by both local and national research ethics 
committees (Royal College of General Practitioners, London School of Hygiene and 
Tropical Medicine, Public Health Laboratory Service). Written, informed consent was 
obtained from all IID cases and controls during the original recruitment. The stool 
specimen archive was anonymised and no further ethical approval was sought for the 
subsequent PCR retesting, although this work was approved by the Study of Infectious 
Intestinal Disease executive committee and the Food Standards Agency. The secondary 
data analyses presented in this thesis received ethical approval from the London School of 
Hygiene and Tropical Medicine research ethics committee. 
Table 3.3 Summary of case and control recruitment and stool specimen testing in the 
community cohort and general practice case-control study in the Study of Infectious 
Intestinal Disease. 
Community General practice Controls 
cohort case-control study 
Ascertained IID cases 781 4011 - 
Stool specimen 761 2893 2819 
EM positive for norovirus 50 169 9 
Stool specimen archived 517 1905 2205 
RT-PCR positive for norovirus' 211 623 361 
Viral load determined with real- 174 544 199 
time RT-PCR for norovirus 
a Includes those previously positive by EM 
Abbreviations: EM, electron microscopy; IID, infectious intestinal disease; RT-PCR, reverse transcription- 
polymerase chain reaction. 
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3.1.12. Use of data from the Study of Infectious Intestinal Disease in this 
thesis 
The use of data from the Study of Infectious Intestinal Disease in this thesis is 
summarised in Table 3.4. In Chapters 4,5 and 6 data from IID cases in the community 
cohort and the general practice case-control study were analysed together and the 
advantages and limitations of this approach are discussed in the individual chapters. In 
Chapter 8 the two groups of IID cases were analysed separately, to estimate the 
incidence of norovirus-associated IID at the community and general practice levels. 
Table 3.4 Use of data from the Study of Infectious Intestinal Disease in this thesis. 
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3.2. Royal College of General Practitioners Surveillance Scheme 
The Royal College of General Practitioners (RCGP) Research and Surveillance Centre 
was established in 1957 to monitor trends in diseases managed by general 
practitioners in England and Walesaes, 484 Aggregated data on consultations for a range 
of infectious and non-communicable diseases are collected from participating general 
practices on a weekly basis. Prior to 1994, data were submitted in paper format, but 
between 1994 and 1998 participating practices were transferred to the current 
electronic reporting systemaea Consultations for specific diseases are extracted from 
the practice patient records using Read codes, which have been mapped to 
International Classification of Disease (ICD) codes. 
Between 1993 and 2006, approximately 70 practices participated in the surveillance 
scheme, covering a registered patient population of approximately 600 000 (Figure 
3.3). After additional practices were recruited in 2006, data are now collected from 
approximately 100 general practices across England and Wales, with a registered 
patient population of 900 000 (Figure 3.3). The participating practices are broadly 
representative of all practices in England and Wales in terms of geographical location 
and socio-demographic characteristicsaas 
Data on IID consultations have been collected since 1967485 Consultations for IID are 
defined as those assigned International Classification of Disease version 9 (ICD9) 
codes between 001 and 009 inclusive. No information on pathogen diagnoses is 
collected. The incidence of general practice consultations for IID has declined 
significantly in the last two decades, particularly amongst children aged less than five 
years (Figure 3.4)485. The reasons for this decline in consultations are unknown, 
although a concurrent increase in the incidence of IID consultations to secondary care 
services has been reported 485 
Data on general practice consultations for IID, occurring between 1993 and 2007, 
provided by the RCGP Research and Surveillance Centre, were used in the 
generalised linear regression analysis, presented in Chapter 7. 
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Figure 3.3 Size of registered patient population covered by the Royal College of 
General Practitioners surveillance scheme, 1993 to 2007. 
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Figure 3.4 Annual incidence of general practice consultations for IID in the Royal 
College of General Practitioners surveillance scheme, 1993 to 2007. 
N 
C 
O 
Co 
7 
N 
C 
O 
U 
O 
yC 
U 
.0 
.ß f0 
f0 j 
as 
0 ma 
G, o 
ca 
rný 
öCL 
U 
C 
C) 
C 
co 
C 
C 
Q 
150 
100- 
501 
o ý-o 
01 
,ýý,, h , 
§) ýýý ýý, 
ý 
ýý, 
ý 
o0ö oo oozy oo, o ooh ooýö ooý '` ', `N ý" `L `L `L LL 
Year 
59 
<5 years ý- 5-64 years o 65+ years 
Chapter 3 
3.3. Health Protection Agency National Surveillance of Laboratory- 
Confirmed Infections 
The Health Protection Agency (HPA) Centre for Infections receives voluntary reports of 
individual laboratory diagnoses, for a range of pathogens, from National Health Service 
(NHS) and HPA laboratories across England and Wales. These data are used to 
monitor trends in the frequency of disease caused by specific pathogens and to detect 
outbreaks. Electronic reporting was implemented in 1989. Each record provides 
diagnostic results for a single episode of illness in an individual patient, making it 
possible to exclude results from duplicate testing within a single patient episode. 
Information provided in each laboratory report record includes the organism identified; 
the diagnostic method used; patient age; the type of specimen e. g. faecal and lower 
gastrointestinal tract; the date of specimen collection; the date of specimen receipt at 
the diagnosing laboratory; and the source of the specimen e. g. general practice patient 
or outbreak investigation. Of these, only the organism, patient age, specimen type and 
the date of specimen receipt in the laboratory are available for all records, because of 
incomplete data entry by the laboratories submitting the reports. Reporting of all 
gastrointestinal pathogen diagnoses to the HPA national surveillance is non- 
mandatory, meaning that diagnoses are under-reported, with the degree of under- 
reporting varying between pathogens83. 
Figure 3.5 Methods used for norovirus diagnosis in the Health Protection Agency 
National Surveillance of Laboratory-Confirmed Infections, 1990 to 2007. 
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Abbreviations: RT-PCR, reverse transcription-polymerase chain reaction. 
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Figure 3.6 Weekly laboratory reports for norovirus in the Health Protection Agency 
National Surveillance of Laboratory-Confirmed Infections, 1990 to 2007. 
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The HPA publishes recommended diagnostic methods and testing policies in the 
National Standard Methods, for HPA and NHS laboratories in the UK486 487 The 
recommended methods and testing policies for the 19 common gastrointestinal 
pathogens included in the analysis in Chapter 7 are summarised in Table 3.5. The 
current National Standard Methods recommend use of enzyme-linked immunosorbent 
assay (ELISA) or RT-PCR for norovirus diagnosis, but prior to 2002 electron 
microscopy was still the main method reported with norovirus diagnoses in the HPA 
laboratory surveillance (Figure 3.5). Electron microscopy has a much higher detection 
limit than ELISA and RT-PCR, much lower throughput and requires highly trained 
technicians. Consequently, with the introduction of ELISA and RT-PCR in laboratories 
across England and Wales, it has been possible to test more specimens and the 
detection rates have improved; this is reflected in the substantial increases in the 
number of norovirus laboratory reports received by the HPA since 1990 (Figure 3.6). 
Whilst it is recommended in the National Standard Methods that all specimens from 
individuals with IID symptoms are screened for Salmonella spp., Campylobacter spp 
Shigella spp, and Escherichla coli 0157, testing for other pathogens is more selective. 
It is recommended that norovirus testing is carried out on all specimens from children 
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aged less than five years and adults aged 60 years and older, but only on specimens 
from children and adults aged between five and 64 years if they are part of a 
recognised IID outbreak (Table 3.5). In addition, the large number of norovirus 
outbreaks investigated in hospitals and other care settings each year in England and 
Wales, mean that the norovirus laboratory report data are dominated by specimens 
from outbreak investigations, rather than from patients with sporadic illness presenting 
to healthcare services. The problems arising from the under-representation of sporadic 
illness in the norovirus laboratory reports when using them to estimate the incidence of 
norovirus-associated IID are discussed further in Chapter 7. 
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Chapter 4: Diagnosing norovirus-associated infectious 
intestinal disease using viral load 
4.1. Background 
The only existing estimates of the incidence of norovirus-associated IID in the 
community in England are based on electron microscopy testing of IID cases in the 
Study of Infectious Intestinal Disease. Whilst electron microscopy was widely used for 
norovirus diagnosis in microbiology laboratories across England and Wales in the mid- 
1990s2, RT-PCR is now the method of choice for detecting norovirus in clinical 
specimens. RT-PCR detects norovirus at lower concentrations and is less affected by 
specimen quality and preparation than electron microscopy' 10,241,243,279,280 ; larger 
numbers of specimens can be tested simultaneously by RT-PCR, compared to the 
single throughput for electron microscopy; and electron microscopy requires highly 
trained and experienced technicians for optimal specimen preparation and virus 
identification 240,242.243 , whereas PCR 
is a now a commonly used technique in 
aea diagnostic laboratories and is largely automated after the assays are developed, ass 
However, whilst the use of RT-PCR has improved the detection rate of norovirus 
amongst IID cases, it is now widely documented that a substantial proportion of healthy 
individuals are also positive for norovirus when tested by RT-PCR5.12 24-43 190, including 
16% of the controls from the Study of Infectious Intestinal Disease specimen archive21. 
It is therefore unclear whether norovirus is actually causing illness in all IID cases who 
are positive by RT-PCR. It is possible that the norovirus infection is 'asymptomatic' in 
some IID cases, with another pathogen, detected or undetected, actually causing their 
symptoms. If RT-PCR positivity does not correlate well with norovirus-associated IID, it 
cannot be used alone to attribute illness to norovirus in IID cases. The poor diagnostic 
specificity of PCR, and the associated difficulties for clinical interpretation of test 
as1 results, have been highlighted for other viral pathogens ass 
Volunteer studies and histopathological investigations of norovirus infection have 
demonstrated differences in faecal viral load between symptomatically and 
asymptomatically infected individuals80 and that damage to the intestinal epithelium, 
caused by norovirus replication, may contribute to the mechanism of pathogenesis in 
norovirus infection5840. It is therefore biologically plausible that IID symptoms may be a 
result of high viral loads and that it may be possible to use viral load to indicate where 
norovirus is causing illness in naturally occurring infections. The aim of this analysis 
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was to use norovirus faecal viral load measurements to determine when illness is 
attributable to norovirus in III) cases. Specific objectives were to: (i) describe and 
compare the distribution of norovirus viral load in IID cases, diagnosed by electron 
microscopy and RT-PCR, and in asymptomatic controls; (ii) compare norovirus viral 
load between community and general practice IID cases, and between children and 
adults, and examine the seasonality of norovirus viral load; (iii) use receiver-operating 
characteristic (ROC) analysis to select an appropriate cut-off in viral load to identify 
where norovirus is the cause of illness in IID cases; and (iv) examine the effects of 
patient age on selection of the cut-off. 
4.2. Methods 
4.2.1. Specimens and testing 
Full details of recruitment and testing during the Study of Infectious Intestinal Disease 
were provided in Chapter 3. During the PCR retesting of the specimen archive, 2422 
IID cases and 2205 controls were tested for norovirus by RT-PCR and of these 834 IID 
cases and 361 controls were positive for norovirus by RT-PCR. The analyses in this 
chapter were based on the 718 norovirus positive IID cases and 199 norovirus positive 
controls for whom a Ct value was determined using real-time RT-PCR. Information 
about other pathogens diagnosed in these III) cases and controls during the original 
study (by bacterial culture, ELISA or light microscopy) was also used in the ROC 
analysis. Cases from the community cohort and the general practice case-control study 
were analysed together, except in the descriptive analysis, where Ct values in cases 
from the two study components were compared. The genogroup of norovirus was 
identified from the genogroup-specific RT-PCR results, as described in Chapter 3. 
The cycle threshold (Ct) value from the real-time RT-PCR was used as a proxy 
measure of faecal viral load. The Ct value is inversely proportional to the amount of 
virus present in the specimen, so the lower the Ct value the higher the faecal viral load. 
The real-time RT-PCR assay was run for 40 cycles, so the maximum possible Ct value 
for positive specimens was 39. Further description of the real-time RT-PCR process is 
provided in Appendix 1.1. 
4.2.2. Descriptive analysis 
The median Ct value and inter-quartile range were calculated for IID cases and 
controls and comparisons were made between the following groups using the rank-sum 
test in Stata 1049,: 
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Electron microscopy positive cases, RT-PCR positive cases and controls; 
ii. IID cases ascertained in the community cohort and in the general practice case- 
control study; 
iii. Cases aged less than five years and cases aged five years or older. 
The seasonality of norovirus Ct values was examined by comparing the median Ct 
value in IID cases and in controls across the months of the year. 
4.2.3. Receiver-operating characteristic analysis 
Receiver-operating characteristic (ROC) analysis was used to select a cut-off in the Ct 
values, to attribute disease to norovirus in IID cases. There is no gold standard test for 
diagnosing norovirus-associated IID. Microbiological and clinical characteristics were 
used to select suitable reference groups for the ROC analysis. The reference positive 
group must have Ct values representative of where norovirus is causing illness and the 
reference negative group must have Ct values representative of where norovirus is not 
causing any illness. 
4.2.3.1. Reference positive groups 
Three reference positive groups were selected and the ROC analysis was carried out 
separately using each group (Table 4.1). Reference Positive Group 1 included only IID 
cases who were norovirus positive by electron microscopy. The high viral loads 
required for detection by electron microscopy correspond to the levels of norovirus 
shedding during acute infection of experimentally inoculated volunteers and in 
individuals infected in point-source norovirus outbreakseo, 99.103.106,240 The electron 
microscopy positive IID cases are therefore very likely to have IID caused by norovirus. 
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Table 4.1 Inclusion criteria for the ROC analysis reference groups. 
Reference group Inclusion Criteria 
Reference Positive 1 1. HD 
2. Norovirus detected by electron microscopy 
3. Norovirus infection confirmed by RT-PCR 
Reference Positive 2 1. IID 
2. Norovirus detected by electron microscopy 
3. Norovirus infection confirmed by RT-PCR 
Or 
1. IID 
2. Electron microscopy negative 
3. Norovirus detected by RT-PCR 
4. No other pathogen detected 
5. Specimen collected within 3 days of symptom 
onset 
Reference Positive 3 1. IID 
2. Norovirus detected by electron microscopy and/or 
RT-PCR 
3. Negative for Campylobacter spp., Salmonella 
spp. and Shigella spp. by bacterial culture and 
Cryptosporidium spp. by light microscopy (and 
rotavirus A by ELISA in children aged <5 years only) 
Reference Negative 1 1. No history of IID in previous 3 weeks 
2. Norovirus detected by RT-PCR 
Reference Negative 2 1. IID 
2. Norovirus detected by RT-PCR 
3. Infection with Salmonella spp., Campylobacter 
spp. or Shigella spp. detected by bacterial culture or 
Cryptosporidium spp. detected by light microscopy 
(or rotavirus A by ELISA in children aged <5 years 
only) 
Abbreviations: ELISA, enzyme-linked immunosorbent assay; IID, infectious intestinal disease; RT-PCR, 
reverse transcription-polymerase chain reaction. 
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In Reference Positive Group 2, IID cases who were electron microscopy negative and 
subsequently RT-PCR positive were included in addition to electron microscopy 
positive IID cases, providing that they had no other pathogens identified in their stool, 
by either the original diagnostic methods (bacterial culture, ELISA, light and electron 
microscopy) or PCR, and that they had collected a specimen early in their illness (less 
than three days after symptom onset) (Table 4.1). These restrictions on the presence 
additional infections and specimen collection timing were used to ensure that norovirus 
was the most likely cause of illness in these IID cases, so that their faecal viral loads 
were representative of acute symptomatic norovirus infection. This second reference 
positive group was selected to assess whether using only electron microscopy positive 
cases in Reference Positive Group 1 may have biased the cut-off to lower Ct values 
(higher viral loads); if the same cut-off was selected using Reference Positive Group 1 
and Reference Positive Group 2, this suggests that using only electron microscopy 
positive cases in Reference Positive Group 1 did not bias the cut-off. 
A third reference positive group was selected that does not use electron microscopy 
diagnosis as an inclusion criterion (Table 4.1). Electron microscopy is no longer used 
for routine norovirus diagnosis in clinical laboratories in the UK, so cannot be used to 
select a reference positive group in future work to validate the cut-offs developed here. 
However, it is important that clinical virology laboratories across the UK independently 
select Ct value cut-offs for their norovirus real-time RT-PCR assays, because there is 
substantial variability between UK virology reference laboratories in the Ct values 
produced from standard reference specimens495; the same cut-off may not be 
appropriate for all laboratories because of these differences in assay performance. In 
addition, if the cut-off based approach to diagnosing norovirus-associated IID is to be 
applied more widely in routine clinical diagnosis in other countries and with other real- 
time RT-PCR protocols, it is important for laboratories to be able to independently 
validate the cut-off selected here. Reference Positive Group 3 included IID cases who 
were RT-PCR positive for norovirus (including those previously positive by EM) and 
were negative for other bacterial, protozoal and viral pathogens that are routinely 
detected in clinical diagnostic algorithms for sporadic'IID in National Health Service and 
Health Protection Agency laboratories in the UK488'496 (Table 4.1). This restriction was 
used to make norovirus the most likely cause of illness in these IID cases, so that their 
Ct values were representative of symptomatic norovirus infection. Furthermore, 
because this third reference group is not reliant on electron microscopy diagnosis, it 
serves as another check of the sensitivity of the cut-off to the use of electron 
microscopy positive cases in Reference Positive Group 1. 
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4.2.3.2. Reference negative groups 
Two reference negative groups were selected to have Ct values representative of 
where norovirus is not causing illness (Table 4.1). Reference Negative Group I 
included norovirus-infected healthy controls (infection was defined as any RT-PCR 
positive result). Reference Negative Group 2 included norovirus infected IID cases with 
a bacterial infection diagnosed by culture, or rotavirus infection diagnosed by ELISA 
(for children aged less than five years only). Bacterial culture without enrichment may 
indicate the presence of high concentrations of viable bacterial cells, meaning that the 
bacteria detected are likely to be causing illness. Similarly, rotavirus ELISA has a high 
detection limit that correlates well with disease 497,498 , meaning that rotavirus 
is probably 
the cause of illness in ELISA-positive individuals. Therefore IID cases positive for these 
other pathogens by bacterial culture or ELISA are likely to have norovirus Ct values 
representative of where norovirus is not causing any illness. This second reference 
negative group was selected to explore whether it is suitable for identifying a cut-off in 
conjunction with Reference Positive Group 3, because specimens from healthy controls 
are not routinely received in clinical laboratories, so cannot be used as the reference 
negative group if clinical virology laboratories are to use this method to develop a cut- 
off for their real-time norovirus RT-PCR assays. 
4.2.4. Cut-off selection 
The diagnostic sensitivity and specificity were calculated for each potential cut-off in the 
range of Ct values, by comparison to the reference group classification, and an 
empirical ROC plot created using Stata 10asa Further explanation of the production and 
interpretation of a ROC curve is provided in Appendix A2.1. The Youden index 
(sensitivity + specificity-1) was calculated at each Ct value and the maximum Youden 
index was used to identify the optimal Ct value cut-off49 50' 
It may not be valid to directly compare the Ct values between the two norovirus 
genogroups because of differences in the efficiency of the genogroup specific real-time 
RT-PCR assays. A particular Ct value may represent a different underlying norovirus 
concentration in the stool specimen for the two genogroups, meaning that the same 
cut-off may not be appropriate. Therefore, the ROC analysis was carried out separately 
for norovirus genogroup I and genogroup II. 
Due to the smaller numbers of genogroup I noroviruses, the ROC analysis was carried 
out only using Reference Positive Group 1 and Reference Negative Group 1, for all age 
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groups together. For genogroup II noroviruses, the ROC analysis was carried out using 
all of the reference groups shown in Table 4.1. The genogroup II ROC analysis using 
Reference Positive Group 1 and Reference Negative Group 1 was repeated separately 
for children aged less than five years and for children and adults aged five years or 
older. 
4.3. Results 
4.3.1. Descriptive analysis 
Ct values were generated for 718 IID cases and 199 healthy controls; 119 (17%) of the 
IID cases were previously positive by electron microscopy and 597 (83%) were 
negative by electron microscopy but subsequently positive by RT-PCR. IID cases were 
aged up to 94 years and controls up to 84 years; 40% of IID cases and 60% of controls 
were aged less than five years. Approximately 80% of both IID cases and controls were 
infected with norovirus genogroup II (Table 4.2). 
Table 4.2 Norovirus genogroup detected in IID cases and controls with real-time RT- 
PCR cycle threshold values determined. 
Number' (percent) 
Total 
Genogroup I Genogroup II Mixed genogroup I& genogroup II 
IID cases All 71(10) 589(82) 56(8) 718 
<5 years 19 (6.5) 255 (88.5) 14 (5) 288 
a5 years 52 (12) 334 (78) 42 (10) 430 
Controls All 18(g) 159 (80) 22(11) 199 
<5 years 14 (11.5) 92(77) 14 (11.5) 120 
Z5 years 4 (5) 67 (85) 8 (10) 79 
The norovirus genogroup was not recorded for two IID cases. 
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The median Ct value was lower in IID cases (median 34) than in controls (median 37) 
(Table 4.3). The difference compared to controls was greatest for IID cases positive by 
electron microscopy (median 24) (Table 4.3); there was very little overlap in the 
distribution of Ct values in electron microscopy positive IID cases and controls (Figure 
4.1). The distribution of Ct values for the IID cases who were negative by electron 
microscopy and subsequently RT-PCR positive (median 35) overlapped substantially 
with the controls, although a small proportion had the higher viral loads seen in the 
electron microscopy positive IID cases (Figure 4.1, Table 4.3). The pattern was the 
same in children and adults (Appendix A2.2) and in genogroup I and genogroup II 
infections (Table 4.3, Appendix A2.3). 
Figure 4.1 Real-time RT-PCR cycle threshold values in IID cases and controls. `EM 
cases' are IID cases positive by electron microscopy, 'RT-PCR cases' are IID cases 
negative by electron microscopy and subsequently positive by RT-PCR. Sample sizes: 
EM cases = 119, RT-PCR cases = 597, controls = 199. 
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Abbreviations Ct, cycle threshold; EM, electron microscopy; RT-PCR, reverse transcription-polymerase 
chain reaction. 
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Whilst the median Ct values for both IID cases and controls were slightly lower in 
genogroup I compared to genogroup II there was no strong statistical evidence of a 
difference in the distribution of the Ct values (rank-sum P: IID cases=0.2; 
controls=0.07). Similarly, there was no strong evidence of a difference in Ct value 
distribution between IID cases aged less than five years and IID cases aged five years 
and older (Table 4.4, Appendix A2.4), or between IID cases ascertained in the 
community cohort and those from the general practice case-control study (Table 4.4, 
Figure 4.2). However, the median Ct value was lower in children aged less than five 
years in the community cohort compared to those in the general practice case-control 
study (Table 4.4). 
The median Ct value in IID cases ranged from 30, in September, to 36 in February, 
although there was no clear seasonal pattern (Appendix A2.5). Similarly, the median Ct 
value in controls varied between 36 and 39 throughout the year, but there was no 
seasonal pattern (Appendix A2.5). 
Figure 4.2 Real-time RT-PCR cycle threshold values in IID cases from the community 
cohort and general practice case-control study. Dark grey bars show IID cases from the 
community cohort (n=174); white bars show IID cases from the general practice case- 
control study (n=544). 
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Abbreviations: Ct, cycle threshold. 
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Table 4.4 Comparison of real-time RT-PCR cycle threshold values in IID cases 
(children vs. adults, community cohort vs. general practice case-control study. ) The 
rank-sum tests compare child cases (<5 years) to older children and adults (aged 5 
years and older) and compare community cohort cases to general practice cases. 
Rank-sum test 
Median Ct Ct value Sample Pvalue Group of cases value IQR size comparing case 
groups 
Children <5 years 34 25 - 37 288 0.8 
Children & adults z5 years 33 25 - 37 430 
Community cohort - all cases 32 24 - 36 174 0.08 
General practice - all cases 34 25 - 37 544 
Community cohort - <5 years 31 22 - 35 59 0.02 
General practice - <5 years 34 26 - 37 229 
Community cohort - Z5 years 33 24 - 37 115 0.6 
General practice - Z5 years 33 25 - 37 315 
Community cohort - EM positive 
cases 23 22 - 26 29 0.2 
General practice - EM positive 
cases 25 22 - 28 90 
Abbreviations: Ct, cycle threshold; EM, electron microscopy; IQR, interquartile range 
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4.3.2. ROC analysis 
The numbers of IID cases and controls meeting the inclusion criteria for each of the 
reference groups are shown in Table 4.5. The Ct value distributions for each of the 
reference groups, the Youden index values and the ROC curves for each ROC 
analysis are provided in Appendices A2.6 to A2.10. 
4.3.2.1. Optimal reference groups - Reference Positive Group 1 and Reference 
Negative Group 1 
The optimal cut-off for attributing illness to genogroup II noroviruses in IID cases was at 
Ct value 31 (Table 4.5), corresponding to the maximum Youden index for the ROC 
analysis with Reference Positive Group 1 and Reference Negative Group 1 (Figure 4.4 
and Figure 4.5). Using this cut-off, IID cases with norovirus genogroup II Ct values of 
31 or below are classified as 'positive' for norovirus-associated IID: they have disease 
caused by norovirus. IID cases with Ct values above 31 are classified as 'negative' for 
norovirus-associated IID: they have IID but their norovirus infection was not the cause 
of their symptoms. 
Figure 4.3 Real-time RT-PCR cycle threshold values in reference positive group 1 and 
reference negative group 1 for genogroup II ROC analysis, all ages. Grey bars show 
reference positive group 1 (n=92); white bars show reference negative group 1 
(n=1 59). 
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The optimal cut-off for genogroup II in children aged less than five years was at Ct 
value 30, whereas for older children and adults it was at Ct value 33 (Table 4.5, 
Appendices A2.6 & A2.7). There was some evidence of a difference in Ct value 
distribution between electron microscopy positive IID cases in these two age groups 
(rank-sum test p=0.036), with the median in children aged less than five years at Ct 
value 23 and at Ct value 25 for older children and adults. This indicates that the 
different cut-offs may reflect a true difference in viral load, during symptomatic 
infection, between these age groups. 
The optimal cut-off for attributing illness to genogroup I noroviruses was at Ct values 
29-30 (Table 4.5, Appendix A2.8). 
Using these cut-offs, approximately 16% of IID cases in the community had norovirus- 
associated IID, and 13% of IID cases who consulted their general practitioner were 
norovirus cases (Table 4.6). 
Figure 4.4 Youden index for genogroup II ROC analysis, all ages, using reference 
positive group 1 and reference negative group 1. 
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Figure 4.5 ROC plot for genogroup II ROC analysis, all ages, using reference positive 
group 1 and reference negative group 1. 
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4.3.2.2. Alternative reference groups 
The optimal genogroup II cut-off (all ages) was also at Ct value 31 when RT-PCR 
positive cases with no other pathogen detected and early specimen collection were 
included in the reference positive group (Reference Positive Group 2) (Table 4.5, 
Appendix A2.9). The optimal genogroup II cut-off was also at Ct value 31 when 
norovirus positive IID cases who were negative for other commonly tested enteric 
pathogens were used as the reference positive group (Reference Positive Group 3), 
and the bacterial culture positive IID cases were used as the reference negative group 
(Reference Negative Group 2) (Table 4.5, Appendix A2.10). 
4.3.2.3. Discriminatory power of Ct values 
In the analysis of both genogroup I and genogroup II norovirus infections, the Ct values 
discriminated well between Reference Positive Group 1 and Reference Negative Group 
1, because the area under the ROC curve was close to the maximum value of one 
(Table 4.5, Figure 4.5). This is consistent with the highly separated distributions of Ct 
values in these reference groups (Figure 4.3). The discriminatory power of the Ct values 
was poorer for the ROC analysis where RT-PCR positive cases with no other pathogen 
78 
0.00 0.25 0.50 0.75 1.00 
1- Specificity 
r- 
m 
y 'C 
7y 
N 
"i 
CL 
' Co 
U0 aý c 
d 10 L 
F- ý- 
C NC 
N 
c) 
U 
U 
Vö 
G) U) 
Q 
N 
ac i rn 
C 
N 
ÖC 
}- 
co Q E 
Q. 
0 
n 
0 
rn 
a) 
rn 
S. 
Cl 
yO 
N 
0) 
It 
ya 
2ö 
ö 
o 
oc 
00 Z 0) 
Co 
(7) 
rn r- 
C) 
ö n ý 0) 00) 00) i o o c 
ö ö ö ö d ö 
d d 0 ö ö 
8 S 1 1 
3 3 LO a i r- CD r- c; v ö v ö v ö v ö ý ö v 
CO 0) (0 CY) (0 CC 
0 o c o 0 0 
0 0) 
6' 
r 
r r- eý O O O 
1 1 1 1 1 1 
Ov Ov Ov Ov Ö O 
ti 
Ö Ö Ö Ö Ö Ö 
((D CO 00) fD 
N 
Ö Ö Ö Ö Ö Ö 
Qe2 0 ei 
) c") MMM N) 
N 
T 
a Q LO V 
U") 
N Q 
> >: 
00öW 
ac ac 
ääWä 
CY- X cc 
CL 
00 
rn ä) 00 c 
C7 0 
NT- 
(D 
Cl) C14 
a) 
N0 N 0) 
0 () 0 4) 
ac nc 
ww 0) Q ww (D 43) it ft 0: 0: 
a a 3 3 
2 2 
0) c) 
0 0 
C C 
Q/ Q) 
0 0 
rn 
Chapter 4 
detected and early specimen collection were included in the reference positive group 
(Reference Positive Group 2, genogroup II only) because the AUC was reduced to 0.87 
(Table 4.5, Appendix A2.9). The discriminatory power was very low for distinguishing 
between Reference Positive Group 3 and Reference Negative Group 2 (genogroup II 
only) because the area under the curve was close to 0.5 (Table 4.5, Appendix A2.10), 
which is indicative of a test with no discriminatory power. 
Table 4.6 Percent of III) cases classified as norovirus cases using different diagnostic 
methods: (1) all electron microscopy positive IID cases; (2) all electron microscopy or 
RT-PCR positive IID cases; (3) IID cases with a Ct value at or below the age group 
specific cut-offs. 
Community cohort General practice 
All 
Children . Children All Children Children All 
aged <5 & adults aged <5 & adults (n=2422) 
years aged k5 years aged k5 
years years 
(n=120) (n=397) (n=517) (n=522) (n=1383) (n=1905) 
(1) EM 10.8 6.0 7.2 10.3 4.6 6.1 6.4 
(2) EM 55.8 36.3 40.8 45.8 27.8 32.7 34.4 
and/or 
RT-PCR 
(3) Ct 20.0 15.4 16.4 14.2 11.3 12.1 13.0 
value at 
or below 
cut-off 
Abbreviations: EM, electron microscopy; RT-PCR, reverse transcription-polymerase chain reaction. 
' Ct values were available for 86% of IID cases positive for norovirus by gel-based RT-PCR; these 
proportions are not adjusted for these additional cases who could not be classified using the Ct value cut- 
off 
h At Ct value 30 for children aged <5 years and Ct value 33 for older children and adults aged 25 years 
with genogroup II norovirus infection and at Ct value 30 for IID cases of all ages with genogroup I infection. 
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4.4. Discussion 
In this analysis, the difference in viral load between naturally occurring symptomatic 
and asymptomatic norovirus infection was described. Whilst healthy controls tended to 
have lower norovirus viral loads than IID cases, a substantial proportion of IID cases 
who were only norovirus positive by RT-PCR had viral loads equivalent to those in 
healthy controls. This supports the hypothesis that norovirus is probably not always the 
cause of illness where it is detected by RT-PCR. ROC analysis was used to select an 
appropriate cut-off in viral load (real-time RT-PCR Ct values) for attributing disease to 
norovirus in IID cases. The optimal cut-off for genogroup II noroviruses was at Ct value 
31, with a slightly lower cut-off (Ct value 30) selected in young children and a slightly 
higher cut-off (Ct value 33) selected in older children and adults. The optimal cut-off for 
genogroup I noroviruses was at Ct value 29 to 30. 
Using these cut-offs, approximately one third (30%) of the IID cases originally negative 
by electron microscopy, but positive by RT-PCR, would be classified as cases of 
norovirus disease, indicating that electron microscopy significantly under-diagnosed 
norovirus cases in the Study of Infectious Intestinal Disease. This is in contrast to the 
results of a similar analysis conducted for rotavirus497 (Appendix 7.1). ELISA was used 
for rotavirus diagnosis during the Study of Infectious Intestinal Disease, and indeed is 
still widely used for diagnosing rotavirus-associated IID; the WHO recommend the use 
of ELISA diagnosis in baseline burden-of-disease studies prior to introduction of 
rotavirus vaccines502. The analysis of rotavirus viral load showed that ELISA positivity 
correlates extremely well with rotavirus disease, based on the relative distribution of Ct 
values in IID cases and controls; no IID cases with rotavirus infection diagnosed only 
by RT-PCR had the high viral loads seen in ELISA positive IID cases. The difference in 
correlation with viral IID between electron microscopy and ELISA probably reflects the 
greater dependence of a positive electron microscopy diagnosis on specimen quality 
and preparation, in addition to viral load, which affects diagnosis by either method' 3,240 
241,243.245.246 
A major strength of the data generated from the Study of Infectious Intestinal Disease 
specimen archive retesting is the availability of specimens from healthy controls. There 
are few community studies of IID with large control groups available, but they are 
essential for interpreting the RT-PCR results in IID cases. Norovirus is detected at such 
high prevalence in healthy individuals by RT-PCR that simple detection in IID cases 
may not be sufficient to give a confident diagnosis of norovirus-associated IID. It is 
essential that the results of norovirus RT-PCR assays can be appropriately interpreted, 
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to increase the specificity of diagnosis, both in clinical diagnostic services for individual 
patients and for generating accurate population-level estimates of norovirus disease 
burden. The Ct value cut-off provides a major improvement in specificity compared to 
the current qualitative use of RT-PCR in norovirus diagnosis because by using the Ct 
value cut-off it is possible to exclude IID cases who are unlikely to have disease 
caused by norovirus. 
It is inevitable that there will be some misclassification of individual IID cases who have 
norovirus Ct values close to the cut-off, especially because the Youden index did not 
show a distinct peak in the ROC analyses, with similar index values across a range of 
Ct values around the selected cut-offs (Figure 4.4, Appendices A2.6 to A2.10). 
However, in population-level studies of norovirus-associated IID incidence, a small 
amount of misclassification will have little impact on the overall estimates because the 
number of misclassified cases on either side of the cut-off is likely to be similar. It may 
also be possible to incorporate the uncertainty in the cut-off into the incidence estimate. 
In a clinical setting, where the focus is on diagnosing the cause of illness to guide 
individual patient care, it is important that other clinical and epidemiological information 
is also considered in the diagnosis of disease aetiology, especially for patients with 
norovirus Ct values close to the cut-off, to prevent misdiagnosis based solely on viral 
load. 
The specimens from the Study of Infectious Intestinal Disease archive were originally 
collected during the mid-1990s and the viral RNA may have degraded during the 
prolonged storage and repeated freeze-thaw cycles for retesting. Therefore the cut-off 
developed here may not be directly applicable to real-time RT-PCR results from fresh 
specimens without further validation. Similarly, the cut-off should not be applied to 
assays with different protocols, because the Ct values may not equate to the same viral 
load per gram of stool. It is unlikely, however, that there will have been differential 
degradation of RNA between specimens during storage, so it is still valid to compare 
the viral load between specimens in this collection, and to assume that the relative 
differences observed between IID cases and controls are a true reflection of 
symptomatic and asymptomatic infection. Indeed, the differences in viral load between 
the natural symptomatic and asymptomatic norovirus infections described in this 
analysis confirm observations from experimental volunteer inoculation studies80. 
Converting the Ct values into actual viral loads per gram of stool would provide cut-offs 
that can be used with different real-time RT-PCR protocols, but there are a number of 
limitations to this approach: (1) generation of standard curves for the conversion of Ct 
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values into actual viral loads is time-consuming and resource-intensive and needs to 
be regularly repeated in case of any changes in assay protocol or conditions; (2) whilst 
the efficiency of the real-time PCR has been characterised (Gray, J. personal 
communication), the exact efficiency of the extraction and reverse transcription steps 
are more difficult to quantify260 261 but will greatly affect the relationship between Ct 
values and viral loads; (3) conversion to viral loads will not remove the need for 
independent verification of the cut-offs because of the possibility of partial RNA 
degradation during storage, as described above. Therefore, the cut-offs have been 
specified using Ct values, which is sufficient for further analysis of the data from the 
Study of Infectious Intestinal Disease in this thesis, and other clinical laboratories are 
encouraged to independently develop cut-offs for their own assays. 
In order to facilitate independent validation of the cut-offs by clinical diagnostic 
laboratories, alternative reference groups were selected that did not use specimens 
from healthy controls or electron microscopy diagnosis. The same all-age genogroup II 
cut-off was selected using both the optimal reference groups (electron microscopy 
positive IID cases and healthy controls) and these alternative reference groups. The 
area under the ROC curve for the alternative reference groups was very low, possibly 
because the viral loads in many of the IID cases in Reference Positive Group 3 were 
not representative of symptomatic norovirus infection; this is reflected in the low 
sensitivity for the cut-off using Reference Positive Group 3 (Table 4.5). Despite this low 
discriminatory power, the same cut-off was selected using the alternative reference 
groups, indicating that these are appropriate selection criteria for future studies without 
a control group or electron microscopy testing. 
The cut-off in viral load should only be applied to specimens collected from IID patients 
during acute symptoms, when the viral load is representative of disease aetiology. After 
symptoms resolve in norovirus-associated IID the viral load quickly drops to levels seen 
in asymptomatic infection80. At the population level, the predictive value of the cut-off 
will decrease as the proportion of specimens collected after symptom resolution 
increases, because the false-negative rate will increase. However, this problem is not 
specific to the norovirus Ct value cut-off; the predictive value of any diagnostic test that 
directly detects the target pathogen in a specimen will be affected by the timing of 
specimen collection 503 
Whilst genotype-specific differences in the efficiency of the norovirus real-time RT-PCR 
assay have been identified (see Chapter 3), the norovirus specimens from the Study of 
Infectious Intestinal Disease archive have not been genotyped. It was therefore only 
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possible to take account of broad differences between the genogroups in the 
underlying viral load represented by specific Ct values. However, there is substantial 
variation in assay efficiency between genotypes within norovirus genogroup I 
(Appendix A1.3), meaning that the degree of misclassification in genogroup I may be 
high and it may not be appropriate to use the cut-off identified here for classification of 
disease aetiology in individual IID cases. There were also a very small number of 
genogroup I specimens meeting the inclusion criteria for the ROC analysis reference 
groups, meaning that there is greater uncertainty in the cut-off selected for genogroup 
1. The real-time RT-PCR assay also has poorer efficiency (higher detection limit) for 
two of the rarer genotypes in genogroup II (GII-7 and GII-8) (Appendix A1.3); however, 
at a population level, the degree of misclassification is likely to be small because of the 
low prevalence of GII-7 and GII-8206,206,504,505 and the misclassification would be 
conservative, i. e. lID cases with disease caused by these two genogroups of norovirus 
would be misclassified as having disease caused by another pathogen. The distribution 
of norovirus genogroups was very similar in IID cases and healthy controls, meaning 
that the difference in assay efficiency between the genogroups is not responsible for 
the differences in viral load between 1113 cases and controls. 
The causal relationship between disease symptoms and norovirus viral load has not 
been established. However, if the relationship between the occurrence of disease and 
viral load is consistent, regardless of whether high viral loads are a cause or a 
consequence of disease, viral load will be a good marker of norovirus-associated IID 
and the approach developed here is valid. Viral load is routinely used to predict 
outcome and guide clinical management for a number of viruses that cause chronic 
infections, such as Epstein-Barr virus506 and cytomegalovirus507 in transplant patients, 
HIV508, hepatitis C509 and Human T-Lymphotrophic Virus 510. However this is the first 
time that viral load has been used to diagnose enteric viruses as the cause of acute 
IID. The method may also be useful for viral pathogens linked to other disease 
syndromes, such as acute respiratory infections, for which the same problems with the 
interpretability of PCR have been described 492 
4.5. Summary 
Examination of norovirus viral load in IID cases and controls from the Study of 
Infectious Intestinal Disease has demonstrated that it is unlikely that all IID cases with 
norovirus detected by RT-PCR actually have disease caused by norovirus. The 
difference in viral load between IID cases and controls has been used to select an 
appropriate cut-off for attributing disease to norovirus in IID cases. Using the viral load 
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measurements and the cut-off, there was a substantial increase in the number of IID 
cases with norovirus-associated IID compared to electron microscopy diagnosis in the 
original study. It is therefore important to update the estimates of norovirus-associated 
IID incidence from the Study of Infectious Intestinal Disease, using this new diagnostic 
method and to re-examine risk factors for norovirus-associated IID using the larger and 
more representative group of cases. This work is described in subsequent chapters. In 
the next chapter, the characteristics of both the norovirus-associated IID cases and the 
asymptomatic norovirus infections in healthy controls are described. 
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Chapter 5: Characteristics of symptomatic and 
asymptomatic norovirus infection 
In Chapter 4, norovirus viral load measurements were compared between IID cases 
and healthy controls, to select a cut-off for identifying IID cases with disease caused by 
norovirus. In this chapter the characteristics of the norovirus cases identified using the 
Ct value cut-off are described and the prevalence and significance of co-infection with 
other pathogens is examined. The prevalence and characteristics of asymptomatic 
norovirus infections are also described. 
5.1. Background 
5.1.1. Characteristics of flora virus-associated lID 
The predominant symptoms of norovirus-associated IID are diarrhoea and vomiting. A 
high prevalence of vomiting amongst cases is a distinguishing characteristic of 
norovirus outbreaks62,5" and a higher frequency of vomiting is reported amongst young 
children with norovirus-associated IID compared to older children and adults84.85,87 
Other frequently reported symptoms include nausea, abdominal pain, muscle ache, 
headache and fever", 62,84,92.94,104,108,414,512. Symptoms last for 24 to 48 hours in 
otherwise healthy adults60' e4,85.92,94,414, but many studies report longer duration of 
symptoms in young children and the elderly92.93,104,108,512,513 One study has suggested 
that viral loads may be correlated with the duration of symptoms102. 
Occasionally, more severe symptoms and some deaths may occur in very young 
children and the elderly with norovirus-associated IID15.16,16-18.88,90,338 A recent 
systematic review indicated that up to 30% of children presenting to hospital 
emergency services with acute IID around the World may be infected with norovirusa9, 
and it is estimated that norovirus may cause up to 3000 hospitalizations amongst the 
elderly in the UK each year339. Several studies have reported that children presenting 
to hospital with norovirus-associated IID suffer symptoms of comparable severity to 
children with rotavirus-associated IID86.88 
5.1.2. Characteristics of asymptomatic norovirus infections 
Norovirus infection has been identified in a substantial proportion of individuals with no 
IID symptoms in several community-based studies, with crude prevalences of up to 
16% reported in high income countries5.21 22.24. Volunteer studies have also 
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demonstrated the occurrence of norovirus infection with no concurrent IID after 
experimental inoculation 56,75,77-80,82 Whilst these volunteer individuals experienced no 
diarrhoea or vomiting, some reported other symptoms such as headache, fever, 
muscle ache, abdominal pain and nausea. 
5.1.3. Gastrointestinal pathogen co-infections 
Co-infection with two or more gastrointestinal pathogens is frequently reported from 
studies of IID, in both high and low income countries345.514-532 Whilst some studies 
have reported potentially poorer clinical outcomes in individuals infected with multiple 
pathogens533.534, the epidemiological relevance of these co-infections remain 
undetermined. Co-infections may be caused by epidemiological mechanisms, such as 
common transmission routes, or by host-level biological factors leading to increased 
susceptibility to infections. However, many gastrointestinal pathogens are commonly 
found infecting healthy individuals as well as individuals with IID21; with such high 
population prevalence, co-infections may occur by chance alone. It is therefore 
important to use statistical methods to examine whether particular pairs of pathogens 
are found co-infecting more often than expected by chance alone, although few studies 
have used such an approach53s The null hypothesis in such statistical analyses is that 
the pathogens are independently distributed across individuals in the study population; 
evidence of deviations from this null distribution may indicate the existence of one or 
more epidemiological and biological mechanisms of co-infection. 
5.1.4. Aims and objectives 
The aims of this analysis were to describe the characteristics of symptomatic and 
asymptomatic norovirus infection in the Study of Infectious Intestinal Disease specimen 
archive and to examine the prevalence and significance of co-infections in norovirus 
cases and asymptomatic norovirus infections. Specific research objectives were to: 
Describe the age- and season-specific prevalence of asymptomatic norovirus 
infection in the population in England; 
ii. Describe the symptoms experienced by norovirus cases and asymptomatic 
norovirus infections, with comparison to norovirus negative healthy controls; 
iii. Describe the prevalence of additional pathogen co-infections in norovirus cases 
and asymptomatic norovirus infections; 
87 
Chapter 5 
iv. Investigate whether the prevalence of additional pathogens in norovirus cases 
and asymptomatic norovirus infections is greater than that expected from the 
population prevalence of these pathogens, i. e. whether particular pathogens are 
detected in norovirus cases or asymptomatic norovirus infections more often 
than expected by chance. 
5.2. Methods 
5.2.1. Specimens and testing 
Recruitment of participants into the Study of Infectious Intestinal Disease was 
described in Chapter 3. All 2205 controls and 2422 IID cases from the specimen 
archive were included in this analysis. For this analysis, controls who had been free of 
diarrhoea and vomiting for at least 10 days prior to recruitment were considered 
asymptomatic with respect to IID, although they may have experienced other 
symptoms during that period and may also have experienced diarrhoea or vomiting 
prior to this 10-day exclusion period. IID cases from the community cohort and general 
practice case-control study were analysed together, except where disease severity was 
compared between cases ascertained through these different routes. Full diagnostic 
results for all of the pathogens targeted in the original and PCR retesting were used in 
the analysis of co-infections. 
5.2.2. Case and control definitions 
Cases of norovirus-associated IID ('norovirus cases') were: 
IID cases infected with genogroup II noroviruses, who had a Ct value 
determined by real-time RT-PCR testing that was equal to or less than the age- 
specific Ct value cut-offs described in Chapter 4 (Ct value 30 for children aged 
less than five years, Ct value 33 for children and adults aged five years and 
older); 
Or 
ii. IID cases infected with genogroup I noroviruses, detected by electron 
microscopy and confirmed by RT-PCR. 
'Asymptomatic norovirus infections' were: 
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Controls who tested positive for norovirus by electron microscopy and/or RT- 
PCR. 
IID cases with disease caused by a pathogen other than norovirus were: 
IID cases who tested negative for norovirus by electron microscopy and RT- 
PCR. 
'Norovirus negative controls' were: 
Controls who tested negative for norovirus by electron microscopy and RT- 
PCR. 
The genogroup I cut-off was not used because it is unlikely that it would accurately 
identify individual IID cases with disease caused by genogroup I noroviruses, due to 
the small sample size for the genogroup I ROC analysis and the problems with variable 
efficiency of the real-time RT-PCR assay between genotypes in genogroup I. Only 
those genogroup I infected IID cases who had been diagnosed by electron microscopy 
were included in the analysis because the high viral loads required for detection of 
norovirus by electron microscopy correlate with norovirus shedding during acute 
norovirus-associated III) in experimentally inoculated volunteers80,240 
5.2.3. Community prevalence of asymptomatic norovirus infections 
The age-specific prevalence of norovirus infection (determined by RT-PCR testing) 
amongst controls from the Study of Infectious Intestinal Disease specimen archive was 
calculated. The age-adjusted prevalence of asymptomatic norovirus infection in the 
community in England was calculated by standardisinge the prevalence in the study 
population against the mid-1994 population estimate for England, obtained from the 
Office for National Statistics, UK. The age-adjusted, monthly prevalence of 
. asymptomatic norovirus 
infection was calculated from the prevalence amongst children 
aged less than five years and amongst older children and adults (aged five years or 
older) in each month, by standardizing against the mid-1994 population estimate for 
England. 
' Weighted sum of the age specific prevalence (age groups shown in Figure 5.1); weights are the 
proportion of the population of England (1994 mid-year estimate) in each age group. 
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5.2.4. Description of symptoms in norovirus cases and asymptomatic 
norovirus infections 
Norovirus cases, asymptomatic norovirus infections and norovirus negative controls 
provided details of gastrointestinal and non-specific symptoms in the epidemiological 
questionnaire (Table 3.1), although details of fever and nausea were not collected from 
controls. Appendix A3.1 shows the symptoms that both IID cases and controls were 
asked to report. IID cases were asked to report symptoms experienced at the time of 
their illness and controls were asked to report symptoms occurring in the previous 
three weeks before questionnaire completion (Table 3.1). In addition to reporting the 
presence of symptoms, IID cases were also asked to report the duration (in days) of 
any symptoms experienced and the maximum number of diarrhoeal and vomiting 
episodes in a given 24-hour period during their illness. 
An adapted version of the Vesikari severity score536 was used to summarise the 
severity of symptoms in norovirus cases. Four components of the Vesikari score were 
used: duration of diarrhoea; duration of vomiting; maximum number of diarrhoeal 
episodes per 24 hours; and maximum number of vomiting episodes per 24 hours. Each 
component had up to three points, with a minimum possible score of three and a 
maximum score of 12 (Table 5.1). 
The prevalence, severity and duration of gastrointestinal symptoms were compared 
between norovirus cases and IID cases with disease caused by other pathogens. This 
comparison was used to determine whether vomiting, which is recognised as a 
characteristic of norovirus outbreaks, is a distinguishing feature of norovirus-associated 
IID in the community and to investigate whether sporadic, community-acquired 
norovirus-associated IID is mild and self-limiting in comparison to IID caused by other 
pathogens. Symptom prevalence, severity and duration were also compared between 
norovirus cases who were positive by electron microscopy and those identified only by 
the Ct value cut-off, to ascertain whether any clinical features correlate with electron 
microscopy positivity and therefore whether the electron microscopy positive cases, 
which were used to define the Ct value cut-off, differ systematically from those 
norovirus cases only identified by RT-PCR. 
Given previous reports of differences in symptom prevalence, duration and severity in 
norovirus cases of different ages, the following comparisons were made. The 
prevalence of vomiting was compared between young children and older children and 
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Table 5.1 Adapted version of the Vesikari severity score used to describe symptom 
severity in norovirus cases. 
Symptom Value Score 
Diarrhoea duration in days 1-4 1 
5 2 
6 or more 3 
Maximum number of diarrhoeal stools per 24 hours 1-3 1 
4-5 2 
6 or more 3 
Vomiting duration in days 1 1 
2 2 
3 or more 3 
Maximum number of vomiting episodes per 24 hours 0 0 
1 1 
2-4 2 
5ormore 3 
Total possible score 12 
adults. The severity and duration of gastrointestinal symptoms in norovirus cases was 
compared between: 
i. Young children (aged less than five years) and older children and adults (aged 
between five and 64 years); 
ii. The elderly (aged 65 years and older) and older children and adults (aged 
between five and 64 years). 
The severity of disease was also compared between norovirus cases in the community 
cohort and the general practice case-control study, to investigate whether symptom 
severity increases the likelihood of healthcare consultation during norovirus-associated 
IID. Symptom prevalences were compared using 95% confidence intervals for 
prevalence differences and the rank-sum test was used to examine differences in 
symptom duration and severity. 
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The relationship between norovirus viral load and the severity and duration of 
symptoms was examined using norovirus cases who collected a stool specimen within 
two days of symptom onset. This restriction was used to ensure that the norovirus viral 
load was representative of norovirus shedding during acute illness in these IID cases. 
A number of volunteer studies have reported non-gastrointestinal symptoms amongst 
norovirus-infected volunteers who do not develop diarrhoea and vomiting. Therefore, 
non-gastrointestinal symptoms reported by norovirus cases and asymptomatic 
norovirus infections were compared to those reported by norovirus negative controls, to 
investigate the association of these particular symptoms with norovirus infection. 
5.2.5. Prevalence and significance of co-infections 
To investigate whether additional pathogens were co-infecting norovirus cases and 
asymptomatic norovirus infections more often than expected by chance, the prevalence 
of additional pathogens was compared to the prevalence amongst norovirus negative 
controls. The additional pathogens included in the analysis were those at a prevalence 
of 1% or more in IID cases in the Study of Infectious Intestinal Disease specimen 
archive (Table 3.2); 14 pathogens, including norovirus, were used in the analysis. The 
prevalence of each additional pathogen detected in norovirus cases and asymptomatic 
norovirus infections was compared to the prevalence of that specific pathogen in 
norovirus negative controls, using a prevalence ratio with a 95% confidence interval 
and a Z-test P value. The analysis was carried out separately for children ages less 
than five years and for older children and adults (aged five years and older) because of 
age-specific differences in pathogen prevalence. 
The prevalence of additional pathogens was also compared between norovirus cases 
with disease caused by genogroup II noroviruses and those IID cases in whom 
genogroup II norovirus infection was detected, but who were not classified as norovirus 
cases using the Ct value cut-off. These comparisons were made to qualitatively assess 
the appropriateness of the Ct value cut-off selected for genogroup II. 
All statistical analyses (95% confidence intervals for prevalence ratios and prevalence 
differences, rank-sum tests) were carried out using Stata 10494 
5.3. Results 
There were 274 IID cases who met the norovirus case definition, 361 asymptomatic 
norovirus infections and 1844 norovirus negative controls in the specimen archive. 
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Epidemiological questionnaires, with details of symptoms, were returned by 237 
norovirus cases (86%), 344 asymptomatic norovirus infections (95%) and 1721 
norovirus negative controls (93%). Of the 1553 IID cases in the specimen archive with 
disease caused by another pathogen, 1301 (84%) returned the epidemiological 
questionnaire. 
5.3.1. Community prevalence of asymptomatic norovirus infection 
The age-adjusted, community prevalence of asymptomatic norovirus infection was 12% 
(95% confidence interval (Cl): 11 - 14), with the highest prevalence in children aged 
less than five years (29%), although more than 5% of individuals in older age groups 
were infected (Figure 5.1). The prevalence of asymptomatic infection showed a 
wintertime peak of 20% during November, December and January (Figure 5.2); the 
seasonal pattern was less distinct for children aged less than five years compared to 
older children and adults (Appendix A3.2). 
Figure 5.1 Age-specific prevalence of asymptomatic norovirus infection during the 
Study of Infectious Intestinal Disease. Numbers above the bars show the number of 
participants tested in each age group. Black T-bars show the 95% confidence intervals. 
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Figure 5.2 Age-adjusted monthly prevalence of asymptomatic norovirus infection 
(detected by RT-PCR) during the Study of Infectious Intestinal Disease. Numbers 
above the bars show the number of participants tested in each month. Black T-bars 
show the 95% confidence intervals. 
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5.3.2. Symptoms in norovirus cases and asymptomatic norovirus 
infections 
5.3.2.1. Comparison of symptoms reported by norovirus cases, other IID cases 
and norovirus negative controls 
The majority of norovirus cases reported having diarrhoea (88%) and vomiting (78%) 
and a substantial number reported experiencing abdominal pain (67%) and loss of 
appetite (82%) (Figure 5.3). Other symptoms that were reported substantially more 
often by norovirus cases compared to norovirus negative controls were headache 
(44%) and aching muscles (37%) (Figure 5.4). The prevalence of vomiting was 
substantially higher in norovirus cases compared to IID cases with disease caused by 
another pathogen (prevalence difference: 34% [95% Cl: 28 - 41]) (Figure 5.3), which 
was true for both children aged less than five years and for older children and adults 
(aged five years and older), although the difference in vomiting prevalence between the 
two groups of cases was greatest in older children and adults (Appendix A3.3). 
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Figure 5.3 Prevalence of gastrointestinal symptoms in norovirus cases (n=237) and IID 
cases with disease caused by another pathogen (n=1301). 
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Figure 5.4 Prevalence of non-gastrointestinal symptoms in norovirus cases (n=237), 
IID cases with disease caused by another pathogen (n=1301), asymptomatic norovirus 
infections (n=344) and norovirus negative controls (n=1721). 
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There was evidence that the duration of symptoms was shorter in norovirus cases 
(median duration: 3 days [IQR: 2 -4; n=178]) compared to IID cases with disease 
caused by other pathogens (median duration: 4 days (IQR: 2-6; n=1 045]) (rank-sum 
test P <0.001); however the severity of symptoms did not differ substantially (norovirus 
cases median severity score: 7 [IQR: 6- 8]; other IID cases median severity score: 7.5 
[IQR: 6- 9]; rank-sum P=0.3). There was weak evidence that the severity of disease 
was slightly higher in cases of rotavirus-associated IIDb (median severity score: 8 [IQR: 
7-9; n=55]) than in norovirus cases (median severity score: 7 [IQR: 6-8; n=55]) 
amongst children aged less than five years (rank-sum P=0.04). 
5.3.2.2. Comparison of symptoms between norovirus case subgroups 
The prevalence of vomiting was slightly higher amongst norovirus cases aged less than 
five years (83%) compared to norovirus cases aged between five and 64 years (75%) 
(prevalence difference: 8% [95% Cl: -3 - 18]). The median duration of symptoms in 
norovirus cases aged less than five years was four days, compared to two days in 
norovirus cases aged between five and 64 years (Table 5.2); the median symptom 
duration in norovirus cases aged 65 years or older was 3 days. There was no evidence 
that norovirus symptoms were more severe in young children or adults aged 65 years 
and older (Table 5.2), compared to children and adults aged between five and 64 
years, nor in individuals with pre-existing long-term illness or disability (median severity 
8 [IQR: 7-9; n=18]) compared to norovirus cases who did not report any long-term 
illness or disability (median duration 2 days [IQR: 2-4, n=33]). 
Symptoms lasted significantly longer and were more severe in norovirus cases 
presenting to their general practitioner compared to those norovirus cases ascertained 
in the community cohort (Table 5.2). Two norovirus cases reported attending hospital 
during their illness; both cases were aged less than five years, one had a concurrent 
Giardia spp. infection and the other had concurrent infection with Salmonella spp., E. 
coli and Clostridium difficile. 
There was also no evidence that norovirus cases with higher viral loads had more 
severe symptoms or that their symptoms lasted longer (Appendix A3.4). There was no 
difference in the prevalence, severity or duration of symptoms reported by electron 
microscopy positive norovirus cases and those norovirus cases diagnosed. only by the 
Ct value cut-off (Appendix A3.5) 
° Defined as IID cases positive for rotavirus by ELISA. 
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5.3.2.3. Recent history of gastrointestinal symptoms in asymptomatic norovirus 
infections 
Nine percent of asymptomatic norovirus infections experienced diarrhoea and/or 
vomiting prior to the 10-day exclusion period, but within three weeks of questionnaire 
completion (Figure 5.5). The prevalence of diarrhoea and/or vomiting was higher 
amongst asymptomatic norovirus infections compared to norovirus negative controls, 
for both children aged less than five years (asymptomatic norovirus infection: 10% 
[95% Cl: 6- 15]; norovirus negative: 7% [95% Cl: 5 -10]; prevalence difference: 3% 
(95% Cl: -2 - 8]), and older children and adults aged five years and older 
(asymptomatic norovirus infection: 8% [95% Cl: 4- 12]; norovirus negative: 4% [95% 
Cl: 3- 5]; prevalence difference: 4% [95% Cl: -0.5 - 8]). Older children and adults 
(aged five years and older) with asymptomatic norovirus infection also reported loss of 
appetite more often than norovirus negative controls in this age group (Figure 5.5) 
(asymptomatic norovirus infection: 9% [95% Cl: 4 -13]; norovirus negative: 3% [95% 
Cl: 2- 4]; prevalence difference: 6% [95% Cl: 1 -11 ]). 
Table 5.2 Symptom severity and duration in norovirus cases by age and route of 
recruitment. 
Symptom severity Symptom duration 
Median Rank- Total cases 
Median 
duration of Rank- 
Total 
severity sum test 
" 
reporting 
severity 
diarrhoea sum test 
" 
cases 
reporting score (IQR) P value components and vomiting P value duration in days (IQR) 
Children aged <5 
years 7(6-9) 0.3 46 4(3-6) <0.001 65 
Elderly (Z65 years) 8(6-8) 0.7 6 3(4-8) 0.1 11 
Older children and 
adults (5-64 years) 7(6-8) 62 2(1-3) 102 
Community cohort 6(6-7) <0.001 31 2(1-3) <0.001 45 
General practice 
case-control study 8(7-9) 83 3(2-5) 133 
1 Rank-sum test is comparing symptom severity/duration in children aged <5 years to older children and 
adults, in the elderly to older children and adults and in the community cohort to the general practice case- 
control study. 
Abbreviations: IQR, interquartile range.. 
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Figure 5.5 History of gastrointestinal symptoms in asymptomatic norovirus infections 
(n=344) and norovirus negative controls (n=1721) (during the period between 10 days 
and 3 weeks prior to recruitment). 
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5.3.2.4. Non-gastrointestinal symptoms in norovirus cases and asymptomatic 
norovirus infections 
During the three weeks preceding questionnaire completion, a cough, sore throat and 
other cold-like symptoms were reported by 61 % of children aged less than five years 
with asymptomatic norovirus infection (95% Cl: 54 - 68), compared to 52% (95% Cl: 
47 - 56) of norovirus negative controls in this age group (Figure 5.4) (prevalence 
difference: 9% [95% Cl: 0.7 -17]; prevalence ratio adjusted for month of the year: 1.2 
[95% Cl: 1.0 - 1.4]). There was a smaller excess of cold-like symptoms in older 
children and adults with asymptomatic norovirus infection; the prevalence in 
asymptomatic norovirus infections was 12% (95% Cl: 7- 17) compared to 9% in 
norovirus negative controls (95% Cl: 7- 10) (prevalence difference: 3% [95% Cl: -2 - 
8]; prevalence ratio adjusted for month of the year 1.3 [95% Cl: 0.8 - 2.0]). Coid-like 
symptoms were also at higher prevalence in both norovirus cases and IID cases with 
disease caused by other pathogens, compared to norovirus negative controls (Figure 
5.4). However after adjusting for month of the year, the prevalence was only higher in 
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those norovirus cases (prevalence ratio: 2.7 [95% Cl: 1.9 - 3.7]) and other IID cases 
(prevalence ratio: 2.7 [95% Cl: 2.2 - 3.4]) who were aged five years and older. 
5.3.3. Prevalence and significance of co-infections 
Amongst norovirus cases aged less than five years, 74% had one or more additional 
pathogens co-infecting at the time of their norovirus-associated IID episode (Figure 
5.6a) compared to 45% of norovirus cases aged five years and older (Figure 5.6b). 
Forty percent of asymptomatic norovirus infections aged less than five years (Figure 
5.6a) and 19% of asymptomatic norovirus infections aged five years and older (Figure 
5.6b) had one or more additional pathogens detected. Rotavirus and Campylobacter 
spp. were the most common, co-infecting pathogens in norovirus cases of all ages 
(Appendix A3.6). Rotavirus and sapovirus were the most common co-infecting 
pathogens in asymptomatic norovirus infections across all ages; Cl. difficile was also at 
high prevalence in asymptomatic norovirus infections aged less than five years, whilst 
Campylobacterspp. were at high prevalence in asymptomatic norovirus infections 
aged five years and older(Appendix A3.6). 
The prevalence of additional pathogens was slightly higher in IID cases with genogroup 
11 norovirus infections who were not classified as norovirus cases using the Ct value 
cut-off (65%) compared to genogroup II norovirus cases (55%) (Figure 5.7). Amongst 
IID cases with genogroup II norovirus infections who were not classified as norovirus 
cases using the Ct value cut-off, there was no difference in the prevalence of additional 
pathogens in those with timely specimen collection (within five days of symptom onset) 
and those with late specimen collection (5 days or more after specimen onset) (Figure 
5.7). Amongst those with timely specimen collection, 36% had no other pathogen 
detected, whilst 34% of those with late samples had no other pathogen detected. Since 
norovirus has been excluded as a possible cause of illness in these individuals, based 
on their norovirus Ct value, they effectively remain undiagnosed, because no other 
pathogens have been detected after both the original and PCR testing. This 
undiagnosed fraction is similar to the 36% of norovirus negative IID cases in the Study 
of Infectious Intestinal Disease specimen archive in whom no pathogens were detected 
after all diagnostic testing was completed. 
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Figure 5.6 Distribution of co-infection with additional pathogens in norovirus cases, 
asymptomatic norovirus infections and norovirus negative controls. Number of 
pathogens includes norovirus in norovirus cases and asymptomatic norovirus 
infections. 
Figure 5.6a Children aged less than five years. 
70 
60 
so 
40 
c 
u d 
30 
20 
10 
0 
  Norovirus cases (n=90) 
p Asymptomatic norovirus 
infections (n=205) 
Q Norovirus negative controls 
(n=494) 
Figure 5.6b Children and adults aged five years and older. 
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Figure 5.7 Number of pathogens (including norovirus) detected in genogroup II 
infected norovirus cases and IID cases who were not classified as norovirus cases 
using the Ct value cut-off. 
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Abbreviations: Ct, cycle threshold. 
The pathogens shown in Table 5.3 were either significantly more or less common in 
norovirus cases and asymptomatic norovirus infections compared to norovirus negative 
controls; the prevalence of these co-infections differed from that expected by chance, 
according to the background prevalence of the additional pathogens in the population 
(represented by norovirus negative controls). Amongst norovirus cases aged less than 
five years, all of the enteric viruses were found co-infecting more often than expected 
by chance; rotavirus and sapovirus were found co-infecting more commonly than 
expected in norovirus cases aged five years and older. Sapovirus and astrovirus were 
also more common than expected in asymptomatic norovirus infections, although there 
was some indication that rotavirus was less common than expected in asymptomatic 
norovirus infections aged five years and older. Campylobacter spp. and 
enteroaggregative E. coli were detected in norovirus cases of all ages more often than 
expected by chance, and Salmonella spp. co-infection were more common than 
expected in norovirus cases aged five years and older. 
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Table 5.3 Pathogens co-infecting norovirus cases and asymptomatic norovirus 
infections more or less often than expected. Prevalence ratios are compared to 
prevalence in norovirus negative controls. Sample sizes: children aged less than five 
years n=494; older children and adults aged five years and older n=1350. ) 
Norovirus cases Asymptomatic norovirus infections 
Prevalence ratio P value 
Prevalence ratio P value (95% Cl) (95% Cl) 
<5 years 
Total 90 205 
Sapovirus 4.7 (1.6 - 13.7) 0.002 2.4 (0.9 - 6.8) 0.09 
Astrovirus 16.5 (1.7 - 156.5) <0.001 7.2 (0.8 - 69.1) 0.04 
Adenovirus 5.5 (0.8 - 38.5) 0.05 - 
Rotavirus 1.7 (1.2 - 2.3) 0.002 - 
Campylobacter spp. 4.7 (2.7 - 8.4) <0.001 - 
Enteroaggregative 
E. soli 4.2 (2.1 - 8.3) <0.001 - 
Z5 years 
Total 184 156 
Rotavirus 2.0 (1.5 - 2.8) <0.001 0.4 (0.2 - 0.9) 0.02 
Campylobacter spp. 3.8 (2.6 - 5.5) <0.001 1.7 (1.0 - 3.1) 0.06 
Salmonella spp. 5.7 (2.2 -15.1) <0.001 - 
Enteroaggregative 
E. coli 3.4 (1.9 - 6.3) <0.001 - 
Sapovirus - 3.9 (1.7 - 8.7) <0.001 
Aeromonas spp. - 0.2 (0.02 - 1.2) 0.04 
Abbreviations: Cl, confidence interval; spp., species 
102 
Chapter 5 
5.4. Discussion 
In this analysis, the community prevalence of asymptomatic norovirus infection in 
England was presented and the characteristics of norovirus cases and asymptomatic 
norovirus infections were described and compared to IID cases with disease caused by 
other pathogens and to norovirus negative controls. Statistical methods were used to 
examine the epidemiological significance of co-infection with other pathogens in 
norovirus cases and asymptomatic norovirus infections. 
The community prevalence of asymptomatic norovirus infection in England was 12%, 
which is higher than that reported in two previous studies, conducted in Germany and 
the Netherlands, which recruited comparable samples of asymptomatic individuals5.22. 
Real-time RT-PCR is known to have slightly higher sensitivity than gel-based RT- 
PCR279 which was used for norovirus diagnosis in these two previous studies. 
However, this is unlikely to account for the difference of 7% between the prevalence of 
asymptomatic norovirus infection described in this analysis and the prevalence in the 
previous study conducted in the Netherlands (5%)5. Nested gel-based RT-PCR was 
used in the study conducted in Germany22; the use of nested PCR primers increases 
the sensitivity of the gel-based assay280, meaning that the assay used in the study in 
Germany is likely to have comparable sensitivity to the real-time RT-PCR used in this 
study. It is possible that the differences in asymptomatic norovirus prevalence between 
the studies are due to differences in the genetic strains of norovirus circulating at the 
time that the studies were carried out. Periodic emergence of new norovirus strains has 
been associated with increases in the incidence of disease, but it is plausible that there 
may be a concomitant increase in the prevalence of infection as well; a new strain 
emerged in 1995 to 1996, during recruitment of participants into the Study of Infectious 
Intestinal Disease 201,201,537 Asymptomatic norovirus infection showed winter-time 
seasonality, matching the seasonality of norovirus-associated IID community incidence 
presented in Chapter 8. 
Previous studies of both community and outbreak cases have described norovirus- 
associated IID as a mostly mild, self-limiting illness in healthy adults, but have 
highlighted a high prevalence of vomiting compared to IID caused by other pathogens. 
The characteristics of the norovirus cases in this study reflected these previous 
findings: symptoms lasted fewer days in norovirus cases compared to IID cases with 
illness caused by other pathogens and vomiting was twice as common amongst 
norovirus cases. The median duration of symptoms in norovirus cases aged less than 
five years was double the duration in norovirus cases aged between five and 64 
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years"- 108.513, although there was little indication that the severity of symptoms or the 
prevalence of vomiting was higher in young children, which have also been reported in 
previous studiesM. 85. It was difficult to assess the relative difference in the 
manifestation of norovirus-associated III) in individuals aged 65 years and older 
because there were very few norovirus cases in this age group who returned the 
epidemiological questionnaire. There was no evidence that symptom duration was 
related to viral load in norovirus cases, which has been reported in one previous 
study102. There was no evidence that symptom severity in norovirus cases varied 
substantially with age or viral load, but norovirus cases presenting to a general 
practitioner had more severe and longer-lasting symptoms compared to those 
norovirus cases ascertained in the community cohort. 
There was an excess of cold-like symptoms in both norovirus cases and asymptomatic 
norovirus infections, compared to norovirus negative controls. After adjustment for 
season, there was only evidence of a significant excess in norovirus cases aged five 
years and older and in asymptomatic norovirus infections aged less than five years. 
Any excess of cold-like symptoms may be due to a co-infection with a respiratory virus, 
because viruses causing the common cold and influenza are transmitted via similar 
routes to norovirus, e. g. through direct person-to-person contact or from contaminated 
environmental surfaces538,539 In previous studies, experimentally-inoculated volunteers 
have reported non-specific symptoms such as headache, fever and muscle ache 
during norovirus infectionBO; details of fever were not collected from asymptomatic 
participants in the Study of Infectious Intestinal Disease, so it is also possible that the 
excess of cold-like symptoms may represent non-specific symptoms associated with 
norovirus infection. 
Diarrhoea, vomiting and loss of appetite were reported more frequently in 
asymptomatic norovirus infections than norovirus negative controls in the three weeks 
prior to recruitment. Healthy controls were recruited into the Study of Infectious 
Intestinal Disease because they had been free of diarrhoea and/or vomiting for at least 
10 days; the aetiology of any recent IID symptoms prior to this 10-day exclusion period 
was not established. Post-symptomatic shedding after experimental inoculation has 
been demonstrated, lasting up to eight weeks80. Therefore it is possible that some of 
the asymptomatic norovirus infections were caused by post-symptomatic shedding, 
rather than being truly asymptomatic infections; this is consistent with the small excess 
of recent diarrhoea and vomiting symptoms in asymptomatic norovirus infections. It is 
also possible that some asymptomatic norovirus infections were due to pre- 
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symptomatic shedding, although the short incubation period of 24 to 48 hours for 
norovirus disease85 means that only a small number of the asymptomatic norovirus 
infections are likely to be due to pre-symptomatic shedding. Pre-existing levels of anti- 
norovirus antibody were not measured in the study, so the role of host immunity in the 
occurrence of these asymptomatic norovirus infections cannot be assessed. 
The highest prevalence of co-infections was in children aged less than five years, for 
both norovirus cases and asymptomatic norovirus infections, reflecting the higher 
prevalence of infection with a range of pathogens in this age group compared to older 
children and adults. Of those co-infecting pathogens, only a small number were found 
in norovirus cases and asymptomatic norovirus infections more often than expected 
from their prevalence in the population (represented by the prevalence in norovirus 
negative controls). Enteric viruses were found co-infecting in both norovirus cases and 
asymptomatic norovirus infections more often than expected, which may reflect the 
common transmission route through person-to-person contact or contact with 
contaminated environmental surfaces389. sao A notable exception to this pattern is the 
lower than expected prevalence of rotavirus in asymptomatic norovirus infections aged 
five years and older. However, this negative association and a number of the other 
associations had only reasonable statistical support from the Z-tests, and given the 
large number of comparisons made, it is possible that some of these were spurious 
associations. Enteric bacteria (Campylobacter spp., Salmonella spp. and 
enteroaggregative E. cols) were detected in norovirus cases more often than expected; 
Campylobacterspp. were also in excess in asymptomatic controls aged five years and 
older. Whilst Campylobacterspp. and Salmonella spp. are commonly reported to be 
predominantly acquired through zoonotic foodborne transmission, a number of studies 
have highlighted the possibility that other modes of transmission, in particular 
environmental contamination, may be of greater importance outside of outbreak 
settings80. "81.541, sax It is therefore plausible that the association with norovirus- 
associated IID and asymptomatic norovirus infection reflects a common transmission 
route. However, no information has been collected on host-level factors, meaning that 
increased susceptibility to infections may also contribute to these associations, 
although further biological studies of the interaction between host cells and norovirus 
and these enteric bacteria would be required to assess the relevance of this 
hypothesis. 
There was no indication that norovirus cases diagnosed only by real-time RT-PCR had 
different symptoms or disease severity to those also positive by electron microscopy, 
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who were used to define the Ct value cut-off. Most importantly, after applying the Ct 
value cut-off, the proportion of norovirus-infected I ID cases above the cut-off who had 
no other pathogens detected, and were therefore effectively undiagnosed, was the 
same as the proportion of all norovirus negative IID cases who were undiagnosed at 
the end of testing. This indicates that the Ct value cut-off selected is unlikely to be 
grossly under-diagnosing norovirus-associated IID in this study population. 
5.5. Summary 
The norovirus cases identified in the Study of Infectious Intestinal Disease specimen 
archive, using real-time RT-PCR testing and the Ct value cut-off, had similar disease 
characteristics to those reported in previous studies, in terms of symptom prevalence, 
duration and severity. There was no difference in disease characteristics between 
norovirus cases previously diagnosed by electron microscopy and those diagnosed 
only by real-time RT-PCR with the Ct value cut-off, providing further support for the 
conclusion in Chapter 4 that it was appropriate to use only electron microscopy positive 
cases in the ROC analysis reference positive group. Further validation of the Ct value 
cut-off is provided by the similar undiagnosed fraction amongst norovirus-infected IID 
cases who were not classified as norovirus cases using the cut-off and other norovirus- 
negative IID cases; if a much larger proportion of the norovirus-infected IID cases had 
remained undiagnosed, this may have indicated that the cut-off was under-diagnosing 
norovirus-associated IID. There was a high population prevalence of asymptomatic 
norovirus infection in England at the time of the Study of Infectious Intestinal Disease 
(1993-1996), although the relative importance of pre- and post-symptomatic shedding 
and true asymptomatic infection could not be determined. Norovirus cases and 
asymptomatic norovirus infections both experienced cold-like symptoms and additional 
enteric virus infections more often than healthy, norovirus-negative individuals in the 
study population, which may be attributable to the common person-to-person 
transmission route for these enteric and respiratory pathogens. In the next chapter, the 
importance of contact with potentially infectious individuals, and other exposures, to the 
acquisition of norovirus-associated III) and asymptomatic norovirus infection will be 
investigated. 
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Chapter 6: Risk factors for symptomatic and 
asymptomatic norovirus infection 
In Chapter 4, norovirus viral load was compared between III) cases and healthy 
controls, to select a cut-off in viral load for attributing disease to norovirus in III) cases. 
In the previous chapter, the characteristics of norovirus cases identified using this viral 
load cut-off, and asymptomatic norovirus infections, were described. In the analysis 
presented in this chapter, risk factors for the acquisition of these symptomatic and 
asymptomatic norovirus infections were investigated. 
6.1. Background 
Norovirus outbreak investigations 4378390391,402,406,543,544 and case-control studies of 
sporadic norovirus-associated 111) 22,133.380 indicate that the predominant mode of 
norovirus transmission is faeco-oral. Norovirus transmission occurs through direct 
physical contact with an infected individual352, and also via food 360,380,397,403,410,412,413, 
545, environmental surfaces or other objects328,329,404-407,546, which have been 
contaminated by an infected person, with susceptible individuals ingesting norovirus 
from their hands or food 329,331,332,4613 Airborne norovirus transmission, following a 
vomiting episode, has also been documented during outbreaks, either through direct 
inhalation of aerosolised virus or through contact with vomit contaminated surfaces and 
foods349-351,393-395,545.547,548. Accordingly, outbreak, experimental and 
seroepidemiological studies have shown that hand-washing is protective against 
norovirus-associated IID33s, aos, aos, ass 
Outbreaks of norovirus are often associated with consumption of oysters and other 
shellfish 42 26"443 and occasionally with contamination of raw fruit and vegetables 
during production444 445. A number of outbreaks have been reported after contamination 
of private 44"48,45° and mains452 water supplies, and also after contamination of 
recreational watersa5 61 Foreign travel has been identified as a risk factor for 
norovirus-associated IID'40,549-551 and outbreaks are frequently reported on cruise 
ship S552-554. 
Whilst there is a large body of epidemiological evidence on the modes of transmission 
and risk factors for norovirus-associated IID during norovirus outbreaks, there have 
been only a few studies examining risk factors for sporadic norovirus-associated IID 
acquired in the community, outside of recognised outbreaks22,140, sao None of these 
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previous risk factor studies, all which used RT-PCR testing, took account of norovirus 
viral load in the selection of norovirus cases; the analysis presented in Chapter 4 
indicates that inclusion of all norovirus RT-PCR positive IID cases, regardless of viral 
load, may lead to outcome misclassification. The only investigation of risk factors for 
norovirus-associated IID in England is the analysis of electron microscopy diagnosed 
norovirus cases from the Study of Infectious Intestinal disease, which excluded children 
aged less than five years83. Risk factors for asymptomatic norovirus infection have 
never been investigated. 
The aim of this analysis was to identify risk factors for both symptomatic and 
asymptomatic norovirus infection in the community, across all ages. The analysis made 
use of the larger group of norovirus cases now identified in the Study of Infectious 
Intestinal Disease specimen archive, through real-time RT-PCR testing and application 
of the viral load cut-off from Chapter 4, and the substantial number of asymptomatic 
norovirus infections identified in the specimen archive retesting. The analysis was 
informed by the large number of studies of norovirus epidemiology that have been 
published since the Study of Infectious Intestinal Disease was carried out, and used 
recently-developed multiple imputation techniques to account for missing responses in 
the dataset55 560 
6.2. Methods 
6.2.1. Inclusion criteria and testing 
Full details of recruitment and testing during the Study of Infectious Intestinal Disease 
were provided in Chapter 3. 
IID cases in the specimen archive, from either the community cohort or the general 
practice case-control study, were eligible for inclusion in this analysis if a norovirus Ct 
value had been determined by real-time RT-PCR. The genogroup II Ct value cut-offs, 
selected in Chapter 4, were used to identify those IID cases who had disease caused 
by genogroup II noroviruses. However, the genogroup I cut-off was not used, because 
it is unlikely that it would accurately identify IID cases with disease caused by 
genogroup I noroviruses, due to the small sample size for the genogroup I ROC 
analysis, and the problems with variable efficiency of the real-time RT-PCR assay 
between genotypes in genogroup I. Therefore, only those IID cases infected with 
genogroup I noroviruses who were previously positive for norovirus by electron 
microscopy were included in this analysis. Use of electron microscopy positive 
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genogroup I-infected IID cases will minimise outcome misclassification because the 
detection limit of electron microscopy is at high viral loads that correlate well with 
norovirus disease80'99' 103,240 Mixed genogroup infections were classified according to 
their genogroup II Ct value using the genogroup II cut-offs. 
All healthy controls from the Study of Infectious Intestinal Disease specimen archive, 
who had been free of diarrhoea and vomiting for at least 10 days, were eligible for 
inclusion in this analysis. These controls were considered asymptomatic with respect to 
IID, although they may have experienced other symptoms during that time, as 
described in Chapter 5. Norovirus-infected individuals who were recruited as controls in 
the original study were used to examine risk factors for asymptomatic norovirus 
infection. Individuals who were recruited as controls in the original study who tested 
negative for norovirus were used as the comparison group in the analyses of risk 
factors for norovirus infection and disease. 
Selection of IID cases and controls for inclusion in this analysis is summarised in 
Figure 6.1. 
6.2.2. Case and control definitions 
Cases of norovirus-associated IID ('norovirus cases') were: 
IID cases infected with genogroup II noroviruses, who had a Ct value 
determined by real-time RT-PCR testing that was equal to or less than the age- 
specific Ct value cut-offs described in Chapter 4 (Ct value 30 for children aged 
less than five years, Ct value 33 for children and adults aged five years and 
older); 
Or 
ii. IID cases infected with genogroup I noroviruses, detected by electron 
microscopy and confirmed by RT-PCR. 
'Asymptomatic norovirus infections' were: 
Controls recruited in the original study who tested positive for norovirus by electron 
microscopy and/or RT-PCR. 
'Norovirus negative controls' were: 
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Controls from the original study who tested negative for norovirus by electron 
microscopy and RT-PCR. 
6.2.3. Epidemiological data 
Norovirus cases, asymptomatic norovirus infections and norovirus negative controls 
provided information on socio-demographic characteristics and risk factors relating to 
IID in the baseline and epidemiological questionnaires, as described in Chapter 3. The 
specific questionnaire items used in this analysis are shown in Appendix A4.1 and the 
variables created from these items are shown in Table 6.1. 
6.2.4. Conceptual framework 
Risk factors for norovirus-associated IID were investigated by comparing norovirus 
cases to norovirus negative controls. Risk factors for asymptomatic norovirus infection 
were investigated by comparing asymptomatic norovirus infections to norovirus 
negative controls. All norovirus cases were analysed together, i. e. community cohort 
and general practice cases and genogroup I and genogroup II cases. 
A hierarchical conceptual framework561 was used to investigate risk factors, separately, 
for norovirus-associated IID and asymptomatic norovirus infection (Table 6.1). The 
conceptual framework had three levels: (i) distal factors, which are general 
characteristics and long-term behaviours e. g. socioeconomic and demographic 
information; (ii) intermediate factors, which are specific behaviours that may increase 
the risk of exposure for a short time but are not necessarily always a direct source of 
infection ; and (iii) proximal factors which are a direct source of infection. Reporting of 
intermediate and proximal risk factors was limited to the previous 10 days before 
symptom onset for norovirus cases, and 10 days before questionnaire completion for 
asymptomatic norovirus infections and norovirus negative controls (Table 3.1). 
The intermediate and proximal risk factor models were adjusted for higher level 
variables in the conceptual framework. Indicator variables for the general practice 
through which each individual was recruited and month since the beginning of the 
study were added to the proximal risk factor models that included infectious contacts, 
to account for potential geographical and temporal variation in norovirus transmission. 
Norovirus cases were allocated to the month in which their symptoms started and 
asymptomatic norovirus infections and norovirus negative controls were allocated to 
the month in which they provided a stool specimen and/or were recruited. 
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Figure 6.1 Summary of testing, case and control selection and sample size for the 
analysis of risk factors for norovirus-associated IID and asymptomatic norovirus 
infection. Abbreviations: GI, genogroup I; Gil, genogroup II; EM, electron microscopy. 
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During the Study of Infectious Intestinal Disease, controls in the nested case-control 
study and general practice case-control study were recruited concurrently to IID cases, 
from within the same general practice, and were matched on age and sex (Appendix 
A1.2). There were insufficient numbers of norovirus cases with matched controls from 
the original recruitment, who were norovirus negative by RT-PCR, to allow a matched 
analysis of risk factors for norovirus-associated IID based on the original matching (18 
pairs aged less than five years, 49 aged five years and older). Therefore, an 
unmatched analysis was performed, but, in addition to including indicator variables for 
time (month since beginning of the study) and recruiting general practice, the 
regression models were also adjusted for the other matching factors (sex and age) to 
account for similarities between norovirus cases and norovirus negative controls 
introduced during recruitment. The age bands used for matching controls to IID cases 
during recruitment were used for age adjustment in the regression models (Appendix 
A1.2). 
Risk factors for norovirus infection and disease were analysed separately in children 
aged less than five years and older children and adults (aged five years or older). 
6.2.5. Dealing with missing values 
Two separate analyses were carried out using: (i) all participants, creating a categorical 
indicator for missing responses (missing indicator); and (ii) all participants with missing 
responses imputed (multiple imputation). 
Missing responses in the explanatory variables included in the conceptual framework 
were imputed, using imputation by chained equations, in Stata 10.1494,559 The 
imputation prediction model, used to select the most likely value for each missing 
response, included all variables in the conceptual framework. In addition, indicator 
variables for the following characteristics were included in the prediction model: 
registered general practice; month since the beginning of the study; the route of 
recruitment into the study (community cohort or general practice case-control study); 
norovirus infection/disease status; and the norovirus season in England and Wales 
during 1993 to 1996 (defined using Health Protection Agency norovirus laboratory 
reports, as described in Appendix A4.2). There were no missing data in these indicator 
variables, they only informed the imputation of missing responses in the explanatory 
variables from the conceptual framework. Twenty imputed datasets were created and 
analysed together. 
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Table 6.1 Conceptual framework for analysis of risk factors for norovirus-associated IID 
and asymptomatic norovirus infection. 
Level Variable 
Distal factors Age 
Sex 
Social class' 
Household size (number of people) 
Household age structure (number of children <5 years) 
Household crowding (number of people per room) 
Baby in nappies in the householdb 
Pet ownership 
Sharing a bathroom or toilet with another household 
Nursery/day care attendance` 
Breast feedingd 
Hand hygiene' 
Intermediate 
factors 
Water sports 
Foreign travel 
Animal contact 
Proximal factors Food (raw fruit/vegetables/shellfish/meals prepared outside 
home) 
Household infectious contact 
Infectious contact outside the household 
References 
83 
163 
562 
336,406,409,466 
458-461 
140,549,551-554 
22,163.380 
349,360,397,410,412, 
413.423,425,426,443- 
445,545,563 
22,83,85,365,380,406 
22,83,380,402,543 
Social class was based on occupation of the wage earner in the householdm4. b Investigated as a risk factor only for children and adults aged five years and older. 
`Investigated as a risk factor only for children aged less than five years. 
d Investigated as a risk factor only for infants aged less than one year. 
Measured as the response of the person in the household responsible for food shopping and preparation 
to the statement "it doesn't matter whether you wash your hands or not before handling food" - response 
options were agree / disagree / don't know. 
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6.2.6. Regression modelling 
The entire model selection process was carried out separately on the missing indicator 
and multiple imputation datasets. 
Standard logistic regression models were fitted using Stata 10.1494. The imputed 
datasets were analysed using the ice suite of commands494.555-560, in which the logistic 
regression model is fitted separately to each of the 20 imputed datasets. The results of 
the 20 regression models are then combined, to give one point estimate for each odds 
ratio, with standard errors that take account of uncertainty in both the multiple 
imputation process and the standard regression. 
For each analysis, the distal risk factor model was fitted first, with all variables included 
together, any variables with aP value below 0.1 were selected for inclusion in the final 
model, for further investigation of their effects. This variable selection process was 
repeated for the intermediate and proximal risk factor models. The results presented 
include variables with aP value less than 0.1 in the final model. 
6.2.7. Population attributable fractions 
Population attributable fractions (PAFs) were calculated in Stata 10.1 from the final 
multiple imputation regression models, using the aflogit programme565,566 within the ice 
programme, with user-defined code (I. White personal communication). 
6.3. Results 
There were 237 norovirus cases, 344 asymptomatic norovirus infections and 1721 
norovirus negative controls available for the analysis (Figure 6.1). Results from the 
multiple imputation models are presented in Tables 6.2 to 6.4. The final model for the 
missing indicator analysis was identical to that from the multiple imputation analysis, 
with very similar effect estimates. Results from the missing indicator analysis are 
provided in Appendices A4.3 and A4.4. 
6.3.1. Risk factors for norovirus-associated lID in children aged less than 
five years 
Children from households in which the main wage earner had a manual or unskilled 
occupation had more than twice the odds of norovirus-associated IID compared to 
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Table 6.2 Risk factors for norovirus-associated IID in children aged less than five years 
(multiple imputation model). 
Exposure prevalence 
Norovirus Norovirus 
cases negative 
controls 
Odds 
Ratioe 
95% Cl P valueb 
Total 81 461 
Social class 
Non-manual 35.8 56.8 1.0 
Manual/Unskilled 50.6 35.6 2.3 1.4-3.9 0.002 
Military 1.2 0.9 2.3 0.2-22.1 0.46 
Housewife/student/carer 6.2 2.6 4.1 1.4,12.3 0.01 
Missing 6.2 4.1 
Foreign travel 2.5 0.9 6.6 0.9-47.3 0.06 
Missing 1.2 1.3 
Animal Contact 32.1 44.5 0.6 0.3-1.0 0.06 
Not sure 1.2 2.0 0.5 0.1-4.8 0.57 
Missing 1.2 3.0 
Fruit eaten 60.5 75.9 0.5 0.3-0.8 0.007 
Pre-prepared raw salad or 
/vegetables eaten 1.2 7.2 0.2 0.0 -1.3 0.08 
Household infectious contact 39.5 9.3 5.7 2.0-16.2 0.001 
Not sure 2.5 1.3 3.6 0.3-47.9 0.33 
Missing 9.9 3.3 
Infectious contact outside the 
household 34.6 6.7 33.9 9.5-121.1 <0.001 
Not sure 16.0 13.9 4.4 1.5-13.3 0.009 
Missing 1.2 0.7 
'All odds ratios are from multiple imputation models and are adjusted for age and sex; odds ratios for 
intermediate and proximal risk factors are adjusted for higher level variables in the conceptual framework 
that were included in the final model. 
bP values are from a Wald test of regression coefficients. 
Abbreviations: Cl, confidence interval. 
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those from non-manual occupational social classes (Table 6.2). Recent foreign travel 
greatly increased the odds of norovirus-associated IID (Table 6.2). Norovirus- 
associated IID was strongly associated with contact with individuals with IID symptoms 
(Table 6.2). Whilst the odds ratio was much higher for contacts outside the household 
(Table 6.2), they accounted for a similar proportion of norovirus-associated IID 
episodes as infectious contacts inside the household (household infectious contacts: 
PAF 33% [95% confidence interval (Cl): 19,48]; infectious contacts outside the 
household: PAF 32% [95% Cl: 20,44]). Together, infectious contacts inside or outside 
the household accounted for 54% of norovirus-associated IID episodes in children 
aged less than five years (95% Cl: 42,66). For infectious contacts inside the 
household, the odds of norovirus-associated IID were higher when the infectious 
contact was another young child, compared to infectious contacts aged five years or 
older, and the odds increased slightly with the number of infectious household contacts 
(Table 6.4). 
Eating fruit and raw vegetables was associated with lower odds of norovirus-associated 
IID in children aged less than five years, as was contact with animals during this time 
(Table 6.2). 
6.3.2. Risk factors for norovirus-associated lID in older children and adults 
Older children and adults (aged five years or older) living in a household with a baby in 
nappies had three times the odds of norovirus-associated IID (Table 6.3). The odds 
were also increased for older children and adults living in households where at least 
one member was a child aged less than five years (Table 6.3) and these two 
exposures accounted for similar proportions of norovirus-associated IID episodes 
(living in a household with children aged less than five years: PAF 20% [95% Cl: 10, 
30]; living with a baby: PAF 16% [95% Cl: 8,25]). 
Individuals reporting recent contact with a person with III) symptoms were at increased 
odds of norovirus-associated IID, but the risk was similar for household contacts and 
contacts outside the household (Table 6.3). Infectious contacts accounted for almost 
half of norovirus-associated IID in older children and adults (household infectious 
contacts: PAF 24% [95% Cl: 13,33]; infectious contacts outside the household: PAF 
22% [95% Cl: 13,30]; combined PAF 39% [95% Cl: 29,49]). For infectious contacts 
inside the household, the odds of norovirus-associated IID were much higher if the 
infectious contact was aged less than five years and the odds increased with the 
number of infectious contacts (Table 6.4). 
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Table 6.3 Risk factors for norovirus-associated IID in older children and adults (aged 
five years and Older) (multiple imputation model). 
Exposure prevalence 
Norovirus Norovirus 
cases negative 
controls 
Odds 
Ratio' 
95% CI P valueb 
Total 156 1260 
Household structure 
Single person household 4.5 6.9 1.1 0.5-2.3 0.86 
Adults and children aged Z5 
years only 53.8 71.0 1.0 
Z1 children aged <5 years 30.1 14.1 2.5 1.6-4.0 <0.001 
Missing 11.5 8.0 
Baby wearing nappies in the 
household 25.0 9.0 2.9 1.8-4.6 <0.001 
Missing 1.9 2.9 
Water sports in last 10 days 10.3 17.9 0.4 0.2-0.8 0.009 
Missing 7.7 6.1 
Foreign travel 7.1 2.5 3.3 1.5-7.3 0.004 
Missing 1.9 2.4 
Animal Contact 19.2 36.3 0.4 0.3-0.7 <0.001 
Not sure 3.8 1.0 3.3 1.0-10.7 0.05 
Missing 5.8 3.2 
Oysters eaten 1.9 0.1 18.3 1.5-226.6 0.02 
Whelks/winkles eaten 1.9 0.1 20.5 1.6-265.7 0.02 
Fruit eaten 71.8 82.5 0.6 0.4-0.8 0.006 
Household infectious contact 26.9 6.7 4.9 2.7-8.8 <0.001 
Not sure 4.5 2.5 2.2 0.7-6.9 0.16 
Missing 12.8 9.8 
Infectious contact outside the 
household 26.9 9.2 4.5 2.5-8.0 <0.001 
Not sure 20.5 14.5 2.1 1.1-3.9 0.01 
Missing 2.6 1.7 
'All odds ratios are from multiple imputation models and are adjusted for age, sex and social class; odds 
ratios for intermediate and proximal risk factors are adjusted for higher level variables in the conceptual 
framework that were included in the final model, except the presence of a baby in the household. 
bP values are from a Wald test of regression coefficients. Abbreviations: Cl, confidence interval. 
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Foreign travel and eating shellfish increased the odds of norovirus-associated IID in 
older children and adults (Table 6.3). Shellfish consumption accounted for a small 
proportion of norovirus-associated IID episodes in older children and adults (oysters 
and whelks or winkles: PAF 2% [95% Cl: 0,4]). 
Consumption of fruit, recent participation in water sports and contact with animals were 
associated with lower odds of norovirus-associated IID (Table 6.3). 
6.3.3. Risk factors for asymptomatic flora virus infection 
Females had slightly increased odds of asymptomatic norovirus infection (children <5 
years odds ratio (OR): 1.4 [95% Cl: 1.0,1.9; P=0.07]; older children and adults OR: 
1.4 [95% Cl: 1.0,2.0; P=0.09]). After adjusting for age and sex, both eating salad 
(OR: 0.6 [95% Cl: 0.4,0.8; P=0.004]) and participation in water sports (OR: 0.6 (95% 
Cl: 0.4,1.0; P=0.06]) were associated with lower odds of asymptomatic norovirus 
infection in older children and adults. No other variables were associated with 
asymptomatic norovirus infection. Appendix A4.5 shows the asymptomatic norovirus 
infection odds ratios for the variables that were associated with norovirus-associated 
11 13. 
Table 6.4 Risk of norovirus-associated IID due to the number and age of household 
infectious contacts (multiple imputation model). 
Children aged <5 years Older children and adults 
aged Z5 years 
OR 95% CI P value OR 95% CI P value 
Number of household infectious 
contacts 
0 
1 
22 
Age of household infectious 
contact 
No infectious contacts 
Children aged <5 years 
1.0 
1.6 0.8-3.1 0.15 
2.9 "0.8-10.3 0.10 5.8 1.7-19.3 
1.0 1.0 
2.6 1.0-6.8 0.06 4.3 1.9-9.6 
1.0 
1.4 0.8-2.4 0.26 
0.005 
<0.001 
Older children & adults 
only (25 years) 1.6 0.8-3.3 0.16 1.5 0.8-1.6 0.172 
' Odds ratios are from multiple imputation models and are adjusted for age, sex, social class and all other 
risk factors included in the final models shown in Table 6.2 and Table 6.3, except a baby in the household 
for older children and adults and infectious contact variable. 
bP values are from a Wald test of regression coefficients. 
Abbreviations: OR, odds ratio; Cl, confidence interval. 
119 
Chapter 6 
6.4. Discussion 
The major risk factors for norovirus-associated IID were related to contact with an 
infectious person. Foreign travel and consumption of shellfish increased the risk of 
norovirus-associated IID, whilst consumption of raw fruit and vegetables, participation 
in water sports and contact with animals were associated with a decreased risk of 
norovirus-associated IID. There was no evidence that any exposure greatly increased 
the risk of asymptomatic norovirus infection, although eating salad and water sports 
participation were associated with a lower risk of asymptomatic infection in older 
children and adults. 
Infectious contacts accounted for more than half of norovirus-associated IID in children 
aged less than five years and almost half in older children and adults. The importance 
of contact with individuals with IID for transmission of norovirus has been reported in 
previous case-control stud ies22,83.380 and there is substantial evidence of person-to- 
person transmission from outbreak investigations4.140.352,378,391,402,406,543,544 Whilst 
neither household size, nor crowding (the number of people per room), affected the risk 
of norovirus-associated IID, the age of household members was a risk factor in older 
children and adults. Living in a household with a baby or young children accounted for 
a third of norovirus-associated IID in this age group. The highest incidence of 
norovirus-associated IID is in young children (see Chapter 8), so this association may 
reflect the fact that they are more likely to introduce norovirus into a household than 
older individuals. Furthermore, when a household contact with IID symptoms was 
reported, the risk of norovirus-associated IID was greatest when this contact was a 
young child. This pattern of transmission, from young children to adults, was also 
observed in a large household transmission study following cases from a point-source 
85 norovirus outbreak 
In young children, the risk of norovirus-associated IID from infectious contacts outside 
the household was much greater than that associated with infectious contacts inside 
the household, although there was no risk specifically associated with attendance at 
day care. Norovirus causes symptomatic infection, with high viral loads, in individuals 
of all ages, so there is potential for transmission to children in a wide variety of settings, 
not just through contact with other young children in day care settings, which has been 
shown to be important for acquiring rotavirus-associated IID386,482,567 Breast-feeding 
was not protective against norovirus-associated IID in infants. Norovirus-specific 
immunoglobulin A has been recovered from breast milk568, but the antigenic variation of 
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noroviruses is extensive, with very little cross-protection between strains123, ßz5.179,191, 
and even strain-specific immunity is believed to last no longer than a year54- 5s 
Individuals of all ages who had recently travelled outside the UK had an increased risk 
of norovirus-associated IID. This risk has been demonstrated in previous studies549, 
and may be attributable to changes in risk behaviours whilst travelling, or exposure to a 
different spectrum of norovirus strains569. Recent foreign travel also increases the 
likelihood that an individual with IID, due to any pathogen, will present to a GP381; the 
majority of the norovirus cases in this analysis (73%) were from the general practice 
case-control study, rather than from the community cohort nested case-control study, 
but the prevalence of recent foreign travel was very similar in general practice and 
community norovirus cases (6% and 5% respectively), so it is unlikely that this 
association is due to the predominance of general practice cases in this analysis. 
However, it is possible that using cases recruited at general practitioners may have 
caused the association between social class and norovirus-associated IID in young 
children, because substantially more community cases were from non-manual 
occupational social classes (community cases 70% vs. general practice cases 41 %). 
There was no evidence that hand washing was protective against norovirus-associated 
IID, despite many experimental, intervention and observational studies showing that 
hand washing with soap and water is an effective method for reducing the incidence of 
infection with directly-transmitted viruses389,570,571, including norovirus336,406.409. ass 
Hand hygiene was not measured directly in the Study of Infectious Intestinal Disease; it 
was collected only in relation to food preparation, by self-report from the person in the 
household responsible for food shopping and preparation (not always the study 
participant). In addition, normal hand-washing practices used by study participants may 
not be as rigorous as those used in experimental studies and participants may also 
have falsely reported good hand hygiene because this is a socially desirable 
response572. It is therefore unlikely that this variable accurately captured the general 
hand hygiene behaviour of study participants. 
A large number of published outbreak investigations have attributed norovirus- 
associated IID to contamination of food during preparation in restaurant and catering 
setting s3'`9' 351,360,397.410,412,413.573, as well as to raw fruit and vegetables contaminated 
during wholesale production444' 445, consumption of oysters and other shellfsh423 4x6,443 
and to contamination of both drinking446448,450.452.574 and recreational water458-461 
Information on drinking water exposures was not collected in a suitable format for 
reliable analysis. Water sports participation and raw fruit and vegetable consumption 
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were actually protective against norovirus-associated IID, as was contact with animals. 
There was no evidence of increased risk associated with eating at restaurants or 
catered events. The reduced risk associated with animal contact has been reported in 
two previous case-control studies of community-acquired norovirus-associated IID in 
high income countries22.3a0 and water sports were associated with a reduced risk of IID 
due to other pathogens in this Study of Infectious Intestinal Disease83. There are a 
number of potential explanations for these exposures reducing the risk of norovirus- 
associated IID: (i) they are correlated with other lifestyle factors that are protective 
against norovirus-associated IID; (ii) they do lead to norovirus transmission but are 
repetitive, long-term behaviours, so exposed individuals have higher levels of norovirus 
immunity, due to regular immune boosting; or (iii) specifically for consumption of fruit 
and vegetables, they have positive effects on gut immunity or the balance of intestinal 
bacterial flora , increasing resistance to IID. In contrast, oysters and other shellfish, 
which may be consumed less frequently than fruit and vegetables, and in which high- 
level norovirus contamination is common 431435.440, did increase the risk of norovirus- 
associated IID, although they accounted for only a small proportion of norovirus 
disease in this study population. Finally, although foods prepared in restaurants are 
commonly reported as vehicles of infection in outbreaks, it is possible that breakdowns 
in food hygiene are relatively infrequent and therefore contribute little to the overall 
population burden of sporadic norovirus-associated IID. 
None of the exposures that increased the risk of norovirus-associated IID were 
associated with asymptomatic norovirus infection, although eating salad and water 
sports participation reduced the risk of asymptomatic infection in older children and 
adults. The asymptomatic norovirus infections detected in this study were prevalent, 
not incident, infections. Asymptomatic individuals were recruited at random from the 
general population and prior to determination of their norovirus infection status. It is 
possible that the transmission event leading to many of these asymptomatic infections 
occurred outside of the 10-day retrospective exposure period that was measured in the 
risk factor questionnaire, and was therefore not captured in the responses. Norovirus 
has been detected by RT-PCR for at least two weeks after experimental inoculation in 
otherwise healthy adult volunteers, who did not develop diarrhoea or vomiting80. 
Prolonged post-symptomatic shedding has also been demonstrated, lasting from one 
to eight weeks8o, 84.1a. 107. los. 504,575 Even for those individuals who were infected during 
the questionnaire exposure period, if they did not collect their specimen concurrently to 
questionnaire completion, their norovirus infection status may not correspond to the 
exposures reported. Only studies with frequent and regular stool specimen collection 
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and testing, irrespective of disease status, could ensure that proximal risk factors 
reported by individuals with asymptomatic norovirus infection relate to the norovirus 
transmission event. However, such studies are resource intensive and may be difficult 
to justify, in terms of the benefits to patients, or improvements in epidemiological 
knowledge, without first demonstrating the importance of asymptomatic infections in 
transmission. 
A recent volunteer study examining the relationship between inoculum size and the 
development of norovirus infection and disease has shown that whilst norovirus 
infection occurred even at very small doses, the development of symptoms after 
infection was linearly related to the concentration of the inoculum: the higher the 
infecting dose the greater the probability of a volunteer developing symptoms once 
norovirus infection has occurred98. It is therefore also possible that the lack of 
association between asymptomatic norovirus infection and symptomatic infectious 
contacts in this analysis reflects a real difference in the route of transmission between 
symptomatic and asymptomatic norovirus infection, i. e. the high viral loads shed by 
norovirus cases tend to lead to further symptomatic norovirus infection, whereas 
asymptomatic norovirus infections tend to arise from the lower-level shedding from 
other asymptomatic norovirus infections. However, given the documented importance 
of environmental contamination for norovirus transmission, and the likelihood that the 
norovirus concentration encountered on contaminated surfaces is much lower than that 
encountered through direct contact with a norovirus case, the transmission pattern 
between symptomatic and asymptomatic norovirus infections is unlikely to be that 
simple. 
Cases from the community cohort and the general practice case-control study were 
analysed together and the matching used for recruitment in the Study of Infectious 
Intestinal Disease was relaxed, to increase statistical power. However, to prevent bias, 
due to relaxing the matching, the regression models were adjusted for the original 
matching factors (age, sex, registered general practice, time)576. Multiple imputation 
was used to account for missing responses in the dataset, so it was possible to fit a 
multivariable regression model without limiting the inclusion criteria to those individuals 
who answered all of the questionnaire items used in the analysis ('complete case 
analysis'), an approach, which is widely recognised to bias results if data are not 
missing completely at random57' 578" The analysis of the multiply imputed dataset and 
the analysis using a categorical indicator for missing values, produced very similar 
results, supporting the use of multiple imputation in future work, which should be the 
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preferred method because it provides standard errors that also take account of 
uncertainty in the results due to the missing data. 
This is the first study of risk factors for norovirus-associated IID to use viral load to 
identify cases of norovirus-associated IID, rather than a positive RT-PCR result or 
electron microscopy detection. The analysis presented in Chapter 4 showed that many 
IID cases in the Study of Infectious Intestinal Disease who were norovirus RT-PCR 
positive had the same viral loads seen in healthy controls, indicating that their norovirus 
infection may not actually be the cause of their illness. Including cases whose IID is not 
caused by norovirus in the analysis would introduce misclassification with respect to 
the outcome; it is likely that the IID cases with low viral loads will have disease caused 
by a range of other gastrointestinal pathogens, so it is difficult to predict the 
consequences of incorrectly including these cases in an analysis of risk factors for 
norovirus-associated IID. However, using viral load to diagnose norovirus-associated 
III) substantially reduces the problem of outcome misclassification, although it may not 
eliminate it completely. 
The genogroup I Ct value cut-off was not used because it was likely that there would 
be substantial outcome misclassification, because of the small sample size for the 
genogroup I ROC analysis and because each Ct value does not represent the same 
underlying viral load for all the genotypes within norovirus genogroup I (see Chapter 3). 
Therefore only those genogroup I norovirus infected cases who were previously 
positive by electron microscopy were included in the analysis. This does mean that 
genogroup I norovirus cases were underrepresented in the analysis, but comparison of 
risk factors between the genogroups was not the aim of the analysis, and even if the 
cut-off had been used, it is unlikely that there would have been sufficient numbers of 
genogroup I cases for such a comparison. There have been no studies comparing risk 
factors between norovirus genogroups or genotypes, so it is unclear what effect, if any, 
grouping them together in the analysis might have had on the results. However, 
evidence from outbreaks indicates that genogroup I and genogroup II noroviruses are 
both directly transmissible, via person-to-person spread, and both genogroups have 
been detected in food- and water-borne outbreaks'`' 354,390.450 The only notable, 
currently recognised difference between norovirus genotypes is the HBGA binding 
specificity required for host cell infection'SO, 154,155, which was not determined in the 
individuals included in this study. A study of risk factors for individual norovirus 
genogroups or genotype, or one that also considers host susceptibility in terms of pre- 
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existing immunity and genetic resistance, would be enormously resource intensive and 
perhaps logistically impossible. 
6.5. Summary 
The results of this updated analysis of risk factors for norovirus-associated IID broadly 
agree with the results from the previous analysis using only electron microscopy 
positive IID cases from the Study of Infectious Intestinal Disease. However, in this 
analysis, with a larger sample size, and with more variables investigated, it has been 
possible to provide a more detailed understanding of the transmission of norovirus in 
the community. In particular characteristics such as household age structure and the 
differing risk associated with child and adult infectious contacts clearly indicate that 
transmission from children to other household members is very important, as has been 
shown for influenza 579,580; this information is important in the design of any potential 
public health interventions to reduce norovirus transmission. Similarly the association 
of particular lifestyle and dietary factors with reduced risk of norovirus infection may 
allow generation of hypotheses about the mechanisms of norovirus pathogenesis and 
the factors that determine whether infection is symptomatic, which could have potential 
for informing efforts to develop therapeutic or prophylactic treatments. 
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Chapter 7: Incidence of general practice consultations 
for norovirus-associated infectious intestinal disease 
in England and Wales based on routine surveillance 
data 
In the previous two sections a method was developed for interpreting real-time RT- 
PCR test results to identify individuals with norovirus-associated IID, the clinical and 
epidemiological characteristics of these norovirus cases, and of individuals with 
asymptomatic norovirus infection, were then examined and compared. In this final 
section, two separate and independent methods will be used to estimate the incidence 
of IID caused by norovirus in the community, and to estimate the frequency of 
consultations to general practitioners for norovirus-associated IID. In this chapter, 
routine surveillance data from England and Wales will be used to estimate the 
incidence of general practice consultations. In Chapter 8, the incidence of community 
disease and general practice consultations for norovirus will be calculated using the 
viral load data from the Study of Infectious Intestinal Disease. 
7.1. Background 
In the UK, the major public health impacts of norovirus-associated IID occur in 
healthcare settings, where norovirus outbreaks disrupt service provision, increase care 
costs, and may worsen patient outcomes 14.92,338, and at the primary-care level, where 
norovirus causes a substantial frequency of consultations for IID8. Whilst the frequency 
of norovirus outbreaks in hospitals in England and Wales is now measured in a routine 
surveillance system348, there is no ongoing surveillance of general practice 
consultations for norovirus-associated IID. 
Prospective research studies, such as the Study of Infectious Intestinal Disease 83 , can 
provide very accurate estimates of the incidence of general practice consultations for 
norovirus-associated IID. However, norovirus has particularly complex epidemiology 
97 
581, making it important to have up-to-date estimates for setting healthcare service 
priorities, and for predicting and assessing the impact of any future vaccination 
programmes, or other public health interventions, against norovirus. Cohort studies are 
particularly expensive, resource intensive and time-consuming, so it is useful to have 
cheaper and more rapid methods for continual assessment of the burden of disease 
caused by norovirus and other pathogens. 
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7.1.1. Routinely available information on general practice consultations 
for norovirus-associated lID in England and Wales 
In England and Wales, general practices record microbiological diagnostic results in 
patients' records. However, only a small proportion of patients presenting to their 
general practitioner with IID are asked to provide stool specimens for diagnostic 
testing, because it is not always necessary for optimal patient care 8.582 . The 
microbiological cause of illness remains undiagnosed in approximately three quarters 
of patients presenting with IID8.582. Physicians may also be more likely to request stool 
specimens from patients with bacterial IID compared to those with viral infections8, 
meaning that norovirus is probably particularly under-diagnosed. Diagnostic results 
from general practice patient records will therefore not provide an accurate estimate of 
the frequency of consultations caused by norovirus. 
National Health Service (NHS) and Health Protection Agency (HPA) laboratories 
voluntarily report norovirus diagnoses to the HPA national surveillance of laboratory- 
confirmed infections. However, diagnostic results for all gastrointestinal pathogens are 
underreported, with the degree of underreporting varying by pathogen8. A large amount 
of norovirus testing in NHS and HPA laboratories is conducted as part of IID outbreak 
investigations, rather than to diagnose microbial aetiology in general practice patients 
with IID. The source of the specimen is reported for very few of the norovirus laboratory 
reports in the national surveillance, so it is not possible to distinguish the diagnoses 
arising from outbreaks versus general practice patients. Due to underreporting and the 
bias towards outbreak investigation in the norovirus reports, national laboratory 
surveillance data cannot directly provide estimates of the frequency of general practice 
consultations for norovirus-associated IID. 
7.1.2. Use of generalised linear regression modelling to attribute 
syndromic disease burden to individual pathogens 
Several previous studies have used generalised linear regression modelling to 
overcome the lack of accurate information on microbial aetiology amongst patients 
presenting with infectious diseases448338,339,583-585 Time series of healthcare 
consultations for a particular syndrome (e. g. IID or acute respiratory infections), are 
modelled as the dependent variable, with time series of un-linked laboratory diagnoses 
for selected pathogens as the independent variables. The pathogen-specific regression 
coefficients are then used to attribute a proportion of the overall disease burden to 
particular pathogens. 
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In the analysis presented below, generalised linear modelling is used to estimate the 
incidence of general practice consultations for norovirus-associated IID in England and 
Wales. The limitations of using the norovirus laboratory report data in these models are 
discussed further and a novel adaptation of the method is presented, to account for 
these limitations. 
7.2. Methods 
7.2.1. Datasets 
7.2.1.1. Royal College of General Practitioners Surveillance Scheme 
Weekly counts of general practice consultations for IID in England and Wales, between 
1993 and 2007, were provided by the Royal College of General Practitioners (RCGP) 
Research and Surveillance Centre483 484 Consultations for IID were defined as those 
assigned International Classification of Disease version 9 (ICD9) codes 001 to 009. 
Repeat consultations by a patient for the same IID episode were excluded. The RCGP 
Surveillance Scheme included approximately 600 000 patients between 1993 and 
2005, and approximately 900 000 from 2006 onwards, when additional general 
practices were recruited (Figure 3.3). Further details about the RCGP Research and 
Surveillance Centre data are provided in Chapter 3. 
Whilst there are other available datasets in the UK that capture information on general 
practice consultations, these other data sources provide individual level data, rather 
than aggregate level data, and therefore also charge a licence fee for access to the 
data, to cover the costs of the more extensive data cleaning and management 
required. Aggregated data was sufficient for the purposes of this analysis, so the 
RCGP Surveillance Scheme data were considered most suitable. 
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Table 7.1 Description of the Royal College of General Practitioners IID consultations 
and pathogen laboratory diagnoses reported to the Health Protection Agency National 
Surveillance of Laboratory-Confirmed Infections, across all ages, 1993 to 2007. 
Median IQR Min Max % zero weeks 
RCGP IID episodes 196 147 - 296 71 456 0 
Campylobacter spp. 896 718 -1165 97 1865 0 
Salmonella spp. 312 195 - 497 0 1279 0.5 
Rotavirus 136 54 - 464 14 1289 0 
Shigella spp. 29 21 - 44 3 444 0 
Giardia lamblia 78 60 -102 6 217 0 
Cryptosporidium spp. 72 49 -107 5 558 0 
Norovirus 36 20 - 66 1 621 0 
Adenovirus 25 18 - 32 3 102 0 
Escherichia coli 18 9-30 1 155 0 
Astrovirus 2 1-6 0 35 24.7 
Staphylococcus aureus 1 0-2 0 424 42.9 
Sapovirus 1 0-2 0 10 43.8 
Vibrio spp. 1 0-2 0 9 29.9 
Clostridium perfringens 0 0-1 0 65 59.3 
Bacillus spp. 0 0 0 4 94.9 
Abbreviations: IID, infectious intestinal disease; IQR, interquartile range; RCGP, Royal College of General 
Practitioners; spp., species. 
7.2.1.2. Health Protection Agency National Surveillance of Laboratory-Confirmed 
Infections 
Weekly counts of laboratory diagnoses of 15 common gastrointestinal pathogens, 
made in England and Wales between 1993 and 2007, were provided by the HPA. 
Electronic reports of laboratory diagnoses are submitted voluntarily by NHS and HPA 
microbiology laboratories. Diagnoses included in this analysis were those made on 
faecal or lower gastrointestinal tract specimens only. Repeat specimens from the same 
patient during investigation of a single disease episode were excluded. The pathogens 
included in the analysis, and the median weekly counts of diagnoses are shown in 
Table 7.1. The diagnostic methods and recommended testing policies for the pathogens 
included in this analysis are summarised in Table 3.5. Further details about the HPA 
national surveillance of laboratory-confirmed infections are provided in Chapter 3. 
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7.2.2. Limitations of the norovirus laboratory report data 
When using generalised linear modelling to attribute healthcare consultations to a 
particular pathogen, it is essential that the time series of laboratory diagnoses, used as 
the explanatory variables, are representative of the overall trends in pathogen 
incidence at the level of healthcare contact under consideration, e. g. community 
disease, primary or secondary care consultations. Given the testing policies 
recommended in the HPA National Standard Methods (summarised in Table 3.5 486,487) 
and the epidemiology of the pathogens considered in this analysis, it is likely that the 
laboratory reports for the majority of pathogens arise from sporadic cases of IID, who 
have presented to primary or secondary healthcare services, rather than cases 
identified during investigations of IID outbreaks2. Individuals tested during IID outbreak 
investigations may not necessarily consult a general practitioner, and outbreaks 
caused by a particular gastrointestinal pathogen may have different epidemiology to 
sporadic cases caused by that pathogen83,4e1' 58&589 
In contrast to the other common gastrointestinal pathogens in the UK, norovirus is a 
major cause of both healthcare-associated and community outbreaks of IID in England 
and Wales; therefore it is likely that a substantial proportion of laboratory reports for 
norovirus arise from outbreak investigations, rather than from individuals consulting 
healthcare services. In the microbiological investigation of IID, the HPA National 
Standard Methods486.87 recommend norovirus testing for all specimens collected from 
children aged less than five years and adults aged 60 years or older; application of 
norovirus testing to specimens from children and adults aged between five and 59 
years is only recommended if they are part of a recognised IID outbreak (Table 3.5). 
However, within inpatient healthcare and other semi-closed residential settings, 
norovirus outbreaks are much more common amongst the elderly than younger age 
groups14'38, meaning that the majority of norovirus laboratory reports in older adults are 
likely to arise from outbreak investigations as well. The age distribution of the patients 
represented in the norovirus laboratory reports indicates that outbreak specimens 
constitute a large majority of the records: 67% of specimens were submitted from 
patients aged 65 years or older (Table 7.2). In contrast, only 9% of patients presenting 
to general practitioners with norovirus-associated 1113 were aged 65 years or 
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Table 7.2: Age distribution of norovirus positive patients with IID from the Health 
Protection Agency National Surveillance of Laboratory-Confirmed Infections and 
general practice patients included in the Study of Infectious Intestinal Disease. 
National Surveillance of Laboratory- The Study of Infectious 
Confirmed Infections Intestinal Disease 
Age 
1993-2007 1993-1996 1993-1996 
(n=37186) (n=6153) (n=232) 
0-4 years 11% 26% 32% 
15 - 64 years 22% 21% 59% 
2: 65 years 67% 53% 9% 
older in the Study of Infectious Intestinal Disease, during which comprehensive 
microbiological testing was carried out in all patients (Table 7.2) 8,51. Children and 
adults aged between five and 64 years are particularly underrepresented in the 
norovirus laboratory report data compared to general practice patients in the Study of 
Infectious Intestinal Disease (Table 7.2). 
The epidemiology of healthcare-associated norovirus outbreaks differs from community 
outbreaks590; there is a distinct winter seasonality in the incidence of outbreaks in 
healthcare settings, whereas outbreaks in community settings show no seasonality. 
This indicates that healthcare-associated norovirus infections, which predominate in 
the norovirus laboratory report data, may have different epidemiology to norovirus 
disease in the community. It is therefore unlikely that norovirus laboratory reports for 
children and adults aged five years or older will be representative of changes in the 
frequency of general practice consultations for norovirus-associated IID, because the 
majority of these reports come from norovirus outbreaks, rather than sporadic cases 
presenting to healthcare services, as described above. Only the norovirus laboratory 
reports for children aged less than five years are likely to be representative of 
healthcare consultations for norovirus-associated IID because comparatively few come 
from norovirus outbreaks. 
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7.2.3. Generalised Linear Regression Model 
7.2.3.1. Overview 
In light of the limitations of the norovirus laboratory report data, the frequency of 
general practice consultations for norovirus-associated IID was estimated using two 
approaches: 
1. The 'direct method' - the norovirus laboratory report data were used as an 
explanatory variable in a generalised linear model of the general practice 
consultations for IID and the norovirus regression coefficient was used to 
estimate the frequency of norovirus consultations; 
2. The 'indirect method' - norovirus was excluded from the explanatory variables 
and laboratory report data for all other gastrointestinal pathogens in Table 7.1 
were used to model variation in general practice consultations for IID; the 
remaining variation in the consultations, after fitting the model, was used to 
estimate the frequency of norovirus consultations. 
The direct method applies the commonly used approach for attributing health outcomes 
to particular pathogens in the absence of data on microbial aetiology, including studies 
that have estimated the incidence of hospitalisations339 and deaths338 due to norovirus 
in England and Wales. These direct estimates are subject to the limitations of the 
norovirus laboratory data described above. The estimates from the indirect method will 
not be affected by these problems because the norovirus reports are not used in the 
model. However, the indirect method does require the assumption that after modelling 
variation due to all other common gastrointestinal pathogens, any remaining variation 
in the general practice consultations must be due to norovirus infections. 
The same basic model structure and confounder model was used in both the direct and 
indirect methods. The model components were fitted in the order: 
1. Confounder variables; 
2. Pathogen explanatory variables; 
3. Investigate interactions between norovirus laboratory reports and time (direct 
model only); 
4. Autocorrelation adjustment; 
5. Sensitivity analyses. 
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7.2.3.2. Model structure 
Multivariable time series-adapted Poisson regression was used to model variation in 
consultations to general practitioners for IID in England and Wales. The weekly counts 
of pathogen laboratory reports were used as the primary explanatory variables. 
Additional explanatory variables were created to model the effects of confounders 
present in time series data. An additive model, on the normal scale, was used because 
changes in general practice consultations are most likely to be proportional to changes 
in the incidence of individual pathogens, rather than the relationship being 
multiplicative; in the additive model, the general practice consultations were modelled 
directly on the normal scale, rather than using the log of the consultation counts as the 
response variable, which is the default link-function used in a Poisson regression 
model. The model residuals were adjusted for Poisson overdispersion in the general 
practice consultations. 
The general practice consultations were modelled separately in three age groups: 
children aged less than five years; children and adults aged between five and 64 years; 
and adults aged 65 years or older. 
The basic structure of the model was: 
Yx =a+i ßixpix + YtxTx + YsxSx + E9.1 eyxDy + YaxAx + Fx Equation 7.1; 
where Y, is the weekly count of general practice consultations for IID in age group x; a 
is a constant term; P1 is the weekly count of laboratory reports for pathogen i in age 
group x, ß, is the corresponding regression coefficient and n is the number of pathogen 
variables included in the model; T, is a trend adjustment term, specific to age group x, 
with coefficient yt; S, is a seasonal adjustment term, specific to age group x, with 
coefficient ys; D,, is a series of nine indicator variables for events such as bank holidays 
and other reporting artefacts, the same in all age groups, and ey is the corresponding 
regression coefficient for age group x; AX is an autocorrelation adjustment term, specific 
to age group x, with coefficient ya; and c, is a model-specific error term. 
7.2.3.3. Confounder model 
Seasonality: Fourier terms were used to adjust for seasonality in the general practice 
consultations (S in Equation 7.1). Fourier terms are linear combinations of pairs of sine 
and cosine functions of time, used to recreate regular temporal patterns in time series 
data. The more Fourier terms added to the model, the more complex the seasonal 
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pattern recreated. The optimal number of Fourier terms was determined using the 
likelihood ratio test to compare the log-likelihood of successive models with increasing 
numbers of Fourier terms; Fourier terms were added until there was no further 
improvement in model fit, evidenced by a change in the log likelihood ratio (likelihood 
ratio test P value >0.1). 
Long-term trends: Optimal adjustment for long term trends in the general practice 
consultations (Tin Equation 7.1) was achieved by successively adding a linear, 
quadratic, then cubic function of time into the model, until there was no further 
improvement in model fit, evidenced by a change in the log likelihood ratio (likelihood 
ratio test P value >0.1). 
Bank holidays and other reporting artefacts: Binary indicator variables (D in Equation 
7.1) were used to adjust for bank holidays in England and Wales and RCGP data 
extraction dates, which cause reductions in the number of general practice 
consultations for IID that are unrelated to changes in disease incidence (see Figure 
3.3). These events were identified a priori and were therefore included in all models, 
without assessing their effect on model fit. 
Appendix A5.1, demonstrates the effects on model fit of adding each of the confounder 
variables (data are shown only for children aged less than five years, to illustrate the 
process). Inclusion of these confounder variables prevents spurious correlations 
between the pathogen laboratory reports and general practice consultations due to 
non-causal similarities in seasonality or long term trends, ensuring that the pathogen 
regression coefficients represent the short term effects of changes in pathogen 
incidence on general practice consultations. 
7.2.3.4. Pathogen explanatory variables 
Model selection: The pathogen laboratory reports were added to the optimal 
confounder model. Any pathogens with a positive regression coefficient that had a 
Wald test P value less than 0.1, were included in the final model, which was used to 
estimate incidence. Norovirus laboratory report data were only included as an 
explanatory variable in the direct models. 
Time lags: The date of specimen receipt in the laboratory was used to temporally relate 
the pathogen laboratory reports to the general practice consultations, because it was 
the only date available for all laboratory report records. The date of specimen collection 
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Figure 7.1 Weekly counts of norovirus laboratory diagnoses for children aged less than 
five years, reported to the Health Protection Agency National Surveillance of 
Laboratory-Confirmed Infections, 1993 to 2007. 
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was not available for laboratory reports prior to 2002, but was reported for the majority 
of specimens tested between 2002 and 2007 (99.6%). If we assume that the laboratory 
reports have arisen from patients consulting their general practitioner, then general 
practice consultations in a given week will correspond to laboratory reports in a 
subsequent week, because of the delay between presentation, specimen collection and 
receipt in the laboratory. Lags between events in the dependent variable and the 
explanatory variables can be explicitly incorporated in time series-adapted regression, 
by modelling the dependent variable against values of the explanatory variable in a 
different week. The median delay between specimen collection and receipt in the 
laboratory was estimated using records between 2002 and 2007 and was used as the 
forward lag applied to the pathogen laboratory report data. General practice 
consultations in week 'n' were therefore fitted against pathogen laboratory reports in 
week 'n+m' where m is the median number of weeks between specimen collection and 
laboratory receipt. The lags used for each pathogen are shown in Appendix A5.2. 
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Figure 7.2 Weekly counts of norovirus laboratory diagnoses for children and adults 
aged five years or older, reported to the Health Protection Agency National 
Surveillance of Laboratory-Confirmed Infections, 1993 to 2007. The black line shows 
children and adults aged between five and 64 years; the red line shows adults aged 65 
years and older. 
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7.2.3.5. Other time series components 
Interactions with time: In the direct models only, changes in the relationship between 
norovirus laboratory reports and general practice consultations during the study period 
were investigated by fitting an interaction between the laboratory reports and a linear 
time variable. The relationship between the norovirus laboratory reports and the 
general practice consultations may change over time due to improvements in the 
sensitivity of diagnostic methods or changes in clinician behaviour with regards to 
requesting stool specimens for testing. If there was evidence of an interaction, it was 
included in the final direct model only if it resulted in positive coefficients throughout the 
study period, i. e. if the interaction term was negative, the coefficient for the norovirus in 
2007 must still be positive. 
Autocorrelation: Autocorrelation is present in any time series data with regular patterns, 
particularly in seasonal infectious disease incidence data. Two adjacent or proximal 
data-points in the time series will have more similar values than if they had occurred 
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through a truly random, Poisson process because there is a deterministic underlying 
mechanism giving rise to the data: pathogen transmission. In weeks when there is high 
incidence, there is very likely to be similar high incidence in subsequent weeks 
because infections occurring in the current week will give rise to further infections. 
Autocorrelation may remain in the general practice consultation data after addition of 
the explanatory and confounder variables into the model if they have not fully explained 
any extra-Poisson variation. Any remaining autocorrelation in the general practice 
consultations will lead to underestimation of the standard errors of the regression 
coefficients. Autocorrelation was assessed in the final model only, by inspection of the 
partial autocorrelations of the deviance residuals from the model. The final model was 
adjusted for autocorrelation by adding autoregressive terms (lagged deviance 
residuals) as indicated by the partial autocorrelation plot. Appendix A5.3 provides an 
explanation of the selection of autoregressive terms. 
7.2.3.6. Modelling strategy and sensitivity analyses 
Direct models: The sensitivity of the norovirus consultation estimates to the method of 
seasonality'adjustment was investigated by refitting the models and replacing the 
Fourier terms with a categorical variable, indicating successive periods of either four or 
13 weeks across the study period. Sensitivity to long-term trend adjustment was 
examined by replacing the continuous (linear, quadratic or cubic) trend term with a 
categorical term for each year of the study period. 
Indirect models: The Pearson's residuals were used to estimate the frequency of 
consultations due to norovirus. It was expected that some seasonality should be 
evident in the residuals for the indirect models if they are to be considered 
representative of norovirus consultations. However, after fitting the models as 
described, the residuals showed no seasonality. Preliminary work applying the direct 
and indirect modelling methods to estimate rotavirus consultations in children aged less 
than five years indicated that the lack of seasonality in the residuals from the indirect 
models was due to the inclusion of seasonal and autocorrelation adjustment terms 
(See Appendix A5.15). The indirect models for norovirus consultations were refitted 
without autocorrelation and seasonality adjustment and further sensitivity analyses 
were carried out. The sensitivity of the results to long-term trend adjustment was 
assessed by replacing the continuous trend term with a categorical year term, and 
sensitivity to the lags used for the pathogen laboratory reports, by fitting general 
practice consultations against laboratory reports from the same week. 
138 
Chapter 7 
7.2.4. Estimating the incidence of general practice consultations for 
norovirus-associated lID 
Direct estimates: The norovirus regression coefficient was multiplied by the norovirus 
laboratory reports, to generate weekly counts of expected general practice 
consultations for norovirus. Where an interaction between norovirus laboratory reports 
and time was included in the final model, the incidence was calculated as the product 
of the norovirus coefficient, the interaction coefficient, the value of the linear term used 
to model time in the interaction and the norovirus laboratory reports in a given week. 
The weekly incidence of norovirus consultations was estimated using the size of the 
patient population registered in the RCGP Surveillance Scheme in each week. To 
account for temporal changes in the size of the RCGP registered patient population, 
which are not reflected in the laboratory reports, an offset was used for 2006 and 2007 
when there was a large increase in the registered population; the incidence in these 
years was multiplied by: 
1+ p"-p193ý Equation 7.2 pi99a 
where P,, is the mean weekly registered population in 2006 or 2007 and P1993 is the 
mean weekly registered population in the first year of the study period. In weeks when 
RCGP Surveillance Scheme data extraction events reduced the registered population, 
the mean of the registered population in the previous and subsequent week was used 
as the denominator for the incidence. Annual incidence was calculated by summing the 
estimated norovirus consultation counts over each year of the study period and using 
the mean registered patient population for each year as the denominator, with the 
offset for 2006 and 2007. 
Indirect estimates: The Pearson's residuals from the indirect models were used to 
estimate of the number of consultations due to norovirus in each week. When fitting a 
generalised linear model the median of the Pearson's residuals should be 
approximately zero, meaning that half of the weekly residuals from the indirect models 
were negative. The most conservative estimate of the weekly count of norovirus 
general practice consultations was based only on the residuals with positive values. A 
plausible upper estimate for the weekly count of norovirus consultations was generated 
by adding the absolute value of the largest negative residual to all other residuals 
within each norovirus year (defined as Ist July in calendar year'n' to 30th June in year 
'n+1'); this standardised the residual series within each norovirus year so that the 
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minimum value was zero. Residuals were standardised within each norovirus year, 
rather than across the whole time series, because norovirus activity varies between 
years. An intermediate estimate was generated by standardising the residual series to 
the 25th percentile within each norovirus year and discarding any remaining negative 
residual values when calculating incidence. The weekly and annual incidence of 
consultations due to norovirus was calculated from these weekly estimated counts of 
norovirus consultations in the same way as for the direct estimates, but without the 
denominator offset. 
This approach, using standardisation of the residual series, was developed in 
preference to the alternative of adding the weekly residual value to the model constant 
term for a number of reasons: 
A priori, using the constant term would lead to overestimation of norovirus 
consultations because this is equivalent to assuming that all consultations 
not accounted for by the explanatory variables are due to norovirus, which 
cannot be true because many minor gastrointestinal pathogens were not 
included as explanatory, variables in the final indirect models; even for the 
common gastrointestinal pathogens included in the final indirect models, ' 
their contribution to the general practice consultations is unlikely to be 
completely captured in such a model; using only the residual series 
therefore provides a more conservative estimate of consultations due to 
norovirus; 
ii. Interactions with time were included in some of the final models, making it 
difficult to interpret the constant term across the whole time series because 
in an interaction model it represents the baseline consultations in the first 
time period considered, e. g. if there was an interaction with year, the 
constant represents the baseline of consultations in 1993; 
iii. The direct and indirect rotavirus models in children aged less than five years 
were used to validate the use of the indirect modelling approach for 
norovirus, but the constant term in the rotavirus indirect models was 
negative, whereas the constant term was large and positive in the norovirus 
models, making it difficult to develop an indirect method appropriate to both 
pathogens that included using the constant term; 
iv. The marked decrease in the weekly counts of general practice consultations 
for IID across the study period meant that the constant term was actually 
larger than the weekly observed counts of consultations in some weeks 
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during the final years of the study period; norovirus incidence estimates 
based on use of the constant would be larger than the total incidence of 
consultations caused by all pathogens, and therefore biologically 
implausible; 
Estimation of general practice consultations due to rotavirus, via both the 
direct and indirect methods in children aged less than five years, allowed 
validation of the indirect method based on the residual series only; the 
laboratory reports for rotavirus are not subject to the limitations described 
for norovirus, so that the direct estimates should provide a reliable estimate 
of the number of general practice consultations due to rotavirus in children 
aged less than five years; the indirect rotavirus consultation estimates were 
very similar to these direct estimates, indicating that the indirect method was 
appropriate. 
All analyses were carried out using Stata v10.1494 
7.3. Results 
7.3.1. Descriptive analysis 
During the study period, the incidence of general practice consultations for IID in the 
RCGP Surveillance Scheme declined substantially, although the greatest decrease 
was amongst children aged less than five years (Chapter 3, Figure 3.4). The weekly 
number of laboratory reports for norovirus remained reasonably constant in children 
aged less than five years (Figure 7.1), but the number of reports in older age groups 
increased substantially (Figure 7.2). 
Figure 7.3 shows the weekly counts of general practice consultations for IID, which 
were used as the dependent variables in the models. Descriptions of the pathogen 
laboratory report data used in this analysis are provided in Appendices A5.4 and A5.6. 
Appendix A5.7 shows the crude correlation between laboratory reports for each 
pathogen and the general practice consultations. In children aged less than five years, 
weekly norovirus laboratory reports and general practice consultations for IID were 
positively correlated across the time series, whereas the correlation was negative in 
children and adults aged five years and older (Appendix A5.7g). 
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Figure 7.3 Weekly counts of general practice consultations for IID, from the Royal 
College of General Practitioners Surveillance Scheme, 1993 to 2007. 
Figure 7.3a Children aged less than five years. 
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Figure7.3b Children and adults aged between five and 64 years 
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Figure7.3c Adults aged 65 years and older 
60 
w 
N 
ö 50 
JS 
40 
8 
30 
ä 
20 
rn 
0 10 
d 
ma E 
0 z 
33333333333333 33 
M 'IT u) CO hM0NM00 CO fý oD 
C> (7) O) 0) M O) O) 0O0O00O000 
NNNNNN 
C) 0N0N 
Year/Week 
7.3.2. Model tit 
Tables 7.3 to 7.5 show the components included in each of the final models. 
Appendices A5.8 to A5.11 show the results for each stage of the model fitting process. 
The direct and indirect models displayed heterogeneity of variance, with larger 
Pearson's residuals at the beginning of the study period, indicating poorer model fit 
prior to the year 2000 (Appendix 5.13 and Appendix 5.14). The model fit was 
particularly poor for adults aged 65 years and older; inspection of the fitted values 
(Appendix 5.14, Figure 5.14m to 5.14q) indicates that very little of the variation in 
general practice consultations is predicted by the pathogen laboratory reports and 
confounder variables in either the direct or indirect models in adults aged 65 years and 
older. 
The norovirus general practice consultation incidence estimates from the direct models 
were sensitive to the method of seasonal adjustment used, but not to the method of 
trend adjustment (Tables 7.3 to 7.5, Appendix A5.12). The estimates from the indirect 
models showed little sensitivity to the method of long-term trend adjustment or 
inclusion of the forward lags on the pathogen laboratory reports (Tables 7.3 to 7.5), 
although there were some changes in the pathogen laboratory report explanatory 
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variables included in the final models when the method of seasonality adjustment was 
changed and the lags were removed. 
In the indirect models, removal of the seasonal and autocorrelation adjustment 
variables slightly increased the seasonality of the estimated norovirus consultations in 
children aged less than five years only (Figure 7.4a and Figure 7.4b). There was no 
seasonality in the estimated norovirus consultations in children and adults aged 
between five and 64 years (Figure 7.5) or adults aged 65 years or older (Figure 7.6), 
regardless of the presence of the seasonality and autocorrelation adjustment variables. 
An interaction between the rotavirus laboratory report explanatory variable and time 
(year of the study period) was introduced into the indirect model for norovirus incidence 
in children aged less than five years, because the higher peak in incidence at week 40 
of the norovirus year, estimated from indirect model 2 (Figure 7.4b), corresponds to the 
single annual peak of rotavirus incidence (Appendix 5.15) and may be due to 
underestimation of the number of consultations attributable to rotavirus in certain parts 
of the study period. Introducing this interaction improved the model fit (AIC reduced 
from 8.89 to 8.57, Table 7.3) and reduced the size of the later peak in norovirus 
incidence (Figure 7.4c), which now matches the seasonality of the norovirus laboratory 
reports in children aged less than five years (Appendix A5.5). 
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7.3.3. Norovirus incidence 
The annual incidence of norovirus consultations amongst children aged less than five 
years, estimated from the optimal indirect model (Indirect Model 4), was 16 per 1000 
population for the period 1993 to 2007, with a plausible range between 8 and 38 per 
1000 (Table 7.6). The annual incidence of consultations was much lower in children 
and adults aged between five and 64 years, and in adults aged 65 years and older 
(based on Indirect Model 2), at 2 per 1000 (range 1-4) and 3 per 1000 (range 1-7) 
respectively (Table 7.6). The incidence for all age groups decreased over the study 
period (Table 7.6). The indirect estimates were substantially higher than the direct 
estimates in all age groups. 
Table 7.6 Incidence of general practice consultations for norovirus-associated IID in 
England and Wales. 
Incidence estimates are presented using only the positive residuals ('positive only'), by 
standardising to the 25th percentile value of the residuals ('25th percentile') and by 
standardising to the value of the lowest residual ('lowest residual'). 
Mean annual incidence of general practice consultations for 
norovirus-associated IID per 1000 po pulation 
1993-2007 1993-1996 2002-2007 
21 
N 
0 
C) 0 m 0 
i`D 
0 öý ö 3ý' U)` `ý 3N Na CL J U) 44) NaO 32 Nä CL J 
< 5years' 15.5 7.7 37.7 17.8 11.3 43.1 11.7 5.4 24.7 
5-64 years' 1.6 0.85 4.0 2.5 1.6 5.8 0.9 0.5 2.7 
Z65 years" 2.8 1.4 6.7 4.0 2.3 9.0 1.9 0.9 4.7 
Based on indirect model 4 (long-term trend adjustment and interaction between rotavirus laboratory 
reports and time) 
`Based on indirect model 2 (long-term trend adjustment only) 
148 
Chapter 7 
Figure 7.4 Seasonality of the incidence of general practice consultations for norovirus- 
associated IID in children aged less than five years. 
Figure 7.4a Indirect model 1 with adjustment for seasonality and autocorrelation. 
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Figure 7.4b Indirect model 2 with adjustment only for long-term trends. 
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Figure 7.4c Indirect model 4 with adjustment for long-term trends and an interaction 
between rotavirus laboratory reports and time. 
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Figure 7.5 Seasonality of the incidence of general practice consultations for norovirus- 
associated IID in children and adults aged between five and 64 years. 
Figure 7.5a Indirect model 1 with adjustment for seasonality and autocorrelation. 
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Figure 7.5b Indirect model 2 with adjustment only for long-term trends. 
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Figure 7.6: Seasonality of the incidence of general practice consultations for norovirus- 
associated IID in adults aged 65 years and older. 
Figure 7.6a Indirect model I with adjustment for seasonality and autocorrelation. 
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Figure 7.6b Indirect model 2 with adjustment only for long-term trends. 
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7.4. Discussion 
In this analysis, time series-adapted Poisson regression was used to estimate the 
incidence of general practice consultations for norovirus-associated IID in England and 
Wales. The limitations of using the norovirus laboratory reports from the HPA national 
surveillance with this widely applied method were described and the modelling 
approach was modified to account for these problems. Using the adapted method, it 
was estimated that approximately 1.5% of children aged less than five years in England 
and Wales presented to their general practitioner with norovirus-associated III) each 
year between 1993 and 2007. The overall incidence of general practice consultations 
for III) declined during this period, so that approximately 1% of children in this age 
group presented with norovirus-associated IID in the last five years of the study (2002 
to 2007). In older age groups, only 0.1 % to 0.2% of individuals presented each year 
between 2002 and 2007, although the fit of the regression models was much poorer in 
these age groups, especially in adults aged 65 years or older, so the results may be 
less reliable. 
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A major advantage of using generalised linear modelling to estimate pathogen-specific 
healthcare consultations is that it does not directly rely on complete reporting of 
pathogen diagnoses or on knowledge of the degree of underreporting. The method 
relies only on using the trends and patterns in the pathogen laboratory report data. 
However, when the laboratory report data are not representative of healthcare 
consultations due to the pathogens considered, which is probably the case for 
norovirus reports from individuals aged five years and older, the reliability of the results 
is greatly reduced. In addition, when the pathogen laboratory counts are very small, 
statistical power is reduced and there is increased probability of type II errors (failing to 
find or underestimating the size of a real association between the consultations and a 
pathogen contributing to them. ) The weekly norovirus report counts from children aged 
less than five years were very small and the direct estimates of norovirus consultations 
in this age group were sensitive to the method of seasonal adjustment, reducing 
confidence in the reliability of these direct estimates. In contrast, the direct estimates of 
the incidence of consultations for rotavirus-associated III) in the same age group, for 
which a much larger number of laboratory reports are received, were robust to changes 
in the seasonal terms used (Appendix A5.15). 
Whilst not subject to the limitations of the norovirus laboratory reports, the indirect 
modelling method does require the significant assumption that, after selecting the best 
fitting model of general practice consultations for IID, all remaining variation in the 
consultation data is attributable to norovirus. The strength of this assumption is 
reduced by the inclusion of a constant term in the models, but this constant term was 
not used to estimate consultations attributable to norovirus, so that a number of 
consultations in each week are attributed neither to norovirus nor to causes explicitly 
represented in the explanatory variables. However, it is still essential that the laboratory 
report data for the pathogens used as explanatory variables in the indirect models are 
of good quality and are representative of consultations made for these pathogens. This 
was assumed to be the case, based on the application of testing recommended by the 
HPA National Standard Methods486 487 and knowledge of the epidemiology of these 
pathogens in England and Wales. Data on Clostridium diffcile were not used because 
of the large amount of testing associated with hospital-acquired infections and hospital 
patient screening in England and Wales, meaning that these data are unlikely to be 
representative of the incidence of general practice consultations for C. difficile. 
However, C. difficile caused only a small number of general practice consultations in 
the Study of Infections Intestinal Disease8, so it is unlikely that exclusion of C. difficile 
laboratory reports in this analysis will have greatly affected the results. There are likely 
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to be a number of other uncommon gastrointestinal pathogens contributing to the 
burden of general practice consultations for IID, which were not included in the models, 
but again the effect of their omission in these particular models is likely to be minimal. 
The inclusion of the constant term further reduces the problem of excluding laboratory 
reports from pathogens that cause a low incidence of general practice consultations. 
Development of the indirect method relied on the existence of good quality laboratory 
report data for rotavirus in children aged less than five years, with which reliable direct 
estimates of general practice consultations due to rotavirus could be made using the 
regression models. It was therefore possible to fit both direct and indirect models for 
rotavirus in children aged less than five years and to compare the rotavirus consultation 
estimates to provide "proof of principle" for the application of the indirect method to 
estimate norovirus consultations. 
The indirect models provided a good fit to the general practice consultations in children 
aged less than five years, evident from inspection of the fitted values. Fitting of the 
Fourier terms indicated two clear annual peaks in general practice consultations for IID 
in children aged less than five years, which correspond to the recognised seasonality of 
norovirus and rotavirus in young children209 and matched the seasonality of the 
norovirus laboratory reports in this age group. This increases confidence in the indirect 
estimate of norovirus consultations because the method independently reproduced the 
expected annual pattern of norovirus incidence. In addition, with such good model fit, 
the assumption that the remaining variation in consultations is due to norovirus is 
justifiable. 
However, the incidence of general practice consultations in older age groups was much 
less seasonal and both the direct and indirect models showed much poorer fit to the 
consultation data. In fact, given the very small amount of overdispersion indicated by 
the Pearson's X2 test, it seems that the consultations for IID in adults aged 65 years 
and older are essentially random. This lack of seasonality in general practice 
consultations for IID in adults contrasts with the distinct and regular seasonality of the 
laboratory reports for pathogens such as Salmonella spp. and Campylobacter spp. 
(Appendix 5.4), which are known to be major causes of IID in adultse. The lack of 
seasonality in adult consultations may indicate that a larger range of pathogens, with 
different and overlapping seasonality, contribute equally to the aetiology of IID in adults 
consulting general practitioners. In contrast, the model fit was very good for children 
aged less than five years, in which enteric viruses are the predominant cause of IID 
consultations and are recognised to have distinct seasonal patterns, with rotavirus, the 
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most common pathogen, having the most consistent seasonality (Appendix 5.4). 
Whatever the underlying reasons for the poorer model fit in adults, with such poor 
explanatory power in the fitted model, it is difficult to justify using the residual series to 
represent norovirus consultations. In addition, the seasonality of norovirus incidence at 
the community level in adults, rather than outbreaks, is poorly described, so it is 
unclear whether the lack of seasonality in the residual series from the indirect models 
in adults should be expected, again making it more difficult to justify the assumption 
that they represent norovirus consultations. Until the expected seasonal pattern of 
norovirus incidence in adults is better described, it remains impossible to determine 
whether the lack of winter-time seasonality in the residuals and the overall general 
practice consultations for IID in adults is due to a difference in norovirus epidemiology 
compared to young children, or because norovirus is not a significant cause of 
consultations in adults. 
The direct estimates were much lower than the indirect estimates, across all age 
groups. In children aged less than five years this may have been expected because the 
weekly counts of norovirus laboratory reports were very small, which may prevent 
accurate estimation of the relationship between norovirus reports and general practice 
consultations. Indeed, the indirect estimates for 1993 tol 996 in this age group are 
much closer to the estimates from the Study of Infectious Intestinal Disease, presented 
in Chapter 8, although the estimates from the Study of Infectious Intestinal Disease lie 
towards the upper limit of the range presented for the indirect estimate in this analysis. 
The 25th percentile from the rotavirus indirect model in children aged less than five 
years gave a reasonable approximation to the direct estimate for rotavirus, but this may 
not necessarily be appropriate for the indirect norovirus estimates. However, it is 
difficult to objectively select a way to present the indirect estimates and the 25th 
percentile provides a mid-point between the lower and upper limits represented by the 
positive residuals and standardisation to the lowest negative residual. The purpose of 
this estimate of norovirus consultation incidence, which can never be as accurate as 
those from prospective research studies, is to provide a plausible range in which the 
number of consultations lies, rather than to produce a single point estimate, so it is 
important not to place too much emphasis on the mid-point presented, because it does 
not represent a point-estimate in the common statistical sense. 
The indirect modelling approach developed here provides a novel way of estimating 
general practice consultations for norovirus-associated IID, in the absence of any 
robust routinely collected data on this outcome. However, it is reliant on the use of 
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good quality laboratory report data for other gastrointestinal pathogens responsible for 
general practice consultations, in order to remove variation from the RCGP 
consultation data attributable to these other pathogens. In children aged less than five 
years, the laboratory report data provided a good fit to the general practice consultation 
data, which may be because of the predominance of rotavirus as a cause of 
consultations in this age group; rotavirus has a distinct annual peak that was correlated 
well to the annual peak in the general practice consultation data. Therefore, the indirect 
estimates of norovirus consultation incidence in children aged less than five years may 
be reasonably reliable. However, the laboratory report data for other age groups did not 
provide as good a fit to the consultation data, meaning that a large amount of variation 
remained unexplained in the model and it was difficult to justify using the residuals as a 
representation of norovirus consultations. It may be that this indirect approach is most 
useful for healthcare consultations that show distinct seasonality, well-matched to the 
seasonality of recognised causative pathogens, but that for less seasonal phenomena 
and in the absence of a priori reasons to believe that the residual variation is all 
attributable to the omitted pathogen, the method is less appropriate. 
156 
Chapter 8 
Chapter 8: Community incidence of norovirus- 
associated infectious intestinal disease in England 
based on viral load 
In Chapter 4 norovirus viral load measurements in IID cases and controls were used to 
select a cut-off in viral load for identifying individual cases of norovirus-associated IID. 
In this final analysis, the same viral load data were used to estimate the incidence of 
norovirus-associated IID in the community in England and the incidence of general 
practice consultations for norovirus-associated IID. However, rather than classifying the 
norovirus aetiology of individual III) cases, exclusion of RT-PCR positive IID cases 
whose illness is unlikely to have been caused by norovirus was carried out at the 
population-level, using a probability-based method. This method was chosen because 
it allows explicit incorporation of uncertainty in the viral load data into the confidence 
bounds of the incidence estimates. 
8.1. Background 
Norovirus is recognised as the most common cause of IID in the community in high 
income countries5"7 and a substantial prevalence of norovirus infection has been 
reported amongst IID cases seeking primary and secondary medical care 49. Existing 
estimates of norovirus-associated IID incidence in the community and of general 
practice consultations caused by norovirus in England are based on electron 
microscopy testing of IID cases in the Study of Infectious Intestinal Disease. The poor 
diagnostic sensitivity of electron microscopy for identifying norovirus-associated IID 
was demonstrated in the analysis of viral load data in Chapter 4, where a substantial 
proportion of those IID cases who were negative by electron microscopy were 
subsequently classified as norovirus cases using the real-time RT-PCR testing and the 
Ct value cut-off. 
It is therefore very likely that the estimates based on electron microscopy under- 
represent the burden of disease caused by norovirus in England and it is important that 
they are updated in light of the RT-PCR retesting of the Study of Infectious Intestinal 
Disease specimen archive. However, it is essential that those IID cases shedding 
norovirus at the low concentrations seen in the healthy controls are excluded from the 
incidence estimate, because it is very unlikely that they actually have disease caused 
by norovirus, despite being infected at the time of their illness. Only individuals with IID 
caused by norovirus should be included in estimates of norovirus disease burden. 
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8.2. Methods 
Full details of recruitment and testing during the Study of Infectious Intestinal Disease 
were provided in Chapter 3. 
8.2.1. Calculating the incidence of all-cause lID in the community and of 
lID consultations to general practitioners 
Poisson regression was used to calculate the incidence of all-cause IID in the 
community, from the number of IID cases ascertained in the community cohort and the 
number of person-years of follow up completed (Table 8.1). Poisson regression was 
also used to calculate the all-cause incidence of general practice consultations for IID. 
The numerator for the incidence of general practice consultations for IID was the 
number of IID cases ascertained in the general practice case-control study and the 
general practice enumeration study, adjusted for the level of case under-ascertainment, 
which was estimated in the under-ascertainment study (see Chapter 3) (Table 8.1). 
The denominator for the incidence of general practice consultations for IID was the 
number of patients registered across all the general practices participating in the study, 
adjusted for list inflation (the number patients who were no longer actively using the 
practices, described Chapter 3), multiplied by the duration of practice participation in 
the study (Table 8.1). 
8.2.2. Norovirus diagnostic testing 
The results from both gel-based RT-PCR and real-time RT-PCR norovirus testing of 
the archived specimens were used in this analysis. The number of IID cases positive 
for norovirus by RT-PCR (Table 8.1) was used directly in calculation of the incidence of 
norovirus-associated IID. The real-time RT-PCR viral load measurements, from both 
IID cases and controls, were used to calculate an adjustment factor, to remove IID 
cases whose disease was not caused by norovirus from the incidence estimate, as 
described below. For those IID cases positive by real-time RT-PCR who had mixed 
genogroup I and genogroup II norovirus infections, the lowest Ct value was used in the 
analysis. 
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Table 8.1 Summary of case recruitment and stool specimen testing in the community 
cohort and general practice case-control and enumeration studies in the Study of 
Infectious Intestinal Disease. 
Person-years of follow-up 
Ascertained cases 
Stool specimen 
Stool specimen archived 
RT-PCR positive for norovirusd 
Ct value determined with real- 
time RT-PCR 
Community Cohort General practice case-control and 
enumeration studies 
4026 409878' 
781 13619b 
761 2893` 
517 1905 
211 623 
174 544 
'Adjusted for registered patients no longer actively using participating GP practices b Adjusted for under-ascertainment 
Stool specimens were only collected from patients in 34 practices participating in the general practice 
case-control study 
d Includes those previously positive by EM 
Abbreviations: Ct, cycle threshold; EM, electron microscopy; GP, general practitioner; RT-PCR, reverse 
transcription-polymerase chain reaction. 
8.2.3. Calculating the incidence of norovirus-associated lID 
The incidence of norovirus-associated IID (INV) was calculated as (Formula 1): 
INV= I xp(NV) xA 
where I is the incidence of all-cause IID per 100 person-years, p(NV) is the proportion 
of IID cases positive for norovirus by RT-PCR in the specimen archive, and A is a 
factor used to adjust for those IID cases with norovirus infection who have low viral 
loads and are therefore unlikely to have disease caused by norovirus. 
Rather than using the Ct value cut-off from Chapter 4 to classify norovirus aetiology for 
individual IID cases, the Ct value distributions from the reference groups in the ROC 
analysis were used to calculate Adjustment Factor A. The ROC analysis did not 
provide confidence limits around the selected Ct value cut-off, whereas calculation of 
Adjustment Factor A, from the same viral load data, allows uncertainty due to sampling 
error in these Ct value distributions to be incorporated into the incidence estimate. The 
reference positive group used to calculated Adjustment Factor A included IID cases 
with norovirus detected by electron microscopy, from both the community cohort and 
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the general practice case-control study (Reference Positive Group 1 from the ROC 
analysis in Chapter 4). IID cases from both study components were analysed together 
to increase the sample size of the reference positive group; there was no evidence 
from the analysis in Chapter 4 that there was a difference in Ct value distribution 
between electron microscopy norovirus positive IID cases in the two study components 
(Table 4.4), so it is appropriate to combine Ct values from IID cases in the two study 
components to calculate the adjustment factor. The reference negative group included 
healthy controls (Reference Negative Group 1 from the ROC analysis in Chapter 4). 
Adjustment factor A was calculated as (Formula 2): 
i=39 
RPi 
A= Cti x RPi + RN, 
i=15 
where RP; is the moving average of the proportion of the reference positive group at Ct 
value i (over i-2 to i+2); RN; is the moving average of the proportion of the reference 
negative group at Ct value i (over i-2 to i+2); Ct; is the proportion of IID cases positive 
by norovirus real-time RT-PCR with Ct value i. Adjustment factor A varies between 
zero and one. Adjustment factor A is therefore a weighted average of the relative 
frequency of the reference positive and reference negative groups at each Ct value, 
weighted by the proportion of all norovirus infected IID cases at each Ct value (shown 
in Figure 8.1). 
Figure 8.2 shows the distribution of Ct values in the reference groups and the value of 
the sub-component [RP; + (RP; + RN, )], which represents the relative frequency of the 
reference groups. At low Ct values, where viral loads are high and there are few 
individuals from the reference negative group, sub-component [RP; + (RP, + RN, )] is 
close to one, indicating that the majority of IID cases with norovirus infection at these 
concentrations have disease caused by norovirus. In contrast, at the high Ct values 
(low viral loads) found in the majority of the disease-free reference negative group, 
sub-component [RP; + (RP; + RN, )] is close to zero, indicating that very few III) cases 
with norovirus infection at these concentrations have disease caused by norovirus; 
these III) cases are likely to have an 'asymptomatic' norovirus infection concurrent to 
illness caused by another pathogen. 
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Figure 8.1 Distribution of real-time RT-PCR cycle threshold values in IID cases from 
the community cohort and the general practice case-control study in the Study of 
Infectious Intestinal Disease. Dark grey bars are IID cases from the community cohort 
(n=174); white bars are IID cases from the GP study (n=544). 
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Abbreviations: Ct, cycle threshold; IID, infectious intestinal disease. 
When calculating age-stratified and age-adjusted incidence, Adjustment Factor A was 
calculated separately for children aged less than five years and for older children and 
adults (aged five years or older), using the corresponding reference groups from the 
ROC analysis in Chapter 4. The same reference groups were used to calculate sub- 
component [RP, + (RP, + RN, )] of Adjustment Factor A for both the community and 
general practice incidence of norovirus-associated IID. Sub-component [RP, + (RP; + 
RN, )] was then applied separately to the Ct value distribution from IID cases in each 
study component (Ct, in Formula 2, shown in Figure 81), to create separate adjustment 
factors specific to the community and general practice norovirus-associated IID 
incidence. 
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8.2.4. Incidence estimation by Monte Carlo simulation in WinBUGS 
The incidence of norovirus-associated IID was estimated using Monte Carlo simulation 
in WinBUGS 0.4591, to incorporate statistical uncertainty due to sampling error in each 
of the component proportions in Formula 1 and Formula 2. Confidence limits for the 
incidence of norovirus-associated IID were based on the Bayesian credibility intervals 
from the posterior sampling distribution. The all-cause IID incidence per 100 person- 
years (I) was modelled using a log-normal distribution, with the log of the point estimate 
as the mean and the log of the standard error as the standard deviation. Proportions 
were modelled using binomial distributions with non-informative uniform priors. 
Multinomial distributions were used to model the Ct value distributions, with non- 
informative Dirichlet prior distributions. The simulation was run for 300000 iterations, 
from three different sets of initial values, to check convergence. 
Figure 8.2: Distribution of real-time RT-PCR cycle threshold values in the reference 
positive and reference negative groups and adjustment factor sub-component RP; / 
(RP, + RN). Grey bars are the reference positive group (n=119); white bars are the 
reference negative group (n=199); triangle symbols show the adjustment factor sub- 
component RP, / (RP, + RN, ). 
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Abbreviations: Ct, cycle threshold; RP;, moving average of the proportion of the reference positive group at 
Ct value i; RN,, moving average of the proportion of the reference negative group at Ct value i. 
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Separate simulations were run to estimate the incidence of illness caused by norovirus 
in the community and the incidence of general practice consultations for norovirus- 
associated IID. The numbers of IID cases with norovirus Ct values limited the number 
of age groups in which the community incidence could be presented. Age- and season- 
stratified incidence was calculated by applying the simulation procedure separately to 
data from each age group or season. Age-adjusted incidence was calculated (also in 
WinBUGS) as a weighted average of the incidence in children aged less than five 
years and older children and adults (aged five years or older); weights were taken from 
the age distribution of the mid-1994 population estimate for England, obtained from the 
Office of National Statistics, UK. The annual numbers of cases of norovirus-associated 
IID were calculated from the incidence estimates and the age-stratified mid-1994 
population estimate for England. 
8.2.5. Alternative methods for estimating the proportion of lID cases with 
disease attributable to norovirus 
Three further methods were used to estimate the proportion of IID cases with disease 
attributable to norovirus, which either do not require a control group or have been used 
in previous studies. The results were compared to those from the method using 
Adjustment Factor A. 
Alternative Method 1: In previous studies where a control group has been recruited and 
tested, but using only RT-PCR not real-time RT-PCR, the proportion of IID cases with 
norovirus infection that have disease attributable to norovirus has been estimated as 
the difference in norovirus prevalence between the control group and IID cases49. 
When using this approach, norovirus-associated IID incidence was calculated as 
(Formula 3): 
INV =Ix [p(NV)case - P(NV)controi] 
where p(NV)case represents norovirus prevalence detected by RT-PCR amongst IID 
cases and p(NV)contmi represents norovirus prevalence detected by RT-PCR amongst 
controls. 
Alternative Method 2: The age-specific genogroup II Ct value cut-offs from Chapter 4 
(at Ct value 30 for children aged less than five years and at Ct value 33 for older 
children and adults) were applied to all IID cases with a norovirus Ct value, from both 
genogroup I and genogroup If. The proportion of IID cases with a norovirus Ct value at 
or below the Ct value cut-off was substituted for Adjustment Factor A in Formula 1. In 
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addition, to explore the effect of late specimen collection on norovirus incidence, 
probable cases of norovirus-associated IID were defined as those IID cases with a Ct 
value above the cut-off, a specimen collected five or more days after symptom onset 
and no other pathogen detected. These probable cases were added to the IID cases 
with a norovirus Ct value at or below the cut-off and incidence recalculated. 
Alternative Method 3: Mixture modelling was used to estimate the proportion of IID 
cases with a norovirus Ct value who have disease attributable to norovirus, using only 
the viral load data from IID cases. This proportion was substituted for Adjustment 
Factor A in Formula 1 and uncertainty around the proportion was represented using a 
beta distribution, based on the 95% confidence interval provided from the mixture 
model. Details of the mixture model are provided in Appendix A6.1. 
8.2.6. Incidence based on electron microscopy and RT-PCR testing 
Incidence of norovirus-associated IID based on electron microscopy testing and based 
on classifying any IID case positive for norovirus by RT-PCR as a case of norovirus- 
associated IID were also calculated, to demonstrate the effect of using the new method 
based on Adjustment Factor A. The estimates based on electron microscopy testing 
were calculated using Formula 4: 
INV=IxP 
where P is the proportion of IID cases positive by electron microscopy. When 
calculating the incidence of norovirus-associated IID based on classifying any norovirus 
RT-PCR positive IID case as a case of norovirus-associated IID, P in Formula 4 was 
the proportion of IID cases positive by gel-based RT-PCR. 
The incidence of rotavirus-associated IID based on ELISA diagnosis (in children aged 
less than five years only), was calculated in the same way. 
8.3. Results 
The crude community incidence of norovirus-associated IID was 4.1 per 100 person- 
years (Table 8.2); after adjusting for the age distribution of the cohort, the community 
incidence was 4.5 episodes per 100 person-years (Table 8.2). The incidence was 
highest in children aged less than five years, with 20% experiencing norovirus- 
associated 1113 every year, but incidence was substantial in all age groups (Table 8.2). 
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Table 8.2 Incidence of norovirus-associated IID in England, 1993 to 1996. 
Community GP consultation 
Ratio of 
Incidence Incidence Community to 
per 100 95% per 100 95% GP cases 
person- Credibility person- Credibility 
years interval years interval 
Crude 4.1 3.4-4.8 0.49 0.43-0.55 8.4 
Age-adjusted 4.5 3.8-5.2 0.54 0.48-0.60 8.3 
Age-stratified 
<5years 21.4 15.9-27.7 3.2 2.6-3.8 6.7 
Z5 years 3.3 2.6-3.9 0.35 0.30-0.39 9.7 
0 -1 years 27.2 17.9-38.6 6.4 5.2-7.7 4.3 
2-4 years 16.7 11.4-23.3 1.5 1.2-2.0 11.1 
5-14 years 6.5 4.5-8.9 0.44 0.31 -0.59 14.8 
15 - 44 years 4.1 3.1-5.3 0.38 0.32-0.45 10.8 
2: 45 years 1.7 1.1-2.3 0.29 0.24-0.35 5.9 
45 - 64 years - - 0.26 0.20-0.32 - 
z65 years - - 0.37 0.27-0.47 - 
Season-stratified 
January - March 4.7 3.4-6.3 0.46 - 0.37-0.57 
April - June 3.8 2.7-5.1 0.52 0.43-0.62 - 
July - September 3.3 2.4-4.5 0.43 0.35-0.51 - 
October - December 4.8 3.6-6.3 0.56 - 0.46-0.66 
Rotavirus-associated IID 
0 -1 years 13.7 5.6-25.1 6.4 5.2-7.7 2.1 
2-4 years 6.2 2.5-11.5 1.5 1.2-2.0 4.1 
<5 years 8.5 4.6-13.6 3.2 2.6-3.8 2.7 
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Table 8.3 Estimated annual numbers of norovirus-associated IID cases in the 
community and consulting a general practitioner in England, 1993 to 1996. 
Community General Practice 
Thousands 95% Credibility Thousands 95% Credibility 
of cases interval of cases interval 
All ages (age-adjusted) 2175.8 1836.8 - 2543.0 261.5 233.4 - 290.6 
0 -1 years - 81.0 65.4-97.8 
2-4 years - 30.4 22.7-38.8 
<5 years 691.4 513.4 - 897.1 103.7 85.2-123.2 
5 -14 years 403.1 279.0 - 550.3 27.1 18.9-36.6 
15 - 44 years 854.3 635.6 - 1104.9 78.6 65.1- 93.0 
Z45 years 308.4 211.4 - 426.8 54.9 45.0-65.6 
45 - 64 years - 
265 years - 
28.2 21.9-35.4 
28.1 21.0-36.2 
Norovirus-associated IID incidence in the community was highest between October 
and March (Table 8.2). 
There were 0.5 general practice consultations for norovirus-associated IID per 100 
person-years (Table 8.2). The incidence of general practice consultations was highest 
amongst children aged less than two years, at 6.4 per 100 person-years (Table 8.2). 
Approximately one in seven children aged less than five years who experienced 
norovirus-associated IID presented to a general practitioner (Table 8.2), compared to 
one in three of those with rotavirus-associated IID in the Study of Infectious Intestinal 
Disease (Table 8.2). The incidence of general practice consultations for norovirus- 
associated IID was similar for all individuals aged five years and older (Table 8.2). The 
seasonality of general practice consultations for norovirus-associated IID was less 
pronounced than the community incidence (Table 8.2). The incidence translates into 
over two million episodes of norovirus-associated IID in the community each year 
during 1993 to 1996 and more than 200 000 general practice consultations (Table 8.3). 
Whilst the highest absolute burden of norovirus-associated IID occurred in adults, the 
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greatest number of general practice consultations occurred in children aged less than 
five years, who accounted for almost half of the consultations (approximately 100 000) 
(Table 8.3). 
The results of the alternative estimation methods and the community incidence based 
on electron microscopy and all norovirus RT-PCR positive IID cases are shown in 
Table 8.4 and Figure 8.3, general practice consultation incidence based on these 
alternative methods is provided in Appendix A6.2. The incidence estimates using the Ct 
value cut-off were slightly lower than those using Adjustment Factor A and the 
confidence intervals were narrower. Subtracting the control norovirus prevalence from 
that in IID cases produced higher incidence estimates in young children, but lower 
estimates in older children and adults. Mixture modelling produced the lowest 
estimates. The age-adjusted incidence in the community based on Adjustment Factor 
A was three times that based on electron microscopy and half the incidence based on 
all RT-PCR positive cases. The age-adjusted incidence of general practice 
consultations based on Adjustment Factor A was two and a half times higher than the 
incidence based on electron microscopy and half that based on all RT-PCR positive IID 
cases. 
The values of Adjustment Factor A calculated in the Monte Carlo simulations are 
shown in Appendix A6.3. 
Figure 8.3 Crude incidence of norovirus-associated IID in the community in England based 
on alternative methods for estimating the proportion of IID cases with norovirus infection 
and disease attributable to norovirus. 
7 
6 
e 5 
C 
0 ýa 
8 
3 
ü c 
Z 
c 
0 
Adjustment Cut-off Cut-off plus Subtract Control Mixture 
Factor A probable cases Prevalence Modelling 
Black T-bars show the 95% credibility intervals. 
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8.4. Discussion 
In this analysis, viral load measurements from the Study of Infectious Intestinal Disease 
specimen archive retesting were used to update estimates of the burden of community 
disease and general practice consultations caused by norovirus in England. This is the 
first time that this quantitative approach has been used. Results from a recent 
volunteer study8°, and the analysis of viral load data in Chapter 4, show that low 
norovirus viral loads detectable by RT-PCR are associated with asymptomatic 
infection. Consideration of viral load therefore provides the greatest diagnostic 
accuracy for identifying cases of norovirus-associated IID. Estimates of norovirus 
disease burden based on viral load are more accurate than those based on electron 
microscopy, because electron microscopy has poor diagnostic sensitivity; they are 
more accurate than those based on RT-PCR, because it is possible to exclude IID 
cases who are RT-PCR positive, but have low viral loads, and are therefore unlikely to 
have disease caused by norovirus. Using this new method, it was estimated that five 
percent of the general population in England experienced an episode of norovirus- 
associated IID between 1993 and 1996, equating to two million episodes per year. 
Incidence was highest amongst children aged less than five years, with one fifth 
suffering norovirus-associated IID and 100 000 of these children visiting their general 
practitioner each year. 
The method used to calculate norovirus-associated IID incidence allowed statistical 
uncertainty in the viral load measurements to be incorporated into the incidence 
confidence limits. This was only possible with the use of Monte Carlo simulation 
methods to combine the multiple components of the formulae and their associated 
statistical uncertainty; this would have been extremely difficult using standard 
frequentist approaches, such as the Delta Method, because of the large number of 
variables in the calculation. Uncertainty in diagnostic test results, in terms of sensitivity 
and specificity, is not normally considered in estimation of pathogen-specific disease 
incidence, probably because the measurement of diagnostic validity is contingent upon 
the existence of an appropriate and accurate gold standard. However, with the use of 
viral load measurements from both IID cases and healthy controls, it was possible to 
calculate Adjustment Factor A, which is an adapted version of the predictive value of 
each Ct value for identifying norovirus-associated IID. Adjustment factor A makes use 
of the information contained in the whole of the viral load distributions, rather than 
using a single cut-off, which may be more heavily reliant on the quality of the ROC 
analysis reference groups. 
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There was limited resolution for estimating age-stratified incidence in the community 
because of the small sample size. Genogroup I and genogroup II norovirus infections 
were combined in this analysis, rather than estimating Adjustment Factor A separately 
for each genogroup, also because of limited sample size. Similarly, in Alternative 
Method 2 the Ct value cut-off for genogroup II specimens was applied to all norovirus 
infections, because of the problems with the genogroup I cut-off, described in Chapters 
3 and 4. There is evidence that the real-time RT-PCR assay has lower efficiency for 
genogroup I norovirus strains; for a particular viral load, a genogroup I norovirus may 
have a higher Ct value than a genogroup II virus. Genogroup I noroviruses constituted 
less than 10% of the norovirus isolates in IID cases, meaning that treating the Ct 
values in the two genogroups as equivalent will probably lead to slight underestimation 
of norovirus incidence; more genogroup I positive IID cases are excluded at a particular 
viral load because they have a higher Ct value than genogroup II viruses at that viral 
load. However, the degree of underestimation introduced by grouping all norovirus 
infections together is likely to be small, because of the low prevalence of genogroup I 
(Table 4.2). 
The concentration of norovirus excretion decreases substantially after symptom 
resolution80, but in the method using Adjustment Factor A there was no direct 
adjustment for the possibility that some IID cases with high Ct values may have had 
disease caused by norovirus, but had low viral loads at the time of specimen collection 
because their symptoms had already resolved. However, Adjustment Factor A 
represents the probability at each Ct value that a norovirus-positive IID case has 
disease caused by norovirus; even at very high Ct values, Adjustment Factor A was 
greater than zero and therefore did allow some IID cases with high norovirus Ct values 
to be incorporated into the incidence estimate (see Figure 8.2). The method therefore 
indirectly allows for the possibility that some IID cases who truly had norovirus- 
associated IID had low viral loads at the time of testing. Direct consideration of delay in 
specimen collection requires classification of norovirus disease status at the individual 
level, as was done when applying the Ct value cut-off (Alternative Method 2). The cut- 
off based incidence of norovirus-associated IID was recalculated, including probable 
cases (defined as having a high Ct value, a late specimen and no other detected 
pathogens); the resulting incidence was slightly higher than when using only the cases 
below the Ct value cut-off, but still very similar to the results obtained using Adjustment 
Factor A. However, caution should be exercised in using such an approach, because 
the number of probable cases will be highly dependent on assay sensitivity and on the 
number of cycles for which the real-time RT-PCR assay is run; not all IID cases with 
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norovirus detected and a late specimen may have actually had disease caused by 
norovirus. 
The method described here is dependent on the recruitment and testing of a large 
control group, which is not always possible in studies of disease aetiology, and on the 
use of real-time RT-PCR for norovirus detection. Therefore a number of alternative 
methods were used to adjust the prevalence of norovirus in IID cases, to explore 
whether these produce suitably similar results to the method using Adjustment Factor 
A, which is believed to be the most robust. As expected, using the Ct value cut-off 
produced slightly lower incidence estimates, because no IID cases with Ct values 
above the cut-off were included, and with narrower confidence intervals, because the 
uncertainty in the cut-off was not represented in the calculations. Mixture modelling 
gave similar results to the Ct value cut-off, although there was a tendency towards 
underestimation in comparison to Adjustment Factor A; mixture modelling also requires 
larger sample sizes than the other methods, preventing estimation of detailed age- 
stratified incidence with the data used in this analysis. Estimates produced by 
subtracting the prevalence of norovirus in controls from that in IID cases were very 
different to those produced using the other methods; incidence in young children was 
substantially overestimated and incidence in older children and adults was 
underestimated compared to the incidence based on Adjustment Factor A. 
Furthermore, estimates produced by subtracting the control norovirus prevalence from 
the case norovirus prevalence will be highly dependent on the case definition used, the 
source of the controls and the study setting. 
The new estimates of norovirus-associated IID incidence presented here are 
approximately three times higher in the community and two and half times higher at the 
general practice level, than the estimates based electron microscopy testing (Table 
8.4). Accordingly, the ratio of community cases to cases presenting to general 
practitioners increased from 6: 1 using electron microscopy diagnosis, to 8: 1 using viral 
load measurements. The incidence estimates are approximately half those that would 
be obtained by assuming that any IID cases with a positive RT-PCR result for norovirus 
had disease caused by norovirus. The incidence of general practice consultations for 
norovirus-associated IID in children aged less than five years was very similar to the 
incidence of consultations for rotavirus-associated IID in this age group in the Study of 
Infectious Intestinal Disease (shown in Table 8.2); the analysis of routine surveillance 
data in Chapter 7 also indicated that norovirus causes an equivalent frequency of 
general practice consultations in young children as rotavirus. However, the ratio of 
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community cases to general practice cases was much higher for norovirus, indicating 
that norovirus causes more illness amongst young children in the community, but that 
symptoms are generally milder and therefore less likely to lead to a healthcare 
consultation. This is consistent with knowledge of the development of immunity to 
these viruses; immunity protective against symptomatic illness develops after the first 
two or three rotavirus infections128, whereas immunity to a particular norovirus strain 
tends to last no more than six months, and with multiple strains co-circulating209, 
repeated symptomatic infections are common throughout life. 
The community incidence of norovirus-associated IID estimated here is comparable to 
that from a study in the Netherlands, which only used RT-PCR testing, not viral load 
measurements, to identify cases of norovirus-associated IID. However the study in the 
Netherlands had a narrower case definition for IID (three or more loose stools, or two 
or more episodes of vomiting in 24 hours), which may not have been sensitive enough 
to ascertain all episodes of norovirus-associated IID at the community level5 . Similarly, 
the incidence of general practice consultations for norovirus in this analysis was only 
slightly lower than that from a recent study in Germany, which used RT-PCR diagnosis 
for norovirus, but again had a narrower case definition for IID (two or more loose stools, 
or two or more vomiting episodes in 24 hours)22. The incidence of norovirus-associated 
IID may also have been higher than normal during the Study of Infectious Intestinal 
Disease because a new variant of norovirus emerged during 1995 and 1996201221.537; 
emergence of norovirus variants is associated with increased disease incidence 222.224, 
229,575,590 
The incidence of norovirus-associated IID in the community showed a slight peak in the 
winter and autumn months, whilst general practice consultations were reasonably 
constant throughout the year. Outbreaks of norovirus-associated IID in community 
settings in the UK show very little seasonality, in strong contrast to outbreaks in 
healthcare settings, which show marked winter-time seasonality588. A number of factors 
may contribute to these differing patterns of seasonality between community disease 
and outbreaks in different settings. Firstly, community norovirus outbreaks notified to 
national surveillance in the UK are more commonly reported from catering settings, 
with transmission occurring through food contamination during preparation; whilst the 
prevalence of norovirus infection amongst food handlers is likely determined by the 
incidence of community disease, the driving factor in these outbreaks is breakdown in 
food hygiene practices, which is not a seasonal phenomenon. Secondly, it has been 
suggested that the marked winter-time increase in hospital admissions for respiratory 
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infections may drive the strong seasonality of norovirus outbreaks in this setting, and 
there are also distinct norovirus strains circulating in hospital populations compared to 
the community, which may have different transmission characteristics588. Therefore the 
incidence of community disease or GP consultations would not necessarily show the 
marked seasonality seen in healthcare-associated outbreaks. However, more detailed 
characterisation of the molecular epidemiology of norovirus infections in the community 
is needed, for comparison to the extensive data that already exist for hospital-acquired 
infections199.592, to better understand the factors driving the different seasonality of 
healthcare outbreaks and community disease. Finally, it is also possible that there was 
more out-of-season norovirus transmission during the Study of Infectious Intestinal 
Disease because of the emergence of a new norovirus variant, as described abovesso 
The seasonality of norovirus-associated IID in the community matches the seasonality 
of asymptomatic infections, described in Chapter 5, although the asymptomatic 
infection winter time peak was more distinct. 
With the widespread use of RT-PCR for norovirus diagnosis in community-based 
studies, it is recommended that a real-time platform is used to allow consideration of 
viral load when calculating norovirus incidence, as has been done in this analysis. This 
approach is preferable to including all IID cases who are RT-PCR positive, regardless 
of their viral load, because many may be shedding norovirus at low concentrations, 
with disease caused by another pathogen. Using the method described here, additional 
real-time testing in a subset of norovirus-infected IID cases would be sufficient, rather 
than testing all IID cases, if resources are limited, providing the subset is of a 
reasonable size and is representative. 
Accurate estimates of norovirus-associated IID incidence at the community level are 
important for understanding the introduction of norovirus into healthcare settings, 
where outbreaks cause substantial economic burden and service disruption14, and for 
informing potential vaccination programmes2°, '62 or other public health interventions 
against norovirus. Whilst the estimates presented here were based on data collected 
between 1993 and 1996, they provide the best available information on the burden of 
norovirus-associated IID in England; the only other published incidence estimates are 
those from the original electron microscopy testing in Study of Infectious Intestinal 
Disease, which most probably greatly underestimate norovirus incidence. Furthermore, 
these results are based on current diagnostic methods; as new studies are carried out, 
they will provide a baseline from which to assess changes in norovirus incidence over 
time that are not confounded by concurrent changes in the sensitivity of diagnostic 
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methods, which is a problem for routinely collected surveillance data, such as the HPA 
norovirus laboratory reports described in Chapter 7. 
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Chapter 9: Discussion of key findings and 
recommendations 
In this thesis, viral load measurements have been used to diagnose sporadic, 
community-acquired norovirus-associated IID. This is the first time that viral load has 
been systematically considered in the diagnosis of IID caused by any enteric viruses, 
despite quantitative real-time RT-PCR being widely available110,261,269-277,281.593-601 The 
availability of viral load measurements from healthy controls was essential for 
interpretation of the viral loads detected in III) cases; the Study of Infectious Intestinal 
Disease specimen archive provided a unique dataset with which to address this issue. 
The new quantitative diagnostic method facilitated the production of improved 
estimates of the incidence of III) caused by norovirus in the community in England, by 
overcoming both the poor diagnostic sensitivity of electron microscopy and the poor 
diagnostic specificity of RT-PCR. In addition, a new and comprehensive description of 
the characteristics of symptomatic and asymptomatic norovirus infection, and of risk 
factors for their acquisition, was produced. Key findings from the work presented were: 
The optimal cut-off for attributing disease to norovirus with the real-time RT- 
PCR assay used in this study was at Ct value 31, which excluded IID cases 
in the top third of the Ct value distribution (the range of Ct values was 15 to 
39); 
ii. Using real-time RT-PCR testing and the Ct value cut-off, norovirus disease 
aetiology was rejected in 48% of norovirus-infected IID cases in the 
community and 57% of norovirus-infected IID cases presenting to general 
practitioners; the equivalent excluded fractions using the viral load-based 
adjustment factor were 50% in the community cohort and 55% amongst 
general practice patients; 
iii. Using viral load to diagnose norovirus-associated IID, the number of IID 
cases with disease attributable to norovirus increased approximately 2.5 
times in the community and two times amongst individuals presenting to 
general practitioners, compared to electron microscopy diagnosis; 
iv. Approximately 5% of the general population in England experienced an 
episode of norovirus-associated IID each year between 1993 and 1996 
(age-adjusted incidence 4.5 episodes per 100 person-years [95% credibility 
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interval (Cl): 3.8 - 5.2]); incidence was highest amongst children aged less 
than five years (21 episodes per 100 person-years [95% Cl: 16 - 28]) but 
still substantial amongst older children and adults aged five years and older 
(3 episodes per 100 person-years [95% Cl: 3- 4]); 
v. Among children aged less than two years with norovirus-associated IID, one 
in four was taken for a general practice consultation; during the study, there 
were 100 000 consultations amongst children aged less than five years for 
I 
norovirus-associated I ID (95% Cl: 85 000 - 123 000), a similar number to 
that due to rotavirus; 
vi. Infectious contacts accounted for a large proportion of norovirus 
transmission leading to norovirus-associated IID; within households, contact 
with infectious children presented the greatest risk of norovirus 
transmission, both to adults and other children; the risk of transmission also 
increased with the number of symptomatic individuals in the household; 
vii. No risk factors were identified for asymptomatic norovirus infection, 
although behaviours such as water sports participation, fruit and vegetable 
consumption and animal contact were associated with decreased risk of 
both symptomatic and asymptomatic norovirus infection. 
9.1. Diagnosing norovirus-associated III) and asymptomatic norovirus 
Infection 
Success in detecting norovirus in clinical and environmental samples has been greatly 
enhanced by the development of RT-PCR assays. However, when diagnosing 
norovirus as the cause of sporadic, community-acquired IID, simple detection by RT- 
PCR is not sufficient for a confident diagnosis because of the high population 
prevalence of asymptomatic norovirus infection detected by RT-PCR5,21-24.43,490 This is 
in contrast to pathogens such as Campylobacter spp. and Salmonella spp., which are 
found at very low prevalence in the general populations, 21,22,43,51,334 ; detection of these 
bacteria by culture in an individual with IID provides convincing evidence that the 
bacteria are the cause of illness. The quantitative approach developed in this thesis 
provides a major advance in the accuracy of norovirus-associated IID diagnosis by RT- 
PCR; using the Ct value cut-off at the individual level, or the adjustment factor for 
calculating population incidence, greatly increased the diagnostic specificity of RT- 
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PCR, to match the high diagnostic sensitivity of the assay. These two parallel 
approaches were developed to: (i) allow examination of norovirus case characteristics 
and risk factors for norovirus-associated IID, which requires classification of norovirus 
aetiology in individual IID cases (with the Ct value cut-off); and (ii) to make full use of 
the information contained in the whole viral load distributions when calculating 
incidence at the population level (using the adjustment factor. ) 
The predictive value of viral load for diagnosing norovirus-associated IID will decrease 
as the proportion of specimens collected late in the clinical course of IID increases, 
because the viral load shed by norovirus cases after symptom resolution quickly 
returns to levels found in asymptomatically infected individuals80. However, this is a 
problem in the interpretation of diagnostic tests for any pathogen and is not unique to 
the quantitative method developed here for norovirus. Whilst tests such as ELISA, 
light/electron microscopy and bacterial culture are not normally considered or 
discussed quantitatively, they are all implicitly quantitative because they have a lower 
limit of detection. A specimen may be ELISA negative for rotavirus, despite there being 
rotavirus present, because there is too little virus for it to be detectable by ELISA, even 
though there may be little actual difference in viral load compared to an ELISA-positive 
specimen with a rotavirus concentration just above the detection limit of the assay497. It 
is not routine practice to adjust for specimen collection delay when using ELISA, 
microscopy or bacterial culture to estimate the burden of sporadic lID caused by other 
pathogens. However, in the calculation of norovirus incidence using the adjustment 
factor in this thesis, the problem of low viral loads caused by late specimen collection 
was indirectly accounted for because the method is probability-based, and therefore 
does not exclude all IID cases with low norovirus viral loads. 
Whilst the diagnostic sensitivity and specificity are of concern when diagnosing 
norovirus-associated IID by RT-PCR, the analytical sensitivity (i. e. the detection limit) 
and specificity (i. e. only producing positive results when norovirus is present in a 
specimen) of RT-PCR must be considered in the diagnosis of asymptomatic norovirus 
infections. It is likely that some healthy controls in the Study of Infectious Intestinal 
Disease were shedding norovirus at levels not detectable by the RT-PCR assays used, 
which have a detection limit of approximately 10° norovirus particles per gram of 
stool10"280; this is evidenced by the apparently right-truncated normal distribution of Ct 
values in controls shown in Chapter 4. Therefore it is likely that the true prevalence of 
asymptomatic norovirus infection is higher than that reported in Chapter 5. Given the 
extremely low infectious dose of norovirus98, which is well below the detection limit of 
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the RT-PCR assays, this underestimation may be particularly important for future 
studies examining the population-level risk of norovirus transmission due to 
asymptomatic carriage. Evaluations of RT-PCR using panels of stool specimens 
containing other enteric viruses have demonstrated that current RT-PCR assays have 
100% analytical specificity 110,248,249 , meaning that very 
few, if any, of the asymptomatic 
infections reported here are likely to be false positives. 
Real-time RT-PCR is now used for routine norovirus diagnosis in clinical virology 
laboratories across the UK488. °B9. Whilst it is likely that clinical virologists already 
informally consider the Ct values associated with a positive norovirus RT-PCR result 
when reporting a diagnosis to a clinician, the cut-off based approach developed in this 
thesis provides a more structured approach to assigning disease aetiology to norovirus 
in individual cases of sporadic IID. However, it is important that the cut-off described 
here is validated before it is applied in other laboratories, because of potential 
performance differences in the assays used495, because the cut-off will be applied to a 
different group of IID cases (population and primary health care patients in this study 
versus predominantly hospital patients in clinical virology laboratories) and because the 
specimens used in this study had been stored for more than ten years prior to 
application of the real-time RT-PCR. Even after this validation, the application of such a 
cut-off in a clinical setting must be considered in the context of the patient's symptoms 
and the detection or absence of other pathogens in the specimen. In a clinical setting, 
the aim of diagnostic testing is predominantly to guide patient treatment; given that 
there are currently no specific anti-viral treatments for viral gastroenteritis, the 
emphasis of clinical diagnosis for IID must be to exclude bacterial causes and the use 
of antibiotics, leaving oral or intravenous rehydration therapy as the main treatment 
option67. In contrast, during research studies investigating the burden of disease 
caused by norovirus in a particular study population, the aim is to provide an 
appropriate estimate of the number of IID cases attributable to norovirus. In these 
population-based studies, a small amount of aetiological misclassification has no 
individual patient-level consequences, and will have little effect on the overall estimate, 
provided positive and negative misclassification is balanced, i. e. a similar number of 
individuals are wrongly classified as norovirus cases as the number of norovirus cases 
who are wrongly classed as not having disease caused by norovirus. 
In addition to the diagnosis of predominantly paediatric, sporadic, community-acquired 
norovirus-associated IID, clinical virology laboratories use real-time RT-PCR to 
investigate the role of norovirus in IID outbreaks, predominantly those occurring in 
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healthcare settings. Whilst consideration of the Ct value for a norovirus-positive 
specimen may still be informative when testing specimens as part of an outbreak 
investigation, the availability of specimens from multiple exposed individuals makes the 
exact viral load detected in a single individual less important. If multiple exposed 
individuals are positive for norovirus by RT-PCR, this provides robust microbiological 
evidence that norovirus is the cause of the outbreak, which is then considered along 
with epidemiological and clinical information to determine the appropriate course of 
intervention to prevent further transmission 487,511. Use of a Ct value cut-off is therefore 
less important in the context of norovirus outbreak investigations. However, the 
concept that not all RT-PCR positive individuals may have disease caused by norovirus 
is informative in situations where only one or a very small proportion of outbreak 
specimens is norovirus-positive. The prevalence of asymptomatic norovirus infection 
provides an indication of the probability that one specimen collected during an outbreak 
caused by another pathogen may be norovirus-positive by chance, although the 
prevalence of asymptomatic infection in hospitals and healthcare settings may differ 
from that reported in the general population in this thesis and may require separate 
measurement. 
A major limitation of the analyses of norovirus viral load presented in this thesis is the 
lack of norovirus genotype information for the specimens in the Study of Infectious 
Intestinal Disease specimen archive. Whilst the efficiency of the real-time RT-PCR 
assay is similar for all the common genotypes in genogroup II, the efficiency is lower for 
a number of the genogroup I genotypes and for the rarer genogroup II genotypes GI1.7 
and GILB (see Chapters 3 and 4, Appendix A1.3). Whilst analysing all norovirus 
genotypes together is likely to have had only a minimal, although currently 
unquantifiable, effect on the incidence estimates and risk factor analyses, it may not be 
appropriate to treat all genotypes equally in a clinical setting, where errors in classifying 
norovirus aetiology may have consequences for patient care. However, even if 
sufficient specimens were collected for the identification of genotype-specific Ct value 
cut-offs in this or future studies, application of the genotype-specific cut-offs would 
require specimen genotyping to be part of routine clinical diagnostic practice, which 
may not be economically or logistically feasible. Further work on a genogroup I-specific 
cut-off would, however, provide some improvement in diagnostic accuracy compared to 
universal application of the genogroup 11 cut-off. 
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9.2. Incidence of norovirus-associated III) 
The updated estimates of norovirus-associated IID incidence based on viral load 
measurements, presented in Chapter 8, confirm that norovirus is the most common 
cause of IID in the community in England. In comparison to the other common 
pathogens causing IID in the community cohort in the Study of Infectious Intestinal 
Disease, norovirus caused approximately five times more episodes per 100 person- 
years than Campylobacter spp., eight times more episodes per 100 person-years than 
enteroaggregative E. coli and six times more episodes per 100 person-years than 
rotavirus, across all ages (comparing crude incidence)8. Norovirus was also amongst 
the most common causes of general practice consultations for IID in the Study of 
Infectious Intestinal Diseases, although the majority of consultations were by paediatric 
norovirus cases, with the number of consultations in children aged less than five years 
very similar to the number due to rotavirus-associated IID during the study. 
The viral-load based norovirus incidence estimates were between two and three fold 
higher than those based on electron microscopy, with a slightly greater relative 
increase in incidence in the community cohort compared to the general practice study. 
This is probably because of the small, but significant, difference in the norovirus Ct 
value distribution in children aged less than five years in the community cohort and the 
general practice case-control study (Table 4.4), combined with the predominance of 
young children amongst norovirus-infected IID cases in the general practice study 
component. Half of the norovirus-infected IID cases in the community cohort and 
slightly more than half of those norovirus-infected general practice patients with IID 
were classified as not having disease caused by norovirus, using the viral load cut-off 
or the population-level adjustment factor (Appendix A6.3). Consideration of viral load 
has therefore prevented substantial overestimation of norovirus incidence based on 
RT-PCR testing. 
Modelling of routinely collected surveillance data on general practice consultations for 
IID and unlinked norovirus laboratory diagnosis reports in England and Wales 
produced- similar estimates of the incidence of norovirus general practice consultations 
as the prospective case ascertainment used in the Study of Infectious Intestinal 
Disease. Due to the poor fit of the models for children and adults aged five years and 
older, the method is probably unsuitable for reliably estimating norovirus consultations 
in these age groups. However, the model for children aged less than five years 
provided a good fit to the general practice consultation data that were used as the 
outcome variable and reproduced the expected seasonal pattern of norovirus activity. 
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The indirect modelling method is therefore suitable for producing regular updates to the 
estimates of paediatric general practice consultations caused by norovirus-associated 
IID. Given that the large majority of the general practice consultations for norovirus in 
the Study of Infectious Intestinal Disease were in children aged less than five years, 
they would be the priority group for any public health intervention aiming to reduce 
consultations for sporadic norovirus-associated IID; it is therefore most important to 
continue monitoring norovirus consultations in young children using routine surveillance 
data and the method presented in Chapter 7. 
The incidence of norovirus-associated IID in the community and of general practice 
consultations for norovirus was low in older adults (aged 45 or 65 years and older for 
the two study components, respectively), in spite of a significant recognised burden of 
norovirus disease in the elderly 14,38.347 However, the high incidence of norovirus- 
associated IID amongst the elderly is reported mostly as norovirus outbreaks in 
hospitals and other healthcare or institutional settings14.38.40,347.602, which were not 
included in the Study of Infectious Intestinal Disease community cohort83,480, so were 
not captured in the incidence estimates. It is also unlikely that many of these elderly 
individuals who become ill during outbreaks in community settings are seen by general 
practitioners; nursing home staff are likely to be experienced in the recognition and 
management of norovirus-associated IID, and given that there is no specific antiviral 
treatment, would be unlikely to consult a general practitioner for the majority of cases. 
In light of the concentration of the norovirus disease burden in elderly individuals in 
easily-identified and well-defined populations in health and community care settings, it 
is less important to have ongoing monitoring of general practice consultations for 
norovirus-associated IID through modelling of routine surveillance data. Enhanced 
surveillance in these vulnerable elderly populations is likely to provide sufficient 
information on the major burden of norovirus disease in this age group; one example of 
such monitoring is the hospital norovirus outbreak surveillance system recently 
introduced by the HPA in England and Wales, which collates reports of norovirus 
outbreaks in elderly hospitalised populations348 
9.3. Norovirus transmission 
The analysis of risk factors for sporadic, community-acquired norovirus-associated IID 
indicated that the predominant source of norovirus infection is other symptomatic, 
norovirus-infected individuals. The risk of acquiring norovirus-associated IID was 
highest when the symptomatic contact was a young child, although transmission was 
associated with infectious contacts of all ages. Furthermore, adults living in a 
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household with young children or a baby were at an increased risk of norovirus- 
associated IID, regardless of whether these children were symptomatic during the 10- 
day exposure period used in the epidemiological questionnaire. This most likely reflects 
the high incidence of symptomatic norovirus infection in young children, demonstrated 
in Chapter B. 
However, only slightly more than half of the cases of norovirus-associated IID in the 
Study of Infectious Intestinal Disease could be attributed to reporting contact with an 
infectious individual and there was no significant risk associated with other 
transmission routes commonly reported for norovirus, such as drinking water and food 
(except oyster consumption, which was reported by only a very small number of 
norovirus cases) 38.349.351,360,397, aoo, 410 -418, aaa, 445,451-457 It is likely that some norovirus 
cases failed to report contact with symptomatic individuals because of poor recall or not 
knowing about the symptoms experienced by individuals with whom they had contact. 
In addition, it is possible that environmental contamination may contribute to the 
transmission of norovirus leading to sporadic norovirus-associated IID. Environmental 
contamination of common surfaces such as door-handles, telephones, computer 
keyboards and a range of other materials have been demonstrated in both 
environmental sampling, within and independently from outbreak investigations, and in 
experimental virus transfer studies'8' 328,329.398-403,403-408 It is therefore possible that 
some norovirus cases in this study did not actually come into direct contact with a 
person with symptomatic norovirus infection, but were in contact with surfaces 
contaminated by such individuals. 
Similarly, it is possible that transmission may have occurred through contact with 
asymptomatically infected individuals or surfaces that they have contaminated, with the 
norovirus cases being unaware of the infection status of these contacts. In addition to 
the description of viral loads shed by healthy controls in the Study of Infectious 
Intestinal Disease specimen archive, presented in Chapter 4, several other studies 
have demonstrated that asymptomatically infected individuals shed norovirus at 
concentrations far greater than the estimated infectious dose for norovirus24,80,98,114 
However, there have been no studies examining the direct person-to-person 
transmission risk from asymptomatically infected individuals in the household or other 
community settings, although some outbreak investigations have attributed foodborne 
norovirus transmission to contamination by asymptomatically infected foodhandlers360 
397,412,414.416 Quantifying the transmission risk from asymptomatically infected 
individuals is important for informing public health action against norovirus. Exclusion of 
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norovirus cases from work in the food industry and healthcare sector currently only 
covers the period of symptoms and the subsequent 48 hours603, but given the extended 
period of low-level norovirus shedding demonstrated in a number of studies, revision of 
these guidelines would be necessary if this level of shedding poses a significant 
transmission risk. However, the major public health intervention against norovirus 
transmission, in any setting, is good hand and environmental hygiene 389,409 604,605 and 
these actions can be promoted without the need for detailed knowledge about the 
exact risks of norovirus transmission from symptomatically and asymptomatically 
infected individuals. Furthermore, the highest burden of asymptomatic infection is in 
young children, so the risk of transmission in the general population from 
asymptomatic infections may be lower than indicated from the age-adjusted community 
prevalence of 12% presented in Chapter 5, because of the high degree of assortative 
social mixing amongst young children and adults606 
No risk factors for asymptomatic norovirus infection were identified. It is likely that a 
small proportion of the asymptomatic infections were actually pre- or post-symptomatic 
norovirus shedding. Just under one tenth of the individuals with asymptomatic 
norovirus infection had experienced gastrointestinal symptoms prior to the ten day 
exclusion period for control recruitment in the Study of Infectious Intestinal Disease, but 
within three weeks of recruitment, although the excess prevalence of gastrointestinal 
symptoms compared to norovirus negative healthy individuals was less than 5%. 
Unfortunately study participants were only asked to report potential infectious contacts 
that occurred within the previous ten days in the epidemiological questionnaire. Where 
asymptomatic norovirus infection was due to contact with symptomatic individuals, this 
information may not have been captured in the questionnaire if norovirus shedding had 
occurred for more than 10 days before recruitment into the study. Elucidation of the 
transmission routes for asymptomatic norovirus infection in the community would 
require studies with frequent and regular testing of healthy individuals to identify 
incident asymptomatic norovirus infections and then capture recent exposure history. 
However, it is unlikely that the economic and human cost of such studies could be 
justified. Norovirus testing of asymptomatic individuals exposed during norovirus 
outbreaks and collection of exposure information from these individuals would probably 
provide more direct and easily available evidence on the routes of transmission leading 
to asymptomatic norovirus infection. Current evidence from volunteer inoculation 
studies indicates that pre-existing immunity, and possibly the inoculum dose, probably 
determine whether symptomatic or asymptomatic infection develops after norovirus 
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exposure, meaning that there may not be different transmission routes, only a different 
138 outcome of exposure depending on these host and viral characteristics", 
A major limitation of the risk factor analysis was that where study participants reported 
symptomatic contacts, the aetiology of IID in these contacts was not established. 
Therefore, whilst the strong association of norovirus-associated IID with symptomatic 
contacts suggests that a large majority of these contacts had a norovirus infection, this 
is an assumption and has not been verified with microbiological testing. 
9.4. Further limitations 
The seasonality and molecular epidemiology of norovirus-associated IID across 
different age groups in the community in the UK are poorly characterised; this 
information is important for understanding the epidemiological relationship between 
sporadic community norovirus cases and norovirus outbreaks, particularly those 
outbreaks occurring in healthcare settings, which have a distinct but unexplained 
seasonality and norovirus genotype distribution 97,197-zoo, 588 Whilst GII. 4 noroviruses 
predominate in causing highly seasonal norovirus outbreaks amongst adults in 
healthcare settings, a broader range of genotypes has been detected both in outbreaks 
in community settings and amongst sporadic paediatric norovirus cases presenting to 
healthcare services, which also have a more constant, year-round incidence. However, 
it remains unclear whether the predominance of GII. 4 in causing hospital outbreaks, 
which occur mostly amongst adults, is because GII. 4 is at high prevalence in adult 
norovirus cases in the community with winter seasonality, or whether higher hospital 
admission rates in the winter lead to more GII. 4 introduction events, or alternatively 
whether the GII. 4 viruses are at lower prevalence in the community but have greater 
transmissibility in semi-closed settings than other genotypes and are therefore more 
likely to cause an outbreak after they are introduced. 
The season-stratified incidence estimates for norovirus-associated IID in the 
community showed a slight winter-time peak. However, the seasonal peak was not as 
marked as that observed in hospital norovirus outbreak incidence588 and unfortunately 
it was not possible to examine the seasonality of norovirus-associated IID separately 
amongst children and adults in the community, because of sample size limitations. In 
addition, no genotype information was available for any of the symptomatic or 
asymptomatic norovirus infections in the Study of Infectious Intestinal Disease 
specimen archive; only the genogroup of the infections was determined in the RT-PCR 
assay. It was therefore not possible to specifically compare the GII. 4 incidence 
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between children and adults, or to examine the seasonality of GI1.4 infection in the 
community. 
The estimates of norovirus-associated (ID incidence produced in this thesis are based 
on data collected in the mid 1990s. The epidemiology of norovirus is particularly 
complex97.581, with substantial variation in norovirus activity across successive years 
identified in surveillance of outbreaks and laboratory diagnoses in England and Wales. 
Reporting artefacts and changes in diagnostic methods may account for some, but 
certainly not all, of the inter-seasonal variation in norovirus activity. Furthermore, a new 
variant of norovirus GII. 4 emerged during 1995 and 1996, when the Study of Infectious 
Intestinal Disease was carried out201' 221' 537 Emergence of new GII. 4 variants has been 
linked to substantial increases in both the number of infections and outbreaks reported 
during the normal season and in out-of-season norovirus activity as well222,224,229,575, 
590 It is therefore impossible to judge how representative these new estimates of 
norovirus-associated IID incidence are of normal norovirus activity in England, 
especially without genotype characterisation to confirm that the emergent GII. 4 variant 
from 1995/1996 was causing illness in the study population. However these new 
estimates are based on current diagnostic methods, and the new quantitative approach 
to norovirus-associated IID diagnosis can now be used in new studies of sporadic, 
community-acquired IID. The results from these new studies will then be directly 
comparable to the incidence estimates presented in this thesis, to allow 
characterisation of recent changes in norovirus community incidence, without problems 
of confounding due to changes in diagnostic methods over the same time period. 
This is the first description of the distribution of viral loads present in naturally occurring 
symptomatic and asymptomatic norovirus infections in the community. Whilst the 
increase in norovirus disease incidence associated with new GII. 4 variants has been 
reported in many countries, the effect of these novel variants on the prevalence of 
asymptomatic infection is unknown; both an increase or decrease in asymptomatic 
prevalence are biologically plausible. Decreased asymptomatic prevalence could be 
expected because the novel GII. 4 variants are antibody-escape mutants 19,223.; if the 
occurrence of symptoms after norovirus infection is predominantly determined by pre- 
existing, short-term immunity, a higher proportion of infections may be symptomatic 
immediately after the emergence of a GII. 4 antibody-escape mutant. Conversely, if 
other mechanisms are involved in the occurrence of asymptomatic infection, such as 
the infecting dose, an increase in asymptomatic prevalence may be expected simply 
because of the greater circulation of norovirus in the population caused by the increase 
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in disease incidence. The prevalence of asymptomatic infections in the community will 
directly affect the degree of overestimation expected by using RT-PCR to diagnose 
norovirus associated-1113; with a higher prevalence of asymptomatic norovirus infection 
in the population, a greater proportion of norovirus-infected IID cases may have a 
coincidental norovirus infection with disease actually caused by another pathogen. 
9.5. Recommendations 
The analysis of viral loads in symptomatic and asymptomatic norovirus infection 
presented in this thesis has shown that the community incidence of sporadic norovirus- 
associated IID would have been greatly over-estimated if all RT-PCR positive III) cases 
in the Study of Infectious Intestinal Disease specimen archive were considered to have 
disease caused by norovirus. Up to 50% of these IID cases were shedding norovirus at 
the same levels seen in healthy controls, indicating that they probably did not have 
disease caused by norovirus, despite being infected at the time of their illness. In 
similar future studies of the population incidence of IID, it is therefore recommended 
that real-time RT-PCR is used for norovirus diagnosis and that a group of healthy 
controls is recruited concurrently to allow application of the adjustment factor method 
described in Chapter B. If recruitment of controls is not possible, application of an 
appropriately validated Ct value cut-off for the assay in use would provide suitably 
similar estimates to those using the adjustment factor method. Whilst the cut-off based 
estimates would not acknowledge the uncertainty in the viral load measurements, it is 
not common practice to explicitly incorporate diagnostic validity when estimating 
pathogen-specific disease incidence with other diagnostic tests. If it is not possible to 
test all IID cases with a real-time assay, testing a representative and sizeable 
proportion would be sufficient to use any of the methods presented in Chapter 8. 
Whilst the focus of the methods developed for norovirus diagnosis in this thesis was to 
identify norovirus cases for the calculation of norovirus-associated IID incidence and 
examination of risk factors for norovirus disease, the work has implications for the 
clinical diagnosis of norovirus-associated IID used to guide patient care. Other 
information on patient history, symptoms and co-infections should still be considered in 
the clinical setting, but development of a cut-off, as described here, for use in clinical 
virology laboratories would better inform the interpretation of norovirus RT-PCR testing. 
The importance of direct person-to-person transmission in the acquisition of sporadic 
norovirus-associated (ID indicates that further reinforcement of existing public health 
messages regarding hand and domestic environmental hygiene could facilitate a 
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reduction in norovirus transmission. Although, given the low infectious dose and the 
current lack of any sanitizers that completely inactivate norovirus, reductions in disease 
incidence may be limited. 
During the Study of Infectious Intestinal Disease, norovirus caused a similar number of 
paediatric general practice consultations as rotavirus. Universal introduction of the 
licensed rotavirus vaccines is under ongoing consideration by the UK Department of 
Health; the results from this study indicate that norovirus may also be a priority for 
public health action. However, it is unlikely that a norovirus vaccine could be 
recommended for use in young children because of the high valency required to cover 
the large number of immunologically distinct genotypes detected in paediatric norovirus 
cases. Further public education about the causes of acute paediatric gastroenteritis 
and appropriate care action may be a more suitable intervention. Conversely, 
vaccination against GII. 4 noroviruses may help to reduce the burden of norovirus 
outbreaks in healthcare settings, although protection will only be short-lived and 
vaccine response may be worse in the predominantly elderly populations that are 
affected by nosocomial norovirus outbreaks. Further characterisation of the molecular 
epidemiology of norovirus in the community would be essential before a GII. 4 vaccine 
could be recommended and also after introduction, to ensure that other strains are not 
likely to replace GII. 4 in healthcare settings and maintain the current level of outbreak 
incidence. 
The quantitative methods developed here for norovirus diagnosis are very likely to be 
applicable to other enteric viruses and to viruses causing other acute infectious disease 
syndromes, such as respiratory viruses. Indeed, a quantitative approach to diagnosis 
would be useful for any pathogen that is at high prevalence in healthy individuals in the 
general population, providing there is evidence that pathogen load is well correlated 
with the occurrence of symptoms. 
9.6. Perspective 
The body of work presented in this thesis has provided a novel approach to the 
diagnosis of norovirus-associated IID, updated estimates of sporadic norovirus 
incidence in England and new evidence to support existing insights into the 
transmission patterns of norovirus in the community. However, the data were collected 
in a single high income country and there is now an emerging interest in norovirus as a 
cause of acute paediatric IID in low and middle income countries49. Whilst the 
epidemiology of norovirus is likely to be different in low income countries, the 
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quantitative method for norovirus-associated IID diagnosis will certainly be of great 
importance in assessing the disease burden caused by norovirus in these settings. 
Indeed, interim results from ongoing studies in low income countries indicate that the 
prevalence of asymptomatic infection is very high, in some places almost equivalent to 
the prevalence of norovirus amongst IID cases607. The quantitative diagnostic methods 
developed in this thesis will therefore be essential for determining the relative 
importance of norovirus as a cause of IID in low income countries, which is currently 
poorly understood. 
The potential certainly exists for a high norovirus disease burden in low income 
countries, given the evidence of food- and water-borne transmission from outbreak 
investigations in high income countries, in addition to direct person-to-person 
transmission. However, it remains to be seen whether the hypothesised higher 
norovirus exposure levels in low income countries actually lead to a higher incidence of 
disease. Volunteer studies have indicated that repeated homotypic norovirus strain 
exposure can lead to longer-lasting immunity that is protective against disease beyond 
the six to twelve months of protection provided by a single infection episode 56,77; if 
there truly is higher exposure to norovirus in low income country settings this may 
serve to boost immunity and prevent more illness. However nutritional status is also 
likely to play an important role in moderating any immune protection resulting from 
frequent norovirus exposure, especially amongst young children. Antigenic drift 
resulting in immune response evasion has been well characterised in GII. 4 noroviruses 
from high income countries "s; norovirus therefore has the potential to respond to 
prevailing population immunity, adding further complexity to the potential picture of 
norovirus epidemiology in low income countries. 
The studies of paediatric IID burden currently being conducted in low income countries 
will hopefully provide the answer to the most important question: how important is 
norovirus as a cause of severe paediatric IID and associated mortality? Whilst there is 
an abundance of work using indirect methods to estimate mortality associated with 
rotavirus-associated IID globally608, it is not appropriate to simply extrapolate the 
spectrum of pathogens detected in children presenting to primary and emergency care 
services directly to the causes of diarrhoeal mortality in this population: outcomes after 
consultation or hospital admission are likely to differ substantially between pathogens. 
Therefore, whilst a recent systematic review has suggested that norovirus may cause 
200000 deaths in children aged less than five years globally49, more robust data are 
required to verify the accuracy of this figure. However, it will be interesting to see where 
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norovirus falls on the public health agenda in low income countries. There can be little 
hope of a vaccine that will be effective in preventing norovirus disease amongst 
children in the general population because of the high antigenic diversity of noroviruses 
and the demonstrated potential for rapid evolution to escape host immune 
responses 111,223 . Therefore limited public health funding and resources may be better 
utilised in improving nutrition and sanitation, which will act to simultaneously reduce the 
burden and mitigate the effects of a host of infectious diseases in low income countries. 
However, norovirus remains firmly on the public agenda in high income countries, with 
extensive media coverage of both nosocomial outbreaks and disease in the general 
population each winter in the UK. Public health priorities are very different in high 
income countries; with very few deaths from norovirus-associated IID, the focus is on 
the disruption to care and particularly the economic costs of hospital norovirus 
outbreaks and the costs of paediatric primary care consultations. Indeed, the incidence 
estimates presented here suggest that norovirus could become the leading cause of 
paediatric primary care consultations for IID if rotavirus vaccination is introduced into 
routine childhood schedules in the UK, given the substantial reduction in severe 
rotavirus disease seen in the United States and Australia since the start of rotavirus 
vaccination 609 612 However, the greatest potential for effective action against norovirus 
probably lies in the healthcare sector, where a GII. 4 specific vaccine may reduce 
disease burden amongst patients and staff, provided strain replacement does not occur 
in this setting. The first tentative steps towards commercial production of a norovirus 
vaccine are now being taken613, making this approach more realistic. However, the 
community of norovirus researchers still has a lot to learn about the pathogenesis and 
transmission dynamics of norovirus and it may be unwise to put all our hopes in a GII. 4 
vaccine: there is a need for controlled trials of interventions addressing the 
effectiveness of other measures such as case isolation, ward closure and 
environmental cleaning for reduction of norovirus outbreaks in healthcare settings, to 
improve the evidence base underpinning current guidelines. Norovirus appears to be a 
clever pathogen: highly infectious, resistant to environmental degradation and cleaning, 
antigenically diverse and constantly evolving. The battle to control norovirus infection is 
likely to be long, hard and intriguing. 
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Appendix 1: Additional information for Chapter 3 
Appendix I. I. Description of the real-time PCR reaction 
In a real-time RT-PCR assay for norovirus, the norovirus RNA is reverse transcribed to 
generate copy DNA (cDNA). The cDNA is then replicated in the real-time PCR assay. 
Primer DNA molecules bind to the target sequence on the cDNA molecules, initiating 
replication of the cDNA. Before the replication reaction, the primer consists of a short DNA 
sequence, complimentary to a sequence in the norovirus cDNA, and a fluorescent 
compound bound to a quencher compound, which suppresses fluorescent activity. As the 
primers are incorporated into the newly synthesised DNA molecule, the fluorescent 
compound and the quencher dissociate and the fluorescent compound emits coloured light 
when white light is directed onto the reaction mixture at the end of the PCR cycle using an 
optical fibre. The primers are designed to be specific to norovirus, so that DNA replication 
and fluorescence only occur in the presence of norovirus cDNA. 
The intensity of the optical signal in the PCR reaction mixture is measured at the end of 
each PCR cycle using a computer and camera connected to the optical fibre in the 
reaction mixture. In each round of the PCR reaction, the number of copies of the target will 
double if the efficiency of the reaction is 100%, i. e. the primers bind to all copies of the 
target sequence in the reaction mixture. The PCR reaction will have 100% efficiency in the 
initial stages of the reaction if the primer is perfectly matched to the target sequence. As 
the number of target sequence copies increases with each successive round of PCR 
replication, the intensity of the fluorescent signal increases. The cycle threshold (Ct) value 
is the number of PCR cycles after which the amount of fluorescence emitted by the 
reaction mixture rises above background noise (see Figure A1.1). The Ct value is 
therefore inversely proportional to the amount of the target sequence present in the 
original specimen, because the lower the initial concentration of the target sequence, the 
more cycles will be required to generate sufficient PCR product for the fluorescent activity 
to rise above this threshold. 
The Ct value therefore acts as a good proxy for the relative amount of norovirus in the 
original specimen, although it may vary with the conditions in the PCR machine, which 
determine the level of background light activity ('noise'), and the efficiency of the PCR 
reaction, which determines the replication rate per PCR cycle. 
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Appendix 1 
Appendix A1.2. Summary of matching criteria for control recruitment in 
the community cohort nested case-control study and the general practice 
case-control study 
Gender matching was performed for IID cases aged older than five years. Table A1.2 
shows the bands used for age-matching between controls and IID cases. 
Table A1.2 Age-matching criteria for controls. 
Age of IID case Permitted age range of matched control 
0 to 5 months 0 to 5 months 
6 to 11 months 6 to 11 months 
I to 4 years 
Within 1 year of the IID case age, not younger than 11 months 
old 
5 to 19 years Within 2 years of IID case age, not younger than 4 years old 
2! 20 years Within 5 years of IID case age, not younger than 18 years old 
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Appendix A1.3. Detection limit of the norovirus real-time RT-PCR assay 
for common norovirus genotypes 
Genotype Genome copies required for detection before cycle 40' 
Genogroup 
GI-1 102 
GI-2 103 
GI-3 103 
GI-4 102 
GI-5 101 
GI-6 102 
GI-7 103 
Genogroup II 
GII-1 101 
GII-2 10' 
GII-3 10' 
GII-4 10' 
GII-5 10' 
GII-6 10' 
GII-7 106 
GII-8 10° 
' In the assay used to test the Study of Infectious Intestinal Disease specimen archive. 
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Appendix A1.4. Age distribution of recruited and archived IID cases and 
controls providing stool specimens for diagnostic testing in the Study of 
Infectious Intestinal Disease 
Figure A1.4a IID cases in the general practice case-control study. 
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Figure A1.4c Controls. 
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Appendix 1 
Appendix A1.5: Sex of recruited and archived III) cases and controls 
providing stool specimens for diagnostic testing in the Study of Infectious 
Intestinal Disease 
General practice Community cohort Controls 
case-control study IID cases 
IID cases 
Recruited Archived Recruited Archived Recruited Archived 
Sex (percent) 
Male 46.0 47.1 46.9 48.4 45.0 46.1 
Female 53.2 52.3 52.2 51.1 54.3 53.2 
Not reported 0.8 0.6 0.9 0.6 0.7 0.7 
Total 2893 1905 761 517 2819 2205 
Abbreviations: IID, infectious intestinal disease 
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Appendix 2: Additional information and results for 
Chapter 4 
Appendix A2.1. Production and interpretation of an empirical ROC curve. 
An empirical ROC curve is produced by plotting the true positive rate (sensitivity) 
against the false positive rate (1-specificity) at each possible cut-off in the range of 
quantitative measurements from the test, in this case at each Ct value. The sensitivity 
and specificity are calculated by comparing the classification of individuals using a cut- 
off at a particular Ct value with the classification of individuals in the reference groups. 
The point on the ROC curve closest to the top left hand corner of the plot represents 
the optimal cut-off in the quantitative test data and has the maximum Youden index. 
The area under the ROC curve (AUC) represents the discriminatory power of the 
quantitative test compared to the reference groups. 
Figure A2.1 Features of an empirical ROC plot. Black dashed line shows a ROC curve 
for a test with no discriminatory power (AUC=0.5); red line shows a ROC curve for a 
theoretical perfect test, which matches the classification of the reference test (AUC=1); 
the black solid line shows a ROC curve for a test with good discriminatory power. J is 
the maximum Youden index value; C indicates the point on the ROC curve 
representing the optimal cut-off in the quantitative test value, which is at the maximum 
value of the Youden index. 
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Appendix 2 
Appendix A2.3. Distribution of norovirus Ct values 
Figure A2.3a Norovirus genogroup I. 'EM cases' are IID cases positive by electron 
microscopy, 'RT-PCR cases' are IID cases negative by electron microscopy and 
subsequently positive by RT-PCR. Sample sizes: EM cases = 13, RT-PCR cases = 58, 
controls = 18. 
RT-PCR cases EM cases Controls 
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Abbreviations: Ct, cycle threshold; EM, electron microscopy; RT-PCR, reverse transcription-polymerase 
chain reaction. 
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Figure A2.3b Norovirus genogroup II. `EM cases' are IID cases positive by electron 
microscopy, 'RT-PCR cases' are IID cases negative by electron microscopy and 
subsequently positive by RT-PCR. Sample sizes: EM cases = 92, RT-PCR cases = 
497, controls = 159. 
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Abbreviations: Ct, cycle threshold; EM, electron microscopy; RT-PCR, reverse transcription-polymerase 
chain reaction. 
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Appendix 2.4. Distribution of Ct values in IID cases aged less than five 
years and IID cases aged five years and older 
Dark grey bars show IID cases aged less than five years (n=288); white bars show IID 
cases aged five years and older (n=430). 
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Abbreviations: Ct, cycle threshold. 
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Appendix A2.5. Monthly median Ct values in III) cases and controls. 
Median 
IID cases 
IQR Total Median 
Controls 
IQR Total 
January 34 27 - 37 63 38 35 - 39 17 
February 36 26 - 38 32 36 30 - 38 12 
March 34 23 - 37 50 38 35 - 39 14 
April 34 27 - 37 52 38 36 - 39 15 
May 32 24 - 37 63 37 35 - 38 12 
June 34 24 - 36 72 36 32 - 37 23 
July 31 21 - 37 47 37 35 - 38 21 
August 34 24 - 37 54 38 32 - 39 13 
September 30 24 - 37 71 38 35 - 39 9 
October 33 28 - 37 85 36 32 - 38 21 
November 34 28 - 37 73 37 29 - 39 25 
December 34 26 - 37 54 38 36 - 39 17 
Abbreviations: lID, infectious intestinal disease; IQR, interquartile range. Appendix 
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Appendix A2.6. ROC analysis for genogroup II, children aged less than 
five years, reference positive group 1 and reference negative group 1. 
Figure A2.6a Distribution of Ct values in reference positive group 1 and reference 
negative group 1. Grey bars show reference positive group 1 (n=48); white bars show 
reference negative group 1 (n=92). 
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Figure A2.6b Youden index. 
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Figure A2.6c ROC curve. 
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Appendix 2.7. ROC analysis for genogroup II, children and adults aged 
five years and older, reference positive group I and reference negative 
group 1. 
Figure A2.7a Distribution of Ct values in reference positive group 1 and reference 
negative group 1. Grey bars show reference positive group 1 (n=44); white bars show 
reference negative group 1 (n=67). 
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Figure A2.7c ROC curve. 
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Appendix 2.8. ROC analysis for genogroup I, all ages, reference positive 
group 1 and reference negative group 1 
Figure A2.8a Distribution of Ct values in reference positive group 1 and reference 
negative group 1. Grey bars show reference positive group 1 (n=13); white bars show 
reference negative group 1 (n=18). 
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Figure A2.8b Youden index. 
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Figure A2.8c ROC curve. 
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Appendix 2.9. ROC analysis for genogroup 11, all ages, reference positive 
group 2 and reference negative group 1. 
Figure A2.9a Distribution of Ct values in reference positive group 2 and reference 
negative group 1. Grey bars show reference positive group 2 (n=169); white bars show 
reference negative group 1 (n=159). 
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Figure A2.9c ROC curve. 
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Appendix 2.10. ROC analysis for genogroup II, all ages, reference positive 
group 3 and reference negative group 2. 
Figure A2.10a Distribution of Ct values in reference positive group 3 and reference 
negative group 2. Grey bars show reference positive group 3 (n=524); white bars show 
reference negative group 2 (n=64). 
ý Reference positive group 30 Reference negative group 2 
20 
15 
0 
CL 
110 
5 
0 
Abbreviations: Ct, cycle threshold. 
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Figure A2.10c ROC curve. 
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Appendix 3: Additional information and results for 
Chapter 5 
Appendix A3.1. Symptoms that III) cases and controls were asked to 
report in the epidemiological questionnaire. 
Symptom Requested from IID cases Requested from Controls 
Diarrhoea Yes Yes 
Vomiting Yes Yes 
Nausea Yes No 
Abdominal pain Yes Yes 
Bloody stool Yes Yes 
Loss of appetite Yes Yes 
High temperature Yes No 
Cough, runny/blocked nose, Yes Yes 
sore throat 
Headache Yes Yes 
Aching muscles Yes Yes 
Joint pains /stiffness Yes Yes 
Back or neck pain /stiffness Yes Yes 
Joint swelling Yes Yes 
Painful red eyes Yes Yes 
Dizziness /faintness Yes Yes 
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Appendix A3.2. Seasonality of asymptomatic norovirus infection. 
Figure A3.2a Seasonality of asymptomatic norovirus infection in children aged less 
than five years. 
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Figure A3.2b Seasonality of asymptomatic norovirus infection in children and adults 
aged five years and older. 
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Appendix A3.3. Prevalence of vomiting in norovirus cases and IID cases 
with disease caused by another pathogen. 
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Appendix A3.4. Variation in symptom severity and duration with norovirus 
viral load in norovirus cases. 
Ct value 
15-24 25-33 
Symptom severity 
Total reporting 23 16 
Median severity score (IQR) 77 
(6 -8) (6-8) 
Rank-sum test P value 0.9 
Duration of symptoms 
Total reporting 36 25 
Median duration of diarrhoea and 22 
vomiting in days (IQR) (1-3) (2-3) 
Rank-sum test P value 0.3 
Abbreviations: Ct. cycle threshold; IQR, interquartile range. 
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Appendix A3.5. Comparison of symptoms in norovirus cases who were 
positive by electron microscopy and norovirus cases diagnosed only by 
the Ct value cut-off. 
Figure A3.5 Prevalence of gastrointestinal symptoms. 
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Table A3.5 Severity and duration of symptoms in norovirus cases. Rank-sum test is 
comparing the difference in score/duration in the two groups of norovirus cases. 
Electron microscopy Ct value cut-off 
positive diagnosed 
Symptom severity 
Total reporting 47 67 
Median severity score (IQR 77 
(6-9) (6-8) 
Rank-sum test P value 0.8 
Duration of symptoms 
Total reporting 69 109 
Median duration of diarrhoea and 33 
vomiting in days (IQR) (2-4) (2-5) 
Rank-sum test P value 0.6 
Abbreviations: Ct, cycle threshold; IQR, interquartile range. 
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Appendix A3.6. Percent prevalence of additional pathogens in norovirus 
cases, asymptomatic norovirus infections and norovirus negative 
controls. 
Children aged less than five Children and adults aged five 
years years and older 
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Appendix 4: Additional information and results for 
Chapter 6 
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Appendix A4.2. Definition of the Norovirus Season. 
Reports of norovirus diagnoses in England and Wales from the Health Protection 
Agency National Surveillance of Laboratory-Confirmed Infections were used to identify 
the times of peak norovirus activity between 1993 and 1996, during the Study of 
Infectious Intestinal Disease. Further details about the norovirus laboratory report data 
are provided in Chapter 3. 
The weekly counts of norovirus laboratory reports between 1993 and 1996 are shown 
in Figure A4.2. The start of the norovirus season was defined as the first of five 
consecutive weeks when the number of norovirus laboratory reports was above the 
median for the whole study period (the dashed black line in Figure A4.2). The end of 
the norovirus season was defined as the first subsequent week of five consecutive 
weeks when the number of laboratory reports was below the median for the whole 
study period. 
Figure A4.2 Weekly norovirus laboratory reports in England and Wales during the 
Study of Infectious Intestinal Disease (1993 to 1996). 
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a Red line indicates when the number of laboratory reports is above the median for the study period. 
b The black dashed line shows the median number of weekly laboratory reports for the study period. 
`The black solid line shows the weekly count of norovirus laboratory reports. 
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Appendix A4.3. Risk Factors for Norovirus III) in Children Aged Less Than 
Five Years in England, 1993 to 1996, From the Missing Indicator Analysis. 
Odds 
Ratio' 95% Cl P value° 
Social class 
Non-manual 1.0 
ManualUnskilled 2.9 1.6-5.1 <0.001 
Military 3.6 0.3-38.1 0.29 
Housewife/student/carer 4.1 1.1-15.2 0.03 
Missing 3.8 1.2-12.1 0.02 
Foreign travel 10.2 0.9-109.4 0.06 
Missing 2.0 0.1-26.1 0.61 
Animal Contact 0.5 0.3-1.0 0.03 
Not sure 0.8 0.1-8.5 0.83 
Missing 0.2 0.0-1.4 0.10 
Fruit eaten 0.6 0.3-1.0 0.06 
Pre-prepared raw salad or /vegetables eaten 0.2 0.0 -1.2 0.07 
Household infectious contact 4.5 1.5-13.3 0.006 
Not sure 2.7 0.2-34.5 0.45 
Missing 10.8 1.6-72.5 0.02 
Infectious contact outside the household 58.7 14.9-230.9 <0.001 
Not sure 6.0 1.9-18.7 0.002 
Missing 54.2 0.5-5424.0 0.089 
'All odds ratios are from multiple imputation models and are adjusted for age and sex; odds ratios for 
Intermediate and proximal risk factors are adjusted for higher level variables in the conceptual framework 
that were included in the final model. 
bP values are from a Wald test of regression coefficients. 
`72 norovirus cases and 348 norovirus negative controls were include in the missing indicator analysis. 
Abbreviations: Cl, confidence interval. 
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Appendix A4.4. Risk Factors for Norovirus III) in Older Children and 
Adults (Aged Five Years and Older) in England, 1993 to 1996, From the 
Missing Indicator Analysis. 
Odds 
Ratioa 95% Cl P valueb 
Household structure 
Single person household 0.9 0.4-2.0 0.77 
Adults and children aged Z5 years only 1.0 
Z1 children aged <5 years 2.4 1.5-3.8 <0.001 
Missing 1.8 1.0-3.4 0.05 
Baby wearing nappies in the household 2.8 1.8-4.5 <0.001 
Missing 0.9 0.3-3.0 0.84 
Water sports in last 10 days 0.5 0.3-0.8 0.01 
Missing 1.4 0.6-3.1 0.44 
Foreign travel 3.3 1.4-7.5 0.005 
Missing 0.6 0.1-2.3 0.44 
Animal Contact 0.4 0.3-0.7 <0.001 
Not sure 3.6 1.1 -12.6 0.03 
Missing 1.6 0.6-3.7 0.32 
Oysters eaten 16.6 1.3-206.4 0.03 
Whelkstwinkles eaten 19.5 1.5-251.2 0.03 
Fruit eaten 0.6 0.4-1.0 0.03 
Household infectious contact 4.9 2.7-9.0 <0.001 
Not sure - 2.0 0.6-6.7 0.25 
Missing 2.9 1.1-7.5 0.03 
Infectious contact outside the household 4.8 2.6-8.8 <0.001 
Not sure 2.1 0.6-6.8 0.23 
Missing 2.9 1.1-7.5 0.02 
'All odds ratios are from multiple imputation models and are adjusted for age, sex and social class; odds 
ratios for intermediate and proximal risk factors are adjusted for higher level variables in the conceptual 
framework that were included in the final model, except the presence of a baby in the household. 
bP values are from a Wald test of regression coefficients. 
`152 norovirus cases and 1097 norovirus negative controls were include in the missing indicator analysis. 
Abbreviations: Cl, confidence interval 
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Appendix A 4.5. Association of Asymptomatic Norovirus Infection With 
Variables Associated With No rovi rus -associated III) 
Table A4.5a Children Aged Less Than Five Years (Multiple Imputation Model). 
Exposure prevalence 
Asymptomatic Norovirus 
norovirus negative Odds 
infections controls Ratio' 95% Cl P value' 
Total 193 
Social class 
Non-manual 59.1 
ManualUnskilled 33.2 
Military 1.5 
Housewife/student/carer 1.5 
Missing 4.7 
461 
56.8 1.0 
35.6 0.9 0.6 -1.2 0.4 
0.9 1.7 0.4-7.6 0.5 
2.6 0.7 0.2-2.4 0.6 
4.1 
Foreign travel 0.5 0.9 0.6 0.1-5.6 0.6 
Missing 2.1 1.3 
Animal Contact 43.5 44.5 0.9 0.7-1.4 0.8 
Not sure 1.0 2.0 0.5 0.1-2.6 0.4 
Missing 2.6 3.0 
Fruit eaten 71.0 75.9 0.8 0.5-1.2 0.3 
Pre-prepared raw salad or 
/vegetables eaten 6.7 7.2 1.0 0.5-2.0 1.0 
Household infectious contact 11.9 9.3 1.2 0.6-2.4 0.6 
Not sure 2.1 1.3 2.6 0.5-13.8 0.3 
Missing 2.6 3.3 
Infectious contact outside the 
household 11.4 6.7 1.9 0.9-4.0 0.1 
Not sure 13.5 13.9 0.8 0.4-1.4 0.4 
Missing 0.5 0.7 
All odds ratios are from multiple imputation models and are adjusted for age and sex; odds ratios for 
intermediate and proximal risk factors are adjusted for higher level variables in the conceptual framework 
that were included in the final model. 
bP values are from a Wald test of regression coefficients. 
Abbreviations: Cl, confidence interval. 
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Table A4.5b Older Children and adults (Multiple Imputation Model). 
Exposure p 
Asymptomatic 
norovirus 
infections 
revalence 
Norovirus 
negative 
controls 
Odds 
Ratio' 95% Cl P value° 
Total 156 1260 
Household structure 
Single person household 6.9 6.9 1.3 0.7-2.6 0.4 
Adults and children aged i 
years only 64.2 71.0 1.0 
2: 1 children aged <5 years 18.5 14.1 1.4 0.8-2.2 0.2 
Missing 8.6 8.0 
Baby wearing nappies in the 
household 12.6 9.0 1.3 0.7-2.3 0.4 
Missing 2.7 2.9 
Foreign travel 2.0 2.5 1.0 0.3-3.5 1.0 
Missing 2.0 2.4 
Animal Contact 38.4 36.3 1.1 0.7- 1.5 0.8 
Not sure - 1.0 
Missing 4.0 3.2 
Fruit eaten 78.2 82.5 0.8 0.5-1.2 0.2 
Household infectious contact 6.6 6.7 0.9 0.4-2.0 0.8 
Not sure 2.7 2.5 1.1 0.3-3.9 0.8 
Missing 12.6 9.8 
Infectious contact outside the 
household 8.3 9.2 1.0 0.5,1.9 1.0 
Not sure 15.9 14.5 1.0 0.6,1.7 0.9' 
Missing 1.3 1.7 
'All odds ratios are from multiple Imputation models and are adjusted for age, sex and social class; odds 
ratios for intermediate and proximal risk factors are adjusted for higher level variables in the conceptual 
framework that were included in the final model, except the presence of a baby in the household. 
bP values are from a Wald test of regression coefficients. 
Abbreviations: Cl, confidence interval. 
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Appendix 5: Additional information and results for 
Chapter 7 
Appendix A5.1. Development of the confounder model for children aged 
less than five years. 
The black line shows the observed weekly counts of general practice consultations for 
IID in children aged less than five years; the red line shows the fitted values from the 
model. 
Figure A5.1a Model including eight Fourier terms 
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Figure 5.1 b Model including eight Fourier terms and a cubic trend term. 
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Figure 5.1c Model including eight Fourier terms, a cubic trend term and the bank 
holiday and data extraction indicator variables. 
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Appendix A5.2. Median delay (in weeks) between specimen collection and 
specimen receipt in the laboratory for HPA laboratory reports (2002-2007). 
The median delay was used as the lag for each pathogen laboratory report variable. 
Lags were fitted forward in time; general practice consultations in week 'n' were 
correlated with pathogen laboratory reports in week 'n+m' where m is the median delay 
shown here. 
<5 years 
Age group 
5-64 years 2: 65 years 
Campylobacter spp. 1 2 1 
Salmonella spp. 1 2 1 
Rotavirus 1 1 1 
Shigella spp. 2 2 2 
Giardia lamblia 1 1 1 
Cryptosporidium spp. 1 1 1 
Adenovirus 1 1 1 
Norovirus 2 2 1 
Escherichia coli 1 1 1 
Astrovirus 2 3 2 
Clostridium perfringens 5 3 10 
Staphylococcus aureus 1 3 1 
Sapovirus 2 2 4 
Vibrio spp. 2 2 2.5 
Bacillus spp. 1 6.5 No reports 
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Appendix A5.3. Explanation of selection of autoregressive terms using the 
partial autocorrelation function 
The partial autocorrelation (PAC) of the deviance residuals from a regression model of 
time series data shows the degree of correlation between the deviance residual in 
week 'n' with week 'n-x', adjusted for correlation in weeks with lower values of x. The 
PAC in week 'n-3' is adjusted for correlation between week 'n' and both weeks 'n-1' 
and 'n-2'. A significant PAC must lie outside the 95% confidence interval of zero, 
shown in grey on Figure A5.3. In Figure A5.3, there are three significant PAC terms at 
weeks 'n-1', 'n-2' and 'n-3', therefore the deviance residuals for each of the preceding 
three weeks would be fitted against the general practice consultations in week 'n' to 
adjust for autocorrelation. 
Figure A5.3 Example of a PAC plot used to select the number of autoregressive terms 
to adjust for autocorrelation. 
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Appendix A5.4. Weekly counts of HPA pathogen laboratory reports, 1993 
to 2007. 
Only those pathogens with a median weekly count greater than one are shown. 
Figure A5.4a Campylobacterspp. 
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Figure A5.4b Salmonella spp. 
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Figure A5.4c Rotavirus. 
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Figure A5.4d Shigella spp. 
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Figure A5.4e Giardia spp. 
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Figure A5.4f Cryptosporidium spp. 
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Figure A5.4g Norovirus. 
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Figure A5.4i Adenovirus. 
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Figure A5.4j Astrovirus. 
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Appendix B. S. Seasonality of norovirus laboratory reports in children aged 
less than five years. 
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Appendix A5.6. Summary statistics for RCGP general practice III) 
consultations and HPA pathogen laboratory reports. 
Table A5.6a Children aged less than five years. 
Median IQR Min Max % zero weeks 
RCGP IID episodes 59 37 - 92 13 206 0 
Campylobacter spp. 76 60 - 96 5 317 0 
Salmonella spp. 55 34 - 83 0 195 0.9 
Rotavirus 120 45 - 424 12 1200 0 
Shigella spp. 3 1-6 0 64 9.8 
Giardia lamblia 11 6-17 0 50 0.1 
Cryptosporidium spp. 25 16 - 37 2 260 0 
Norovirus 4 2-8 0 37 7.9 
Adenovirus 23 16 - 30 3 98 0 
Escherichia coli 6 3-10 0 54 6.4 
Astrovirus 2 0-5 0 33 30.0 
Staphylococcus aureus 0 0 0 23 94.0 
Sapovirus 1 0-2 0 9 48.5 
Vibrio spp. 0 0 0 3 94.5 
Clostridium per ingens 0 0 0 3 96.9 
Bacillus spp. 0 0 0 1 99.6 
Abbreviations: IID, infectious intestinal disease; IQR, interquartile range; RCGP, Royal College of General 
Practitioners; spp., species. 
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Table A5.6b Children and adults aged 5-64 years. 
Median IQR Min Max % zero weeks 
RCGP IID episodes 117 90-168 25 305 0 
Campylobacter spp. 685 539 - 904 63 1407 0 
Salmonella spp. 207 131 - 354 0 919 0.5 
Rotavirus 6 2-13 0 34 5.4 
Shigella spp. 24 16 - 36 3 367 0 
Giardia lamblia 60 48 - 74 4 167 0 
Cryptosporidium spp. 41 28 - 63 3 255 0 
Norovirus 7 4-13 0 136 2.2 
Adenovirus 1 0-3 0 18 25.8 
Escherichia coli 9 4-17 0 113 3.7 
Astrovirus 0 0-1 0 7 71.6 
Staphylococcus aureus 0 0-1 0 273 65.9 
Sapovirus 0 0 0 8 92.0 
Vibrio spp. 1 0-2 0 8 36.8 
Clostridium perfringens 0 0 0 11 76.1 
Bacillus spp. 0 0 0 4 91.2 
Abbreviations: IID, infectious intestinal disease; IQR, interquartile range; RCGP, Royal College of General 
Practitioners; spp., species. 
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Table A5.6c Adults aged 65 years and older. 
Median IQR Min Max % zero weeks 
RCGP IID episodes 23 17 - 31 5 55 0 
Campylobacter spp. 106 80 -105 28 306 0 
Salmonella spp. 29 20 - 44 0 119 0.8 
Rotavirus 3 1-8 0 44 14.7 
Shigella spp. 1 0-2 0 24 29.1 
Giardia lamblia 3 2-5 0 27 4.7 
Cryptosporidium spp. 2 1-3 0 35 22.2 
Norovirus 18 B-40 0 431 2.3 
Adenovirus 0 0 0 8 81.1 
Escherichia coli 2 1-3 0 29 24.8 
Astrovirus 0 0 0 7 87.1 
Staphylococcus aureus 0 0-1 0 128 59.5 
Sapovirus 0 0 0 5 96.0 
Vibrio spp. 0 0 0 2 88.6 
Clostridium perfringens 0 0 0 63 78.3 
Bacillus spp. 0 0 0 1 99.7 
Abbreviations: IID, infectious intestinal disease; IQR, interquartile range; RCGP, Royal College of General 
Practitioners; spp., species. 
286 
Appendix 5 
Appendix A5.7. Correlation of HPA pathogen laboratory reports with RCGP 
general practice consultations for IID, 1993-2007. 
Graphs show data from all age groups, tables provide age group specific Spearman's rank 
correlations statistics. 
Figure A5.7a Campylobacterspp. 
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Figure A5.7b Salmonella spp. 
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Figure A5.7c Rotavirus. 
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Figure A5.7d Shigella spp. 
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Figure A5.7e Giardia spp. 
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Figure A5.7f Cryptosporidium spp. 
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Figure A5.7g Norovirus. 
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Figure A5.7h Adenovirus. 
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Figure A5.7i Escherichia coli. 
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Figure A5.7j Astrovirus. 
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Figure A5.7I Staphylococcus aureus. 
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Figure A5.7m Sapovirus. 
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Figure A5.7p Vibrio spp. 
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Figure A5.7k Clostridium penfringens. 
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Figure A5.7q Bacillus spp. 
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Appendix A5.9. Pathogen regression coefficients and Wald test P values 
used to select pathogens for inclusion in the final models. 
Table A5.9a Direct models using Fourier terms for seasonal adjustment (Direct Model 
1). 
<5 years 5-64 years Z65 years 
CL a 
ä - ä 
a 
U) 
F N 
.. 
N 
.. 
N 
N va > ýaý > ö 
V ý> 0ý> 0 
Campylobacter spp. -0.03 0.2 -0.02 0.007 0.0 1.0 
Salmonella spp. 0.03 0.3 0.05 <0.001 0.02 0.4 
Rotavirus 0.05 <0.001 0.60 0.001 0.17 <0.001 
Shigella spp. 0.44 0.002 0.15 0.006 0.12 0.5 
Giardia lamblia -0.05 0.7 0.10 0.1 -0.13 0.4 
Cryptosporidium spp. 0.006 0.9 0.03 0.3 -0.02 0.9 
Adenovirus -0.03 0.6 -0.34 0.5 -0.31 0.5 
Norovirus 0.74 <0.001 0.47 <0.001 0.05 <0.001 
Escherichia coli -0.05 0.6 -0.10 0.2 -0.17 0.1 
Astrovirus -0.18 0.3 2.3 0.1 0.95 0.1 
Clostridium perfringens 4.9 0.3 0.08 0.9 -0.05 0.7 
Staphylococcus aureus -0.59 0.3 0.07 0.6 -0.06 0.3 
Sapovirus -0.58 0.3 0.31 0.9 0.11 0.9 
Vibrio spp. 0.54 0.8 -1.0 0.3 0.18 0.9 
Bacillus spp. 10.9 0.07 -6.7 0.3 - - 
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Table A5.9b Direct models using a 13-week indicator variable for seasonal adjustment 
(Direct Model 2). 
<5 years 5-64 years 2: 65 years 
aý N Ch . () 
Gi N 
- 
7 N7 N 7 
0 ý co 00ý> Ü0 ý> 
Campylobacter spp. -0.02 0.2 0.01 0.01 0.01 0.2 
Salmonella spp. -0.04 0.3 0.02 0.07 0.005 0.8 
Rotavirus 0.06 <0.001 0.36 0.009 0.09 0.09 
Shigella spp. 0.50 0.02 0.19 0.007 0.35 0.1 
Giardia lamblia 0.15 0.3 0.07 0.2 -0.06 0.7 
Cryptosporidium spp. -0.06 0.2 -0.04 0.2 -0.13 0.3 
Adenovirus -0.03 0.7 -0.33 0.5 -0.18 0.7 
Norovirus 0.35 0.08 0.18 0.09 0.02 0.02 
Escherichia coli -0.12 0.2 -0.12 0.2 -0.12 0.3 
Astrovirus -0.15 0.5 0.21 0.9 0.20 0.8 
Clostridium perfringens -17.7 0.007 -0.85 0.4 0.22 0.3 
Staphylococcus aureus 0.22 0.7 -0.09 0.5 -0.07 0.3 
Sapovirus 1.1 0.08 1.6 0.5 0.29 0.9 
Vibrio spp. 2.7 0.2 -0.27 0.8 -1.8 0.1 
Bacillus spp. 9.5 0.1 7.7 0.3 
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Table A5.9c Direct models using a 4-week indicator variable for seasonal adjustment. 
<5 years 5-64 years 2: 65 years 
C 
V 
U) 
a 
7 
-> 
- N 
N 
Ü 
o_ 
U) 
7 
> 
ý-. 
N 
Z 
N 
Ü 
d 
U) 
4) 
7 
> 
Campylobacter spp. 0.004 0.9 0.02 0.08 0.02 0.2 
Salmonella spp. -0.02 0.7 -0.02 0.2 0.05 0.3 
Rotavirus 0.06 <0.001 0.61 0.007 0.08 0.3 
Shigella spp. 0.02 1.0 0.13 0.2 0.36 0.3 
Giardia lamblia 0.26 0.1 0.13 0.10 -0.07 0.7 
Cryptosporidium spp. -0.03 0.6 0.05 0.3 -0.19 0.3 
Adenovirus -0.10 0.2 -0.20 0.7 -0.79 0.2 
Norovirus 0.17 0.4 -0.05 0.7 0.03 0.1 
Escherichia coli -0.07 0.6 -0.12 0.2 -0.13 0.4 
Astrovirus 0.08 0.8 1.5 0.5 1.8 0.03 
Clostridium perfringens 1.6 0.8 1.5 0.3 -0.55 0.3 
Staphylococcus aureus 0.17 0.8 -0.30 0.07 -0.08 0.2 
Sapovirus 0.40 0.6 1.8 0.5 -6.1 0.05 
Vibrio spp. -0.32 0.9 " -1.5 0.2 -0.09 1.0 
Bacillus spp. 12.1 0.06 2.5 0.8 - - 
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Table A5.9d Indirect model with seasonal and autocorrelation adjustment (Indirect 
Model 1). 
<5 years 5-64 years 2: 65 years 
a -a 
Ü N N N 
E 'a 7 N 'a 3 
V ý> 0ý> 0ý> 
Campylobacter spp. -0.03 0.3 -0.02 0.003 -0.005 0.6 
Salmonella spp. 0.04 0.1 0.06 <0.001 0.04 0.03 
Rotavirus 0.06 <0.001 0.72 <0.001 0.19 <0.001 
Shigella spp. 0.51 0.001 0.16 0.004 0.17 0.4 
Giardia lamblia -0.01 0.9 0.10 0.1 -0.04 0.8 
Cryptosporidium spp. -0.03 0.5 0.01 0.7 -0.09 0.5 
Adenovirus -0.02 0.8 0.07 0.1 0.25 0.6 
Norovirus 
Escherichia coil -0.02 0.8 -0.16 0.05 -0.28 0.01 
Astrovirus -0.03 0.9 2.4 0.1 1.3 0.03 
Clostridium per ringens 2.5 0.6 0.35 0.7 -0.01 0.9 
Staphylococcus aureus -0.48 0.4 0.11 0.4 -0.03 0.6 
Sapovirus -0.09 0.9 -0.06 1.0 1.6 0.2 
Vibrio spp. 0.37 0.9 -0.80 0.4 -0.08 0.9 
Bacillus spp. 9.8 0.1 -4.6 0.5 - - 
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Table A5.9e Indirect model with adjustment only for long-term trends (Indirect Model 
2). 
<5 years 5-64 years Z65 years 
(D 
a w o. C: n. 
) 
N 0 Cl) 
N 
0 .2 
N-7 N 7 
V > 0> Ü > 
Campylobacter spp. -0.10 <0.001 -0.006 0.2 -0.01 0.07 
Salmonella spp. 0.0 0.8 0.05 <0.001 0.03 0.03 
Rotavirus 0.05 <0.001 0.32 0.002 0.16 <0.001 
Shigella spp. 0.51 0.001 0.13 0.02 0.16 0.4 
Giardia lamblia 0.27 0.07 0.12 0.05 -0.02 0.9 
Cryptosporidium spp. 0.06 0.07 -0.03 0.2 -0.06 0.6 
Adenovirus 0.08 0.2 0.12 0.8 0.28 0.6 
Norovirus 
Escherichia coli -0.17 0.06 -0.20 0.01 -0.30 0.004 
Astrovirus 0.53 0.008 3.1 0.05 1.4 0.02 
Clostridium perfringens -0.67 0.9 0.01 1.0 -0.03 0.8 
Staphylococcus aureus 0.51 0.4 0.17 0.2 -0.02 0.8 
Sapovirus 0.89 0.1 -1.5 0.5 2.1 0.1 
Vibrio spp. -0.72 0.8 -1.9 0.05 -0.01 1.0 
Bacillus spp. 5.2 0.4 -8.9 0.2 - - 
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Table A5.9f Indirect model with adjustment for long-term trend and no pathogen 
laboratory report lags (Indirect Model 3) 
<5 years 5-64 years 265 years 
c I CL a N 
(ý 
N 
N 
D 
Cl) 
N 15 
U)) 
0 
N 
N 
U -N 7 
"p N 
N N 2 
V > 0> Ü > 
Campylobacter spp. -0.11 <0.001 0.0 0.8 -0.01 0.09 
Salmonella spp. -0.03 0.2 0.04 <0.001 0.006 0.7 
Rotavirus 0.05 <0.001 0.28 0.003 0.10 0.004 
Shigella spp. 0.43 0.001 0.12 0.01 0.12 0.4 
Giardia lamblia 0.23 0.04 0.07 0.2 0.07 0.5 
Cryptosporidium spp. 0.04 0.2 -0.03 0.2 0.02 0.9 
Adenovirus 0.10 0.04 -0.01 1.0 0.26 0.5 
Norovirus 
Escherichia coli -0.12 0.1 -0.15 0.01 -0.23 0.004 
Astrovirus 0.38 0.02 1.2 0.2 0.34 0.3 
Clostridium penfringens 0.78 0.7 -0.21 0.7 -0.03 0.5 
Staphylococcus aureus 0.18 0.7 0.03 0.6 0.05 0.3 
Sapovirus 0.39 0.4 0.26 0.9 0.93 0.2 
Vibrio spp. -1.9 0.2 -0.70 0.2 1.2 0.04 
Bacillus spp. 2.3 0.7 -2.0 0.4 - - 
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Appendix A5.10. Results of fitting interactions between norovirus and 
rotavirus laboratory reports and time. 
Age group Interaction Null Pathogen Interaction LRT P Null Interaction 
pathogen model coefficient coefficient value Model model 
AIC AIC 
<5 years Norovirus Direct I 
Rotavirus Indirect 2 
5-64 years Norovirus Direct 1 
1.99 -0.16 <0.001 7.67 8.02 
0.10 -0.003 <0.001 8.89 8.57 
1.53 -0.08 <0.001 8.69 9.10 
X65 years Norovirus Direct 1 0.14 -0.007 <0.001 6.39 6.41 
Abbreviations: AIC, Akaike's information criterion; LRT, likelihood ratio test. 
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Appendix A5.1 1. Partial autocorrelation plots for the final models 
Figure A5.11a Children aged less than five years Direct Model 1. 
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Figure A5.11 b Children aged less than five years Direct Model 2. 
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Figure A5.1Ic Children aged less than five years Indirect Model 1 
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Figure A5.11d Children aged less than five years Indirect Model 2. 
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Figure A5.11e Children aged less than five years Indirect Model 3. 
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Figure A5.11g Children and adults aged between five and 64 years Direct Model 1 
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Figure A5.11 h Children and adults aged between five and 64 years Direct Model 2. 
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Figure A5.11 i Children and adults aged between five and 64 years Indirect Model 1 
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Figure A5.11 j Children and adults aged between five and 64 years Indirect Model 2. 
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Figure A5.11 k Children and adults aged between five and 64 years Indirect Model 3. 
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Figure A5.11m Adults aged 65 years or older Direct Modell 
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Figure A5.1 In Adults aged 65 years or older Direct Model 2. 
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Figure A5. l1o Adults aged 65 years or older Indirect Modell. 
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Figure A5.1 1p Adults aged 65 years or older Indirect Model 2. 
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Figure A5.11q Adults aged 65 years or older Indirect Model 3. 
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Appendix A5.12. Norovirus coefficients in the final direct models 
Age group Model Norovirus coefficient Interaction coefficient 
<5 years Direct I- Fourier adjustment 0.59 (0.33,0.86) 
Direct 2 -13 week adjustment 0.36 (0.00,0.72) 
Direct 1- categorical year term 0.54 (0.25,0.83) 
replaces cubic trend 
5- 64 years Direct 1- Fourier adjustment 1.39 (0.73,2.06) -0.08 (-0.13, -0.03) 
Direct 2 -13 week adjustment 0.20 (0.00,0.41) 
Direct 1- categorical year term 1.39 (0.68,2.09) -0.09 (-0.14, -0.04) replaces cubic trend 
Z65 years Direct 1- Fourier adjustment 0.14 (0.07,0.20) -0.007 (-0.01, -0.002) 
Direct 2- 13 week adjustment 0.02 (0.003,0.041) 
Direct 1-categorical year term 0.12 (0.05,0.19) -0.006 (-0.01, -0.0007) 
replaces cubic trend 
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Appendix A5.13. Changes in Pearson's residuals over the study period 
Figure A5.13a Children aged less than five years Direct Model 1 
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Figure A5.13b Children aged less than five years Direct Model 2. 
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Figure A5.13c Children aged less than five years Indirect Model 1. 
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Figure A5.13d Children aged less than five years Indirect Model 2. 
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Figure A5.13e Children aged less than five years Indirect Model 3. 
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Figure A5.13g Children and adults aged between five and 64 years Direct Model 1. 
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Figure A5.13h Children and adults aged between five and 64 years Direct Model 2. 
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Figure A5.13i Children and adults aged between five and 64 years Indirect Model 1. 
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Figure A5.13j Children and adults aged between five and 64 years Indirect Model 2. 
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Figure A5.13k Children and adults aged between five and 64 years Indirect Model 3. 
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Figure A5.13m Adults aged 65 years or older Direct Model 1. 
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Figure A5.13n Adults aged 65 years or older Direct Model 2. 
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Figure A5.13o Adults aged 65 years or older Indirect Model 1. 
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Figure A5.13p Adults aged 65 years or older Indirect Model 2. 
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Figure A5.13q Adults aged 65 years or older Indirect Model 3. 
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Appendix A5.14. Fitted values from final models 
The black line shows the observed weekly counts of general practice consultations for 
IID; the red line shows the fitted values from the model. 
Figure A5.14a Children aged less than five years Direct Model 1. 
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Figure A5.14b Children aged less than five years Direct Model 2. 
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Figure A5.14c Children aged less than five years Indirect Model 1. 
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Figure A5.14d Children aged less than five years Indirect Model 2. 
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Figure A5.14e Children aged less than five years Indirect Model 3. 
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Figure A5.14e Children aged less than five years Indirect Model 4. 
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Figure A5.14g Children and adults aged between five and 64 years Direct Model 1. 
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Figure A5.14h Children and adults aged between five and 64 years Direct Model 2. 
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Figure A5.14i: Children and adults aged between five and 64 years Indirect Model 1. 
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Figure A5.14j Children and adults aged between five and 64 years Indirect Model 2. 
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Figure A5.14k Children and adults aged between five and 64 years Indirect Model 3. 
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Figure A5.14m Adults aged 65 years or older Direct Model 1. 
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Figure A5.14n Adults aged 65 years or older Direct Model 2. 
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Figure A5.14o Adults aged 65 years or older Indirect Model 1. 
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Figure A5.14p Adults aged 65 years or older Indirect Model 2. 
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Figure A5.14q Adults aged 65 years or older Indirect Model 3. 
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Appendix A5.15. Model fitting and results for estimation of general 
practice consultations due to rotavirus in children aged less than five 
years 
Table A5.1 5a Model components and incidence of general practice consultations for 
rotavirus-associated IID. 
Direct 
Model1 
Indirect 
Model1 
Indirect 
Model 2 
Pathogens Rotavirus Shigella Shigella 
Norovirus Norovirus Norovirus 
Shigella Astrovirus Astrovirus 
Season 8 Fourier 8 Fourier No 
Trend Cubic Cubic Cubic 
Autocorrelation adjustment Yes Yes No 
(2 AR terms) (2 AR terms) 
Interaction pathogen*time Rotavirus No No 
*time' 
AIC 7.62 7.86 11.26 
Incidence of general practice 
consultations per 1000 population 
1993-2007 Direct 
Indirect 
25th percentile 
Positive only 
Lowest 
23.2 -- 
(18.9,27.5)" 
- 10.3 20.5 
- 6.1 10.3 
- 32.0 44.4 
1994-1996 Direct 30.3 
(18.3,42.2)" 
Indirect 
25th percentile 15.3 28.3 
Positive only - 9.7 16.1 
Lowest - 40.0 57.0 
1 Interaction P value <0.001; rotavirus coefficient 0.09 (95% confidence interval: 0.08,0.10); interaction 
coefficient -0.003 (95% confidence interval : -0.004, -0.002) i 95% Confidence intervals 
Abbreviations: AIC, Akaike's Information criterion. 
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Table A5.15b Rotavirus coefficients in the direct models. 
Age group Model Rotavirus coefficient Interaction coefficient 
<5 years Direct 1- Fourier adjustment 0.09 (0.08,0.10) -0.003 (-0.004, -0.002) 
Direct 2- 13 week adjustment 0.12 (0.10,0.13) -0.005 (-0.007, -0.004) 
Direct 1- categorical year term 0.10 (0.08,0.11) -0.004 (-0.005, -0.003) 
replaces cubic trend 
Figure 5.15 Mean weekly incidence of general practice consultations for rotavirus- 
associated IID. 
Figure 5.15a Direct model 1. 
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Figure 5.15b Indirect model 1 (25th percentile standardised residuals). 
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Figure 5.15c Indirect model 2 (25th percentile standardised residuals). 
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Appendix 6: Additional information and results for 
Chapter 8 
Appendix A6.1. Description of mixture model of norovirus Ct values 
A model with two component distributions was fitted to the Ct value distribution from IID 
cases only. Two model components were used because it was believed a priori that there 
were two groups of IID cases: those with high viral loads and disease caused by norovirus; 
and those with low norovirus load and disease caused by another pathogen. Modelling 
was carried out separately for IID cases in the community cohort and the general practice 
study, to allow a different proportion of cases to have disease caused by norovirus in the 
two study components. 
A maximum likelihood method was used to estimate the mean and standard deviation of 
the two component distributions imposed on the Ct value data. The model and maximum 
likelihood method have been described previously*. IID cases who were positive for 
norovirus by non-quantitative RT-PCR, but negative by real time RT-PCR were 
represented as censored values at Ct value 39, to allow a normal distribution to be fitted to 
both component distributions in the model. The model provided the proportion of IID cases 
in the group with disease caused by norovirus, with a likelihood-based 95% confidence 
interval. This proportion was substituted for Adjustment Factor A in Formula 1. 
For the crude incidence estimates, data from IID cases of all ages were analysed together, 
therefore assuming that the distribution of Ct values is the same across all ages. To 
produce age-stratified and age-adjusted incidence estimates, the mixture model was fitted 
separately to the data from children aged less than five years and to older children and 
adults. Age-adjusted and age-stratified estimates were only produced for the general 
practice study; it was not possible to fit age-stratified models in the community cohort, 
because of the smaller sample size. Figures A1.1 to A1.4 show the fit of the modelled 
distributions to the observed data. 
Gay NJ. Analysis of serological surveys using mixture models: application to a survey of parvovirus 1319. 
Stat. Med. 1996; 15(14): 1567-73. 
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Figure A6.1a Fit of mixture model to distribution of Ct values from IID cases of all ages in 
the community cohort. Bars show the number of IID cases at each Ct value in the 
community cohort. Black line shows the fitted number of IID cases at each Ct value 
predicted by the model. 
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Figure A6.1 b Fit of mixture model to distribution of Ct values from IID cases of all ages in 
the general practice study. Bars show the number of IID cases at each Ct value in the 
general practice study. Black line shows the fitted number of IID cases at each Ct value 
predicted by the model. 
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Figure A6.1c Fit of mixture model to distribution of Ct values from IID cases aged less 
than five years in the general practice study. Bars show the number of IID cases aged less 
than five years at each Ct value in the general practice study. Black line shows the fitted 
number of IID cases at each Ct value predicted by the model. 
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Figure A6.1d Fit of mixture model to distribution of Ct values from IID cases aged five 
years or older in the general practice study. Bars show the number of IID cases aged five 
years or older at each Ct value in the general practice study. Black line shows the fitted 
number of IID cases at each Ct value predicted by the model. 
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Appendix A6.3. Age-specific adjustment factors calculated in each study 
component. 
Adjustment factor A 
Community General Practice 
All ages 0.50 0.45 
<5 years 0.48 0.40 
Z5 years 0.55 0.52 
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Appendix 7: Published papers and conference 
presentations 
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Appendix 7.1. Phillips G, Lopman B, Tam C C, Iturriza-Gomara M, Brown 
D, & Gray J. Diagnosing rotavirus A associated IID: Using ELISA to 
identify a cut-off for real time RT-PCR. J. Clin. Virol. 2009; 44(3): 242-5. 
Juutnal u1CIin al Virulogy44 (2009; 242 245 
Contents lists available at ScienceDirect 
Journal of Clinical Virology 
journal homepage. www. alsevier. com/locate/jcv 
Shun Conununication 
Diagnosing rotavirus A associated IID: Using ELISA to identify 
a cut-off for real time RT-PCR 
Gemma Phillipsa b ", Ben Lopmand b, Clarence C. Tamb, Miren Iturriza-Gomarac 
David Brown', Jim Gray` 
" Orprnnrnt o1 C au,, rn . nnM. Fmngl g and 7 onnnr Infrcnonr. llenfth Protection Agency Centre for Infections, 61 Colindak Avenue. 
London (N9 StO, UK 
" Infr noua OBrvte Epdnnioloxy U. N. London School of f iyK, eoe and lmpcuf Mevlrcmr, Krpprl St-t, London NT I ft 7fü (IX 
yo Reference Deportment. Health Rotection Agency Crntrr Jor tnkctiona, 61 Cofinddir Awn or, London NW9SEQ UK 
ARTICLE INFO 
Mndf history 
Rnervrd 16 , %-ber 2008 
At cplnl 2 Dacmbcr 200! 
gym: Ro«avirus A 
FlLSA 
RT-PLR 
Vu.. l lu+d 
Ac*io oRY 
Asymptuuut. 
ABSTRACT 
Background The use of RT-PCR for diagnosis of group A rotaviruses is increasing, but up to 14% of healthy 
individuals maybe positive by RT-I'CR. If RT-PCR is not well correlated with disease. rotavirus A may not 
always be the cause of illness in RT-KR positive patients with infectious intestinal disease (11D). 
Objectives: To describe thedifferences in faecal viral load between EUSA positive IlLcases. RT-PCR positive 
cases and healthy controls. To develop a cut-of in faecal viral load lot attributing illness to rotavirus Ain 
RT-PCR positive IID cases. 
Study design: Faecal viral load was measured, using real time RT PCR. in I I8 community IID cases and 65 
healthy cnntmis, previously tested by FLISA. Cycle threshold (CO values from the real-time RT-KR were 
used as a proxy measure of viral load. A cut-off for attributing Illness to rotavirus A was selected, using 
RUC analysis. 
Results: There was little overlap in viral load between l'USA positive III) cases (median Ct 17) and healthy 
controls (median Ct 37). but FLISA negative. RT-PCR positive IID cases (median Ct 37) had viral loads 
similar to healthy controls, indicating that RT-PCR is not detecting extra cases of group A rolavirus 
associated IID, only sub-clinical infections. The optimal cut-off in the real time RT-NCR was at Ct value 
24-27. 
Conclusion: FUSA is the best method for the laboratory diagnosis of rotavirus A associated III). IrRT-t CR is 
used, at is advisable to use a real time platform and to use a viral load cut-off equivalent to the detection 
limit of EUSA. 
02008 Elsevici B. V. All rights rescivcd. 
1. Background 
Enzyme linked immunosoibent assay (ELISA) has tradition- 
ally been the method of choice for laboratory diagnosis of group 
A rotavirus associated infectious intestinal disease (11D). 12 How- 
cver, with the availability of reverse transcription-polymerase chain 
reaction (RT-PCR) assays for rotavirus A'"' and the move towards 
multiplexing in clinical virology, s-b the use of RT-PCR is increas- 
ing Whilst RT-PCR does identify more iutavirus A infections than 
AAMevmnons ALK. ama niMer the ROCcurve; Ct. cycle threshold; rLISA. enzyme 
hr*nd immmwsorbent assay. 11D. infectious intestinal disease; IQR. mlerguartile 
range; RT-PCR, reverse transcnprbn-polynxrase chain reaction; ROC. receiver opcr- 
ating characteristic. 
" Corresponding author at Department of Gastrointestinal. Emerging and 
/nononc Infections. health Protenron Agency Centre for Infections. 61 Colindale 
Avenue. London `1W9 SLQ, UK. 
E mori address: gemmaphlllipslhpa. orguk (C Phillips) 
I )8b-e5)213 xe frond mauer 02008 ! lever &V. All nghI resnved. 
dor: IüIOlbl )cv1008.12001 
ELISA. 7 up to 14% of healthy individuals may be positive by Kf-PCR, B 
indicating that in some RT-PCR positive III) cases. rotavirus A may 
not actually be the cause of illness. 
Differences in faecal viral load between symptomatically and 
asymptomatically infected individuals have been demonstrated 
using real time RT-PCR° and histopathological studies indicate that 
damage to intestinal epithelial cells, caused by viral replication, may 
play a role in pathogenesis. 10 It may therefore be possible to use fae- 
cal viral load to indicate where rotavirus A is the cause of illness in 
RT-PCR positive IID cases. 
2. Objectives 
Research objectives were to describe ttie differences in rotavirus 
Aviral load detected in IIUcases positive byELISA. III) cases negative 
by ELISA but positive by RT-PCR and healthy controls: to develop a 
cur-off in faecal viral load for attributing illness to rotavirus Ain IID 
cases. 
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G MUdps n at /)oumn7of CMakol WoIay 44(200)242-245 243 
Table 1 
DislrlUwion of rotavirvs A rat tlm RT-KR R -Ines In IID cases and healthy cdnlrols. IQJI is the interquartile ran{e. I ISA indicates chat the 1ID cane was EU SA posttwc, 
! i-KA wdirates that the IID use was ELSA neptlve and Wt-F ! prIstlne. 
Method o(muvinu A detec*bn III) aus 
MedlanCtvalw IQR Sample the 
Comrott 
Median CtvaWe 
Rank sum rest pYA10 
Ot 5nmplelise compui cases to romrolss 
All ; es 
All 1$ Is 30 153 37 33.39 65 . 0.0001 
ELISA 17 15-20 116 40.0001 
RT-ICR (ElJSA negtt W) 77 32-39 35 0.911 
<S yean 
All 17 15-22 62 37 33-40 46 <0OO0l 
[LISA 16 Is 30 79 40.0001 
RT-PCR (EUSA lwpl* ) 35 32-39 11 0.37 
I The lank sum MI for ELLSA and R7- Kit pdsit*r 9D casts rumparc them to all r nrrob, 
I study design 
11. Specimens 
lower the Ct value the higher the faecal viral load. Thereat time RT- 
KR assay was run for 45 cycles so the maximum possible Ct value 
for a positive specimen was 44. 
Faecal specimens were collected from III) cases and healthy 
controls during the Infectious Intestinal Disease Study for Eng- 
land (1993-1996)" Ill) cases were recruited from a community 
cohort, or at consultation with their general practitioner. IID cases 
had acute diarrhoea or vomiting lasting less than 2 weeks, with no 
known non-infectious cause, preceded by a symptom-free period of 
3 weeks. 'a Healthy controls, with no history of lit) for the preceding 
3 weeks, were recruited concurrently to IID cases, from the com- 
munity cohort or from the registration list of participating general 
practices (not after consultation for another condition). 12 IiD cases 
provided a faecal specimen during acute illness; controls provided 
a specimen at recruitment. 
9.7.1Esti, g 
In the original study. faecal specimens frotn IID cases and con- 
trols were tested for rotavlrus A using ELISA. tt Specimens with 
sufficient volume remaining after testing were archived in froren 
storage. t3 Subsequently. all archived specimens were retested for 
rotavirus A using RT-PCR! In this study, a real time RT-PCR assay 
(method previously described) was used to determine the viral 
load in specimens that were previously positive for rotavirus A by 
EUSA or RT-KR, 
The cycle threshold (Ct) values from the real time RT-PCR were 
used as a proxy measure of viral load. The Ct value is inversely pro- 
portional to the. amount of vims present in the specimen, so the 
s o 
3.1 Descriptive analysis 
The median Ct value and interquartile range were calculated for 
111) cases and controls and comparisons were made between groups 
using the rank-sum test in Stata 10.1' 
3.4. Receiver operating choracterlstic analysis 
Receiver operating ci radcristic (ROC) analysis was used to 
select a cur-off in faccal viral load for attributing illness to rotavirus 
A. [LISA was used as the gold standard reference test to indicate 
where rotavirus A was the cause of illness in 11D cases. The optimal 
cut-off was identified at the maximum value of the Youden Index 
(sensitivity+specificity- I). tß-ts The ROC analysis was repeated, 
using healthy controls In the reference negative group, to Increase 
the sample size for the analysis in children aged less than 5 years. 
Healthy controls should serve as a suitable reference negative group 
because they have viral loads representative of rotavirus A infection 
without disease. 
4. Results 
4.1. Vescrtptlve anaºysts 
110 cases were aged up to 83 years and controls were aged up 
to 46 years; 60% of cases and 71% of controls were aged less rhan 
C vilw 
Rj. 1. Percentage dautäuioo of real time KT-ICR Ct vaWes in IID uses am! contmu. taw Ct vibes cunt pund to Aiah vital loads: the nral loaf deceeasa with inrreauns Ct 
value. 'WSA cash' are ipcus poskIve by EUSA. RT-PCR casts' are ID cases negative by EUSAand subsequently positive by R -PCL Sample sixes: EtßA cases. I li, RT PCR 
can-3s, mends-es. 
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1, k . *. mesrthe $a casuals 24-27 oil o. B l (090.094) 0. N (0.60496) 0.92 x)a 63 
Apd S. n 
Orkveem wyche gmI owuwb 24 064 0.95 (0.90-1.0) 019 (0.80-OA! ) 0.93 70 46 
S years. The median ß value In EUSA positive 1ID cases was sub- 
stantially lower than in controls (Table 1) and there was very little 
overlap between the distributions o1Ct values In these two groups 
IRS. 1} There was no evidence of a difference in Ct value distri- 
bution between the EUSA negative. RT-PCR positive IID cases and 
the controls (Fig. 1. Table 1), In all ages and when the analysts was 
restricted to children aged less than 5 years 
42 ROCana4sis 
Using EUSA as the gold standard, the optimal Ct value cut-off for 
attributing Illness to totavi ns A In IiD cases, for all ages, was in the 
range 2S-211. There was a clear bimodal distribution of Ct values, 
with few observations in the range 25-22, so it was not possible to 
distinguish between these cut-of values. Using healthy controls as 
the reference negative group produced similar results (Table 2): The 
optimal cut-off for children aged Less than S years was at Ct value 
24. although the Youden Index declined only slightly (difference 
less than 0.1) at Ct values 01`25-27 (data not shown). 
S. Discussion 
We have used faecal viral load to demonstrate that EUSA 
diagnosis is highly correlated with disease in rotavirus A Infec- 
tion, In accordance with other community and hospital-based 
studim'SJO-3' and that RT-PCR Is probably only detecting addl- 
tional infections in IID cases at levels not associated with illness. We 
have selected a cut-off in the real time RT PCR assay to Improve the 
specificity or diagnosing rotavlrvs A associated IID by this method. 
A major strength of this study Is the availability of specimens 
frwn healthy controls, which were essential for Interpreting the 
RT-PCR results In UD cases. Degradation of the rotavirus A genome, 
during the prolonged storage of these specimens, is likely tobe min. 
1mal. because the double stranded RNA is relatively stable. It is also 
unlikely that degradation will have occurred differentially across 
the specimen collection. Therefore, the patterns in faecal viral load 
described for IID cases and controls should reflect relative levels 
at the time of specimen collection. However, the actual Ct value 
cut-off identified here should not be applied directly to real time 
RT-lCR results from fresh specimens, nor to results generated using 
a different assay protocol. because theCtvalues may not necessarily 
equate to the same viral load per gram of faeces. 
IL Confusion 
RT-PCR does not provide sufficient speci&ity for attributing Ill- 
ness to rotivitus A In IID cases, As the use of multiplex PCR assays 
for enteric viruses increases In routine diagnosis of 110, there will 
be a need to Interpret the results of these sensitive tests to deter- 
mine disease aedoiogy. W) We have shown that LUSA positivity 
remains a good correlate of disease In rotavirus A Infection, sup- 
porting the use of ELISA In the WHO protocol for surveillance of 
rotavirus associated gastroenteritis. 4 We have demonstrated that 
clinical laboratories can use real time RT-KCR testing of ELISA- 
positive and EUSA-negative specimens to define a suitable cut-off 
for their neat time RT-KR assays. Accurate diagnosis of disease 
aetiology is important both for individual patient cafe, where cor- 
rect Identification of the cause of illness Is essential for clinical 
management, and at the population level, to ensure that estimates 
of rotavirus A disease burden are accurate, for assessing vaccine 
Impact In immunized populations. 
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Abstract 
Background: Reverse transcription-polymerase chain reaction (RT-PCR) is the main method for 
laboratory diagnosis of norovirus-associated infectious intestinal disease (IID). However, up to 16% 
of healthy individuals in the community, with no recent history of IID, may be RT-PCR positive; so 
it is unclear whether norovirus is actually the cause of illness in an IID case when they are RT-PCR 
positive. It is important to identify the pathogen causing illness in sporadic 110 cases, for clinical 
management and for community based incidence studies. The aim of this study was to investigate 
how faecal viral load can be used to determine when norovirus is the most likely cause of illness in 
an 110 case. 
Methods: Real-time RT-PCR was used to determine the viral load in faecal specimens collected 
from 589 IID cases and 159 healthy controls, who were infected with genogroup II noroviruses. 
Cycle threshold (Ct) values from the real-time RT-PCR were used as a proxy measure of viral load. 
Receiver-operating characteristic (ROC) analysis was used to identify a cut-of in viral load for 
attributing illness to norovirus in IID cases. 
Results: One hundred and sixty-nine IID cases and 159 controls met the inclusion criteria for the 
ROC analysis. The optimal Ct value cut-off for attributing IID to norovirus was 31. The same cut- 
off was selected when using healthy controls, or IID cases who were positive by culture for 
bacterial pathogens, as the reference negative group. This alternative reference negative group can 
be identified amongst specimens routinely received in clinical virology laboratories. 
Conclusion: We demonstrated that ROC analysis can be used to select a cut-off for a norovirus 
real time RT-PCR assay, to aid clinical interpretation and diagnose when norovirus is the cause of 
IID. Specimens routinely received for diagnosis in clinical virology laboratories can be used to select 
an appropriate cut-off. Individual laboratories can use this method to define in-house cut-offs for 
their assays, to provide the best possible diagnostic service to clinicians and public health workers. 
Other clinical and epidemiological information should also be considered for patients with Ct 
values close to the cut-off, for the most accurate diagnosis of IID aetiology. 
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Background 
Infectious intestinal disease (110) is a syndrome of mixed 
aetiology; many different pathogens can infect the human 
gastrointestinal tract and produce diarrhoea, vomiting 
and other characteristic symptoms. Mixed gastrointestinal 
infections are frequently detected, especially In infants 
and young children and when poiymerase chain reaction 
(PC R) assays are used for diagnosis [1,2[. It Is important 
to determine which pathogen Is the cause of illness, In 
order to direct clinical management for individual 
patients and to advance epidemiological understanding 
of 110. 
Reverse transcription. PCR (R- PCR) Is now the method 
of choice for detecting norovirua to clinical specimens, 
Rr PCR detects norovirus at lower concentrations and is 
less affected by specimen quality and preparation than 
electron microscopy 13-5j; large numbers of specimens 
can be tested simultaneously, compared to the single 
throughput for electron microscopy. RT PCR also detects 
a much wider range of norovirus genetic variants than 
enzyme-linked Immunosorbent assays (ELISA) and may 
be more easily adaptable for detection of new strains 161. 
Ilowever, many healthy individuals, with no recent his- 
tory ofilD, are RT-PCR positive 17-91, meaning that virus 
detection by Rr. PCR is not well correlated with disease in 
norovinu Infection. If RT PCR positivity does not neces- 
sarily equate to norovinu-associated lID, It cannot be 
used alone to attribute illness to norovirus In III) cases; it 
is possible that the norovirus infection is 'asymptomatic' 
In the IID case, with another pathogen, detected or unde- 
tected, actually causing the symptoms. 9he poor diagnos- 
tic specificity of PCR and the associated difficulties for 
clinical Interpretation of test results have been highlighted 
for other viral pathogens 110,111. 
Previous studies have demonstrated differences in faecal 
norovirus load. between symptomatically and asympta- 
matically infected individuals 17,121. Histopathotogical 
investigations of experimentally Inoculated volunteers 
and naturally infected individuals also indicate that the 
mechanism of pathogenesis In norovitus infection may 
rely on damage to the intestinal epithelium, caused by 
viral replication 113-151, to that symptoms may be a result 
of high viral loads. The aim of this study was to use faecal 
viral load measurements to detennine when illness is 
attributable to norovirus In III) cases. 
Methods 
Sp. dm. nt 
Faecal specimens were collected from 110 cases and 
healthy controls during the Infectloui Intestinal Disease 
Study for England (1993-1996) 1161. i1D cases were 
recruited from a prospectively followed cohort in the 
community, or on consultation with their general practi- 
hitp Itw . 
biomedcentrai. cor+V1471233419/63 
tioner for 110. IID cases had acute diarrhoea or vomiting, 
lasting less than two weeks, with no known non- 
Infec-tious cause, preceded by a symptom free period of at least 
three weeks 1171. Healthy controls, with no history of IID 
for the preceding three weeks, were recruited from within 
the community cohort or from the registration lists of par- 
ticipating general practices (but not after consultation for 
another condition) 1171. Controls were recruited concur- 
rently to lID cases. III) cases were asked to provide a faecal 
specimen during acute illness and controls provided a 
specimen at recruitment. 
Testing 
In the original study, norovirus was detected using elec. 
tron microscopy. Faecal specimens were also tested for a 
range of other bacterial, viral and protozoal pathogens, 
using bacterial culture, microscopy or GUSH. Specimens 
with sufficient volume remaining after testing were 
archived In frozen storage 1181. Subsequently the archived 
specimens were all retested for norovirus using RT"PCR 
17,191. PCR testing was also used to detect seven other 
common bacterial, viral and protozoal pathogens. 
For the present study, norovitus RNA was re-extracted 
from the stored faecal specimens that were previouslypos- 
itive for norovirus by EM or R'T-PCR, and real-time Rr- 
PCR (method previously described 71) was used to deter- 
mine the viral load. The real time RT PCR assay has sepa- 
rate primer pairs for norovirus, genogroup I and 
genogroup It, so it was possible to use the assay to identify 
the genogroup of norovirus present. Only viral load meas- 
urements from norovirus genogroup II positive specimens 
were used for this analysis; differences in the performance 
of the two genogroup specific assays mean that it is not 
appropriate to directly compare the results between the 
two genogroups (J. Cray, personal communication). Spec. 
irren collection and testing for norovirus Is summarised 
in Additional Pile 1. 
Data 
the cycle threshold (Ct) value from the real time RT-PCR 
was used as a proxy measure of faecal viral load. The Ct 
value is Inversely proportional to the amount of virus 
present in the specimen, so the lower the Ct value the 
higher the faecal viral load. The Ct value represents the 
number of rounds of PCR replication required to raise the 
number of copies of the target sequence in the reaction 
mixture above a pre-determined threshold [201. The real 
time RT-MR assay was run for 40 cycles, so the maximum 
possible Ct value for positive specimens in this study was 
39. 
Descriptive analysis 
The median Ct value and inter quartile range were calcu- 
lated for IID cases and controls; comparisons were made 
between groups using the rank-sum test in Stata 10 1211. 
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Recelverogerutfng characteristic analysis 
Receiver-operating characteristic (ROC) analysis was used 
to define a cut-off in the Ct values, to attribute disease to 
norovinw in RID cases. There is no gold standard test for 
diagnosing norovirus-associated UD. We therefore used 
microbiological and clinical characteristics to select refer. 
ence groups for the ROC analysis. 
Refer P-Vve r ps 
We defined three reference positive groups, selected to 
have Ct values that are representative of where norovirus 
is causing Illness (Table 1). Reference positive group I 
included only IID cases who were diagnosed as norovirus 
positive by electron microscopy; the high viral loads 
required for detection by electron microscopy correspond" 
to viral shedding during acute infection in experimentally 
inoculated volunteers (22.231, so these III) cases are 
highly likely to have lit) caused by norovirus. 
In reference positive group 2, we additionally included 
li D cases who were electron microscopy negative and sub- 
sequently RT-PCR positive, providing that they had no 
other pathogens identified in their stool and that they had 
collected a specimen early in their illness (less than three 
days since symptom onset). 'Ihese two restrictions were 
used to ensure that norovinu was the most likely cause of 
their Illness and to ensure that their faecal viral load Is rep. 
http: # w. biomedcentraf. com/1471-2334J91ß3 
resentadve of acute symptomatic norovirus infection 
112,22,231. We defined this second reference group to 
determine whether using only electron microscopy posi- 
tive cases in reference group i biased the cut-off to lower 
Ct values (higher viral loads). 
Reference positive group 4 Included III) cases who were 
RT-PCR positive for norovirus (including those previously 
positive by EM) and who were negative for other bacterial 
protozoal and viral pathogens drat are routinely detected 
in clinical diagnostic algorithms for sporadic III) In 
National Health Service laboratories in the UK (24,25). 
This restriction was used to make norovirus the most 
likely cause of illness in these III) cases, so that their Ct 
values should be representative of where norovirus Is 
causing Illness. We defined this third reference positive 
group to explore whether it is suitable for selecting a Ct 
value cut-oft, because electron microscopy diagnosis is no 
longer used In clinical laboratories In the UK so cannot be 
used to select a reference positive group In future studies. 
Reference negative groups 
We defined two reference negative groups, selected to 
have Ct values representative of where norovirus is not 
causing illness (Table 1). Reference negative group 1 
inducted norovirus infected healthy controls. Reference 
negative group 2 included norovirus infected RID cases 
Table I: Inclusion criteria for the ROC analysis reference groups 
Reference group In union Criteria 
Reference 1. no 
pouove I 2. Norovirw detected by electron microscopy 
3. Norovlrus Infection confirmed by RT"PCR 
Reference 1. IID 
poeti. e 22 Norovirus detected by electron microscopy 
3. Nor**% Infection confirmed by RT"PCR 
Or 
1.00 
2. Electron mIcroscopy neyadve 
3. Noradrus detected by RT-PCR 
4. No other pathogen detected 
9. Specimen cohected within 3 days of symptom onset 
Reference 1.110 
positive 3 2. Norovirus detected by electron microscopy and/or RT-PCR 
3. Neptive for Compy(obocrer app.. Soknenefe app, and Skigelb spp. by bacterial culture and Gyprospork$um spp. by Bahr 
microscopy 
(and rotaviras A by ELSA in chädrnn ged Iwo than 6rw years only) 
Reference I. No history of RD In previous 3 weeks 
negative I 2. Norovi us detected by RT"PCR 
Reference I. I10 
negative 2 2. Nororirus detected by RT"PCR 
3. Infection wich Soknoaeila spp, Campyiobocter spp. or SNyeNe spp. detected by bacteria) culture or Srypmspoddlum app. detected 
by light microscopy 
(or roavkus A by EUSA In children aged las than five yearn only) 
Page3of9 
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with a bacterial infection diagnosed by culture or rotavi- 
rus A infection diagnosed by LLISA (for children aged less 
than five years only). Bacterial culture without enrich- 
ment may indicate the presence of high concentrations of 
viable bacterial cells, meaning that the bacteria detected 
are likely to be causing illness, rather than the norovinis 
infection Similarly, l LISA for rotavirus A has a high detec- 
tion limit that correlates well with disease 126,271, so rota- 
virus A is pmhahly the cause of illness in GJtiA positive 
individuals, rather than the norovints infection We 
defined this second reference negative group to explore 
whether it is suitable for selecting a nit-off, because spec- 
imens from healthy controls are not routinely received in 
clinical laboratories, so cannot be used as the reference 
negative group it other laboratories want to use this 
method to develop a cut-off for their real time assays. 
http. /Nvww. biomedcentral com/1471-2334/9/63 
- RT. PCRcwses Em-S _ C-IMK 
Ci va Le 
In each ROC analysis, the sensitivity and specificity were 
calnilated for each potential cut-off in the range of Ct val- 
ues and an empirical RUC plot created using Stata 10 1211. 
The Youden index (sensitivity . specificity-! ) was calcu- 
lated and the maximum value used to identify the optimal 
cut-off l28.301 Ihr analysis was done for all ages together 
and then separately, in children aged less than five years 
and individuals aged five years or older 
Edda 
Fthic al approval was granted from both local and national 
research ethics committees (Royal College of General 
Practitioners. London School of Hygiene and Tropical 
Medicine, Public Health Laboratory S(rvice) for the III) 
study, including creation of the faecal specimen archive 
1171. Written, informed consent was obtained from all 
cases and controls. l'hc faecal specimen archive was ano- 
nynused and no further ethical approval was sought for 
the rctcsting in this study. 
Results 
Descriptive anolyds 
Ct values were generated for 589 III) cases and 159 
healthy controls, who were infected with genogroup 11 
noroviruses; 92 of the III) cases were positive by electron 
microscopy and 497 were negative by electron micros- 
copy but subsequently positive by NT-PC: R. ILL) cases were 
aged up to 94 years and controls up to 84 years; 40% of 
III) cases and (0% of controls were aged less than five 
years 
The median (a value was lower in IID cases (median '14) 
than in controls (median 38) ('fable 2). the difference 
compared to controls was greatest for 1111 cases positive by 
electron microscopy (median 24); there was very little 
overlap in the distribution of (: t values in electron micro- 
scopy positive IID cases and controls (Figure 1). The dis- 
tribution of (a values for the IID cases who were negative 
Figure I 
Percentage distribution of real time RT-PCR Ct val- 
ues in IID cases and controls. Low Cc values correspond 
to high viral loads; the viral load decreases with increasing Ct 
value. 'EM cases are IID cases positive by electron micros- 
copy, 'RT-PCR cases are IID cases negative by electron 
microscopy and subsequently positive by RT-PCR. Sample 
sizes: EM cases = 92, RT-PCR cases = 497, controls = 159. 
by electron microscopy and subsequently RT"PCR positive 
overlaps substantially with the controls, although a small 
proportion have the higher viral loads seen in the electron 
microscopy positive IID cases (figure 1, l able 2). 
ROC onolysis 
11we numbers of specimens meeting the inclusion criteria 
for each of the reference groups are shown in'Iable 3. 
The optimal cut-oil for attributing illness to genogroup 11 
noroviruses in III) cases was at Ct value 31, corresponding 
to the maximum Youden index for the ROC analysis with 
reference positive group 1 and reference negative group I 
(Figure 2). 
I lsing this cut-off, I ID cases with Ct values of 31 or below 
are classified as 'positive for norovirus-associated III): 
they have disease caused by norovirus. 110 cases with Ct 
values above 31 are classified as 'negative' for norovirus- 
associated Ill): they have disease but their norovirus infec- 
tion was not the cause of their symptoms. 
The optimal cut-off for children aged less than five years 
was at Ct value 30, whereas for older children and adults 
it was at Ct value 33 ('fable 3). There was some evidence 
of a difference in Ct value distribution between electron 
microscopy positive III. ) cases in these two age groups 
(rank sum test p=0.036), with the median in children 
aged less than five years at Ct value 2 land at Ci value 25 
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Tabu 2* Ct values in pnozroup 11 norovirus poahivw 110 caws and h. althy control,. 
Medal d naro* m detection 
Median Ct 
value 
IID Cues 
Ctwiw 
IQR 
Sample 
tue 
C 
me" Ct 
value 
ontrols 
Ct value 
)QR 
Sample 
$ue 
Renk4um Last p-Wue 
comparing cuss to eon*cI; 
N asee 
/y 04 75-37 589 38 35-39 159 4.0001 
pettron mioasco" 24 21-273 92 <0.000I 
RT PGl 35 29-38 497 '0.0001 
(Eiectron mlaowop7 netadve) 
<iýars 
N 34 26.37 233 37 3438 92 <0.0001 
flectson ndaoecop7 23 21-23 48 c0AOOI 
RT-PCR 35 32-37 205 0.0001 
(E ectron mit oaoop7 nepdse) 
a N 
34 25-38 334 38 36-39 67 '0.0001 
Elecooe eictoscapr 25 22-28.5 44 '0.0001 
RT4'CR 35 27-38 290 90.0001 
(Hecvon Miau °p7 nie) 
TM rok4wss tens for electron microscopy and RT. PCR positive IID Cues compare Chem a ad Controls. Aje we not recorded for two IID casts 
PR Y do imagsrvle rant.. 
for older children and adults (Table 2). This indicates that and early specimen collection were included in the refer. 
the different cut-offs may reflect a true difference in viral ence positive group (reference positive group 2) (Table 3). 
load between these age groups. This was also true for the age-group specific ROC analyses 
(data not shown). The optimal cut-off was also at Ct value 
The optimal cut-off (all ages) was also at Ct value 31 when 31 when norovints positive 110 cases who were negative 
RT-PCR positive cases with no other pathogen detected for other commonly tested enteric pathogens were used as 
Table Sa ROC wlrir vssutn. 
Rderaw cope w td Opdmal Ct awo8 faulen Index SenrltMty Sped" AUC Sample 6xa, 
(9S% CA) (95% co 
Referee. p otM Reference nepttve 
P44 PO$idv I 
R. 1 JIapt)N I 
AI 31 0.77 0.88 0.89 0.93 92 159 
(0.6$-I. 00) (0140.94) 
Kd c5 Few$ 30 0.80 0.94 036 0193 48, 92 
(0.84-1.00) (0.79-0.93) 
eged I'S years 33 0.83 0.89 0.94 0.96 44 47 
(0.79-0.98) (0.88-1400) 
Rdpmkh+2 
Rd ngatM 
31 0.61 0.72 089 0.87 169 139 
(0 66-0.79) (0.84-0.94) 
Rd pwove 3 
Rd nejxnv 2 
31' 0.29 0.43 0.86 0.64 $24 64 
(0.39-0.47) (0.77-0.94) 
TM Mararce poops are damöed in Tibit 1. AUC a dw am under do cuewa 
Pago5of9 
(Paw n , mbereor forctt1nM purpaw4 
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Figure 2 
Youden Index from ROC analysis for reference poss. 
clue group I and reference negative group 1. Refer- 
ence positive group I were electron microscopy positive IID 
cases and reference negative group I were RT-PCR positive 
healthy controls. 
the reference positive group (reference positive group 3), 
and the bacterial culture positive III) cases were used as 
the reference negative group (reference negative group 2). 
The Cs values discriminated well between reference posi- 
tive group I and reference negative group I, because the 
area under the ROC curve was close to the maximum 
value of one (Figure 3, Table 3). 'the discriminatory power 
of the Ct values was poorer for the ROC analysis when Kf- 
PCR positive cases with no other pathogen detected and 
early specimen collection were included in the reference 
positive group (reference positive group 2). '1 he discrimi- 
natory power was very low for distinguishing between ref. 
erencr positive group 3 and reference negative group 2 
because the area under the curve was close to 0 5, which is 
indicative of a test with no discriminatory power. 
Discussion 
In this study we have demonstrated a diference in viral 
load between symptomatic and asymptomatic norovirus 
infection. A substantial proportion of 111) cases who were 
positive only by Kf-I'CR had viral loads equivalent to 
those in healthy controls. This supports the hypothesis 
that norovirus is not always the cause of illness where it is 
detected by Kf--t'CR. We have shown that it is possible to 
use the viral load in clinical specimens to indicate where 
norovirus Is the most likely cause of illness, by selecting a 
cut-off for the norovirus real time RT-PC: R assay. We have 
also shown that the method of cut-off selection can be 
adapted for use with specimens that are routinely received 
and tested in clinical laboratories, to help other laborato- 
ries develop in-house nu-oils for their assays. This is 
http: //www. biomedcentral. com11471-233419! 63 
Figure 3 
ROC plot for reference positive group I and refer- 
ence negative group I. Reference positive group i were 
electron microscopy positive IID cases and reference nega- 
tive group I were RT-PCR positive healthy controls. The 
diagonal line represents a ROC plot for a test with no dis- 
criminatory power. 
essential because there is substantial variability between 
IIK virology reference laboratories in the ü values pro- 
duced front standard reference specimens (31 1; the same 
cut-off may not be appropriate for all laboratories because 
of these differences in assay performance. 
A major strength of this study is the availability of speci- 
mens from healthy controls. There are few community 
studies of IID with large control groups available, but they 
arc essential for interpreting the R"I'1'CR data In III) cases. 
Importantly, it has been possible to validate the use of 
bacterial culture positive III'. ) cases as a reference negative 
group, by comparison to the ROC analysis using healthy 
eonuols; this removes the need to collect further control 
specimens in future studies. We have also shown that KI'- 
PUR positive III? cases, who are negative for other com- 
mon bacterial, protozoal and vital pathogens. are a suita- 
ble reference positive group, so that the method can be 
used by laboratories without EM testing facilities. '11iese 
reference groups can now be used by other laboratories 
for development of cut-offs for their assays. 
The area under the ROC curve I'or the alternative reference 
groups is very low, possibly because the viral loads in 
many of the IIt) cases in the reference positive group were 
not representative of symptomatic norovints infection; 
this Is reflected In the low sensitivity for the cut-off at Ct 
value 31 when using these groups in the ROC analysis. 
However, selection of an appropriate cut-off is the main 
aim of this method and we have shown that this is possi- 
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bit with these reference groups. It is also Important that 
the diagnostic performance (sensitivity, spedßdty, pre. 
dietive values) of the cut-off is determined using an inde- 
pendent dataset, which was not possible in this study, the 
sensitivity and specificity calculated in the ROC analysis 
may misrepresent the performance of the cut-off In clini- 
cal application. because the cut-off is selected by optimis- 
ing the diagnostic accuracy compared to the gold standard 
(32.33]. 
ht4 JMnvw. biomedcentraLcom(1471.233419! 63 
viral load for all genogroup H genotypes with the same 
may efficiency. Selection of a single cut-off may also not 
be appropriate If the Youden index is similar for a range of 
Ct values between 28 and 33, as was the case in this anal- 
ysis. With a larger sample size, in future studies, there may 
be better power to discriminate between potential cutoffs 
in this range. Nevertheless, the cut-off provides a major 
improvement in diagnostic specificity compared to the 
current qualitative use of RT-PCR In norovirus diagnosis. 
The specimens used in this study were originally collected 
during the mid 1990s and the viral RNA may have 
degraded during the prolonged storage and repeated 
freeze-thaw cycles for re-testing. Therefore the cutoff 
developed here should not be directly applicable to real- 
time irr-PCR results from fresh specimens without valida. 
tion. Similarly, the cut-off should not be applied to assays 
with different protocols, because the Ct values may not 
equate to the same viral load per gram of faeces. It is 
unlikely, however. that there will have been differential 
degradation of RNA between specimens during storage, so 
it is still valid to compare the viral load between sped. 
mens In this collection, and to assume that the relative dif- 
ferences observed between DO cases and controls are a 
trau reflection of symptomatic and asymptomatic infec- 
tlon. it 13 also Important to note that any cut-off In viral 
load can only be applied to specimens collected from lID 
patients during acute symptoms, when the viral load is 
representative of disease aetiology. After symptoms 
resolve In norovirus-assodated LID, the viral load quickly 
drops to levels seen in asymptomatic infection 1121 and 
the predictive value of the cut-off will be greatly reduced. 
The cut-off developed here Is not applicable to two of the 
rarer genotypes in genogroup It (CII-7 and CII-8), 
because the real time RT-PCR assay has poorer efficiency 
(a higher detection limit) forthesegenotypes (J. Gray, per- 
sonal communication), so the Ct values do not represent 
the same faecal viral loads as for the other genotypes. At a 
population level, the degree of misclassification would be 
small because of the low prevalence of Gli-7 and CH-8 
134.361. However, correct Identification of illness caused 
by these genotypes may be important for clinical manage- 
ment. but would require development of genotype-spe- 
cific cutofs. Similarly, we have excluded genogroup I 
noroviruses from this analysis because the efficiency of 
the assay is highly variable for genotypes within In this 
genogroup. Development of a cut-off for CT47 and CII-8 
or genogroup I norovinues would require collection of 
sufßdent specimens for genotype-specific ROC analyses. 
clinical application would require genotyping to be part 
of routine diagnosis, which may not be economically or 
logistically feasible. Further work is also needed to charac, 
tense the kinetics of the real time RT-PCR assay, to deter- 
mine whether a Ct value of 31 translates to the same faecal 
The causal relationship between disease symptoms and 
viral load has not been established. However, if the rela- 
tionship between the occurrence of disease and viral load 
is consistent, regardless of whether high viral loads are a 
cause or a consequence of disease, viral load will be a 
good marker of norovirus-associated IID and the 
approach developed here Is valid. Viral load is routinely 
used to predict outcome and guide clinical management 
for a number of viruses that cause chronic Infections, auch 
as Epstein-Barr virus 1371 and cytomegalovlrus 1381 In 
transplant patients, I IIV 1391, hepatitis C 1401 and I ITV 
(411. However this is the first time, to our knowledge, that 
viral load has been used as a tool for diagnosing enteric 
viruses as the cause of acute III). 
Conclusion 
As PCR diagnosis is applied to an increasing number of 
viral pathogens, the debate is growing about the clinical 
interpretation of positive results and the utility of PCR In 
diagnostic Services 110,42,431. PCR has many advantages 
over traditional diagnostic methods, including higher 
throughput, shorter turnaround time, adaptability to new 
strains and production of data for molecular epidemio, 
logical surveillance. it is therefore important to ensure 
that clinically informative results are produced from PCR 
assays, to provide a high standard of patient care along- 
side these other benefits. The method developed here 
shows that the real-time RT-PCR output for norovirus can 
be used to attribute disease to norovirus in ltd cases, 
where simple detection may not be sufficient to give a 
confident diagnosis of norovirus-associated HO., This 
semi-quantitative approach to diagnosis can improve 
both the accuracy of community based estimates of now. 
virus associated III) incidence and the interpretability of 
diagnostic results provided to clinicians from clinical 
virology laboratories. However it is important that clinical 
and epidemiological information is considered in the 
diagnosis of disease aetiology for individual patients with 
Ct values close to the cut-of. 
Independent validation ofthis method is required priorto 
application In other studies and laboratories; we have pro- 
vided a method for validation without the need for collet 
Lion of specimens from healthy controls or further use of 
EM. The method may also be useful for other viral patho- 
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Bens, for which the same problems with the interpretabil- 
Ity of PCR have been desaibed. Future work will focus on 
applying this approach for estimation of norovirus assod- 
ated III) incidence and describing the implications fur 
diagnosis of norovirus outbreaks. 
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Community Incidence of Norovirus-associated Infectious Intestinal Disease In 
England: Improved Estimates Using Viral Load for Norovirus Diagnosis 
Gemma Phillips, Clarence C. Tam, Stefano Conti, Laura C. Rodrigues, David Brown, 
Wren Iturriza-Gomara, Jim Gray, and Ben Lopman 
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Exbany estimates of the Incidence of Infectious Intestinal disease (IID) caused by norovirus are based on 
electron microscopy or reverse transcription-poymeraa dram reaction (RT-PCR). Neither method accurately 
wprewnte noravfus disease burden: Electron microscopy has poor diagnostic senatthAty, and RT-PCR has poor 
diagnostic speci8dy. In this study, viral bad measurements were used to Identify cases of norovirue-assodated 
00 and to produce new incidence estimates for England. 110 Cases were ascerained In the Study of infectious 
Inteelind Disease In England (1993-1996), and stool specimens were tested by semiquanlitative reahäme RT- 
PCR tar norovkus. The age-Ousted community Incidence of norovinn-associated IID was 45! 100 person-years 
(95% crodbiy interval: 3 8,52), equating to 2 million episodes/year. Among children aged less than S year, the 
community Incidence was 21.4/100 person-years (%% credibility Interval: 151,27.7). and the Incidence of con- 
sultations to general practitioners for norovfnn-asaodated 110 was 321100 person-years (95% credibility interest: 
2.8,3.8), with 100,000 children visiting their genera( practitioner for norovlrus-associated 110 each year. Norovitus 
Is the most common cause of 8D in the community in England and Is responsible for a similar number of pediatric 
primary care consultations as rotedrus. 
England; gastroenteri is; incidence, Monts Carlo method; Norovkus primary health care; reverse tnuucdptsse 
poymerese d, etn reaction 
Abbrevla8ons: IID, Wectloue Intestinal disease; ROC. receiver operating characteristic; RT-PCR, reverse trarwafptlon-polymer- 
sae chain reaction. 
Norovints is the most common cause of infectious Intes- 
tinal disease (11D) In the community in high-income coun- 
vks (1-4), and a substantial prevalence of norovirus 
Infection has been reported among IID cases seeking med- 
ical eve (S). Existing estimates of noroviruaassociated lID 
incidence in the community and among individuals present. 
ing to their general practitioner in England are based on 
electron microscopy, which has poor diagnostic sensitivity 
for Identifying norovinu-associated lID (6-8); it is vary 
likely that these estimates underrepresent the burden of 
noaovirus disease. 
Reverse tranwiption-polymemse chain reaction (RT 
PCR) is now the preferred diagnostic method for noroviros. 
}towevor. semiquantitaiive real-time RT-PCR testing has 
demonstrated a w[do range of viral Ioeds in norovirus- 
infected LID cases (8): many IID cases shed trorovims at 
the some concentration as healthy Individuals, with no re- 
cent history of IID (8,9). It is therefore unlikely that all LID 
cases with aorovirus infection detected by RT"PCR have 
disease caused by noroviras, another pathogen is probably 
causing illness in IID cases shedding norovinu at very low 
concentrations. Only individuals with DD caused by note- 
virus should be included in estimates of norovirus disease 
burden. 
Wo demonstrated in previous work that viral load mea- 
surements can be used to identify IID cases with disease 
caused by norovirus and to exclude AD cases with "asymp- 
tomatic" norovirus infection concurrent with disease caused 
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by another pathogen (8). In this study, we used viral 
load 
measurements from iD cases in the Study of Infectious 
Intestinal Disease in England to improve estimates of 
the incidence of norovirus-associated IID In the community 
and leading to general practice consultations. Accurate es- 
timates of norovirus-associated HD incidence at the oommu- 
nity level are essential for understanding the introduction of 
notovirus into health-care settings, where outbreaks cause 
substantial economic burden and service disruption (10), 
and for informing potential vaccination programs (11.12). 
MATERIALS AND METHODS 
R, cruitmsnt and &I-cause 110 inc'idenc. 
Data are taken from the Study of Infectious Intestinal 
Disease in England ("the III) Study"), conducted between 
1993 and 1996 (13). The incidence of IID In tho community, 
caused by any pathogen, was estimated in a prospective co- 
hort, which was demographically representative of the pop- 
ulation of England. Cohort members were actively followed 
up. with weekly null reporting, to ensure that all UD epi- 
sodes were recorded (14). 
The incidence of general practitioner consultations for 
IID, caused by any pathogen, was estimated by recruiting 
individuals with III) presenting to one of the 70 participating 
general practices (14). Incidence numerators were adjusted 
for underascertainment of 17D eases, and denominators were 
adjusted for registered patients no longer using the practices 
(4,14). 
IID cases were individuals with diarrhea (any loose 
stools) or significant vomiting (>_2 vomiting episodes/24 
hour), lasting less than 2 weeks, without a known nonin- 
fectious cause, preceded by a symptom-free period of at 
least 3 weeks (14). Healthy controls, with no recent history 
of ED. were recruited concurrently to cases in both study 
components, from the community cohort or from the gen- 
eral practice patient registration lists (13). Informed 
consent was obtained from all participants at the time of 
recruitment. 
Specimens and tsstng 
M cases provided a fecal specimen during acute illness, 
and controls provided a specimen at recruitment. Norovirus 
was detected by electron microscopy, and specimens were 
archived in frozen storage (15). All specimens, including 
those previously positive by electron microscopy, were 
later retested for norovirus using a more sensitive RT-'CR 
assay. All norovirus RT"PCR-positive spectmens were to- 
tested by using a scmiquantitative RT-PCR assay (run for 
40 cycles) (16). Recruitment and stool testing in RD cases 
are summarized in Table 1. 
The cycle threshold value from the real-time RT-PCR 
assay provides a proxy measure of fecal viral load, it is 
inversely proportional to the amount of virus present in 
the specimen The distribution of norovirus cycle threshold 
values in IID cases and controls used in this study has been 
described previously (8). 
Table I. Summary of Caeo Recruamom and Stool Specimen 
Testing in the Community Cohort and General Practice Component 
of the Study of Itdechvus Intestinal Deeseo, England. 1903-1990 
General 
CO°tý' Pnaka Study 
Bass population, 4,026 409.878' 
person-yaara of folow. tp 
Ascertained cases, no. 781 13,81 p° 
Stool specimens, no. 761 28113° 
Electron microscopy 6o 169 
positive for norovints, no. 
Stool specimen archived, no. $17 1.905 
RT-PCs pasche for 211 623 
noronrus. no 
Cycle threshold value 174 $44 
determined with real. 
bmo RT"PCR, no. 
Abbreviation: RT-PCR, reverse baneufptIon potyrrterose chain re. 
action. 
" Adjusted for registered patients no longer actively using panics' 
paring general practices. 
Adjusted for undorascentainment. 
' Stool specimens were collected from patients in only 34 of the 70 
general practices recruiting eases. 
Includes those previously positive by electron microscopy. 
Calculating norovirus incidence 
The incidence of norovinu-associated Ill) (INV) was 
calculated as follows: 
1NV-1Xp(NV)XA, (1) 
where I is the incidence of all-cause ITQ110t1 person-years, 
p(NV) Is the proportion of III) cases positive for norovirus 
by RT-PCR. and A is a factor used to adjust for those IID 
cases with norovirus infection at low viral loads who there- 
fore do not have disease caused by norovirus. 
In a previous analysis of norovirus cycle threshold values 
from the LID Study, we used receiver operating characteris- 
tic (ROC) analysis to select a cutofffor attributing disease to 
norovirus in IID cases (8). However, standard ROC analysis 
does not provide confidence limits around the selected cut- 
off. In this analysis, the cycle threshold value distributions 
from the reference groups in the ROC analysis were used to 
calculate adjustment factor A. incorporating uncertainty in 
these distributions due to sampling error into the incidence 
estimate. The reference-positive group included IID cases 
with norovirus detected by electron microscopy, because 
they have viral loads representative of where norovirus in- 
fection is causing disease (17.18). The reference-negative 
group included healthy controls, because they have viral 
loads representative of where norovirus infection is not 
causing tiny illness. 
Adjustment factor A was calculated as follows: 
A Cr x --. 
RNf, (2) 
i-is 
where RP, is the moving average of the proportion of the 
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ffpurn t. Disv1Dutlon or norovirus cycle threshold values kt HID cases from the Study of InlucUous Intestinal Disoaso, England. 1993-1996. Black 
Dsrs are IID cases from tM community cohort (n - 174): white here aro IID oases from the general practitioner study (n - 544). Ct. cycle threshold; 
110. inlttlous intesW" dis&N. 
reference-positive group at cycle threshold (CO value i (over 
i-2 to I+ 2); RN, is the moving average of the proportion 
of the reference-negative group at cycle threshold value i 
(over i-2 to i+ 2); and Ct; is the proportion of IID casas 
positive by real-time RT-PCR with cycle threshold value i. 
Adjustment factor A varies between O and 1. Adjustment 
factor .4 is a weighted average of the relative 
frequency of 
the rcfercnce-positive and rcfcrence-negative groups at each 
cycle threshold value, weighted by the proportion of all 
norovirus"infected lID cases at each cycle threshold value 
(Figure I). 
Figure 2 shows the distribution of cycle threshold values 
in the reference groups and the value of the subcomponent 
(RPJ(RP; + RN, )), which represents the relative frequency 
of the reference groups. At lowcycle threshold values, 
where viral loads are high and there are few individuals 
from the reference-negative group, the subcomponent 
(RP, /(RP, + RN, )) is close to I, indicating that the majority 
of AD cases with norovirus infection at these concentra- 
tions have disease caused by norovirus. In contrast, 
at the high-cycle threshold values (low viral loads) found 
in the majority of the disease-free reference-negative 
group, the subcomponent (RP: /(RP, I- RN)) is close to 
0, indicating that very few lID cases with norovirus 
infection at these concentrations have disease caused by 
norovirus. 
Adjustment factor A was calculated separately for chil- 
dren aged less than 5 years and for older children and adults 
(aged 5 years or older) in the age-stratified and age-adjusted 
incidence. 
Incidence estimation by Monte Carlo simulation In 
Win6UGS 
The incidence of nc rovirus-associated 111) was calculated 
by using Monte Carlo simulation in WinBUGS, version 1.4, 
software (I9), Confidence limits for norovirus-associated 
lID incidence are provided as Bayesian credibility intervals 
from the posterior sampling distribution. The all-cause 11D 
incidence/tOO person-yews (I) from the III) Study was mod- 
eled by using a log-normal distribution. Proportions were 
modeled by using binomial distributions with noninforma- 
tive unifortn priors. Multinomial distributions were used to 
model the cycle threshold value distributions, with nonim 
formative Dirichlet prior distributions. The simulation was 
run for 3(l), WU iterations, from 3 ditTorcut sets of initial 
values, to check convergence. 
Separate simulations were run to estimate the incidence 
of norovirus in the community and the incidence of general 
practice consultations and to calculate age- and season-strat- 
ifted incidence. The numbers of IID cases with norovirus 
cycle threshold values limited the number of age groups in 
which the community incidence could be presented. Age- 
adjusted incidence was calculated as a weighted average of 
the incidence in children aged leas than 5 years and in older 
children and adults (aged 5 years or older); weights were taken 
fom the mid- 199 4 population estirruvlc for England, obtained 
form the Office of National Statistics, United Kingdom. The 
annual numbers of cases of norovirus-associated 111) were 
calculated from the incidence estimates and the age-stratified 
mid 1994 population estimate for England 
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Rqure 2. DWouson of norovinrs cycle threshold values in reference-positive and reference-negative groups, selected from participants in tho 
Study or Infectious intestinal Disease, England, 1993-1996, and adjustment factor subcomporreM HP, /(HP; i, RN, ). Black bars are the reforence- 
positna group in -119), white bars are em reference-negative group in r 199); triangle SymbolS show the adjustment factor subcomponent HPr1 
(RP, + RN. ). RP,. moving average of the proportion of the reference-positive group at cycle threshold value t: AN,, moving average of the 
proportion of the reference-negative group at cyclo threshold value I. 
Alternative methods for estimating the proportion of III) 
cases with disease attributable to norovirus 
We used 3 further methods to estimate the proportion of 
IID cases with disease attributable to norovirus, which either 
do not require a control group or have been used in previous 
studies. 
Altemanve method 1. In previous studies using only RT- 
K, 1ý, not semiquantitative real-time RT-PCR, the proportion 
of norovirus-infected lID cases with disease attributable to 
nonwirus has been estimated as the difference in norovirus 
prevalence between the control group and III) cases (5). We 
calculated norovirus-associated III) incidence as follows- 
INV -IX (P(NV)ý - P(NV)ý 1), (3) 
where p(NV),. _ represents the norovirus prevalence among 
IID cases, and p(NV)i, ,, represents the norovirus preva- 
lence among controls. 
Alremarhro motod 2. We have previously defined a cut- 
off in norovirus genogroup U cycle threshold values for 
altrilnning disease to norovirus (8). We applied this cutoff 
(at cycle threshold value 30 for children aged <5 years and 
at cycle threshold value 33 for older children and adults) to 
111) cases with a cycle threshold value for either namvints 
genogroup I or genogroup 11. The proportion of 111) cases 
with a norovinrs cycle threshold value at or below the cycle 
threshold value cutoff was substituted for adjustment factor 
A in equation I. To explore the effect of late specimen 
collection on norovitus incidence, we defined probable 
cases of norovirus-associated 1113 as those LID cases with 
a cycle threshold value above the cutoff, a specimen col- 
lected 5 or more clays after symptom onset, and no other 
pathogen detected. These probable cases were added to the 
111) cases with a norovirus cycle threshold value at or below 
the cutoff. 
Alternative method 3. We used mixture modeling to es- 
timate the proportion of IID cases with a norovirus cycle 
threshold value that have disease attributable to norovirus. 
using only data front IID cases. This proportion was 
substituted for adjustment factor A in equation I and un- 
certainty represented by using a beta distribution, based on 
the confidence interval provided front the mixture model. 
Details of the mixture model are provided in the Web 
Appendix (http: //aje. oxfordiouriials. org/). 
We also estimated the incidence of norovirus-associated 
IID based on electron microscopy testing using equation 3: 
INV :=IXP, (4) 
where P is the proportion of cases positive by electron mi- 
croscopy. The incidence of norovirus-ass ciated 1113 based 
on classifying any norovirus R'I'-PCR-posi(ive IIl) case as 
a case of norovirus-associated IID and the incidence of 
rotavirus-associated I1D based on enzyme-linked immuno- 
sorbent assay diagnosis (20) (in children aged <5 years 
only) were calculated in the same way. 
RESULTS 
The crude community incidence of norovirus-associated 
lID was 4.1! 100 person-years (Table 2): aller age 
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Table 2. k CWence of Nw"ruwawwdaled Infectious Intestinal Dieeue in England, 1993- 
1D06 
Congnanlty 
InoltNncc 95% 
100 Penes- Credibluty 
years Interval 
Oawral Practice 
canWINtlon 
InCMNna/ 96% 
100 Parson- Crodlbl0ty 
Years Interval 
Ratio of 
ConuwJMtyto 
ß°a°M 
Pace 
Cam 
CNdo 4.1 3.4,4.8 0.49 0.43,0.55 8A 
Aga adjusted 4.5 3.8,5.2 0.54 '0.48,0.00 8.3 
Ape stuanf'ied 
<5 years 21.4 15.9,27.7 3.2 2.6.3.8 6.7 
>5 years 3.3 26,3.9 0.35 0.30,0.39 0.7 
0-1 year 27.2 17.9,38b 64 3.2,7.7 4.3 
2-4 years 16.7 11.4,23.3 1.5 12,2.0 11.1 
6-14 yeas 8.5 4.5,8.9 0.44 0.31,0.59 14.8 
16-44 years 4.1 3.1,6.3 0.38 0.32.0.45 10.8 
245 years 1.7 1.1,22 029 0.24,0.35 5.9 
45-64 years 0.26 0.20.0.32 
265 years 0.37 0.27,0.47 
Season stranlred 
Janualy. Manxt 4.7 3.4,6.3 046 0.37.0.57 
Apra-June 3.6 2.7,5.1 0.52 0.43.0.62 
July-Sepsember 3.3 2.4,4.5 0.43 0.35.0.51 
October-0ecsmbaw 4.8 3.6.6.3 OS8 0.46,0.86 
RotavKm-a aonatad 110 
0-1 yew 13.7 5.6.25.1 6.4 62.7.7 21 
2-4 years 6.2 2.6,11.5 1.6 1.2,2.0 4.1 
>5 years 8.5 4.6,13.6 3.2 2.8.3.8 2.7 
Abbr9Watton IID, kdtctlout imestinal disease. 
The Wilence of mW rus-es clate0 lntectIou Intestinal Weoase i shown also ! or ahadren 
aged last than 5 year. 
adjustment, the community incidence was 4.5 episodo, 4100 
person-years (fable 2). Incidence was highest in children 
aged less than 5 years, with 20% experiencing nororirus- 
associated nD every year. Community norovirus-associated 
UD incidence peaked between October and March (Table 2). 
There were 0.5 general practice consultations for 
norovitus-associated RD/100 person-years (Table 2). The 
Incidence of general practice consultations was highest 
among children aged less than 2 years, at 6.4/100 person- 
years, Approximately I of 7 children aged less than 5 years 
with norovirus-associated IID consulted a general practi. 
tioner. compared with I of 3 of those with rotavirus- 
associated lID in this study population (Table 2). The 
seasonality of general practice consultations for norovirus- 
associated IID was less pronounced than in the community 
(Table 2). 
Incidence based on the cycle threshold value cutoff was 
slightly lower than using adjustment factor A, and the cred- 
ibility intervals were narrower, as shown in Table 3 and the 
Web table (hitp: //aje. oxfordjournals. otg/)., Subtracting the 
control norovirus prevalence from that In IID cases plo- 
duced higher incidence estimates in young children, but 
lower estimates in older children and adults. Mixture 
modeling produced the lowest estimates. 
DISCUSSION 
This is the first study to use viral load measurements to 
estimate the incidence of norovirus-associated IID. A recent 
volunteer study showed that low norovirus viral loads, de- 
tectable by RT-PCP, are associated with asymptomatic 
infection (9). Consideration of viral load therefore provides 
the greatest diagnostic accuracy for identifying cases of 
norovirus-associated IID. Using such an approach, we have 
demonstrated that norovirus is this most common cause of 
IID, 'across all ago groups, in the community in England (4), 
and that there is a substantial incidence of general practice 
consultations for norovinis-associated RID among young 
children (Table 4), similar to that caused by rotavirus. 
Estimates of norovims disease burden based on viral load 
are very likely to be more accurate than those based on 
electron microscopy, because electron microscopy has poor 
diagnostic sensitivity, or those based on RT-PCR, because it 
is possible to exclude ITD cases who are RT-PCR positive 
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! e0 
but have low viral loads and are therefore Unlikely to have' 
,ea, ai ýd disease caused by norovirus. We developed a method for 
4*; hhw calculating norovirvs-associated III) incidence that allowed 
ä statistical uncertainty in the viral load measurements to be 
U incorporated Into the confidence limits. This was only pos- 
O If/ q at sible with the use of Monte Carlo simulation methods to 
g 
`e `Q to 
Is combine the multiple components of 
the calculation and 
I their associated statistical uncertainty; this would 
have been 
r *º extremely difficult using standard frequentist approaches, 
such as the Delta Method, because of the large number of 
variables in the calculation. Although the estimates pre- 
sented here are based on data collected between 1993 and 
aJa 1996, they provide the best available information on that 
yee agý; 4 burden of norovirus disease in England, Furthermore, those 
wg results are based on current diagnostic methods, as new 
studies are carried out, they will provide a baseline from 
vxm ýýy which to assess changes 
in norovirus incidence over time 
gp that are not confounded by concurrent changes In the sen- 
sitivity of diagnostic methods, 
$ There was limited resolution for estimating ago-stratified incidence in the community because of the small sample 
a8o size. We combined genogroup I and genogroup II norovirus 
Infections in this analysis, rather than estimating adjustment 
factor A separately for each genogroup, also because of 
$'s ääv vN, limited sample size. Similarly, In alternative method 2, we 
atf4 used a Cycle threshold value cutoff developed for genogroup 
II specimens only, because no published cutoff exists for 
genogroup I. There is evidence that the real-time RT PCR 
J"r. assay has lower efficiency for genogroup I norovirus strains d 
8> r+ ä (Jim Gray, Health Protection Agency Centre for Infcctions, 
personal communication, 2009), so that a given cycle 
u+ o threshold value may represent a higher viral load in the ö, gö original stool specimen for some genogroup I strains, earn- 
pared with genogroup II strains. Genogroup t noroviruses $ constituted less than 10% of the norovirus isolates in the 
study, so we believe that grouping the genogroups would 
N , °r g result in conservative incidence estimates, rather than $g overestimation. 
to The concentration of norovirus excretion decreases sub- 
xeo. 
a stantially after symptom resolution (9). Although we made 
no direct adjustment for the possibility that some IID cases 
i$ es Mq ý°i with high cycle threshold values may have had disease 
g caused by norovirus, but had low viral loads at the time 
of specimen collection because their symptoms had at- 
' res :n ready resolved, the method used to calculate adjustment 
factor A does allow some III) cases with high notonvirus 
cycle threshold values to be incorporated into the Incidence 
ýc FmNn o+ estimate (Figure 2). It therefore indirectly allows for the $n possibility that some IID casts who truly had norovirus- g 
,., MM^t associated IID had low viral loads at the time of testing, It 
is not possible to directly allow for late specimen collec- 
tion using adjustment factor A, because It is calculated at 
the population level, Direct consideration of delay in spec- 
Wen collection requires classification of norovirus disease 
status at the individual level, as was dune when applying a the cycle threshold value cutoff (alternative method 2). We 
recalculated the cutoff based Incidence of norovirus-asso- 
`ý ciated IID, including probable cases (defined as having 
v At it high cycle threshold value, a late specimen, and no other 
detected pathogens) and found that the incidence was 
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Table 4. Eatlmeted Annual Numbers of Nomvints"assoclat*d Infectious Intest}nel 0isesse 
Cas« in u» CCnizmm y aM Censutung a Dental Prec0Uonet' In Eng end 1993-1896 
Aye Group Thousands 
of c.... 
Community 
95% 
tndibltity 
alarm 
Gsnwai Pnctk. Consultation 
95S< Thousands Crod10191y 
of c,... rn«val 
Age actuated 2.175.8 1,836.8.2.543.0 261.5 233.4,290.6 
0-1 you 81.0 65.4,97.8 
2-4 years 30.4 22.7,38.8 
<5 yeas 891.4 513.4,897.1 103.7 85.2,123.2 
5-14 years 403.1 279.0,550.3 27.1 18.9,36.5 
15-44 years 054.8 636.6,1,104.9 78.6 65.1,93.0 
Z45 years 308.4 211.4.426.8 64.6 45.0,65.8 
45-64 years 28.2 21.9,35.4 
265 years 28.1 21.0.382 
slightly higher than using only the cases below the cycle 
threshold value cutoff, but still very similar to those ob- 
tained using adjustment factor A. However, we would urge 
caution in using such an approach, because the number of 
probable cases will be highly dependent on assay sensitiv. 
ity and on the number of cycles for which the real-time ItT 
PCR assay is run; not all lID cases with norovirus detected 
and a late specimen may have actually had disease caused 
by norovinis. 
The method we used is dependent on the recruitment and 
testing of a large control group, which are not always pos. 
sible. We used a number of alternative methods to adjust the 
prevalence of norovirus in IID cases, to explore whether 
these produce suitably similar results to our method, which 
we believe to be most robust. As expected, using the cycle 
threshold value cutoff produced slightly lower incidence 
estimates with narrower credibility intervals, because the 
uncertainty in the cutoff was not represented in the calcula- 
tions. We found that mixture modeling gave similar results 
to the cycle threshold value cutoff, although there was 
a tendency toward underestimation; mixture modeling also 
requires larger sample sizes than the other methods, prevent. 
ing estimation of detailed age-stratified incidence estimates, 
Estimates produced by subtracting the prevalence of noro- 
virus in controls from that in IID cases were very different 
from those produced using the other methods; incidence in 
young children was substantially overestimated, and inci- 
dence in older children and adults was underestimated. Fur- 
thermore, estimates produced with this method will be 
highly dependent on the case definition used. the source of 
the controls, and die study setting. 
The new estimates of nerovirus-associated IID inci- 
dence presented here are approximately 3 times higher in 
the community and 2.5 times higher at the general practi- 
tioner level than previous estimates for England based on 
electron microscopy (4). Accordingly, the ratio of commu- 
nity cases to cases presenting to general practitioners in- 
creased from 6 to 1, using electron microscopy diagnosis. 
to 8 to t, using viral load measurements (4). The incidence 
estimates are approximately half those obtained by assum- 
ing that any 11D cases with a positive RT PCR result for 
norovirus has disease caused by norovirus, Indicating that 
without consideration of viral load there is the potential for 
substantial overestimation of the burden of norovirus 
disease. 
The community incidence estimates are comparable to 
those from a study In the Netherlands, which used RT- 
PCR testing to identify cases of norovirus-associated lID 
but had a narrower case definition for lID (3 or more loose 
stools, or 2 or more episodes of vomiting in 24 hours), which 
may not have been sensitive enough to ascertain all episodes 
of norovirus-associated 11D at the community level (I). Sim- 
ilarly, the incidence of general practitioner consultations for 
norovirus was only slightly lower than that from a recent 
study in Germany, which used RT-PCR diagnosis for nor- 
ovirus, but again this study had a narrower case definition 
for IID (2 or more loose stools, or 2 or more vomiting 
episodes in 24 hours) (21). The incidence of norovirusas- 
sociated IID may also have been higher than normal during 
our study because a new variant of norovirus emerged dur- 
ing 1995 and 1996 (22-24); emergence of norovirus variants 
has been associated with increased disease incidence (25- 
28). 
The incidence of norovirus-associated 11D in the commu- 
nity showed a slight peak in the winter and autumn months. 
while general practice consultations were reasonably con- 
stant throughout the year. Outbreaks of norovirus-associated 
üD In community settings in the United Kingdom show 
very little seasonality, in strong contrast to outbreaks in 
health-carp settings, which show marked winter-time sea- 
sonality (29). A number of factors may contribute to those 
differing patterns of seasonality between community dis- 
ease and outbreaks in different settings. First, community 
norovirus outbreaks are more commonly reported from ca- 
tering settings, with transmission occurring through food 
contaminadtm; while the prevalence of norovtrus infection 
among food handlers is likely determined by the incidence 
of community disease, the driving factor in these outbreaks 
is breakdown in food hygiene practices, which is not a sea- 
sonal phenomenon. Second, it has been suggested that the 
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marked winter time increase in hospital admissions for re- 
spiratory infections may drive the strong seasonality of nor- 
ovirus outbreaks in this setting, and that there are distinct 
norovirus strains circulating in hospital populations and in 
the community that may have different transmission char- 
acteristics (29); therefore, the incidence of community 
disease or general practitioner consultations would not nec- 
essarily show the marked seasonality seen in health care- 
associated outbreaks. However, detailed characterization of 
the molecular epidemiology of norovirus infections in the 
community is needed, for comparison with the extensive 
data that already exist for hospital-acquired hdections (30, 
31). to understand better the factors driving the different 
seasonality of health-care outbreaks and community dis- 
ease, Finally, it is also possible that them was more out- 
ot-scason norovirus transmission during this study because 
or the emergence of a new norovirus variant, as described 
above (32). 
We have demonstrated, for the first time, how virnl load 
measurements can be used to make improved estimates of 
norovirus disease burden. This approach is preferable to 
including all IID cases who are RT-PCR positive, regard. 
less of their viral load, because many may be shedding 
norovirus at low concentrations, with disease caused by 
another pathogen. With the widespread use of RT-PCR 
for norovirus diagnosis in community-based studies, we 
recommend using a real-time platform to allow consider- 
ation of viral load when calculating norovirus incidence; 
we have shown that additional real-time testing in a subset 
of norovirus-lnfectcd lID cases would be sufficient to use 
this approach, providing the subset is of a reasonable size 
and is representative. Further work is needed to validate the 
use of a cycle threshold value cutoff for use in studies 
without a control group. Asymptomatic norovirus infection 
is very common (1,16.21.33-35). Therefore, this quan- 
titative approach provides the most rigorous estimate of 
norovirus disease burden. 
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SUMMARY 
Norovirus is a major cause of infectious intestinal disease, and a substantial prevalence 
of asymptomatic infection has been reported. We describe the prevalence, seasonality and 
characteristics of asymptomatic norovirus infection in England. Healthy individuals were 
recruited at random from the general population during the Study of Infectious Intestinal Disease 
(1993-1996). Norovirus was identified using rcal"timc RT-PCR. The age-adjusted prevalence 
of asymptomatic norovirus infection was 12%; prevalence was highest in children aged <S years 
and showed wintertime seasonality. More work is needed to understand whether asymptomatic 
infections are important for norovirus transmission leading to sporadic illness and outbreaks. 
Key words: Asymptomatic viral infections. England, infectious disease epidemiology, norovirus. 
prevalence. 
Norovirus is the most common cause of infectious 
intestinal disease (TID) in the community in high- 
income countries 11). Norovirus infection has also 
been identified in a substantial proportion of indi- 
viduals with no TTD symptoms in several community- 
based studies, with crude prcvulences of up to 16 % 
reported in high-income countries 11-31. Volunteer 
studies have demonstrated the occurrence of noro- 
virus infection with no concurrent 18) after exper- 
imental inoculation [4]. While these volunteer 
individuals experienced no 110 symptoms, some re- 
ported other non-specific symptoms such as head. 
ache, fever, muscle ache, abdominal pain and nausea. 
" Author for comspoadcean: G. Ph Hips Depanmem of Epi- 
demiology and Popultion Hahh. London Schal of Hyyan and 
Trop. cd Mhar. K"pp"I Sirm. London WC) E 7HT. 
(Einnil: jemmu. pMhp/, Ishtm ae. uk) 
The objectives of this study was to describe the age 
and seasonal distribution of norovirus infection with- 
out lID (hereafter referred to as `asymptomatic noro- 
virus infection') in the community in England and 
to describe the characteristics of these infections. 
Wo used data from participants in the Study of 
Infectious Intestinal Disease in England, conducted 
between 1993 and 1996 (5). These individuals were 
recruited as controls for a case-control study, either 
from a prospectively followed community cohort, 
or from the registration lists of general praclitioners 
participating in the study (4 Informed consent was 
obtained at the time of recruitment (5]. The inclusion 
criteria specified that participants should have no re- 
cent history of diarrhoea (any loose stools) or signifi- 
cant vomiting (a 2 vomiting episodes per 24 h) prior 
to recruitment (5]. 
At recruitment, participants submitted stoul speci- 
mens for microbiological testing, in order to detect 
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Fig. 1. Agoapecific prevalence of asymplomatio norovirus infection in the Study of Infectious Intestinal Disease, England 
(1993-1996). Numbers above the histograms show the number of participants tested in each age group. Black bare (i) show 
the 93% confidence intervals. 
a range of 18 bacterial, viral and protozoal gastro- 
intestinal pathogens. Norovirus was detected by elec- 
tron microscopy in the original study [61. Stool 
specimens were archived and subsequently retested, 
using real-time reverse transcription-polymerase 
chain reaction (RT-PCR) to detect norovirus [1,6]. 
In the current study, participants were classified as 
having norovirus infection if they tested positive 
either by electron microscopy or real-time RT-PCR, 
or both. The real-time RT-PCR assay has separate 
sets of primers and probes for genogroup I and geno- 
group It noroviruses, making it possible to distinguish 
the gcnogroup of norovirus present in the positive 
specimens. No further gcnotyping was performed. 
Participants provided details of gastrointestinal 
and non-specific symptoms in the previous 3 weeks in 
an epidemiological questionnaire (although details 
of fever and nausea were not collected), Adults 
completed the questionnaire themselves; a parent or 
guardian completed the questionnaire on behalf of 
children aged < 16 years (5]. For this analysis, partici- 
pants who bad been free of diarrhoea and vomiting 
for at least 10 days prior to recruitment were con- 
sidered asymptomatic with respect to TID, although 
they may have experienced other symptoms during 
that period. 
Stool specimens were received from 2205 asympto- 
matic participants, and 2065 returned the question- 
naire providing information on recent symptoms. Of 
the 2205 asymptomatic participants, 361 had an 
asymptomatic norovirus infection and 1844 tested 
negative for norovirus; the age- and season-specific 
prevalence of asymptomatic norovirus infection was 
based on these 2205 participants. Of the 2065 asymp- 
tomatic participants who returned questionnaires, 
344 had an asymptomatic norovirus infection and 
1721 were norovirus negative; these 2065 participants 
were used for the analysis of recent symptoms. 
The age-adjusted prevalence of asymptomatic noro- 
virus infection in the community in England was 
calculated by standardizing against the age-stratified 
mid-1994 population estimate for England, obtained 
from the Office for National Statistics, UK. Symp- 
toms that were in excess in asymptomatic norovirus 
infections compared to norovirus-negative partici- 
pants are presented. The analysis of symptoms is 
intended to be exploratory, to generate hypotheses 
for future work; the original study was not designed 
or powered to examine diti'erenon in symptom pro- 
files between asymptomatic norovirua infections and 
norovirus-negative participants. Accordingly, confi- 
dence intervals are provided for symptom preva- 
lenees. prevalence differences and prevalence ratios, 
but no hypothesis tests (or P values) are presented. 
The age-adjusted, community prevalence ofasymp- 
tomatic norovirus infection was 12% [95% confi- 
dence interval (Cl) 11-141, with the highest prevalence 
in children aged <5 years, although more than 5% of 
individuals in older ege groups were infected (Pig. 1). 
The prevalence of asymptomatic infection showed 
a wintertime peak of 20% during November, 
December and January (Fig. 2); the seasonal pattern 
was less distinct for children aged <5 years compared 
to older children and adults (data not shown). 
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Fig. 2. Age-adjusted monthly prevalence of asymptomatic norovirus infection in the Study of Infectious Intestinal Disease, 
England (1993-1996). Numbers above the histograms show the number of participants tested in each month. Black bars (T) 
show the 95 % confidence intervals. 
Genogroup U noroviruses were most common, rep- 
resenting 78% of the 361 asymptomatic noiovirus 
infections, with 13 % of specimens positive for geno- 
group I and 9% positive for both genogroups. The 
prevalence of genogroup II, compared to genogroup I 
and mixed genogroup infections, varied between 63 % 
and 86% over the year, with the highest prevalence 
during October-December, and in April and May. 
However, the number of asymptomatic infections 
occurring per month was <40 throughout most of 
the year, so some of this variation could be due to 
sampling error. 
During the 3 weeks preceding questionnaire 
completion, a cough, sore throat and other cold-like 
symptoms were reported by 61 % of participants aged 
<5 years with asymptomatic norovirus infection 
(95 %" CI 54-68), compared to 52 % (95 % Cl 47-56) 
of norovirus-negative participants in this age group 
[prevalence difference 9% (95% Cl 0-7-17); preva- 
lence ratio adjusted for month of the year 1-2 (95 /. 
CI 1-0-I'4)). 'lucre was a smaller excess of cold-like 
symptoms in older children and adults with asymp., 
tomatic norovirus infection; the prevalence in, in- 
dividuals with asymptomatic norovirus infection was 
12% (95% Cl 7-17) and 9% in norovirus-negative 
participants (95% Cl 7-10) (prevalence difference 3% 
(95'/, CI -2 to 8); prevalence ratio adjusted for 
month of the year 1-3 (95% Cl 0.8-2.0)]. No other 
non-gastrointestinal symptoms were found to be in 
excess in participants with asymptomatic norovirus 
infection. 
Nine percent of participants with asymptomatic 
norovirus infection experienced diarrhoea and/or 
vomiting prior to the 10-day exclusion period, but 
within 3 weeks of questionnaire completion (95 % Cl 
6-12), The prevalence was higher in participants 
with asymptomatic norovirus infection compared 
to norovirus-negative participants, for both children 
aged <5 years [asymptomatic norovirus Infection 
10% (95% CI 6-15); norovirus negative 7% (95% 
CI 5-10); prevalence difference 3% (95 % CI -2 to 
8)], and older children and adults [asymptomatic 
norovirus infection 8% (95% CI 4-12); norovirus 
negative 4% (95 % C13-5); prevalence difference 4% 
(95% CI -0.5 to 8)]. Older children and adults with 
asymptomatic norovirus infection also reported loss 
of appetite more often than norovirus-negative par" 
ticipants in this age group [asymptomatic norovirus 
infection 9% (95 °%e CC 4-13); norovirus negative 3% 
(95% Cl 2-4): prevalence difference 6% (95% Cl 
1-11)]. 
The prevalence or asymptomatic norovirus infec- 
tion in our study is higher than that reported in 
previous studies conducted in other high-income 
countries, which had comparable samples of asymp- 
tomatic individuals 12,3]. Real-time RT-PCP. is 
known to have slightly higher sensitivity than gel. 
based RT PCR M. However, this is unlikely to ac- 
count for'the difference 01 77% between the prevalence 
of asymptomatic norovirus infection in the current 
study and the prevalence in a previous study in The 
Netherlands (21, which used gel-based RT-PCR. 
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A previous study conducted in Germany used nested 
gel-based RT-PCR [3]; the use of nested PCR primers 
increases the sensitivity of the gel-based assay [8j, 
meaning that the assay used in the study in Germany 
is likely to have comparable sensitivity to the real- 
time RT-PCR used in the current study. It is possible 
that the differences in asymptomatic norovirus preva- 
lence between the studies are due to differences in the 
genetic strains of norovirus circulating at the time 
that the studies were performed. Periodic emergence 
of new norovirus strains has been associated with 
increases in the incidence of infection and a new strain 
emerged in 1995-1996, during recruitment of partici- 
pants into the Study of Infectious Intestinal Disease 
[9,101. 
Diagnostic evaluation studies using panels of stool 
specimens containing other enteric. viruses have 
demonstrated that current norovirus RT-PCR assays 
have 100% analytical specificity, including the assay 
used in the current study [11-13]. Therefore, very few, 
if any, of the asymptontatic norovirus infections re- 
ported here are likely to be false positives. Some 
asymptomatic participants in this study may have 
been sheMing nerevirus at levels not detectable by 
the RT-PCR may Used, which has a detection limit 
of -10' norovirus particies/g stool [8,13]; it is there- 
fore possible that the true prevalence of asymptomatic 
norovirus infection is higher than reported. 
Asymptomatic norovirus infection showed winter. 
time seasonality. Outbreaks of norovirus-associated 
[ID in healthcare settings in England and Wales show 
strong wintertime seasonality, but. In contrast, there 
is little seasonality in norovirus outbreaks reported 
from community settings [141. The seasonality of 
norovirus-associated III) incidence at the community 
level in England has not been described. 
Gastrointestinal and cold-like symptoms were more 
common in asymptomatic norovirus Infections than 
norovirus-negative participants. The original study 
was not designed or powered to examine differences 
in symptom prevalence between these groups, and we 
had no a priori hypotheses about the relative fre- 
quency of symptoms. Therefore, while the 95% 
confidence mtcrvals for the majority of symptom- 
prevalence differences did include zero, potential 
reasons for the observed excess prevalence in asymp- 
tomatic norovirus infections are discussed below. 
Even after adjustment for season, cold-like symp- 
toms were at higher prevalence in participants with 
asymptomatic norovirus infection; this may be due to 
a co-infection with a respiratory virus, because viruses 
causing the common cold and Influenza are trans- 
mitted via similar routes to norovirus, e. g. through 
direct person-to-person contact or from contami- 
nated environmental surfaces 115,161. To previous 
studies, experimentally inoculated volunteers have 
reported non-specific symptoms such as headache, 
fever and muscle ache during norovirus Infection (41: 
details of fever were not collected from asymptomatic 
participants in the Study of Infectious Intestinal 
Disease, so it is also possible that the excess of cold- 
like symptoms may represent non-specific symptoms 
associated with norovirus infection. The prevalence 
of headache and muscle ache in individuals with 
asymptomatic norovirus infections was slightly lower 
than that in norovirus"negative participants; while 
these symptoms have been reported in experimentally 
inoculated volunteers, symptoms may have been more 
accurately reported over the shorter clinical obscr- 
vation period in the inoculation studies, compared 
to the 3-week recall period used for self-reporting of 
symptoms in the current study. 
Participants in the current study were recruited be- 
cause they had been free of diarrhoea and/or vomiting 
for at lea-, t 10 days; the aetiology of any recent lID 
symptoms prior to this period was not established. 
Therefore. we do not know how many of the noro- 
virus infections detected were truly asymptomatic 
rather than post-symptomatic shedding. Post- 
symptomatic shedding after experimental inoculation 
has been demonstrated, lasting up to 8 weeks (41, so 
it is likely that some of the asymptomatic infections 
reported bore are the result or prolonged post- 
symptomatic shedding. This is consistent with the 
small excess of diarrhoea and vomiting symptoms in 
participants with asymptomatic norovirus infection. 
If is also possible that some asymptomatic norovirus 
infections were duo to pro-symptomatic shedding, 
although the short incubation period of 24-48 It for 
norovirus disease (171 means that only a small number 
of the infections in the current study are likely to be 
pre-symptomatic shedding. 
Irrespective of the source of asymptomatic noro- 
virus infection, further work is needed to understand 
whether these infections contribute substantially to 
norovirus transmission leading to sporadic illness 
or outbreaks. A few published foodborne norovirus 
outbreak investigations have attributed illness to food 
contamination by asymptomatically infected food 
handlers (18). However, the importance of asympto- 
matic infections for norovirus transmission outside 
of food catering settings has not been investigated. 
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While norovirus is stied at much lower concentrations 
by asymptomatically infected individuals compared 
to those with disease (19], the estimated infectious 
dose is exceptionally small [201, so norovirus shedding 
at low concentrations could still potentially lead to 
transmission. Only studies identifying incident asymp- 
tomatic infections, with follow-up of contacts during 
infection, will reveal the importance of asymptomatic 
infections for continued norovirus transmission. 
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